Sentence	entity_1	entity_2	entity_3	json	split
Microsatellite regions in the type II transforming growth factor - beta receptor ( TGF - beta RII) gene appear to be targets for mutation in some cancers displaying microsatellite instability ( replication error phenotype, RER +).	type II transforming growth factor - beta receptor,30,80,Gene_or_gene_product	TGF - beta RII,83,97,Gene_or_gene_product	cancers,146,153,Cancer	"[{""token"": ""type II transforming growth factor - beta receptor"", ""start_span"": 30, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta RII"", ""start_span"": 83, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Cancer""}]"	train
Furthermore, TGF - beta RII mutations in RER + tumors have been associated with decreased TGF - beta RII mRNA levels.	TGF - beta RII,13,27,Gene_or_gene_product	RER + tumors,41,53,Cancer	TGF - beta RII,90,104,Gene_or_gene_product	"[{""token"": ""TGF - beta RII"", ""start_span"": 13, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""RER + tumors"", ""start_span"": 41, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""TGF - beta RII"", ""start_span"": 90, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}]"	train
As TGF - beta is a potent negative growth regulator of hematopoietic cells, investigations were undertaken to determine whether inactivation of the receptor by microsatellite alteration might be involved in the progression of CML.	TGF - beta,3,13,Gene_or_gene_product	hematopoietic cells,55,74,Cell	CML,226,229,Cancer	"[{""token"": ""TGF - beta"", ""start_span"": 3, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""hematopoietic cells"", ""start_span"": 55, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""CML"", ""start_span"": 226, ""end_span"": 229, ""type"": ""Cancer""}]"	train
However, during each phase of the disease, low levels of TGF - beta RII were detected when compared with the hematopoietic cells of normal donors.	TGF - beta RII,57,71,Gene_or_gene_product	hematopoietic cells,109,128,Cell	donors,139,145,Organism	"[{""token"": ""TGF - beta RII"", ""start_span"": 57, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""hematopoietic cells"", ""start_span"": 109, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""donors"", ""start_span"": 139, ""end_span"": 145, ""type"": ""Organism""}]"	train
The leukemia cell lines K562 and HL - 60 had no detectable TGF - beta RII mRNA.	leukemia cell lines K562,4,28,Cell	HL - 60,33,40,Cell	TGF - beta RII,59,73,Gene_or_gene_product	"[{""token"": ""leukemia cell lines K562"", ""start_span"": 4, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""HL - 60"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""TGF - beta RII"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}]"	train
Decreased expression of TGF - beta RII in CML cells and leukemia cell lines raises the possibility that altered expression of the receptor may play a role in the initiation and / or maintenance of the disease state.	TGF - beta RII,24,38,Gene_or_gene_product	CML cells,42,51,Cell	leukemia cell lines,56,75,Cell	"[{""token"": ""TGF - beta RII"", ""start_span"": 24, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""CML cells"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""leukemia cell lines"", ""start_span"": 56, ""end_span"": 75, ""type"": ""Cell""}]"	train
Treatment with tunicamycin produced a 40 - 50% inhibition of 2 - deoxyglucose uptake and this was associated with a 2 - 2. 5 - fold decrease in transporter affinity for glucose ( Km) without a change in Vmax.	tunicamycin,15,26,Chemical	2 - deoxyglucose,61,77,Chemical	glucose,169,176,Chemical	"[{""token"": ""tunicamycin"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Chemical""}, {""token"": ""2 - deoxyglucose"", ""start_span"": 61, ""end_span"": 77, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 169, ""end_span"": 176, ""type"": ""Chemical""}]"	train
Treatment of K562 cells with tunicamycin for 18 h, resulted in extensive loss of the 50 - 60 kDa glycoprotein, appearance of a 30 - 40 kDa band and increased staining of a 45 kDa band.	K562 cells,13,23,Cell	tunicamycin,29,40,Chemical	glycoprotein,97,109,Gene_or_gene_product	"[{""token"": ""K562 cells"", ""start_span"": 13, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""tunicamycin"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""glycoprotein"", ""start_span"": 97, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"	train
In contrast, tunicamycin had little effect on the viability and MTT responses of the cells used.	tunicamycin,13,24,Chemical	MTT,64,67,Chemical	cells,85,90,Cell	"[{""token"": ""tunicamycin"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""MTT"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Cell""}]"	train
We examined the expression of nm23 - H1 gene product in surgically resected 46 pairs of primary lung cancers and metastatic lymph nodes by immunohistochemistry.	nm23 - H1,30,39,Gene_or_gene_product	lung cancers,96,108,Cancer	lymph nodes,124,135,Multi	"[{""token"": ""nm23 - H1"", ""start_span"": 30, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung cancers"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Multi""}]"	train
The positive staining of nm23 - H1 gene product in primary cancers and metastatic lymph nodes were observed in 56. 5 and 67. 4%, respectively.	nm23 - H1,25,34,Gene_or_gene_product	primary cancers,51,66,Cancer	lymph nodes,82,93,Multi	"[{""token"": ""nm23 - H1"", ""start_span"": 25, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary cancers"", ""start_span"": 51, ""end_span"": 66, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Multi""}]"	train
The heterogeneity of nm23 - H1 gene product expression between primary cancers and metastatic lymph nodes was observed in 41. 3%.	nm23 - H1,21,30,Gene_or_gene_product	primary cancers,63,78,Cancer	lymph nodes,94,105,Multi	"[{""token"": ""nm23 - H1"", ""start_span"": 21, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary cancers"", ""start_span"": 63, ""end_span"": 78, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Multi""}]"	train
No correlations were found between the nm23 - H1 gene product expression in lung cancers and the patients survival.	nm23 - H1,39,48,Gene_or_gene_product	lung cancers,76,88,Cancer	patients,97,105,Organism	"[{""token"": ""nm23 - H1"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung cancers"", ""start_span"": 76, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Organism""}]"	train
No significant association was also observed between nm23 - H1 gene product expression in lymph nodes and the patients survival.	nm23 - H1,53,62,Gene_or_gene_product	lymph nodes,90,101,Multi	patients,110,118,Organism	"[{""token"": ""nm23 - H1"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph nodes"", ""start_span"": 90, ""end_span"": 101, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Organism""}]"	train
Expression of nm23 - H1 gene product in metastatic lymph nodes was also unrelated to patients survival.	nm23 - H1,14,23,Gene_or_gene_product	lymph nodes,51,62,Multi	patients,85,93,Organism	"[{""token"": ""nm23 - H1"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph nodes"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Organism""}]"	train
Bradycardia was induced in rats by administering the bradycardic drug alinidine ( 3 mg / kg body weight) twice daily.	rats,27,31,Organism	alinidine,70,79,Chemical	body,92,96,Organism_subdivision	"[{""token"": ""rats"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Organism""}, {""token"": ""alinidine"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Chemical""}, {""token"": ""body"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Organism_subdivision""}]"	train
Left ventricular capillary length density ( mm / mm ( 3)) increased gradually with alinidine administration; a 15% increase after 2 weeks and a 40% increase after 3 weeks of alinidine treatment were documented.	Left ventricular capillary,0,26,Tissue	alinidine,83,92,Chemical	alinidine,174,183,Chemical	"[{""token"": ""Left ventricular capillary"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Tissue""}, {""token"": ""alinidine"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Chemical""}, {""token"": ""alinidine"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Chemical""}]"	train
Left ventricular weight, body weight, and their ratio were not significantly altered by alinidine treatment.	Left ventricular,0,16,Multi	body,25,29,Organism_subdivision	alinidine,88,97,Chemical	"[{""token"": ""Left ventricular"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Multi""}, {""token"": ""body"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Organism_subdivision""}, {""token"": ""alinidine"", ""start_span"": 88, ""end_span"": 97, ""type"": ""Chemical""}]"	train
VEGF protein was higher in alinidine - treated rats than in controls after 2 weeks and increased further after 3 weeks of treatment.	VEGF,0,4,Gene_or_gene_product	alinidine,27,36,Chemical	rats,47,51,Organism	"[{""token"": ""VEGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""alinidine"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""rats"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Organism""}]"	train
This first analysis is based on 73 patients ( 50 women, 23 men, median age 74. 3 years), with a median follow - up of 13. 3 months and a minimum follow - up of 11 months.	patients,35,43,Organism	women,49,54,Organism	men,59,62,Organism	"[{""token"": ""patients"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Organism""}, {""token"": ""women"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Organism""}, {""token"": ""men"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Organism""}]"	train
Insulin - induced vascular endothelial growth factor expression in retina.	Insulin,0,7,Gene_or_gene_product	vascular endothelial growth factor,18,52,Gene_or_gene_product	retina,67,73,Multi	"[{""token"": ""Insulin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 18, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""retina"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Multi""}]"	train
The mechanisms underlying the initial insulin - induced deterioration of retinal status in patients with diabetes remain unknown.	insulin,38,45,Gene_or_gene_product	retinal,73,80,Multi	patients,91,99,Organism	"[{""token"": ""insulin"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""retinal"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Organism""}]"	train
The current study was conducted to characterize the effect of insulin on retinal VEGF gene expression in vitro and in vivo.	insulin,62,69,Gene_or_gene_product	retinal,73,80,Multi	VEGF,81,85,Gene_or_gene_product	"[{""token"": ""insulin"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""retinal"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Multi""}, {""token"": ""VEGF"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}]"	train
The capacity of insulin to stimulate the VEGF promoter linked to a luciferase reporter gene was characterized in transient transfection assays.	insulin,16,23,Gene_or_gene_product	VEGF,41,45,Gene_or_gene_product	luciferase,67,77,Gene_or_gene_product	"[{""token"": ""insulin"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}]"	train
Insulin treatment also increased VEGF protein levels in conditioned RPE cell media in a dose - dependent manner with a median effective concentration of 5 nM.	Insulin,0,7,Gene_or_gene_product	VEGF,33,37,Gene_or_gene_product	RPE cell,68,76,Cell	"[{""token"": ""Insulin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""RPE cell"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Cell""}]"	train
The antiangiogenic agent linomide inhibits the growth rate of von Hippel - Lindau paraganglioma xenografts to mice.	linomide,25,33,Chemical	von Hippel - Lindau paraganglioma xenografts,62,106,Cancer	mice,110,114,Organism	"[{""token"": ""linomide"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""von Hippel - Lindau paraganglioma xenografts"", ""start_span"": 62, ""end_span"": 106, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Organism""}]"	train
In addition, LMP1 plays pleiotropic roles in cell growth arrest, differentiation, and apoptosis, depending on the background of the target cells.	LMP1,13,17,Gene_or_gene_product	cell,45,49,Cell	cells,139,144,Cell	"[{""token"": ""LMP1"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Cell""}]"	train
In addition, it significantly extends the passage number of MEF cells to more than 30 after retroviral infection, compared with less than 5 for uninfected MEF cells.	MEF cells,60,69,Cell	retroviral,92,102,Organism	MEF cells,155,164,Cell	"[{""token"": ""MEF cells"", ""start_span"": 60, ""end_span"": 69, ""type"": ""Cell""}, {""token"": ""retroviral"", ""start_span"": 92, ""end_span"": 102, ""type"": ""Organism""}, {""token"": ""MEF cells"", ""start_span"": 155, ""end_span"": 164, ""type"": ""Cell""}]"	train
Autotaxin ( ATX), an exo - nucleotide pyrophosphatase and phosphodiesterase, was originally isolated as a potent stimulator of tumor cell motility.	Autotaxin,0,9,Gene_or_gene_product	ATX,12,15,Gene_or_gene_product	tumor cell,127,137,Cell	"[{""token"": ""Autotaxin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATX"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cell"", ""start_span"": 127, ""end_span"": 137, ""type"": ""Cell""}]"	train
In MatrigelTM invasion assays, all subclones, which secreted enzymatically active ATX, demonstrated greater spontaneous and ATX - stimulated invasion than appropriate controls.	subclones,35,44,Cell	ATX,82,85,Gene_or_gene_product	ATX,124,127,Gene_or_gene_product	"[{""token"": ""subclones"", ""start_span"": 35, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""ATX"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATX"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}]"	train
In vivo studies with athymic nude mice demonstrated that injection of atx - transfected NIH3T3 cells resulted in a weak tumorigenic capacity with few experimental metastases.	athymic nude mice,21,38,Organism	atx,70,73,Gene_or_gene_product	NIH3T3 cells,88,100,Cell	"[{""token"": ""athymic nude mice"", ""start_span"": 21, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""atx"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH3T3 cells"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Cell""}]"	train
Thus, ATX appears to augment cellular characteristics necessary for tumor aggressiveness.	ATX,6,9,Gene_or_gene_product	cellular,29,37,Cell	tumor,68,73,Cancer	"[{""token"": ""ATX"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Cancer""}]"	train
We have previously characterized the structure of a gene in A - 172 human glioma cells that encodes a 190 - kDa EGFR mutant with tandem duplication of the tyrosine kinase ( TK) and calcium - mediated internalization ( CAIN) domains.	A - 172 human glioma cells,60,86,Cell	EGFR,112,116,Gene_or_gene_product	calcium,181,188,Chemical	"[{""token"": ""A - 172 human glioma cells"", ""start_span"": 60, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""EGFR"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""calcium"", ""start_span"": 181, ""end_span"": 188, ""type"": ""Chemical""}]"	train
Fluroquinolone antibiotics such as ciprofloxacin, which can be administered p. o., may have a profound effect in bladder cancer management.	Fluroquinolone,0,14,Chemical	ciprofloxacin,35,48,Chemical	bladder cancer,113,127,Cancer	"[{""token"": ""Fluroquinolone"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""ciprofloxacin"", ""start_span"": 35, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""bladder cancer"", ""start_span"": 113, ""end_span"": 127, ""type"": ""Cancer""}]"	train
Recent studies revealed that p21WAF1 protects cells from apoptosis by arresting them in G1 and further binds to pro - caspase - 3, preventing its activation and thus, inhibiting the apoptotic cascade.	p21WAF1,29,36,Gene_or_gene_product	cells,46,51,Cell	pro - caspase - 3,112,129,Gene_or_gene_product	"[{""token"": ""p21WAF1"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""pro - caspase - 3"", ""start_span"": 112, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}]"	train
The results of our current studies provide strong experimental evidence for the use of ciprofloxacin as a potential preventive and / or therapeutic agent for the management of transitional cell carcinoma of the bladder.	ciprofloxacin,87,100,Chemical	transitional cell carcinoma,176,203,Cancer	bladder,211,218,Organ	"[{""token"": ""ciprofloxacin"", ""start_span"": 87, ""end_span"": 100, ""type"": ""Chemical""}, {""token"": ""transitional cell carcinoma"", ""start_span"": 176, ""end_span"": 203, ""type"": ""Cancer""}, {""token"": ""bladder"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Organ""}]"	train
The hypothesis that modifications of activity and / or expression of nitric oxide synthase ( NOS) isozymes might play a role in these modifications, via enhanced local production of nitric oxide, was tested in this study.	nitric oxide synthase,69,90,Gene_or_gene_product	NOS,93,96,Gene_or_gene_product	nitric oxide,182,194,Chemical	"[{""token"": ""nitric oxide synthase"", ""start_span"": 69, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""NOS"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""nitric oxide"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Chemical""}]"	train
Peritoneal NOS activity is increased fivefold in long - term PD patients compared with control subjects.	Peritoneal,0,10,Multi	NOS,11,14,Gene_or_gene_product	patients,64,72,Organism	"[{""token"": ""Peritoneal"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Multi""}, {""token"": ""NOS"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Organism""}]"	train
Increased NOS activity is mediated solely by Ca ( 2 +) - dependent NOS and, as shown by immunoblotting, an upregulation of endothelial NOS.	NOS,10,13,Gene_or_gene_product	NOS,67,70,Gene_or_gene_product	endothelial NOS,123,138,Gene_or_gene_product	"[{""token"": ""NOS"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""NOS"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial NOS"", ""start_span"": 123, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}]"	train
These data provide a morphologic ( angiogenesis and increased endothelial area) and molecular ( enhanced NOS activity and endothelial NOS upregulation) basis for explaining the permeability changes observed in long - term PD.	endothelial area,62,78,Tissue	NOS,105,108,Gene_or_gene_product	endothelial NOS,122,137,Gene_or_gene_product	"[{""token"": ""endothelial area"", ""start_span"": 62, ""end_span"": 78, ""type"": ""Tissue""}, {""token"": ""NOS"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial NOS"", ""start_span"": 122, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"	train
Thus, angiogenesis is a physiologic event in normal postnatal murine skin, apparently is dictated by the hair follicle, and appears to be required for normal anagen development.	murine,62,68,Organism	skin,69,73,Organ	hair follicle,105,118,Multi	"[{""token"": ""murine"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Organism""}, {""token"": ""skin"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Organ""}, {""token"": ""hair follicle"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Multi""}]"	train
RESULTS: Chang hepatocytes grown in the coculture conditioned media have an increase in TNF - alpha and Fas ligand.	Chang hepatocytes,9,26,Cell	TNF - alpha,88,99,Gene_or_gene_product	Fas ligand,104,114,Gene_or_gene_product	"[{""token"": ""Chang hepatocytes"", ""start_span"": 9, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""TNF - alpha"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas ligand"", ""start_span"": 104, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}]"	train
CONCLUSIONS: Neuroblastoma cells grown in coculture conditioned media show increased expression of Bcl - 2 and decreased Fas ligand levels.	Neuroblastoma cells,13,32,Cell	Bcl - 2,99,106,Gene_or_gene_product	Fas ligand,121,131,Gene_or_gene_product	"[{""token"": ""Neuroblastoma cells"", ""start_span"": 13, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""Bcl - 2"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas ligand"", ""start_span"": 121, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"	train
A tumor ' s ability to successfully metastasize may be dependent on mediators generated in the tumor - host interaction, and may not be just an independent characteristic of the tumor itself.	tumor,2,7,Cancer	tumor,95,100,Cancer	tumor,178,183,Cancer	"[{""token"": ""tumor"", ""start_span"": 2, ""end_span"": 7, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Cancer""}]"	train
Notch proteins are plasma membrane - spanning receptors that mediate important cell fate decisions such as differentiation, proliferation, and apoptosis.	Notch,0,5,Gene_or_gene_product	plasma membrane,19,34,Cellular_component	cell,79,83,Cell	"[{""token"": ""Notch"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasma membrane"", ""start_span"": 19, ""end_span"": 34, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Cell""}]"	train
The prevailing model for Notch signaling suggests that ligand, presented on a neighboring cell, triggers proteolytic processing of Notch.	Notch,25,30,Gene_or_gene_product	cell,90,94,Cell	Notch,131,136,Gene_or_gene_product	"[{""token"": ""Notch"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""Notch"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}]"	train
Following proteolysis, it is thought that the intracellular portion of Notch ( N ( ic)) translocates to the nucleus, where it is involved in regulating gene expression.	intracellular,46,59,Immaterial_anatomical_entity	Notch,71,76,Gene_or_gene_product	nucleus,108,115,Cellular_component	"[{""token"": ""intracellular"", ""start_span"": 46, ""end_span"": 59, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""Notch"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""nucleus"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Cellular_component""}]"	train
There is considerable debate concerning where in the cell Notch functions and what proteins serve as effectors of the Notch signal.	cell,53,57,Cell	Notch,58,63,Gene_or_gene_product	Notch,118,123,Gene_or_gene_product	"[{""token"": ""cell"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""Notch"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""Notch"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"	train
Activation of Notch proto - oncogenes has been associated with tumorigenesis in several human and other mammalian cancers.	Notch,14,19,Gene_or_gene_product	human,88,93,Organism	mammalian cancers,104,121,Cancer	"[{""token"": ""Notch"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""mammalian cancers"", ""start_span"": 104, ""end_span"": 121, ""type"": ""Cancer""}]"	train
Alpha - melanocyte - stimulating hormone ( alpha - MSH) has evolved as a mediator of diverse biological activities in an ever - growing number of non - melanocytic cell types.	Alpha - melanocyte - stimulating hormone,0,40,Gene_or_gene_product	alpha - MSH,43,54,Gene_or_gene_product	non - melanocytic cell,146,168,Cell	"[{""token"": ""Alpha - melanocyte - stimulating hormone"", ""start_span"": 0, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - MSH"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""non - melanocytic cell"", ""start_span"": 146, ""end_span"": 168, ""type"": ""Cell""}]"	train
One mechanism by which alpha - MSH exerts its effects is modulation of AP - 1 and NF - kappa B.	alpha - MSH,23,34,Gene_or_gene_product	AP - 1,71,77,Gene_or_gene_product	NF - kappa B,82,94,Gene_or_gene_product	"[{""token"": ""alpha - MSH"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 1"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappa B"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}]"	train
These effects of alpha - MSH may have important regulatory functions in extracellular matrix composition, wound healing, or angiogenesis.	alpha - MSH,17,28,Gene_or_gene_product	extracellular matrix,72,92,Cellular_component	wound,106,111,Pathological_formation	"[{""token"": ""alpha - MSH"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular matrix"", ""start_span"": 72, ""end_span"": 92, ""type"": ""Cellular_component""}, {""token"": ""wound"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Pathological_formation""}]"	train
CD40 expression on human lung cancer correlates with metastatic spread.	CD40,0,4,Gene_or_gene_product	human,19,24,Organism	lung cancer,25,36,Cancer	"[{""token"": ""CD40"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Organism""}, {""token"": ""lung cancer"", ""start_span"": 25, ""end_span"": 36, ""type"": ""Cancer""}]"	train
However, a statistically significant correlation was found between the surface expression of CD40 and the metastatic spread of the tumor.	surface,71,78,Cellular_component	CD40,93,97,Gene_or_gene_product	tumor,131,136,Cancer	"[{""token"": ""surface"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Cellular_component""}, {""token"": ""CD40"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Cancer""}]"	train
In this study, 14 of 18 lung cancer cell lines ( 78%) expressed CD40 on their surface.	lung cancer cell lines,24,46,Cell	CD40,64,68,Gene_or_gene_product	surface,78,85,Cellular_component	"[{""token"": ""lung cancer cell lines"", ""start_span"": 24, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""CD40"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""surface"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Cellular_component""}]"	train
All of the 4 tumors that were CD40 - negative, were stage I tumors, without any evidence of regional or distant metastasis.	tumors,13,19,Cancer	CD40,30,34,Gene_or_gene_product	tumors,60,66,Cancer	"[{""token"": ""tumors"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Cancer""}, {""token"": ""CD40"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Cancer""}]"	train
Of the 14 tumors that expressed CD40, all but 1 ( 93%) had either nodal or systemic metastasis at the time of diagnosis.	tumors,10,16,Cancer	CD40,32,36,Gene_or_gene_product	nodal,66,71,Multi	"[{""token"": ""tumors"", ""start_span"": 10, ""end_span"": 16, ""type"": ""Cancer""}, {""token"": ""CD40"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""nodal"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Multi""}]"	train
Interleukins ( ILs) may mediate regression or progression of cancer.	Interleukins,0,12,Gene_or_gene_product	ILs,15,18,Gene_or_gene_product	cancer,61,67,Cancer	"[{""token"": ""Interleukins"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""ILs"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Cancer""}]"	train
Unexpectedly, cells expressing both Ras and TEL grew as aggregates.	cells,14,19,Cell	Ras,36,39,Gene_or_gene_product	TEL,44,47,Gene_or_gene_product	"[{""token"": ""cells"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""Ras"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEL"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}]"	train
TEL bound sequences in the stromelysin - 1 promoter and repressed the promoter in transient - expression assays, suggesting that it is a direct target for TEL - mediated regulation.	TEL,0,3,Gene_or_gene_product	stromelysin - 1,27,42,Gene_or_gene_product	TEL,155,158,Gene_or_gene_product	"[{""token"": ""TEL"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromelysin - 1"", ""start_span"": 27, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEL"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"	train
Mutants of TEL that removed a binding site for the mSin3A corepressor but retained the ETS domain failed to repress stromelysin - 1.	TEL,11,14,Gene_or_gene_product	mSin3A,51,57,Gene_or_gene_product	stromelysin - 1,116,131,Gene_or_gene_product	"[{""token"": ""TEL"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""mSin3A"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromelysin - 1"", ""start_span"": 116, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"	train
In addition, TEL inhibited the invasiveness of Ras - transformed cells in vitro and in vivo.	TEL,13,16,Gene_or_gene_product	Ras,47,50,Gene_or_gene_product	cells,65,70,Cell	"[{""token"": ""TEL"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ras"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Cell""}]"	train
Our results suggest that TEL acts as a tumor suppressor, in part, by transcriptional repression of stromelysin - 1.	TEL,25,28,Gene_or_gene_product	tumor,39,44,Cancer	stromelysin - 1,99,114,Gene_or_gene_product	"[{""token"": ""TEL"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""stromelysin - 1"", ""start_span"": 99, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}]"	train
Reconstitution of MCF - 7 cells by stable transfection of CASP - 3 cDNA restores all these defects and results in an extensive apoptosis after cisplatin treatment.	MCF - 7 cells,18,31,Cell	CASP - 3,58,66,Gene_or_gene_product	cisplatin,143,152,Chemical	"[{""token"": ""MCF - 7 cells"", ""start_span"": 18, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""CASP - 3"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""cisplatin"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Chemical""}]"	train
Reconstitution of MCF - 7 cell extracts with procaspase - 3 corrects this defect, resulting in an efficient and complete processing of procaspase - 9.	MCF - 7 cell extracts,18,39,Organism_substance	procaspase - 3,45,59,Gene_or_gene_product	procaspase - 9,135,149,Gene_or_gene_product	"[{""token"": ""MCF - 7 cell extracts"", ""start_span"": 18, ""end_span"": 39, ""type"": ""Organism_substance""}, {""token"": ""procaspase - 3"", ""start_span"": 45, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""procaspase - 9"", ""start_span"": 135, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}]"	train
In this study, we have expressed wild - type and mutant forms of VASP in endothelial cells to determine in what aspects of cytoskeletal behavior this protein participates.	VASP,65,69,Gene_or_gene_product	endothelial cells,73,90,Cell	cytoskeletal,123,135,Cellular_component	"[{""token"": ""VASP"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 73, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""cytoskeletal"", ""start_span"": 123, ""end_span"": 135, ""type"": ""Cellular_component""}]"	train
Deletion of the proline - rich domain of VASP abolishes its ability to bind profilin but does not affect ruffling or stress fiber formation.	VASP,41,45,Gene_or_gene_product	profilin,76,84,Gene_or_gene_product	stress fiber,117,129,Cellular_component	"[{""token"": ""VASP"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""profilin"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""stress fiber"", ""start_span"": 117, ""end_span"": 129, ""type"": ""Cellular_component""}]"	train
Ruffling occurs only on the expression of forms of VASP that possess bundling activity and the capacity to bind zyxin / vinculin - derived peptide.	VASP,51,55,Gene_or_gene_product	zyxin,112,117,Gene_or_gene_product	vinculin,120,128,Gene_or_gene_product	"[{""token"": ""VASP"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""zyxin"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""vinculin"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}]"	train
uPAR is also coexpressed with caveolin and members of the integrin adhesion receptor superfamily.	uPAR,0,4,Gene_or_gene_product	caveolin,30,38,Gene_or_gene_product	integrin adhesion receptor,58,84,Gene_or_gene_product	"[{""token"": ""uPAR"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""caveolin"", ""start_span"": 30, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin adhesion receptor"", ""start_span"": 58, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}]"	train
The formation of functional units with these various proteins allows the uPAR to mediate the focused proteolysis required for cell migration and invasion and to contribute both directly and indirectly to cell adhesive processes in a non - proteolytic fashion.	uPAR,73,77,Gene_or_gene_product	cell,126,130,Cell	cell,204,208,Cell	"[{""token"": ""uPAR"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Cell""}]"	train
p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA.	p75,0,3,Gene_or_gene_product	neuroblastoma cells,26,45,Cell	TrkA,76,80,Gene_or_gene_product	"[{""token"": ""p75"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuroblastoma cells"", ""start_span"": 26, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""TrkA"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}]"	train
BACKGROUND: Neurotrophins mediate their effects by binding to members of the Trk family of receptor tyrosine kinases and to the low - affinity nerve growth factor receptor p75.	Neurotrophins,12,25,Gene_or_gene_product	Trk,77,80,Gene_or_gene_product	p75,172,175,Gene_or_gene_product	"[{""token"": ""Neurotrophins"", ""start_span"": 12, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Trk"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""p75"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}]"	train
Nerve growth factor ( NGF) has been demonstrated to support survival and differentiation of neuroblastoma ( NB) cells by activation of the TrkA receptor.	Nerve growth factor,0,19,Gene_or_gene_product	NGF,22,25,Gene_or_gene_product	TrkA,139,143,Gene_or_gene_product	"[{""token"": ""Nerve growth factor"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""NGF"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""TrkA"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}]"	train
RESULTS: Cell clones expressing elevated levels of p75 showed a high degree of apoptosis even in 10% serum - supplemented medium.	Cell clones,9,20,Cell	p75,51,54,Gene_or_gene_product	serum,101,106,Organism_substance	"[{""token"": ""Cell clones"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""p75"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""serum"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Organism_substance""}]"	train
CONCLUSIONS: Thus, expression of the TrkA receptor itself inhibits p75 mediated apoptosis in NB cells.	TrkA,37,41,Gene_or_gene_product	p75,67,70,Gene_or_gene_product	NB cells,93,101,Cell	"[{""token"": ""TrkA"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""p75"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""NB cells"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Cell""}]"	train
RNA damage and inhibition of neoplastic endothelial cell growth: effects of human and amphibian ribonucleases.	neoplastic endothelial cell,29,56,Cell	human,76,81,Organism	ribonucleases,96,109,Gene_or_gene_product	"[{""token"": ""neoplastic endothelial cell"", ""start_span"": 29, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Organism""}, {""token"": ""ribonucleases"", ""start_span"": 96, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"	train
Recombinant EBV containing LMP1 with TES2 deleted induces a limited proliferation of B cells.	EBV,12,15,Organism	LMP1,27,31,Gene_or_gene_product	B cells,85,92,Cell	"[{""token"": ""EBV"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""LMP1"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""B cells"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Cell""}]"	train
However, it is not sufficient for the immortalization of MEF, and MEF - LMP1 ( TRADD) cells eventually enter growth arrest.	MEF,57,60,Cell	LMP1,72,76,Gene_or_gene_product	TRADD,79,84,Gene_or_gene_product	"[{""token"": ""MEF"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""LMP1"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRADD"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}]"	train
The migration of vascular endothelial cells ( ECs) plays an important role in vascular remodeling.	vascular endothelial cells,17,43,Cell	ECs,46,49,Cell	vascular,78,86,Multi	"[{""token"": ""vascular endothelial cells"", ""start_span"": 17, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""ECs"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""vascular"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Multi""}]"	train
TSP - 2 deficiency dramatically enhanced susceptibility to skin carcinogenesis and resulted in accelerated and increased tumor formation.	TSP - 2,0,7,Gene_or_gene_product	skin,59,63,Organ	tumor,121,126,Cancer	"[{""token"": ""TSP - 2"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""skin"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Organ""}, {""token"": ""tumor"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Cancer""}]"	train
While TSP - 2 deficiency did not affect tumor differentiation or proliferation, tumor cell apoptosis was significantly reduced.	TSP - 2,6,13,Gene_or_gene_product	tumor,40,45,Cancer	tumor cell,80,90,Cell	"[{""token"": ""TSP - 2"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""tumor cell"", ""start_span"": 80, ""end_span"": 90, ""type"": ""Cell""}]"	train
The purpose of this study was to evaluate the biological features of gastric cancer of the remnant stomach ( RSC).	gastric cancer,69,83,Cancer	remnant stomach,91,106,Organ	RSC,109,112,Cancer	"[{""token"": ""gastric cancer"", ""start_span"": 69, ""end_span"": 83, ""type"": ""Cancer""}, {""token"": ""remnant stomach"", ""start_span"": 91, ""end_span"": 106, ""type"": ""Organ""}, {""token"": ""RSC"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Cancer""}]"	train
In animal or cell culture studies, the growth and spread of cancer can be slowed by many nutrients, food factors, herbal extracts, and well - tolerated, available drugs that are still rarely used in the clinical management of cancer, in part because they seem unlikely to constitute definitive therapies in themselves.	cell,13,17,Cell	cancer,60,66,Cancer	cancer,226,232,Cancer	"[{""token"": ""cell"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 226, ""end_span"": 232, ""type"": ""Cancer""}]"	train
We also demonstrated that Evi - 1 represses Smad - induced transcriptional activation by recruiting CtBP as a corepressor.	Evi - 1,26,33,Gene_or_gene_product	Smad,44,48,Gene_or_gene_product	CtBP,100,104,Gene_or_gene_product	"[{""token"": ""Evi - 1"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""CtBP"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}]"	train
Antibodies to PAI - 1 alter the invasive and migratory properties of human tumour cells in vitro.	PAI - 1,14,21,Gene_or_gene_product	human,69,74,Organism	tumour cells,75,87,Cell	"[{""token"": ""PAI - 1"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""tumour cells"", ""start_span"": 75, ""end_span"": 87, ""type"": ""Cell""}]"	train
Recent reports suggest that elevated levels of plasminogen activator inhibitor - 1 ( PAI - 1) may contribute to tumour progression.	plasminogen activator inhibitor - 1,47,82,Gene_or_gene_product	PAI - 1,85,92,Gene_or_gene_product	tumour,112,118,Cancer	"[{""token"": ""plasminogen activator inhibitor - 1"", ""start_span"": 47, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAI - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Cancer""}]"	train
SPARC ( secreted protein, acidic, and rich in cysteine) is a matrix - associated glycoprotein that modulates the adhesion and proliferation of vascular cells.	SPARC,0,5,Gene_or_gene_product	matrix,61,67,Cellular_component	vascular cells,143,157,Cell	"[{""token"": ""SPARC"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Cellular_component""}, {""token"": ""vascular cells"", ""start_span"": 143, ""end_span"": 157, ""type"": ""Cell""}]"	train
Binding studies with SPARC and SPARC peptides indicate specific and saturable interaction with smooth muscle cells that involves the C - terminal Ca2 + - binding region of the protein.	SPARC,21,26,Gene_or_gene_product	SPARC peptides,31,45,Gene_or_gene_product	smooth muscle cells,95,114,Cell	"[{""token"": ""SPARC"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC peptides"", ""start_span"": 31, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""smooth muscle cells"", ""start_span"": 95, ""end_span"": 114, ""type"": ""Cell""}]"	train
Heat shock protein 27 ( HSP27) is one of the small heat shock proteins.	Heat shock protein 27,0,21,Gene_or_gene_product	HSP27,24,29,Gene_or_gene_product	small heat shock proteins,45,70,Gene_or_gene_product	"[{""token"": ""Heat shock protein 27"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""HSP27"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""small heat shock proteins"", ""start_span"": 45, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}]"	train
RESULTS: VEGF isoforms and its receptors ' mRNA were expressed in neuroblastoma and control tissues.	VEGF,9,13,Gene_or_gene_product	neuroblastoma,66,79,Cancer	tissues,92,99,Tissue	"[{""token"": ""VEGF"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuroblastoma"", ""start_span"": 66, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""tissues"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Tissue""}]"	train
VEGF - A ( 165) mainly contributes to increased serum VEGF levels and may serve as a diagnostic tool in advanced - stage neuroblastoma.	serum,48,53,Organism_substance	VEGF,54,58,Gene_or_gene_product	advanced - stage neuroblastoma,104,134,Cancer	"[{""token"": ""serum"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""advanced - stage neuroblastoma"", ""start_span"": 104, ""end_span"": 134, ""type"": ""Cancer""}]"	train
Almost all patients respond to G - CSF with increased neutrophils, reduced infections, and improved survival.	patients,11,19,Organism	G - CSF,31,38,Gene_or_gene_product	neutrophils,54,65,Cell	"[{""token"": ""patients"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Organism""}, {""token"": ""G - CSF"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""neutrophils"", ""start_span"": 54, ""end_span"": 65, ""type"": ""Cell""}]"	train
Some responders with congenital neutropenia and Shwachman - Diamond syndrome ( SDS) have developed myelodysplastic syndrome and acute myeloid leukemia ( MDS / AML), which raises the question of the role of G - CSF in pathogenesis.	acute myeloid leukemia,128,150,Cancer	AML,159,162,Cancer	G - CSF,206,213,Gene_or_gene_product	"[{""token"": ""acute myeloid leukemia"", ""start_span"": 128, ""end_span"": 150, ""type"": ""Cancer""}, {""token"": ""AML"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Cancer""}, {""token"": ""G - CSF"", ""start_span"": 206, ""end_span"": 213, ""type"": ""Gene_or_gene_product""}]"	train
In murine models, the latter produces a hyperproliferative response to G - CSF, confers resistance to apoptosis, and enhances cell survival.	murine,3,9,Organism	G - CSF,71,78,Gene_or_gene_product	cell,126,130,Cell	"[{""token"": ""murine"", ""start_span"": 3, ""end_span"": 9, ""type"": ""Organism""}, {""token"": ""G - CSF"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Cell""}]"	train
In patients who transform to overt MDS or AML, hematopoietic stem cell transplantation is the only chance for cure.	patients,3,11,Organism	AML,42,45,Cancer	hematopoietic stem cell,47,70,Cell	"[{""token"": ""patients"", ""start_span"": 3, ""end_span"": 11, ""type"": ""Organism""}, {""token"": ""AML"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""hematopoietic stem cell"", ""start_span"": 47, ""end_span"": 70, ""type"": ""Cell""}]"	train
Hypoxic induction of HIF - 1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases.	HIF - 1alpha,21,33,Gene_or_gene_product	VEGF,38,42,Gene_or_gene_product	head and neck squamous cell carcinoma lines,57,100,Cell	"[{""token"": ""HIF - 1alpha"", ""start_span"": 21, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""head and neck squamous cell carcinoma lines"", ""start_span"": 57, ""end_span"": 100, ""type"": ""Cell""}]"	train
The mechanisms by which hypoxic tumor environments induce HIF - 1alpha and VEGF expression are largely unknown.	tumor,32,37,Cancer	HIF - 1alpha,58,70,Gene_or_gene_product	VEGF,75,79,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Cancer""}, {""token"": ""HIF - 1alpha"", ""start_span"": 58, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}]"	train
Jun N terminal kinase ( JNK1) and p38 kinase are activated by a variety of stress stimuli.	Jun N terminal kinase,0,21,Gene_or_gene_product	JNK1,24,28,Gene_or_gene_product	p38 kinase,34,44,Gene_or_gene_product	"[{""token"": ""Jun N terminal kinase"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK1"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38 kinase"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}]"	train
Hypoxia rapidly induced both JNK1 and p38 activity in these cells.	JNK1,29,33,Gene_or_gene_product	p38,38,41,Gene_or_gene_product	cells,60,65,Cell	"[{""token"": ""JNK1"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Cell""}]"	train
Hypoxia also increased VEGF production by SCC lines, which was inhibited by treatment with SB203580.	VEGF,23,27,Gene_or_gene_product	SCC lines,42,51,Cell	SB203580,91,99,Chemical	"[{""token"": ""VEGF"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""SCC lines"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""SB203580"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Chemical""}]"	train
Transformation of primary cells in cultures requires both overcoming growth arrest by stimulating the cell cycle and blocking cell death activities presumably activated by oncogene - mediated hyperproliferation signals.	cells,26,31,Cell	cell,102,106,Cell	cell,126,130,Cell	"[{""token"": ""cells"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Cell""}]"	train
An N - terminal segment containing the first 127 T - antigen amino acids ( T1 - 127) was sufficient to sensitize cells.	T - antigen,49,60,Gene_or_gene_product	amino acids,61,72,Amino_acid	cells,113,118,Cell	"[{""token"": ""T - antigen"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""amino acids"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Amino_acid""}, {""token"": ""cells"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Cell""}]"	train
Optimizing treatment of choroidal neovascularization feeder vessels associated with age - related macular degeneration.	choroidal,24,33,Multi	feeder vessels,53,67,Multi	macular,98,105,Tissue	"[{""token"": ""choroidal"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Multi""}, {""token"": ""feeder vessels"", ""start_span"": 53, ""end_span"": 67, ""type"": ""Multi""}, {""token"": ""macular"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Tissue""}]"	train
The system also permits precise aiming and delivery of 810 - nm wavelength photocoagulation laser energy to target FVs on a real - time ICG angiogram image of the choroidal vasculature.	FVs,115,118,Multi	ICG,136,139,Chemical	choroidal vasculature,163,184,Multi	"[{""token"": ""FVs"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Multi""}, {""token"": ""ICG"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Chemical""}, {""token"": ""choroidal vasculature"", ""start_span"": 163, ""end_span"": 184, ""type"": ""Multi""}]"	train
Successful FV closure was usually indicated immediately by presence of incarcerated ICG dye in the vessel adjacent to the burn site.	FV,11,13,Multi	ICG dye,84,91,Chemical	vessel,99,105,Multi	"[{""token"": ""FV"", ""start_span"": 11, ""end_span"": 13, ""type"": ""Multi""}, {""token"": ""ICG dye"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Chemical""}, {""token"": ""vessel"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Multi""}]"	train
After 7 days, the pellets from animals fed the control diet were infiltrated by abundant branching networks of blood vessels with patent lumen - containing RBCs.	networks of blood vessels,99,124,Multi	lumen,137,142,Immaterial_anatomical_entity	RBCs,156,160,Cell	"[{""token"": ""networks of blood vessels"", ""start_span"": 99, ""end_span"": 124, ""type"": ""Multi""}, {""token"": ""lumen"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""RBCs"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Cell""}]"	train
Both levels of dietary CLA showed similar effects, with the number of RBC - containing vessels per 20x field decreased to a third of that seen in control.	CLA,23,26,Chemical	RBC,70,73,Cell	vessels,87,94,Multi	"[{""token"": ""CLA"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Chemical""}, {""token"": ""RBC"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""vessels"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Multi""}]"	train
Attenuation of the proangiogenic effects by neutralizing VEGF antibodies suggests VEGF play a key role in the acquisition of the angiogenic phenotype in oral cancer cells.	VEGF antibodies,57,72,Gene_or_gene_product	VEGF,82,86,Gene_or_gene_product	oral cancer cells,153,170,Cell	"[{""token"": ""VEGF antibodies"", ""start_span"": 57, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""oral cancer cells"", ""start_span"": 153, ""end_span"": 170, ""type"": ""Cell""}]"	train
In summary, the angiogenic property of oral cancer cells is mediated by many factors in addition to VEGF and the functional status of p53.	oral cancer cells,39,56,Cell	VEGF,100,104,Gene_or_gene_product	p53,134,137,Gene_or_gene_product	"[{""token"": ""oral cancer cells"", ""start_span"": 39, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"	train
Brn - 3a, a neuronal transcription factor of the POU gene family: indications for its involvement in cancer and angiogenesis.	Brn - 3a,0,8,Gene_or_gene_product	neuronal,12,20,Cell	cancer,101,107,Cancer	"[{""token"": ""Brn - 3a"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Cancer""}]"	train
In neuronal cells, following Brn - 3a gene transfection and superexpression, an increase of 30 fold of the Bcl - 2 protein occurs, leading to apoptosis protection.	neuronal cells,3,17,Cell	Brn - 3a,29,37,Gene_or_gene_product	Bcl - 2,107,114,Gene_or_gene_product	"[{""token"": ""neuronal cells"", ""start_span"": 3, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""Brn - 3a"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}]"	train
The A431 cells exhibited typical in vitro cell adhesion to the endothelial F - 2 cells.	A431 cells,4,14,Cell	cell,42,46,Cell	endothelial F - 2 cells,63,86,Cell	"[{""token"": ""A431 cells"", ""start_span"": 4, ""end_span"": 14, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""endothelial F - 2 cells"", ""start_span"": 63, ""end_span"": 86, ""type"": ""Cell""}]"	train
The initial step of adhesion was mediated by sialyl Lewis ( x) ( Le ( x)) and sialyl Le ( a), the carbohydrate determinants expressed on the cancer cells, and E - selectin expressed constitutively on F - 2 cells.	cancer cells,141,153,Cell	E - selectin,159,171,Gene_or_gene_product	F - 2 cells,200,211,Cell	"[{""token"": ""cancer cells"", ""start_span"": 141, ""end_span"": 153, ""type"": ""Cell""}, {""token"": ""E - selectin"", ""start_span"": 159, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""F - 2 cells"", ""start_span"": 200, ""end_span"": 211, ""type"": ""Cell""}]"	train
Prolonged culture led to the implantation of cancer cells into the monolayer of the F - 2 cells, which was mediated mainly by alpha ( 3) beta ( 1) - integrin.	cancer cells,45,57,Cell	monolayer,67,76,Cell	F - 2 cells,84,95,Cell	"[{""token"": ""cancer cells"", ""start_span"": 45, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""monolayer"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""F - 2 cells"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Cell""}]"	train
The tumor mass thus formed was an average 5. 8 - fold as large as control A431 tumors that were grown without F - 2 cells.	tumor,4,9,Cancer	A431 tumors,74,85,Cancer	F - 2 cells,110,121,Cell	"[{""token"": ""tumor"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Cancer""}, {""token"": ""A431 tumors"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""F - 2 cells"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Cell""}]"	train
The size of these A431 tumors did not differ significantly from those of control A431 tumors raised without F - 2 cells.	A431 tumors,18,29,Cancer	A431 tumors,81,92,Cancer	F - 2 cells,108,119,Cell	"[{""token"": ""A431 tumors"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""A431 tumors"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Cancer""}, {""token"": ""F - 2 cells"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Cell""}]"	train
Keratinocyte progenitor cells from TPA - treated Tg. AC mice were isolated with fluorescence - activated cell sorting and expression was analyzed using cDNA microarray technology.	Keratinocyte progenitor cells,0,29,Cell	TPA,35,38,Chemical	cell,105,109,Cell	"[{""token"": ""Keratinocyte progenitor cells"", ""start_span"": 0, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""TPA"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Cell""}]"	train
cDNA microarray expression analysis showed that the mouse homologue of Dss1 is induced by TPA.	mouse,52,57,Organism	Dss1,71,75,Gene_or_gene_product	TPA,90,93,Chemical	"[{""token"": ""mouse"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Organism""}, {""token"": ""Dss1"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""TPA"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Chemical""}]"	train
These results strongly suggest that Dss1 is a TPA - inducible gene that may play an important role in the early stages of skin carcinogenesis.	Dss1,36,40,Gene_or_gene_product	TPA,46,49,Chemical	skin,122,126,Organ	"[{""token"": ""Dss1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""TPA"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""skin"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Organ""}]"	train
Downregulation of c - FLIP sensitizes DU145 prostate cancer cells to Fas - mediated apoptosis.	c - FLIP,18,26,Gene_or_gene_product	DU145 prostate cancer cells,38,65,Cell	Fas,69,72,Gene_or_gene_product	"[{""token"": ""c - FLIP"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""DU145 prostate cancer cells"", ""start_span"": 38, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""Fas"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}]"	train
The purpose of this study was to try to understand why DU145 cells are resistant to CH - 11 and determine the signaling pathway utilized by AdGFPFasL ( TET) to induce apoptosis in these Fas - resistant cells.	DU145 cells,55,66,Cell	Fas,145,148,Gene_or_gene_product	cells,202,207,Cell	"[{""token"": ""DU145 cells"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""Fas"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Cell""}]"	train
Using c - FLIP anti - sense oligonucleotides to down - regulate c - FLIP we sensitized DU145 cells to CH - 11 - induced apoptosis.	c - FLIP,6,14,Gene_or_gene_product	c - FLIP,64,72,Gene_or_gene_product	DU145 cells,87,98,Cell	"[{""token"": ""c - FLIP"", ""start_span"": 6, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - FLIP"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""DU145 cells"", ""start_span"": 87, ""end_span"": 98, ""type"": ""Cell""}]"	train
Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.	Topoisomerase I,0,15,Gene_or_gene_product	primary colorectal cancer,38,63,Cancer	lymph node metastases,68,89,Cancer	"[{""token"": ""Topoisomerase I"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary colorectal cancer"", ""start_span"": 38, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""lymph node metastases"", ""start_span"": 68, ""end_span"": 89, ""type"": ""Cancer""}]"	train
Topo I expression was described as the percentage of cells staining positive for topo I, along with the intensity and localization of the staining.	Topo I,0,6,Gene_or_gene_product	cells,53,58,Cell	topo I,81,87,Gene_or_gene_product	"[{""token"": ""Topo I"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""topo I"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}]"	train
Clinicopathologic data ( sex, age, Dukes ' stage, differentiation grade, survival status), p53 status, and PCNA status were statistically analyzed for association with topo I protein expression.	p53,91,94,Gene_or_gene_product	PCNA,107,111,Gene_or_gene_product	topo I,168,174,Gene_or_gene_product	"[{""token"": ""p53"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCNA"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""topo I"", ""start_span"": 168, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}]"	train
Topo I protein expression was detected in 127 ( 51%) samples, including 24. 4% with > 50% positive tumor cells.	Topo I,0,6,Gene_or_gene_product	samples,53,60,Cancer	tumor cells,99,110,Cell	"[{""token"": ""Topo I"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""samples"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Cancer""}, {""token"": ""tumor cells"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Cell""}]"	train
The majority had nuclear ( 70. 1%) or nuclear and cytoplasmic staining ( 17. 3%).	nuclear,17,24,Cellular_component	nuclear,38,45,Cellular_component	cytoplasmic,50,61,Organism_substance	"[{""token"": ""nuclear"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Cellular_component""}, {""token"": ""nuclear"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Cellular_component""}, {""token"": ""cytoplasmic"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Organism_substance""}]"	train
A higher percentage of cells expressing topo I in primary colorectal cancer was significantly associated with advanced age ( P =. 040).	cells,23,28,Cell	topo I,40,46,Gene_or_gene_product	primary colorectal cancer,50,75,Cancer	"[{""token"": ""cells"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""topo I"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary colorectal cancer"", ""start_span"": 50, ""end_span"": 75, ""type"": ""Cancer""}]"	train
No significant correlation was found between topo I protein expression and sex, Dukes ' stage, differentiation grade, survival status, p53 status, and PCNA status.	topo I,45,51,Gene_or_gene_product	p53,135,138,Gene_or_gene_product	PCNA,151,155,Gene_or_gene_product	"[{""token"": ""topo I"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCNA"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"	train
Concordance in topo I staining between primary and lymph node metastases was observed in 33 of 42 cases ( P =. 029).	topo I,15,21,Gene_or_gene_product	primary,39,46,Cancer	lymph node,51,61,Multi	"[{""token"": ""topo I"", ""start_span"": 15, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 51, ""end_span"": 61, ""type"": ""Multi""}]"	train
This suggests that the activity of topo I inhibitors will not differ across various tumor stages, pathology, and patient gender.	topo I,35,41,Gene_or_gene_product	tumor,84,89,Cancer	patient,113,120,Organism	"[{""token"": ""topo I"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Cancer""}, {""token"": ""patient"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Organism""}]"	train
Topo I expression now needs to be evaluated in patients undergoing topo I - inhibitor therapy, to better define the role of this protein as a predictive marker.	Topo I,0,6,Gene_or_gene_product	patients,47,55,Organism	topo I,67,73,Gene_or_gene_product	"[{""token"": ""Topo I"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""topo I"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}]"	train
Dysregulation of the signaling mechanisms of the TGF - beta superfamily proteins is associated with clinical diseases such as cancer, fibrotic diseases, and vascular disorders.	TGF - beta,49,59,Gene_or_gene_product	cancer,126,132,Cancer	vascular,157,165,Multi	"[{""token"": ""TGF - beta"", ""start_span"": 49, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Cancer""}, {""token"": ""vascular"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Multi""}]"	train
OBJECTIVE: To investigate the effect of the expression and mutation of c - kit gene and its relationship with clinical pathology and prognosis of gastrointestinal stromal tumor ( GIST).	c - kit,71,78,Gene_or_gene_product	gastrointestinal stromal tumor,146,176,Cancer	GIST,179,183,Cancer	"[{""token"": ""c - kit"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastrointestinal stromal tumor"", ""start_span"": 146, ""end_span"": 176, ""type"": ""Cancer""}, {""token"": ""GIST"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Cancer""}]"	train
We investigated how inhibition of glucose metabolism could affect death receptor - mediated apoptosis in human tumor cells of diverse origin.	glucose,34,41,Chemical	human,105,110,Organism	tumor cells,111,122,Cell	"[{""token"": ""glucose"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Organism""}, {""token"": ""tumor cells"", ""start_span"": 111, ""end_span"": 122, ""type"": ""Cell""}]"	train
Caspase activation, mitochondrial depolarization, and cytochrome c release were increased under these conditions.	Caspase,0,7,Gene_or_gene_product	mitochondrial,20,33,Cellular_component	cytochrome c,54,66,Gene_or_gene_product	"[{""token"": ""Caspase"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 20, ""end_span"": 33, ""type"": ""Cellular_component""}, {""token"": ""cytochrome c"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}]"	train
Glucose deprivation - mediated sensitization to apoptosis was prevented in MCF - 7 cells overexpressing BCL - 2.	Glucose,0,7,Chemical	MCF - 7 cells,75,88,Cell	BCL - 2,104,111,Gene_or_gene_product	"[{""token"": ""Glucose"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""MCF - 7 cells"", ""start_span"": 75, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""BCL - 2"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}]"	train
Changes in c - FLIP ( L) and cFLIPs levels were observed in some but not all the cell lines studied following glucose deprivation.	cFLIPs,29,35,Gene_or_gene_product	cell lines,81,91,Cell	glucose,110,117,Chemical	"[{""token"": ""cFLIPs"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell lines"", ""start_span"": 81, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Chemical""}]"	train
Glucose deprivation enhanced death receptor - triggered formation of death - inducing signaling complex and early processing of procaspase - 8.	Glucose,0,7,Chemical	death - inducing signaling complex,69,103,Gene_or_gene_product	procaspase - 8,128,142,Gene_or_gene_product	"[{""token"": ""Glucose"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""death - inducing signaling complex"", ""start_span"": 69, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""procaspase - 8"", ""start_span"": 128, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"	train
Many observations in various animal models and humans support that the remodeling of preexisting collateral vessels is the mechanism of collateral artery formation.	humans,47,53,Organism	collateral vessels,97,115,Multi	collateral artery,136,153,Multi	"[{""token"": ""humans"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Organism""}, {""token"": ""collateral vessels"", ""start_span"": 97, ""end_span"": 115, ""type"": ""Multi""}, {""token"": ""collateral artery"", ""start_span"": 136, ""end_span"": 153, ""type"": ""Multi""}]"	train
In addition, reverse transcription - polymerase chain reaction and prostaglandin E ( 2) ( PGE ( 2)) immunoassay were performed to verify whether BV possesses an inhibitory effect on the expression of cyclooxygenase ( COX) and PGE ( 2) synthesis.	BV,145,147,Organism_substance	cyclooxygenase,200,214,Gene_or_gene_product	COX,217,220,Gene_or_gene_product	"[{""token"": ""BV"", ""start_span"": 145, ""end_span"": 147, ""type"": ""Organism_substance""}, {""token"": ""cyclooxygenase"", ""start_span"": 200, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX"", ""start_span"": 217, ""end_span"": 220, ""type"": ""Gene_or_gene_product""}]"	train
None of the inhibitors had any effect on the weight of the superovulated ovaries or on the synthesis of progesterone by cultured luteal cells.	superovulated ovaries,59,80,Organ	progesterone,104,116,Chemical	cultured luteal cells,120,141,Cell	"[{""token"": ""superovulated ovaries"", ""start_span"": 59, ""end_span"": 80, ""type"": ""Organ""}, {""token"": ""progesterone"", ""start_span"": 104, ""end_span"": 116, ""type"": ""Chemical""}, {""token"": ""cultured luteal cells"", ""start_span"": 120, ""end_span"": 141, ""type"": ""Cell""}]"	train
The expression of endothelial cell ( EC) adhesion molecules involved in leukocyte - vessel wall interactions is suppressed in malignancies.	leukocyte,72,81,Cell	vessel wall,84,95,Multi	malignancies,126,138,Cancer	"[{""token"": ""leukocyte"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""vessel wall"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Multi""}, {""token"": ""malignancies"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Cancer""}]"	train
In the present study, we investigated in vivo the regulation of leukocyte - vessel wall interactions by the presence of a tumor.	leukocyte,64,73,Cell	vessel wall,76,87,Multi	tumor,122,127,Cancer	"[{""token"": ""leukocyte"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""vessel wall"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Cancer""}]"	train
This study was designed to investigate the effect of EBV - LMP1 on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1.	EBV,53,56,Organism	LMP1,59,63,Gene_or_gene_product	nasopharyngeal carcinoma cell line CNE1,100,139,Cell	"[{""token"": ""EBV"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""LMP1"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""nasopharyngeal carcinoma cell line CNE1"", ""start_span"": 100, ""end_span"": 139, ""type"": ""Cell""}]"	train
Cell - matrix adhesion assay was used to study the adhesive ability of CNE1 - GL cells.	Cell,0,4,Cell	matrix,7,13,Cellular_component	CNE1 - GL cells,71,86,Cell	"[{""token"": ""Cell"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 7, ""end_span"": 13, ""type"": ""Cellular_component""}, {""token"": ""CNE1 - GL cells"", ""start_span"": 71, ""end_span"": 86, ""type"": ""Cell""}]"	train
The positive rates of expression of MMP - 9 in CNE1 and CNE1 - GL cells were 30. 2% and 98. 2%, respectively ( P < 0. 05).	MMP - 9,36,43,Gene_or_gene_product	CNE1,47,51,Cell	CNE1 - GL cells,56,71,Cell	"[{""token"": ""MMP - 9"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""CNE1"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""CNE1 - GL cells"", ""start_span"": 56, ""end_span"": 71, ""type"": ""Cell""}]"	train
CONCLUSION: The transfection of LMP1 can increase the expression of MMP - 9 in CNE1 cells.	LMP1,32,36,Gene_or_gene_product	MMP - 9,68,75,Gene_or_gene_product	CNE1 cells,79,89,Cell	"[{""token"": ""LMP1"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""CNE1 cells"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Cell""}]"	train
It is suggested that MMP - 9 may have a role in the LMP1 - induced acceleration of invasion and metastasis of NPC cells.	MMP - 9,21,28,Gene_or_gene_product	LMP1,52,56,Gene_or_gene_product	NPC cells,110,119,Cell	"[{""token"": ""MMP - 9"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""LMP1"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""NPC cells"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Cell""}]"	train
PURPOSE: The goal of this research was to evaluate a potential therapeutic agent for breast cancer based on galectin - 3 that has been implicated in tumorigenicity and metastasis of breast cancer.	breast cancer,85,98,Cancer	galectin - 3,108,120,Gene_or_gene_product	breast cancer,182,195,Cancer	"[{""token"": ""breast cancer"", ""start_span"": 85, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""galectin - 3"", ""start_span"": 108, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 182, ""end_span"": 195, ""type"": ""Cancer""}]"	train
The hypothesis was that therapy with NH ( 2) - terminally truncated form of galectin - 3 ( galectin - 3C) will be efficacious for reduction in tumor growth and for inhibition of metastases.	galectin - 3,76,88,Gene_or_gene_product	galectin - 3C,91,104,Gene_or_gene_product	tumor,143,148,Cancer	"[{""token"": ""galectin - 3"", ""start_span"": 76, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""galectin - 3C"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Cancer""}]"	train
The elimination half - life when administered i. m. was found to be 3. 0 h in the serum and 4. 3 h in the cellular fraction of the blood.	serum,82,87,Organism_substance	cellular,106,114,Cell	blood,131,136,Organism_substance	"[{""token"": ""serum"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Organism_substance""}, {""token"": ""cellular"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Cell""}, {""token"": ""blood"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Organism_substance""}]"	train
The most common genetic alterations found in a wide variety of cancers are p53 tumor suppressor gene mutations.	cancers,63,70,Cancer	p53,75,78,Gene_or_gene_product	tumor,79,84,Cancer	"[{""token"": ""cancers"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Cancer""}]"	train
Vascular endothelial growth factor ( VEGF), a recently identified growth factor with significant angiogenic properties, may be a major tumor angiogenesis regulator.	Vascular endothelial growth factor,0,34,Gene_or_gene_product	VEGF,37,41,Gene_or_gene_product	tumor,135,140,Cancer	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Cancer""}]"	train
Few studies have investigated the association between p53 and VEGF expressions and prognosis in esophageal carcinoma.	p53,54,57,Gene_or_gene_product	VEGF,62,66,Gene_or_gene_product	esophageal carcinoma,96,116,Cancer	"[{""token"": ""p53"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""esophageal carcinoma"", ""start_span"": 96, ""end_span"": 116, ""type"": ""Cancer""}]"	train
VEGF and p53 expressions were observed in 40% and 53% of the tumors, respectively.	VEGF,0,4,Gene_or_gene_product	p53,9,12,Gene_or_gene_product	tumors,61,67,Cancer	"[{""token"": ""VEGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Cancer""}]"	train
Dioleoyl phosphatidylethanolamine - based lipoplexes were found to give low expression, apparently because of an immediate loss of integrity in serum, without lipid - DNA dissociation.	Dioleoyl phosphatidylethanolamine - based lipoplexes,0,52,Chemical	serum,144,149,Organism_substance	DNA,167,170,Cellular_component	"[{""token"": ""Dioleoyl phosphatidylethanolamine - based lipoplexes"", ""start_span"": 0, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Organism_substance""}, {""token"": ""DNA"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Cellular_component""}]"	train
"Our study suggests that efficient in vivo lipofection is the result of cross - talk between lipoplex composition, interaction with serum, hemodynamics, and target tissue "" susceptibility "" to transfection."	lipoplex,92,100,Chemical	serum,131,136,Organism_substance	tissue,163,169,Tissue	"[{""token"": ""lipoplex"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Organism_substance""}, {""token"": ""tissue"", ""start_span"": 163, ""end_span"": 169, ""type"": ""Tissue""}]"	train
Aqueous humor was collected at cataract surgery from 19 diabetic patients and from 13 age - and sex - matched normoglycemic controls.	Aqueous humor,0,13,Organism_substance	patients,65,73,Organism	controls,124,132,Organism	"[{""token"": ""Aqueous humor"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Organism_substance""}, {""token"": ""patients"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Organism""}, {""token"": ""controls"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Organism""}]"	train
Angiogenic activity in samples of patients from the control group was generally inhibitory due to PEDF, and inhibition was blocked by neutralizing antibodies to PEDF.	patients,34,42,Organism	PEDF,98,102,Gene_or_gene_product	PEDF,161,165,Gene_or_gene_product	"[{""token"": ""patients"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""PEDF"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""PEDF"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}]"	train
In contrast, osteoprotegerin ( OPG) inhibits osteoclast development.	osteoprotegerin,13,28,Gene_or_gene_product	OPG,31,34,Gene_or_gene_product	osteoclast,45,55,Cell	"[{""token"": ""osteoprotegerin"", ""start_span"": 13, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPG"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""osteoclast"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Cell""}]"	train
Osteoclast - like cells and tartarate resistant acid phosphatase ( TRAP) activities were then quantitated.	Osteoclast - like cells,0,23,Cell	tartarate resistant acid phosphatase,28,64,Gene_or_gene_product	TRAP,67,71,Gene_or_gene_product	"[{""token"": ""Osteoclast - like cells"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""tartarate resistant acid phosphatase"", ""start_span"": 28, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRAP"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}]"	train
MDA - MB - 231 cells alone or breast cancer samples did not express RANKL mRNA.	MDA - MB - 231 cells,0,20,Cell	breast cancer,30,43,Cancer	RANKL,68,73,Gene_or_gene_product	"[{""token"": ""MDA - MB - 231 cells"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""breast cancer"", ""start_span"": 30, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""RANKL"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}]"	train
Interleukin - 1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat.	Interleukin - 1 receptor antagonist,0,35,Gene_or_gene_product	neuronal,71,79,Cell	rat,94,97,Organism	"[{""token"": ""Interleukin - 1 receptor antagonist"", ""start_span"": 0, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Organism""}]"	train
Excitotoxic damage due to striatal infusion of an NMDA - receptor agonist ( cis - 2, 4 - methanoglutamate) was also markedly inhibited ( 71%) by injection of the IL - 1ra.	striatal,26,34,Multi	NMDA,50,54,Chemical	IL - 1ra,162,170,Gene_or_gene_product	"[{""token"": ""striatal"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Multi""}, {""token"": ""NMDA"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""IL - 1ra"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}]"	train
Tie1 is an orphan tyrosine kinase receptor expressed almost exclusively in endothelial cells and is required for normal vascular development and maintenance.	Tie1,0,4,Gene_or_gene_product	endothelial cells,75,92,Cell	vascular,120,128,Multi	"[{""token"": ""Tie1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 75, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""vascular"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Multi""}]"	train
This down - regulation is accompanied by a rapid cleavage of Tie1 and binding of the cleaved Tie1 45 kDa endodomain to Tie2.	Tie1,61,65,Gene_or_gene_product	Tie1,93,97,Gene_or_gene_product	Tie2,119,123,Gene_or_gene_product	"[{""token"": ""Tie1"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tie1"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tie2"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"	train
Blood and vascular disorders underlie a plethora of pathologic conditions and are the single most frequent cause of human disease.	Blood,0,5,Organism_substance	vascular,10,18,Multi	human,116,121,Organism	"[{""token"": ""Blood"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism_substance""}, {""token"": ""vascular"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Organism""}]"	train
There is accumulating evidence of a role for IGF - 1 in multiple vascular pathologies, including atherosclerosis, hypertension, restenosis, angiogenesis, and diabetic vascular disease.	IGF - 1,45,52,Gene_or_gene_product	vascular,65,73,Multi	vascular,167,175,Multi	"[{""token"": ""IGF - 1"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Multi""}, {""token"": ""vascular"", ""start_span"": 167, ""end_span"": 175, ""type"": ""Multi""}]"	train
Vascular endothelial growth factor ( VEGF) is a mitogen that acts exclusively on endothelial cells.	Vascular endothelial growth factor,0,34,Gene_or_gene_product	VEGF,37,41,Gene_or_gene_product	endothelial cells,81,98,Cell	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 81, ""end_span"": 98, ""type"": ""Cell""}]"	train
CONCLUSION: The data suggest that both h - MVD and VEGF immunoreactivity may be useful predictors for the progression of a subset of OSCC associated mostly with betel use.	VEGF,51,55,Gene_or_gene_product	OSCC,133,137,Cancer	betel,161,166,Organism_subdivision	"[{""token"": ""VEGF"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""OSCC"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Cancer""}, {""token"": ""betel"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Organism_subdivision""}]"	train
Molecular analyses of tumors in beclin 1 heterozygous mice show that the remaining wild - type allele is neither mutated nor silenced.	tumors,22,28,Cancer	beclin 1,32,40,Gene_or_gene_product	mice,54,58,Organism	"[{""token"": ""tumors"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Cancer""}, {""token"": ""beclin 1"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Organism""}]"	train
Thus, mutation of beclin 1 or other autophagy genes may contribute to the pathogenesis of human cancers.	beclin 1,18,26,Gene_or_gene_product	human,90,95,Organism	cancers,96,103,Cancer	"[{""token"": ""beclin 1"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Cancer""}]"	train
Weaning IL - 2 ( null) x beta ( 2) m ( null) mice were randomized to receive 0 ( deficient; n = 40), 2 ( basal requirement; control; n = 46), or 8 ( supplemented; n = 36) mg folate / kg diet for 32 weeks.	IL - 2,8,14,Gene_or_gene_product	mice,45,49,Organism	folate,174,180,Chemical	"[{""token"": ""IL - 2"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Organism""}, {""token"": ""folate"", ""start_span"": 174, ""end_span"": 180, ""type"": ""Chemical""}]"	train
At necropsy, all macroscopic colonic tumors were identified and histologically classified as dysplasia or adenocarcinoma.	colonic tumors,29,43,Cancer	dysplasia,93,102,Pathological_formation	adenocarcinoma,106,120,Cancer	"[{""token"": ""colonic tumors"", ""start_span"": 29, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""dysplasia"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Pathological_formation""}, {""token"": ""adenocarcinoma"", ""start_span"": 106, ""end_span"": 120, ""type"": ""Cancer""}]"	train
These data also suggest that folate deficiency may inhibit colorectal carcinogenesis in chronic UC.	folate,29,35,Chemical	colorectal,59,69,Multi	UC,96,98,Pathological_formation	"[{""token"": ""folate"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""colorectal"", ""start_span"": 59, ""end_span"": 69, ""type"": ""Multi""}, {""token"": ""UC"", ""start_span"": 96, ""end_span"": 98, ""type"": ""Pathological_formation""}]"	train
Most Group I compounds except doxorubicin ( which induced DNA fragmentation less effectively than others) activated caspase 3 more efficiently than Group II compounds.	doxorubicin,30,41,Chemical	DNA,58,61,Cellular_component	caspase 3,116,125,Gene_or_gene_product	"[{""token"": ""doxorubicin"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Cellular_component""}, {""token"": ""caspase 3"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}]"	train
The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.	tumour,14,20,Cancer	ING4,40,44,Gene_or_gene_product	brain tumour,55,67,Cancer	"[{""token"": ""tumour"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Cancer""}, {""token"": ""ING4"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain tumour"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Cancer""}]"	train
Here we report that a candidate tumour suppressor gene, ING4, is involved in regulating brain tumour growth and angiogenesis.	tumour,32,38,Cancer	ING4,56,60,Gene_or_gene_product	brain tumour,88,100,Cancer	"[{""token"": ""tumour"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Cancer""}, {""token"": ""ING4"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain tumour"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Cancer""}]"	train
TGFbeta1 was initially identified in culture media from transformed cells as part of a factor that could produce a transformed phenotype in a nontransformed cell line.	TGFbeta1,0,8,Gene_or_gene_product	transformed cells,56,73,Cell	nontransformed cell,142,161,Cell	"[{""token"": ""TGFbeta1"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""transformed cells"", ""start_span"": 56, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""nontransformed cell"", ""start_span"": 142, ""end_span"": 161, ""type"": ""Cell""}]"	train
Subsequently this activity was separated into TGFbeta and TGFalpha an EGF receptor ligand.	TGFbeta,46,53,Gene_or_gene_product	TGFalpha,58,66,Gene_or_gene_product	EGF,70,73,Gene_or_gene_product	"[{""token"": ""TGFbeta"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGFalpha"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}]"	train
It is proposed that the switch from tumor suppressor to oncogene reflects genetic or epigenetic alterations in signaling pathways in tumor cells that alter the readout from the TGFbeta1 pathway.	tumor,36,41,Cancer	tumor cells,133,144,Cell	TGFbeta1,177,185,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""tumor cells"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""TGFbeta1"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"	train
Clinical, laboratory, histopathological, and pharmacological evidence support the notion that the coagulation system, which is activated in most cancer patients, plays an important role in tumor biology.	cancer,145,151,Cancer	patients,152,160,Organism	tumor,189,194,Cancer	"[{""token"": ""cancer"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 189, ""end_span"": 194, ""type"": ""Cancer""}]"	train
Thrombin decreases the ability of endothelial cells to attach to basement membrane proteins.	Thrombin,0,8,Gene_or_gene_product	endothelial cells,34,51,Cell	basement membrane,65,82,Cellular_component	"[{""token"": ""Thrombin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 34, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""basement membrane"", ""start_span"": 65, ""end_span"": 82, ""type"": ""Cellular_component""}]"	train
These results could explain the angiogenic and tumor - promoting effect of thrombin and provide the basis for development of thrombin receptor mimetics or antagonists for therapeutic application.	tumor,47,52,Cancer	thrombin,75,83,Gene_or_gene_product	thrombin receptor,125,142,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""thrombin"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin receptor"", ""start_span"": 125, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"	train
However, after they formed tumors in nude mice, every clone acquired high metastatic ability and the gene amplification increased, with elevated mRNA expression.	tumors,27,33,Cancer	nude mice,37,46,Organism	clone,54,59,Cell	"[{""token"": ""tumors"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""nude mice"", ""start_span"": 37, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""clone"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Cell""}]"	train
The low metastatic and G - 418 - resistant H - 3 cells were co - cultured with BALB / c3T3 fibroblasts for 2 - 4 weeks.	G - 418,23,30,Chemical	H - 3 cells,43,54,Cell	BALB / c3T3 fibroblasts,79,102,Cell	"[{""token"": ""G - 418"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Chemical""}, {""token"": ""H - 3 cells"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""BALB / c3T3 fibroblasts"", ""start_span"": 79, ""end_span"": 102, ""type"": ""Cell""}]"	train
Fibroblasts of the host animal may thus have an important role in generating enhanced metastatic activity of H - 3 cells.	Fibroblasts,0,11,Cell	animal,24,30,Organism	H - 3 cells,109,120,Cell	"[{""token"": ""Fibroblasts"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""animal"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""H - 3 cells"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Cell""}]"	train
Western blot analysis demonstrated a > 2. 5 - fold increase in Fas protein expression, as well as elevation of the active forms of both caspase - 8 and caspase - 3.	Fas,63,66,Gene_or_gene_product	caspase - 8,136,147,Gene_or_gene_product	caspase - 3,152,163,Gene_or_gene_product	"[{""token"": ""Fas"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 8"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 3"", ""start_span"": 152, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}]"	train
These results suggest that apoptosis caused by elevated expression of Fas is involved in chemoprevention by lactoferrin of colon carcinogenesis.	Fas,70,73,Gene_or_gene_product	lactoferrin,108,119,Gene_or_gene_product	colon,123,128,Organ	"[{""token"": ""Fas"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""lactoferrin"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Organ""}]"	train
Dynein light chain 1, a p21 - activated kinase 1 - interacting substrate, promotes cancerous phenotypes.	Dynein light chain 1,0,20,Gene_or_gene_product	p21 - activated kinase 1,24,48,Gene_or_gene_product	cancerous,83,92,Cancer	"[{""token"": ""Dynein light chain 1"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21 - activated kinase 1"", ""start_span"": 24, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancerous"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Cancer""}]"	train
Pak1 associates with the complex of DLC1 and BimL, a proapoptotic BH3 - only protein, and phosphorylates both proteins.	Pak1,0,4,Gene_or_gene_product	DLC1,36,40,Gene_or_gene_product	BimL,45,49,Gene_or_gene_product	"[{""token"": ""Pak1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""DLC1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""BimL"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}]"	train
Phosphorylation of BimL by Pak1 prevents it from interacting with and inactivation of Bcl - 2, an antiapoptotic protein.	BimL,19,23,Gene_or_gene_product	Pak1,27,31,Gene_or_gene_product	Bcl - 2,86,93,Gene_or_gene_product	"[{""token"": ""BimL"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pak1"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}]"	train
DLC1 protein level is elevated in more than 90% of human breast tumors.	DLC1,0,4,Gene_or_gene_product	human,51,56,Organism	breast tumors,57,70,Cancer	"[{""token"": ""DLC1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""breast tumors"", ""start_span"": 57, ""end_span"": 70, ""type"": ""Cancer""}]"	train
Matrix metalloproteinases can collectively cleave all components of the extracellular matrix, with the endogenous tissue inhibitor of metalloproteinase - 1 regulating their activity.	Matrix metalloproteinases,0,25,Gene_or_gene_product	extracellular matrix,72,92,Cellular_component	tissue inhibitor of metalloproteinase - 1,114,155,Gene_or_gene_product	"[{""token"": ""Matrix metalloproteinases"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular matrix"", ""start_span"": 72, ""end_span"": 92, ""type"": ""Cellular_component""}, {""token"": ""tissue inhibitor of metalloproteinase - 1"", ""start_span"": 114, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"	train
Immunohistochemistry scores for matrix metalloproteinase - 9 expression were significantly elevated compared to controls in scar endothelial cells and fibroblasts from 2 until 12 and 20 weeks, respectively.	matrix metalloproteinase - 9,32,60,Gene_or_gene_product	scar endothelial cells,124,146,Cell	fibroblasts,151,162,Cell	"[{""token"": ""matrix metalloproteinase - 9"", ""start_span"": 32, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""scar endothelial cells"", ""start_span"": 124, ""end_span"": 146, ""type"": ""Cell""}, {""token"": ""fibroblasts"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Cell""}]"	train
These results show that matrix metalloproteinases are present at elevated levels during early wound healing, when angiogenesis occurs, and suggest that matrix metalloproteinase - 9 may play a significant role.	matrix metalloproteinases,24,49,Gene_or_gene_product	wound,94,99,Pathological_formation	matrix metalloproteinase - 9,152,180,Gene_or_gene_product	"[{""token"": ""matrix metalloproteinases"", ""start_span"": 24, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""wound"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Pathological_formation""}, {""token"": ""matrix metalloproteinase - 9"", ""start_span"": 152, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}]"	train
Enhanced IGF - 1 expression improves smooth muscle cell engraftment after cell transplantation.	IGF - 1,9,16,Gene_or_gene_product	smooth muscle cell,37,55,Cell	cell,74,78,Cell	"[{""token"": ""IGF - 1"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""smooth muscle cell"", ""start_span"": 37, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Cell""}]"	train
The functional benefit of cell transplantation after a myocardial infarction is diminished by early cell losses.	cell,26,30,Cell	myocardial,55,65,Multi	cell,100,104,Cell	"[{""token"": ""cell"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""myocardial"", ""start_span"": 55, ""end_span"": 65, ""type"": ""Multi""}, {""token"": ""cell"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Cell""}]"	train
The proportion of SMCs surviving in the implanted region was greater ( P less than 0. 05) in the IGF - 1 - transfected group than in the vector or cell controls.	SMCs,18,22,Cell	IGF - 1,97,104,Gene_or_gene_product	cell,147,151,Cell	"[{""token"": ""SMCs"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""IGF - 1"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Cell""}]"	train
Gene enhancement with IGF - 1 improved donor cell proliferation, survival, and engraftment after cell transplantation, perhaps mediated by enhanced angiogenesis and reduced apoptosis.	IGF - 1,22,29,Gene_or_gene_product	donor cell,39,49,Cell	cell,97,101,Cell	"[{""token"": ""IGF - 1"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""donor cell"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Cell""}]"	train
OBJECTIVE: To investigate the expression of PTEN and loss of heterozygosity ( LOH) of its epigenetic microsatellite in gastric carcinoma and explore their roles in progression of gastric carcinoma.	PTEN,44,48,Gene_or_gene_product	gastric carcinoma,119,136,Cancer	gastric carcinoma,179,196,Cancer	"[{""token"": ""PTEN"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinoma"", ""start_span"": 119, ""end_span"": 136, ""type"": ""Cancer""}, {""token"": ""gastric carcinoma"", ""start_span"": 179, ""end_span"": 196, ""type"": ""Cancer""}]"	train
Expression of PTEN mRNA and protein in normal gastric mucosa and gastric cancer was evaluated by RT - PCR and SABC immunohistochemistry, respectively.	PTEN,14,18,Gene_or_gene_product	gastric mucosa,46,60,Multi	gastric cancer,65,79,Cancer	"[{""token"": ""PTEN"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric mucosa"", ""start_span"": 46, ""end_span"": 60, ""type"": ""Multi""}, {""token"": ""gastric cancer"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Cancer""}]"	train
The positive rates of PTEN mRNA expression were 80. 4% ( 45 / 56), 45. 5% ( 5 / 11) and 32. 1% ( 18 / 56) in normal mucosa, early and advanced gastric carcinomas, respectively, while 78. 6% ( 44 / 56), 44. 5% ( 5 / 11) and 28. 6% ( 16 / 56) at the protein level.	PTEN,22,26,Gene_or_gene_product	mucosa,116,122,Multi	gastric carcinomas,143,161,Cancer	"[{""token"": ""PTEN"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""mucosa"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Multi""}, {""token"": ""gastric carcinomas"", ""start_span"": 143, ""end_span"": 161, ""type"": ""Cancer""}]"	train
PTEN mRNA and protein were less frequently expressed in early and advanced gastric carcinomas than that in normal gastric mucosa ( P < 0. 05).	PTEN,0,4,Gene_or_gene_product	gastric carcinomas,75,93,Cancer	gastric mucosa,114,128,Multi	"[{""token"": ""PTEN"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinomas"", ""start_span"": 75, ""end_span"": 93, ""type"": ""Cancer""}, {""token"": ""gastric mucosa"", ""start_span"": 114, ""end_span"": 128, ""type"": ""Multi""}]"	train
The expression of PTEN mRNA and protein was negatively correlated with lymph node metastasis of advanced gastric carcinomas ( P < 0. 05).	PTEN,18,22,Gene_or_gene_product	lymph node,71,81,Multi	gastric carcinomas,105,123,Cancer	"[{""token"": ""PTEN"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 71, ""end_span"": 81, ""type"": ""Multi""}, {""token"": ""gastric carcinomas"", ""start_span"": 105, ""end_span"": 123, ""type"": ""Cancer""}]"	train
3H - Cytosine arabinoside incorporation into the DNA was enhanced 1. 33 - to 18. 3 - fold over respective controls in 14 of 17 patients.	3H - Cytosine arabinoside,0,25,Chemical	DNA,49,52,Cellular_component	patients,127,135,Organism	"[{""token"": ""3H - Cytosine arabinoside"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Cellular_component""}, {""token"": ""patients"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Organism""}]"	train
Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study.	monocarboxylate transporters,13,41,Gene_or_gene_product	cell,113,117,Cell	malignant glioma,127,143,Cancer	"[{""token"": ""monocarboxylate transporters"", ""start_span"": 13, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""malignant glioma"", ""start_span"": 127, ""end_span"": 143, ""type"": ""Cancer""}]"	train
Hypoxia - inducible factor - 1 ( HIF - 1) is one of the key mammalian transcription factors and shows increased levels in both protein stability and intrinsic transcriptional activity during low oxygen tension.	Hypoxia - inducible factor - 1,0,30,Gene_or_gene_product	HIF - 1,33,40,Gene_or_gene_product	oxygen,195,201,Chemical	"[{""token"": ""Hypoxia - inducible factor - 1"", ""start_span"": 0, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""oxygen"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Chemical""}]"	train
Our data showed that under hypoxia the secreted sTie2 selectively inhibited tube formation and migration capacities of endothelial cells in vitro.	sTie2,48,53,Gene_or_gene_product	tube,76,80,Tissue	endothelial cells,119,136,Cell	"[{""token"": ""sTie2"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""tube"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Tissue""}, {""token"": ""endothelial cells"", ""start_span"": 119, ""end_span"": 136, ""type"": ""Cell""}]"	train
Hence, we propose that the vector system, 5xHRE / SV40 / sTie2, might be a useful tool for down - regulating tumor angiogenesis under hypoxic condition.	SV40,50,54,Gene_or_gene_product	sTie2,57,62,Gene_or_gene_product	tumor,109,114,Cancer	"[{""token"": ""SV40"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""sTie2"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Cancer""}]"	train
Galpha ( 12), the alpha - subunit of the G12 family of heterotrimeric G proteins is involved in the regulation of cell proliferation and neoplastic transformation.	G12,41,44,Gene_or_gene_product	heterotrimeric G proteins,55,80,Gene_or_gene_product	cell,114,118,Cell	"[{""token"": ""G12"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""heterotrimeric G proteins"", ""start_span"": 55, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Cell""}]"	train
GTPase - deficient, constitutively activated mutant of Galpha ( 12) ( Galpha ( 12) Q229L or Galpha ( 12) QL) has been previously shown to induce oncogenic transformation of NIH3T3 cells promoting serum - and anchorage - independent growth.	GTPase,0,6,Gene_or_gene_product	NIH3T3 cells,173,185,Cell	serum,196,201,Organism_substance	"[{""token"": ""GTPase"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH3T3 cells"", ""start_span"": 173, ""end_span"": 185, ""type"": ""Cell""}, {""token"": ""serum"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Organism_substance""}]"	train
Thus, our results from differential proteome analysis presented here report for the first time a role for SET in Galpha ( 12) - mediated signaling pathways and a role for Galpha ( 12) in the regulation of the leukemia - associated SET - protein expression.	SET,106,109,Gene_or_gene_product	leukemia,209,217,Cancer	SET,231,234,Gene_or_gene_product	"[{""token"": ""SET"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukemia"", ""start_span"": 209, ""end_span"": 217, ""type"": ""Cancer""}, {""token"": ""SET"", ""start_span"": 231, ""end_span"": 234, ""type"": ""Gene_or_gene_product""}]"	train
EXPERIMENTAL DESIGN: In the present study, we investigated the effects of 2ME2 alone and in combination with paclitaxel, an active agent in recurrent or advanced head and neck squamous cell carcinoma.	2ME2,74,78,Chemical	paclitaxel,109,119,Chemical	head and neck squamous cell carcinoma,162,199,Cancer	"[{""token"": ""2ME2"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""paclitaxel"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""head and neck squamous cell carcinoma"", ""start_span"": 162, ""end_span"": 199, ""type"": ""Cancer""}]"	train
CONCLUSIONS: These results provide support for the use of 2ME2 in combination with paclitaxel for the treatment of recurrent or advanced head and neck squamous cell carcinoma.	2ME2,58,62,Chemical	paclitaxel,83,93,Chemical	head and neck squamous cell carcinoma,137,174,Cancer	"[{""token"": ""2ME2"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""paclitaxel"", ""start_span"": 83, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""head and neck squamous cell carcinoma"", ""start_span"": 137, ""end_span"": 174, ""type"": ""Cancer""}]"	train
Key players in this process are the hypoxia - inducible factors ( HIF - 1alpha to 3alpha).	hypoxia - inducible factors,36,63,Gene_or_gene_product	HIF - 1alpha,66,78,Gene_or_gene_product	3alpha,82,88,Gene_or_gene_product	"[{""token"": ""hypoxia - inducible factors"", ""start_span"": 36, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""3alpha"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}]"	train
With regard to differentiation, hypoxic cells lost their neuronal / neuroendocrine features and gained marker gene expression associated with an immature, neural crest - like phenotype.	hypoxic cells,32,45,Cell	neuronal,57,65,Cell	neuroendocrine,68,82,Cell	"[{""token"": ""hypoxic cells"", ""start_span"": 32, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""neuronal"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""neuroendocrine"", ""start_span"": 68, ""end_span"": 82, ""type"": ""Cell""}]"	train
One such receptor, VEGFR - 2 / KDR, plays a key role in VEGF - induced angiogenesis.	VEGFR - 2,19,28,Gene_or_gene_product	KDR,31,34,Gene_or_gene_product	VEGF,56,60,Gene_or_gene_product	"[{""token"": ""VEGFR - 2"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}]"	train
Here, we expressed the catalytic domain of VEGFR - 2 as a soluble active kinase using Bac - to - Bac expression system, and investigated correlations between VEGFR - 2 activity and enzyme concentration, ATP concentration, substrate concentration and divalent cation type.	VEGFR - 2,43,52,Gene_or_gene_product	VEGFR - 2,158,167,Gene_or_gene_product	ATP,203,206,Chemical	"[{""token"": ""VEGFR - 2"", ""start_span"": 43, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATP"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Chemical""}]"	train
Hemostatic factors play a crucial role in generating thrombotic plugs at sites of vascular damage ( atherothrombosis).	Hemostatic factors,0,18,Gene_or_gene_product	thrombotic plugs,53,69,Pathological_formation	vascular,82,90,Multi	"[{""token"": ""Hemostatic factors"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombotic plugs"", ""start_span"": 53, ""end_span"": 69, ""type"": ""Pathological_formation""}, {""token"": ""vascular"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Multi""}]"	train
Autopsy studies have revealed that intimal thickening represents the first stage of atherosclerosis and that lipid - rich plaque arises from such lesions.	intimal,35,42,Tissue	lipid - rich plaque,109,128,Pathological_formation	lesions,146,153,Pathological_formation	"[{""token"": ""intimal"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Tissue""}, {""token"": ""lipid - rich plaque"", ""start_span"": 109, ""end_span"": 128, ""type"": ""Pathological_formation""}, {""token"": ""lesions"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Pathological_formation""}]"	train
Platelets release several growth factors and bioactive agents that play a central role in development of not only thrombus but also of intimal thickening.	Platelets,0,9,Cell	thrombus,114,122,Pathological_formation	intimal,135,142,Tissue	"[{""token"": ""Platelets"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Cell""}, {""token"": ""thrombus"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Pathological_formation""}, {""token"": ""intimal"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Tissue""}]"	train
Factors including thrombin and fibrin, which are downstream of the coagulation cascade activated by TF, also contribute to atherosclerosis.	thrombin,18,26,Gene_or_gene_product	fibrin,31,37,Gene_or_gene_product	TF,100,102,Gene_or_gene_product	"[{""token"": ""thrombin"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibrin"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""TF"", ""start_span"": 100, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}]"	train
Hereditary paraganglioma / pheochromocytoma and inherited succinate dehydrogenase deficiency.	paraganglioma,11,24,Cancer	pheochromocytoma,27,43,Cancer	succinate dehydrogenase,58,81,Gene_or_gene_product	"[{""token"": ""paraganglioma"", ""start_span"": 11, ""end_span"": 24, ""type"": ""Cancer""}, {""token"": ""pheochromocytoma"", ""start_span"": 27, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""succinate dehydrogenase"", ""start_span"": 58, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}]"	train
These discoveries have dramatically changed the work - up and genetic counseling of patients and families with paragangliomas and / or pheochromocytomas.	patients,84,92,Organism	paragangliomas,111,125,Cancer	pheochromocytomas,135,152,Cancer	"[{""token"": ""patients"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Organism""}, {""token"": ""paragangliomas"", ""start_span"": 111, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""pheochromocytomas"", ""start_span"": 135, ""end_span"": 152, ""type"": ""Cancer""}]"	train
The INK4 family of proteins negatively regulates cell cycle progression at the G ( 1) - S transition by inhibiting cyclin - dependent kinases.	INK4,4,8,Gene_or_gene_product	cell,49,53,Cell	cyclin - dependent kinases,115,141,Gene_or_gene_product	"[{""token"": ""INK4"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""cyclin - dependent kinases"", ""start_span"": 115, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}]"	train
We conducted a retrospective medical record review of patients treated with rofecoxib for acute haemarthrosis, chronic synovitis, target joint or pain.	patients,54,62,Organism	rofecoxib,76,85,Chemical	joint,137,142,Multi	"[{""token"": ""patients"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""rofecoxib"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Chemical""}, {""token"": ""joint"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Multi""}]"	train
Angiostatin and thalidomide both inhibited tumor growth by about 55%.	Angiostatin,0,11,Gene_or_gene_product	thalidomide,16,27,Chemical	tumor,43,48,Cancer	"[{""token"": ""Angiostatin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""thalidomide"", ""start_span"": 16, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Cancer""}]"	train
BACKGROUND: The effects of a rectified semi - sinewave signal ( 15 mT amplitude, 120 pulses per second, EMF Therapeutics, Inc.) ( TEMF) alone and in combination with gamma irradiation ( IR) therapy in nude mice bearing a human MDA MB231 breast cancer xenograft were tested.	nude mice,201,210,Organism	human,221,226,Organism	MDA MB231 breast cancer xenograft,227,260,Cancer	"[{""token"": ""nude mice"", ""start_span"": 201, ""end_span"": 210, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 221, ""end_span"": 226, ""type"": ""Organism""}, {""token"": ""MDA MB231 breast cancer xenograft"", ""start_span"": 227, ""end_span"": 260, ""type"": ""Cancer""}]"	train
RESULTS: Most tumors less than 35 mm3 were white but tumors greater than 35 mm3 were pink and had a vascularized capsule.	tumors,14,20,Cancer	tumors,53,59,Cancer	capsule,113,120,Cancer	"[{""token"": ""tumors"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Cancer""}, {""token"": ""tumors"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""capsule"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Cancer""}]"	train
The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.	adenomatous polyposis coli,23,49,Gene_or_gene_product	mouse,62,67,Organism	intestinal,68,78,Organ	"[{""token"": ""adenomatous polyposis coli"", ""start_span"": 23, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""intestinal"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Organ""}]"	train
Although both hypomorphic heterozygotes developed intestinal polyps, tumor multiplicities were much lower than that in Apc ( Delta716) mice, heterozygotes of an Apc null allele.	intestinal polyps,50,67,Pathological_formation	tumor,69,74,Cancer	Apc,119,122,Gene_or_gene_product	"[{""token"": ""intestinal polyps"", ""start_span"": 50, ""end_span"": 67, ""type"": ""Pathological_formation""}, {""token"": ""tumor"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""Apc"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"	train
We further estimated the threshold of APC protein level that forms one polyp per mouse as approximately 15% of the wild type.	APC,38,41,Gene_or_gene_product	polyp,71,76,Pathological_formation	mouse,81,86,Organism	"[{""token"": ""APC"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""polyp"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Pathological_formation""}, {""token"": ""mouse"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Organism""}]"	train
Recent studies on factors involved in tumor vascular development have identified new therapeutic targets for inhibiting tumor neovascularization and thus tumor progression.	tumor vascular,38,52,Multi	tumor,120,125,Cancer	tumor,154,159,Cancer	"[{""token"": ""tumor vascular"", ""start_span"": 38, ""end_span"": 52, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Cancer""}]"	train
However, the process of tumor blood vessel formation is complex, and each tumor exhibits unique features in its vasculature.	tumor blood vessel,24,42,Multi	tumor,74,79,Cancer	vasculature,112,123,Multi	"[{""token"": ""tumor blood vessel"", ""start_span"": 24, ""end_span"": 42, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""vasculature"", ""start_span"": 112, ""end_span"": 123, ""type"": ""Multi""}]"	train
In addition, selected novel classes of antivascular therapies, including those targeting tumor endothelial cells and other components of the tumor vasculature, are summarized.	antivascular,39,51,Multi	tumor endothelial cells,89,112,Cell	tumor vasculature,141,158,Multi	"[{""token"": ""antivascular"", ""start_span"": 39, ""end_span"": 51, ""type"": ""Multi""}, {""token"": ""tumor endothelial cells"", ""start_span"": 89, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""tumor vasculature"", ""start_span"": 141, ""end_span"": 158, ""type"": ""Multi""}]"	train
Converging studies from many investigators indicate that RUNX1 has a critical role in the correct maintenance of essential cellular functions during embryonic development and after birth.	RUNX1,57,62,Gene_or_gene_product	cellular,123,131,Cell	embryonic,149,158,Developing_anatomical_structure	"[{""token"": ""RUNX1"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Cell""}, {""token"": ""embryonic"", ""start_span"": 149, ""end_span"": 158, ""type"": ""Developing_anatomical_structure""}]"	train
The discovery that this gene is also frequently mutated in human leukemia has increased the interest in the role that RUNX1 plays in both normal and transforming pathways.	human,59,64,Organism	leukemia,65,73,Cancer	RUNX1,118,123,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Organism""}, {""token"": ""leukemia"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Cancer""}, {""token"": ""RUNX1"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"	train
Domain 5 of cleaved high molecular weight kininogen inhibits endothelial cell migration through Akt.	high molecular weight kininogen,20,51,Gene_or_gene_product	endothelial cell,61,77,Cell	Akt,96,99,Gene_or_gene_product	"[{""token"": ""high molecular weight kininogen"", ""start_span"": 20, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 61, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""Akt"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}]"	train
Angiogenesis, new blood vessel formation, is a multistep process, precisely regulated by pro - angiogenic cytokines, which stimulate endothelial cells to migrate, proliferate and differentiate to form new capillary microvessels.	blood vessel,18,30,Multi	endothelial cells,133,150,Cell	capillary microvessels,205,227,Tissue	"[{""token"": ""blood vessel"", ""start_span"": 18, ""end_span"": 30, ""type"": ""Multi""}, {""token"": ""endothelial cells"", ""start_span"": 133, ""end_span"": 150, ""type"": ""Cell""}, {""token"": ""capillary microvessels"", ""start_span"": 205, ""end_span"": 227, ""type"": ""Tissue""}]"	train
Excessive vascular development and blood vessel remodeling appears in psoriasis, rheumatoid arthritis, diabetic retinopathy and solid tumors formation.	vascular,10,18,Multi	blood vessel,35,47,Multi	solid tumors,128,140,Cancer	"[{""token"": ""vascular"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Multi""}, {""token"": ""blood vessel"", ""start_span"": 35, ""end_span"": 47, ""type"": ""Multi""}, {""token"": ""solid tumors"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Cancer""}]"	train
Administration of thalidomide at the concentration of 0. 01 microM increased cell migration, while at 10 microM, it decreased cell migration.	thalidomide,18,29,Chemical	cell,77,81,Cell	cell,126,130,Cell	"[{""token"": ""thalidomide"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Cell""}]"	train
Thalidomide in concentrations from 0. 1 microM to 10 microM did not change cell proliferation of 72 - h cell cultures.	Thalidomide,0,11,Chemical	cell,75,79,Cell	cell cultures,104,117,Cell	"[{""token"": ""Thalidomide"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""cell cultures"", ""start_span"": 104, ""end_span"": 117, ""type"": ""Cell""}]"	train
We conclude that anti - angiogenic action of thalidomide is due to direct inhibitory action on VEGF secretion and capillary microvessel formation as well as immunomodulatory influence on EA. hy 926 cells migration and adhesion.	thalidomide,45,56,Chemical	VEGF,95,99,Gene_or_gene_product	capillary microvessel,114,135,Tissue	"[{""token"": ""thalidomide"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary microvessel"", ""start_span"": 114, ""end_span"": 135, ""type"": ""Tissue""}]"	train
Regulation of skin microvasculature angiogenesis, cell migration, and permeability by a specific inhibitor of PKCalpha.	skin microvasculature,14,35,Tissue	cell,50,54,Cell	PKCalpha,110,118,Gene_or_gene_product	"[{""token"": ""skin microvasculature"", ""start_span"": 14, ""end_span"": 35, ""type"": ""Tissue""}, {""token"": ""cell"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""PKCalpha"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}]"	train
These studies therefore indicate a specific and a regulatory role of the PKCalpha isoform in three major endothelial cell functions that are important in the maintenance of microvascular homeostasis.	PKCalpha,73,81,Gene_or_gene_product	endothelial cell,105,121,Cell	microvascular,173,186,Tissue	"[{""token"": ""PKCalpha"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 105, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""microvascular"", ""start_span"": 173, ""end_span"": 186, ""type"": ""Tissue""}]"	train
hTERT activity is associated with nodal metastases and cellular proliferation.	hTERT,0,5,Gene_or_gene_product	nodal,34,39,Multi	cellular,55,63,Cell	"[{""token"": ""hTERT"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""nodal"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Multi""}, {""token"": ""cellular"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Cell""}]"	train
An understanding of the molecular basis of TSP - 1 - mediated inhibition of angiogenesis and tumor progression will aid in the development of novel therapeutics for the treatment of cancer.	TSP - 1,43,50,Gene_or_gene_product	tumor,93,98,Cancer	cancer,182,188,Cancer	"[{""token"": ""TSP - 1"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 182, ""end_span"": 188, ""type"": ""Cancer""}]"	train
The ability of LRP - 1 to regulate expression of the factors identified here suggests a role for LRP - 1 in determining blood vessel structure and in angiogenesis.	LRP - 1,15,22,Gene_or_gene_product	LRP - 1,97,104,Gene_or_gene_product	blood vessel,120,132,Multi	"[{""token"": ""LRP - 1"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP - 1"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessel"", ""start_span"": 120, ""end_span"": 132, ""type"": ""Multi""}]"	train
Similarly, flow cytometric measurements revealed that leukocyte apoptosis was increased in MTX - treated animals, while L - Car reversed these effects.	leukocyte,54,63,Cell	MTX,91,94,Chemical	L - Car,120,127,Chemical	"[{""token"": ""leukocyte"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""MTX"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""L - Car"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Chemical""}]"	train
Together, these findings suggest that NCAM may limit tumor cell metastasis by stabilizing the microvessel wall.	NCAM,38,42,Gene_or_gene_product	tumor cell,53,63,Cell	microvessel wall,94,110,Tissue	"[{""token"": ""NCAM"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cell"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""microvessel wall"", ""start_span"": 94, ""end_span"": 110, ""type"": ""Tissue""}]"	train
NF - kappaB and IKK as therapeutic targets in cancer.	NF - kappaB,0,11,Gene_or_gene_product	IKK,16,19,Gene_or_gene_product	cancer,46,52,Cancer	"[{""token"": ""NF - kappaB"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""IKK"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Cancer""}]"	train
A role for NF - kappaB in cancer cells appears to involve regulation of cell proliferation, control of apoptosis, promotion of angiogenesis, and stimulation of invasion / metastasis.	NF - kappaB,11,22,Gene_or_gene_product	cancer cells,26,38,Cell	cell,72,76,Cell	"[{""token"": ""NF - kappaB"", ""start_span"": 11, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 26, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Cell""}]"	train
However, other experimental data indicate that NF - kappaB can play a tumor suppressor role in certain settings and that it can be important in promoting an apoptotic signal downstream of certain cancer therapy regimens.	NF - kappaB,47,58,Gene_or_gene_product	tumor,70,75,Cancer	cancer,196,202,Cancer	"[{""token"": ""NF - kappaB"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Cancer""}]"	train
Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.	Runx2,0,5,Gene_or_gene_product	MYC,10,13,Gene_or_gene_product	lymphoma,29,37,Cancer	"[{""token"": ""Runx2"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""MYC"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphoma"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Cancer""}]"	train
As shown previously, ectopic expression of Runx2 in the thymus leads to a preneoplastic state defined by an accumulation of cells with an immature phenotype and a low proliferative rate.	Runx2,43,48,Gene_or_gene_product	thymus,56,62,Organ	cells,124,129,Cell	"[{""token"": ""Runx2"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""thymus"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Organ""}, {""token"": ""cells"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Cell""}]"	train
Furthermore, the Runx2 / MYC combination overcomes the requirement for genetic inactivation of the p53 pathway in vivo.	Runx2,17,22,Gene_or_gene_product	MYC,25,28,Gene_or_gene_product	p53,99,102,Gene_or_gene_product	"[{""token"": ""Runx2"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""MYC"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}]"	train
Paclitaxel, a potent anti - neoplastic agent, has been found to be effective against several tumours, including cervical cancer.	Paclitaxel,0,10,Chemical	tumours,93,100,Cancer	cervical cancer,112,127,Cancer	"[{""token"": ""Paclitaxel"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical""}, {""token"": ""tumours"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""cervical cancer"", ""start_span"": 112, ""end_span"": 127, ""type"": ""Cancer""}]"	train
The aim of this study was to investigate the molecular pathway of the cytotoxic effect of paclitaxel in human cervical cancer cell lines.	paclitaxel,90,100,Chemical	human,104,109,Organism	cervical cancer cell lines,110,136,Cell	"[{""token"": ""paclitaxel"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Organism""}, {""token"": ""cervical cancer cell lines"", ""start_span"": 110, ""end_span"": 136, ""type"": ""Cell""}]"	train
Four human cervical cancer cell lines were treated for 24 h with various concentration of paclitaxel, and the sensitivity was analysed by an MTT assay.	human,5,10,Organism	cervical cancer cell lines,11,37,Cell	paclitaxel,90,100,Chemical	"[{""token"": ""human"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Organism""}, {""token"": ""cervical cancer cell lines"", ""start_span"": 11, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""paclitaxel"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Chemical""}]"	train
Our results showed that HeLa cells demonstrated the highest sensitivity to paclitaxel, whereas CaSki cells showed the lowest.	HeLa cells,24,34,Cell	paclitaxel,75,85,Chemical	CaSki cells,95,106,Cell	"[{""token"": ""HeLa cells"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""paclitaxel"", ""start_span"": 75, ""end_span"": 85, ""type"": ""Chemical""}, {""token"": ""CaSki cells"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Cell""}]"	train
Another marker being investigated in the context of vascular dysfunction and coagulopathy is the endothelial microparticle ( EMP).	vascular,52,60,Multi	endothelial microparticle,97,122,Cellular_component	EMP,125,128,Cellular_component	"[{""token"": ""vascular"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Multi""}, {""token"": ""endothelial microparticle"", ""start_span"": 97, ""end_span"": 122, ""type"": ""Cellular_component""}, {""token"": ""EMP"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Cellular_component""}]"	train
GDP and AGE receptors: mechanisms of peritoneal damage.	GDP,0,3,Chemical	AGE,8,11,Chemical	peritoneal,37,47,Multi	"[{""token"": ""GDP"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""AGE"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""peritoneal"", ""start_span"": 37, ""end_span"": 47, ""type"": ""Multi""}]"	train
Structural changes were promoted by toxicity of glucose degradation products ( GDPs) which are generated during heat sterilization in peritoneal dialysis fluids ( PDFs).	glucose degradation products,48,76,Chemical	GDPs,79,83,Chemical	peritoneal,134,144,Multi	"[{""token"": ""glucose degradation products"", ""start_span"": 48, ""end_span"": 76, ""type"": ""Chemical""}, {""token"": ""GDPs"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Chemical""}, {""token"": ""peritoneal"", ""start_span"": 134, ""end_span"": 144, ""type"": ""Multi""}]"	train
Besides their direct toxicity GDPs promote formation of advanced glycation endproducts ( AGEs).	GDPs,30,34,Chemical	advanced glycation endproducts,56,86,Chemical	AGEs,89,93,Chemical	"[{""token"": ""GDPs"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""advanced glycation endproducts"", ""start_span"": 56, ""end_span"": 86, ""type"": ""Chemical""}, {""token"": ""AGEs"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Chemical""}]"	train
The effects of PDFs with different amounts of GDPs were compared on morphological changes in the peritoneal membrane in a RAGE - / - mouse model.	GDPs,46,50,Chemical	peritoneal membrane,97,116,Multi	RAGE,122,126,Gene_or_gene_product	"[{""token"": ""GDPs"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""peritoneal membrane"", ""start_span"": 97, ""end_span"": 116, ""type"": ""Multi""}, {""token"": ""RAGE"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}]"	train
Hyperfibrinogenemia ( > 310 mg / dl) was independently associated with lymph node ( Odds Ratio; 2. 342, P = 0. 0032) and liver ( Odds Ratio; 2. 933, P = 0. 0147) metastasis, not with peritoneal metastasis in this series.	lymph node,71,81,Multi	liver,121,126,Organ	peritoneal,183,193,Multi	"[{""token"": ""lymph node"", ""start_span"": 71, ""end_span"": 81, ""type"": ""Multi""}, {""token"": ""liver"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Organ""}, {""token"": ""peritoneal"", ""start_span"": 183, ""end_span"": 193, ""type"": ""Multi""}]"	train
CONCLUSION: Our results might support the idea that hyperfibrinogenemia can augment lymphatic and hematogeneous metastasis of advanced gastric cancer, which is major determinant of the prognosis in T2 gastric cancer.	lymphatic,84,93,Cell	gastric cancer,135,149,Cancer	T2 gastric cancer,198,215,Cancer	"[{""token"": ""lymphatic"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""gastric cancer"", ""start_span"": 135, ""end_span"": 149, ""type"": ""Cancer""}, {""token"": ""T2 gastric cancer"", ""start_span"": 198, ""end_span"": 215, ""type"": ""Cancer""}]"	train
Our aim is to verify the alterations in the HRK gene in primary central nervous system lymphomas ( PCNSLs).	HRK,44,47,Gene_or_gene_product	primary central nervous system lymphomas,56,96,Cancer	PCNSLs,99,105,Cancer	"[{""token"": ""HRK"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary central nervous system lymphomas"", ""start_span"": 56, ""end_span"": 96, ""type"": ""Cancer""}, {""token"": ""PCNSLs"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Cancer""}]"	train
RESULTS: A total of 13 PCNSLs ( 31%) demonstrated hypermethylation in either the promoter or exon 1; loss of HRK expression was immunohistochemically observed in 9 tumors and was significantly associated with promoter methylation.	PCNSLs,23,29,Cancer	HRK,109,112,Gene_or_gene_product	tumors,164,170,Cancer	"[{""token"": ""PCNSLs"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""HRK"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Cancer""}]"	train
Comet assay revealed a late onset of DNA breaks in the presence of 2 - DG following irradiation only in spheroids, which corroborated well with the late onset of oxidative stress.	DNA,37,40,Cellular_component	2 - DG,67,73,Chemical	spheroids,104,113,Cell	"[{""token"": ""DNA"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Cellular_component""}, {""token"": ""2 - DG"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Chemical""}, {""token"": ""spheroids"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Cell""}]"	train
There is evidence in experimental and clinical studies that adult bone marrow - derived stem cells and endothelial progenitor cells participate in the development of new blood vessels, called neoangiogenesis or neovascularization.	bone marrow - derived stem cells,66,98,Cell	endothelial progenitor cells,103,131,Cell	blood vessels,170,183,Multi	"[{""token"": ""bone marrow - derived stem cells"", ""start_span"": 66, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""endothelial progenitor cells"", ""start_span"": 103, ""end_span"": 131, ""type"": ""Cell""}, {""token"": ""blood vessels"", ""start_span"": 170, ""end_span"": 183, ""type"": ""Multi""}]"	train
We examined the effect of distraction rate on blood vessel growth in intramembraneous ossification after vertical distraction osteogenesis in the human mandible.	blood vessel,46,58,Multi	human,146,151,Organism	mandible,152,160,Organ	"[{""token"": ""blood vessel"", ""start_span"": 46, ""end_span"": 58, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Organism""}, {""token"": ""mandible"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Organ""}]"	train
Six edentulous patients ( aged 60 + / - 9 years) with a severely atrophic mandible underwent bone augmentation with distraction osteogenesis.	patients,15,23,Organism	mandible,74,82,Organ	bone,93,97,Tissue	"[{""token"": ""patients"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Organism""}, {""token"": ""mandible"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Organ""}, {""token"": ""bone"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Tissue""}]"	train
For distraction of the human mandible in elderly patients, a distraction rate of 0. 5 mm / day seems beneficial.	human,23,28,Organism	mandible,29,37,Organ	patients,49,57,Organism	"[{""token"": ""human"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""mandible"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Organ""}, {""token"": ""patients"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Organism""}]"	train
AIM: To determine whether a variety of ciliary body tumours synthesise opticin to characterise further its role in ciliary body health and disease.	ciliary body tumours,39,59,Cancer	opticin,71,78,Gene_or_gene_product	ciliary body,115,127,Multi	"[{""token"": ""ciliary body tumours"", ""start_span"": 39, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""opticin"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""ciliary body"", ""start_span"": 115, ""end_span"": 127, ""type"": ""Multi""}]"	train
Punica granatum ( pomegranate) and its potential for prevention and treatment of inflammation and cancer.	Punica granatum,0,15,Organism	pomegranate,18,29,Organism	cancer,98,104,Cancer	"[{""token"": ""Punica granatum"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""pomegranate"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Cancer""}]"	train
The pomegranate tree, Punica granatum, especially its fruit, possesses a vast ethnomedical history and represents a phytochemical reservoir of heuristic medicinal value.	pomegranate,4,15,Organism	tree,16,20,Organism_subdivision	Punica granatum,22,37,Organism	"[{""token"": ""pomegranate"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""tree"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Organism_subdivision""}, {""token"": ""Punica granatum"", ""start_span"": 22, ""end_span"": 37, ""type"": ""Organism""}]"	train
These data suggest that inhibition of B16F10 melanoma metastasis by rk - 2 was caused by inhibition of neovascularization and reduction of matrix metalloproteinase expression.	B16F10 melanoma,38,53,Cancer	rk - 2,68,74,Gene_or_gene_product	matrix metalloproteinase,139,163,Gene_or_gene_product	"[{""token"": ""B16F10 melanoma"", ""start_span"": 38, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""rk - 2"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase"", ""start_span"": 139, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}]"	train
WIT003, as well as pure 20 - HETE, stimulated EC proliferation by approximately 40%.	WIT003,0,6,Chemical	20 - HETE,24,33,Chemical	EC,46,48,Cell	"[{""token"": ""WIT003"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""20 - HETE"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""EC"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Cell""}]"	train
We have reported important benefits and survival with an immunotherapy schedule in patients with endocrine - dependent breast cancer and distant metastases.	patients,83,91,Organism	endocrine,97,106,Anatomical_system	breast cancer,119,132,Cancer	"[{""token"": ""patients"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""endocrine"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Anatomical_system""}, {""token"": ""breast cancer"", ""start_span"": 119, ""end_span"": 132, ""type"": ""Cancer""}]"	train
Furthermore, Trib1 by itself is a novel myeloid oncogene, enhancing phosphorylation of ERK, resulting in inhibition of apoptosis.	Trib1,13,18,Gene_or_gene_product	myeloid,40,47,Cell	ERK,87,90,Gene_or_gene_product	"[{""token"": ""Trib1"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""ERK"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}]"	train
Organic peroxides, widely used in the chemical and pharmaceutical industries, can act as skin tumor promoters and cause epidermal hyperplasia.	Organic peroxides,0,17,Chemical	skin tumor,89,99,Cancer	epidermal hyperplasia,120,141,Pathological_formation	"[{""token"": ""Organic peroxides"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""skin tumor"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Cancer""}, {""token"": ""epidermal hyperplasia"", ""start_span"": 120, ""end_span"": 141, ""type"": ""Pathological_formation""}]"	train
Hyperforin ( Hyp), a polyphenol - derivative of St.	Hyperforin,0,10,Chemical	Hyp,13,16,Chemical	polyphenol,21,31,Chemical	"[{""token"": ""Hyperforin"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical""}, {""token"": ""Hyp"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Chemical""}, {""token"": ""polyphenol"", ""start_span"": 21, ""end_span"": 31, ""type"": ""Chemical""}]"	train
OBJECTIVES: This study sought to assess the cellular and histologic basis of irreversible pulmonary hypertension ( PHT) in the clinical setting of congenital heart disease ( CHD).	cellular,44,52,Cell	pulmonary,90,99,Organ	heart,158,163,Organ	"[{""token"": ""cellular"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""pulmonary"", ""start_span"": 90, ""end_span"": 99, ""type"": ""Organ""}, {""token"": ""heart"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Organ""}]"	train
Immunostaining for endothelial nitric oxide synthase, vascular endothelial growth factor, and CD34 ( markers of vasoactivity and neoangiogenesis) was also performed.	endothelial nitric oxide synthase,19,52,Gene_or_gene_product	vascular endothelial growth factor,54,88,Gene_or_gene_product	CD34,94,98,Gene_or_gene_product	"[{""token"": ""endothelial nitric oxide synthase"", ""start_span"": 19, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 54, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD34"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}]"	train
RESULTS: The antiapoptotic protein Bcl - 2 was highly expressed by pulmonary endothelial cells in all cases of irreversible PHT but in no cases of reversible PHT, nor in control patients ( p less than 0. 001).	Bcl - 2,35,42,Gene_or_gene_product	pulmonary endothelial cells,67,94,Cell	patients,178,186,Organism	"[{""token"": ""Bcl - 2"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""pulmonary endothelial cells"", ""start_span"": 67, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Organism""}]"	train
Irreversible PHT cases were also more likely to show compensatory upregulation of vascular endothelial growth factor and new small vessel formation at the sites of native vessel stenosis or occlusion ( p less than 0. 001).	vascular endothelial growth factor,82,116,Gene_or_gene_product	vessel,131,137,Multi	vessel,171,177,Multi	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 82, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""vessel"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Multi""}, {""token"": ""vessel"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Multi""}]"	train
These changes are associated with intimal proliferation and vessel narrowing, and thereby may contribute to clinical outcomes associated with pulmonary hypertension.	intimal,34,41,Tissue	vessel,60,66,Multi	pulmonary,142,151,Organ	"[{""token"": ""intimal"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Tissue""}, {""token"": ""vessel"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Multi""}, {""token"": ""pulmonary"", ""start_span"": 142, ""end_span"": 151, ""type"": ""Organ""}]"	train
Inhibition of Dll4 - mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion.	Dll4,14,18,Gene_or_gene_product	vessels,74,81,Multi	tissue,102,108,Tissue	"[{""token"": ""Dll4"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""vessels"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Multi""}, {""token"": ""tissue"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Tissue""}]"	train
Dll4 is one of the Notch ligands that regulates arterial specification and maturation events.	Dll4,0,4,Gene_or_gene_product	Notch,19,24,Gene_or_gene_product	arterial,48,56,Multi	"[{""token"": ""Dll4"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""Notch"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""arterial"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Multi""}]"	train
SWAP - 70 is a phosphatidylinositol trisphosphate ( PtdIns ( 3, 4, 5) P ( 3)) binding protein, which acts in F - actin rearrangement.	SWAP - 70,0,9,Gene_or_gene_product	phosphatidylinositol trisphosphate,15,49,Chemical	F - actin,109,118,Gene_or_gene_product	"[{""token"": ""SWAP - 70"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphatidylinositol trisphosphate"", ""start_span"": 15, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""F - actin"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}]"	train
In this study, we show that Tsg101 is highly expressed in a subset of invasive human breast cancers.	Tsg101,28,34,Gene_or_gene_product	human,79,84,Organism	breast cancers,85,99,Cancer	"[{""token"": ""Tsg101"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""breast cancers"", ""start_span"": 85, ""end_span"": 99, ""type"": ""Cancer""}]"	train
The overexpression of Tsg101 resulted in increased phosphorylation of the epidermal growth factor receptor and downstream activation of MAP kinases.	Tsg101,22,28,Gene_or_gene_product	epidermal growth factor receptor,74,106,Gene_or_gene_product	MAP kinases,136,147,Gene_or_gene_product	"[{""token"": ""Tsg101"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""epidermal growth factor receptor"", ""start_span"": 74, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAP kinases"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"	train
However, owing to the long latency of tumor formation and the sporadic occurrence of bona fide mammary cancers, we conclude that the Tsg101 protein has only weak oncogenic properties.	tumor,38,43,Cancer	mammary cancers,95,110,Cancer	Tsg101,133,139,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""mammary cancers"", ""start_span"": 95, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""Tsg101"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}]"	train
Instead of cancer initiation, it is therefore likely that Tsg101 plays a more predominant role in the progression of a subset of spontaneously arising breast cancers.	cancer,11,17,Cancer	Tsg101,58,64,Gene_or_gene_product	breast cancers,151,165,Cancer	"[{""token"": ""cancer"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Cancer""}, {""token"": ""Tsg101"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancers"", ""start_span"": 151, ""end_span"": 165, ""type"": ""Cancer""}]"	train
Analysis of associations among studied proteins revealed positive correlation between Bcl - xL and Bax in primary tumors ( P < 0. 03, r = 0. 307).	Bcl - xL,86,94,Gene_or_gene_product	Bax,99,102,Gene_or_gene_product	tumors,114,120,Cancer	"[{""token"": ""Bcl - xL"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Cancer""}]"	train
An antibody directed against PDGF receptor beta enhances the antitumor and the anti - angiogenic activities of an anti - VEGF receptor 2 antibody.	antibody directed against PDGF receptor beta,3,47,Gene_or_gene_product	antitumor,61,70,Cancer	anti - VEGF receptor 2 antibody,114,145,Gene_or_gene_product	"[{""token"": ""antibody directed against PDGF receptor beta"", ""start_span"": 3, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""antitumor"", ""start_span"": 61, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""anti - VEGF receptor 2 antibody"", ""start_span"": 114, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}]"	train
Here we produced a neutralizing antibody, 1B3, directed against mouse PDGFRbeta.	1B3,42,45,Chemical	mouse,64,69,Organism	PDGFRbeta,70,79,Gene_or_gene_product	"[{""token"": ""1B3"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""mouse"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Organism""}, {""token"": ""PDGFRbeta"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}]"	train
1B3 binds to PDGFRbeta with high affinity ( 9x10 ( - 11) M) and blocks PDGF - BB from binding to the receptor with an IC ( 50) of approximately 1. 2 nM.	1B3,0,3,Chemical	PDGFRbeta,13,22,Gene_or_gene_product	PDGF - BB,71,80,Gene_or_gene_product	"[{""token"": ""1B3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""PDGFRbeta"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""PDGF - BB"", ""start_span"": 71, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}]"	train
Taken together, these results lend great support to use PDGFRbeta antagonists in combinations with other antitumor and / or anti - angiogenic agents in the treatment of a variety of cancers.	PDGFRbeta antagonists,56,77,Gene_or_gene_product	antitumor,105,114,Cancer	cancers,182,189,Cancer	"[{""token"": ""PDGFRbeta antagonists"", ""start_span"": 56, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""antitumor"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Cancer""}, {""token"": ""cancers"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Cancer""}]"	train
Conditioned media prepared from colon cells treated with an adenosine analog increased human umbilical vein endothelial cell migration.	colon cells,32,43,Cell	adenosine,60,69,Chemical	human umbilical vein endothelial cell,87,124,Cell	"[{""token"": ""colon cells"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""adenosine"", ""start_span"": 60, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""human umbilical vein endothelial cell"", ""start_span"": 87, ""end_span"": 124, ""type"": ""Cell""}]"	train
To confirm the role of lymphangiogenesis in mediating metastasis, the low - metastatic LAPC - 9 tumor cells were engineered to overexpress VEGF - C, and the development of metastases was evaluated.	LAPC - 9 tumor cells,87,107,Cell	VEGF - C,139,147,Gene_or_gene_product	metastases,172,182,Cancer	"[{""token"": ""LAPC - 9 tumor cells"", ""start_span"": 87, ""end_span"": 107, ""type"": ""Cell""}, {""token"": ""VEGF - C"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""metastases"", ""start_span"": 172, ""end_span"": 182, ""type"": ""Cancer""}]"	train
Taken together, our studies, based on a molecular imaging approach for semiquantitative detection of micrometastases, point to an important role of tumor lymphatics in the metastatic process of human prostate cancer.	tumor lymphatics,148,164,Multi	human,194,199,Organism	prostate cancer,200,215,Cancer	"[{""token"": ""tumor lymphatics"", ""start_span"": 148, ""end_span"": 164, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Organism""}, {""token"": ""prostate cancer"", ""start_span"": 200, ""end_span"": 215, ""type"": ""Cancer""}]"	train
A validated assay in human fat tissue is needed to study the role of angiogenesis in human obesity.	human,21,26,Organism	fat tissue,27,37,Tissue	human,85,90,Organism	"[{""token"": ""human"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Organism""}, {""token"": ""fat tissue"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Organism""}]"	train
Taxol at 10 ( - 6) and 10 ( - 7) M completely inhibited angiogenesis, while Taxol 10 ( - 8) and 10 ( - 9) M and the heparin - steroid partially inhibited angiogenesis.	Taxol,0,5,Chemical	Taxol,76,81,Chemical	heparin - steroid,116,133,Chemical	"[{""token"": ""Taxol"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Chemical""}, {""token"": ""Taxol"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""heparin - steroid"", ""start_span"": 116, ""end_span"": 133, ""type"": ""Chemical""}]"	train
The vessels are derived from quiescient vessels within the fat.	vessels,4,11,Multi	quiescient vessels,29,47,Multi	fat,59,62,Tissue	"[{""token"": ""vessels"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Multi""}, {""token"": ""quiescient vessels"", ""start_span"": 29, ""end_span"": 47, ""type"": ""Multi""}, {""token"": ""fat"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Tissue""}]"	train
In oral cancers, cytoplasmic BAG - 1 overexpression is a marker of poor prognosis.	oral cancers,3,15,Cancer	cytoplasmic,17,28,Organism_substance	BAG - 1,29,36,Gene_or_gene_product	"[{""token"": ""oral cancers"", ""start_span"": 3, ""end_span"": 15, ""type"": ""Cancer""}, {""token"": ""cytoplasmic"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Organism_substance""}, {""token"": ""BAG - 1"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}]"	train
By contrast to the cytoplasmic BAG - 1 isoforms, BAG - 1L may act to suppress tumorigenesis.	cytoplasmic,19,30,Organism_substance	BAG - 1,31,38,Gene_or_gene_product	BAG - 1L,49,57,Gene_or_gene_product	"[{""token"": ""cytoplasmic"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Organism_substance""}, {""token"": ""BAG - 1"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAG - 1L"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}]"	train
Liver tissue spaces, investigated with multiple indicator dilution technique in liver perfusion studies, were unchanged at week 3 after tumor induction.	Liver tissue,0,12,Tissue	liver,80,85,Organ	tumor,136,141,Cancer	"[{""token"": ""Liver tissue"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Tissue""}, {""token"": ""liver"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organ""}, {""token"": ""tumor"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Cancer""}]"	train
These observations suggest that stem / progenitor cells in the mammary gland may be especially susceptible to oncogenic transformation.	stem,32,36,Cell	progenitor cells,39,55,Cell	mammary gland,63,76,Organ	"[{""token"": ""stem"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""progenitor cells"", ""start_span"": 39, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""mammary gland"", ""start_span"": 63, ""end_span"": 76, ""type"": ""Organ""}]"	train
Whether more differentiated cells may also be transformed by particular oncogenes is actively debated; it is presently unclear whether stem cells or differentiated mammary cells are more susceptible to transformation by individual oncogenes.	cells,28,33,Cell	stem cells,135,145,Cell	mammary cells,164,177,Cell	"[{""token"": ""cells"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Cell""}, {""token"": ""stem cells"", ""start_span"": 135, ""end_span"": 145, ""type"": ""Cell""}, {""token"": ""mammary cells"", ""start_span"": 164, ""end_span"": 177, ""type"": ""Cell""}]"	train
In damaged and inflamed tissue, LL - 37 functions as a chemoattractant, mitogen and pro - angiogenic factor suggesting that the peptide may potentiate tumor progression.	tissue,24,30,Tissue	LL - 37,32,39,Gene_or_gene_product	tumor,151,156,Cancer	"[{""token"": ""tissue"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Tissue""}, {""token"": ""LL - 37"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Cancer""}]"	train
Protein expression was statistically compared to the degree of immune cell infiltration and microvessel density in epithelial - derived ovarian tumors and a significant correlation was observed for both.	immune cell,63,74,Cell	microvessel,92,103,Tissue	epithelial - derived ovarian tumors,115,150,Cancer	"[{""token"": ""immune cell"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""microvessel"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Tissue""}, {""token"": ""epithelial - derived ovarian tumors"", ""start_span"": 115, ""end_span"": 150, ""type"": ""Cancer""}]"	train
Treatment of ovarian cancer cell lines with recombinant LL - 37 stimulated proliferation, chemotaxis, invasion and matrix metalloproteinase expression.	ovarian cancer cell lines,13,38,Cell	LL - 37,56,63,Gene_or_gene_product	matrix metalloproteinase,115,139,Gene_or_gene_product	"[{""token"": ""ovarian cancer cell lines"", ""start_span"": 13, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""LL - 37"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase"", ""start_span"": 115, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}]"	train
To grow, invade and metastasize, a treacherous society between cancer and host cells must be formed, and this association provides novel and effective clinical targets for cancer control and prevention.	cancer,63,69,Cancer	host cells,74,84,Cell	cancer,172,178,Cancer	"[{""token"": ""cancer"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""host cells"", ""start_span"": 74, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Cancer""}]"	train
An increase of atrophy over the Retinal Pigment Epithelium ( RPE) was observed in another patient.	Retinal Pigment Epithelium,32,58,Tissue	RPE,61,64,Tissue	patient,90,97,Organism	"[{""token"": ""Retinal Pigment Epithelium"", ""start_span"": 32, ""end_span"": 58, ""type"": ""Tissue""}, {""token"": ""RPE"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Tissue""}, {""token"": ""patient"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Organism""}]"	train
CONCLUSIONS: PDT can reduce the clinical signs of activity, such as choroidal hyperpermeability or neurosensorial retinal detachment, in patients affected by chronic CSC.	choroidal,68,77,Multi	retinal,114,121,Multi	patients,137,145,Organism	"[{""token"": ""choroidal"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Multi""}, {""token"": ""retinal"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Organism""}]"	train
This ultimately deprives VEGF receptors of an essential molecule required for promoting the disruption of endothelial cell - cell contacts and paracellular permeability.	VEGF,25,29,Gene_or_gene_product	endothelial,106,117,Cell	paracellular,143,155,Immaterial_anatomical_entity	"[{""token"": ""VEGF"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""paracellular"", ""start_span"": 143, ""end_span"": 155, ""type"": ""Immaterial_anatomical_entity""}]"	train
We did not found any mutation in de novo BCR - ABL + ALLs or lymphoid BC CML.	BCR,41,44,Gene_or_gene_product	ABL,47,50,Gene_or_gene_product	lymphoid BC CML,61,76,Cancer	"[{""token"": ""BCR"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphoid BC CML"", ""start_span"": 61, ""end_span"": 76, ""type"": ""Cancer""}]"	train
The therapeutic efficacy of rAAV2 / 5 - VAS was determined by monitoring tumor volume, survival rate, and degree of neovascularization after treatment in these models.	rAAV2,28,33,Organism	5 - VAS,36,43,Organism	tumor,73,78,Cancer	"[{""token"": ""rAAV2"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Cancer""}]"	train
Radiation retinopathy is treatable with anti - vascular endothelial growth factor bevacizumab ( Avastin).	anti - vascular endothelial growth factor,40,81,Gene_or_gene_product	bevacizumab,82,93,Chemical	Avastin,96,103,Chemical	"[{""token"": ""anti - vascular endothelial growth factor"", ""start_span"": 40, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""bevacizumab"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""Avastin"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Chemical""}]"	train
PATIENTS AND METHODS: Twenty - one patients with radiation retinopathy ( edema, hemorrhages, capillary dropout, and neovascularization) and a subjective or objective loss of vision were treated.	patients,35,43,Organism	edema,73,78,Pathological_formation	capillary,93,102,Tissue	"[{""token"": ""patients"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Organism""}, {""token"": ""edema"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Pathological_formation""}, {""token"": ""capillary"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Tissue""}]"	train
RESULTS: Bevacizumab treatment was followed by reductions in retinal hemorrhage, exudation, and edema.	Bevacizumab,9,20,Chemical	retinal,61,68,Multi	edema,96,101,Pathological_formation	"[{""token"": ""Bevacizumab"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Chemical""}, {""token"": ""retinal"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Multi""}, {""token"": ""edema"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Pathological_formation""}]"	train
Western blots confirmed that LeTx treatment reduced the levels of phosphorylated extracellular signal - regulated kinase and p38 MAPK in vitro.	LeTx,29,33,Chemical	extracellular signal - regulated kinase,81,120,Gene_or_gene_product	p38 MAPK,125,133,Gene_or_gene_product	"[{""token"": ""LeTx"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""extracellular signal - regulated kinase"", ""start_span"": 81, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38 MAPK"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}]"	train
Although short treatments with LeTx only modestly affected cell proliferation, sustained treatment markedly reduced cell numbers.	LeTx,31,35,Chemical	cell,59,63,Cell	cell,116,120,Cell	"[{""token"": ""LeTx"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Cell""}]"	train
In vivo, LeTx decreased MAPK activity and blocked fibrosarcoma growth.	LeTx,9,13,Chemical	MAPK,24,28,Gene_or_gene_product	fibrosarcoma,50,62,Cancer	"[{""token"": ""LeTx"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""MAPK"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibrosarcoma"", ""start_span"": 50, ""end_span"": 62, ""type"": ""Cancer""}]"	train
We have detected transforming activity by a tumorigenicity assay using NIH3T3 cells transfected with DNA from a chronic myeloproliferative disorder patient.	NIH3T3 cells,71,83,Cell	DNA,101,104,Cellular_component	patient,148,155,Organism	"[{""token"": ""NIH3T3 cells"", ""start_span"": 71, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Cellular_component""}, {""token"": ""patient"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Organism""}]"	train
The predicted UFO protein exhibits characteristic features of a transmembrane receptor with associated tyrosine kinase activity.	UFO,14,17,Gene_or_gene_product	transmembrane,64,77,Cellular_component	tyrosine,103,111,Amino_acid	"[{""token"": ""UFO"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""transmembrane"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Cellular_component""}, {""token"": ""tyrosine"", ""start_span"": 103, ""end_span"": 111, ""type"": ""Amino_acid""}]"	train
CONTEXT: Nasopharyngeal carcinoma ( NPC), common in southern China and North Africa, has a complex etiology involving interplay between viral, environmental, and hereditary factors and is almost constantly associated with the Epstein - Barr virus.	Nasopharyngeal carcinoma,9,33,Cancer	NPC,36,39,Cancer	Epstein - Barr virus,226,246,Organism	"[{""token"": ""Nasopharyngeal carcinoma"", ""start_span"": 9, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""NPC"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Cancer""}, {""token"": ""Epstein - Barr virus"", ""start_span"": 226, ""end_span"": 246, ""type"": ""Organism""}]"	train
After confirmation by immunocytochemical staining, their expression in patient samples was measured using 40 pairs of undifferentiated NPCs together with their adjacent normal epithelia.	patient,71,78,Organism	NPCs,135,139,Cell	normal epithelia,169,185,Tissue	"[{""token"": ""patient"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""NPCs"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""normal epithelia"", ""start_span"": 169, ""end_span"": 185, ""type"": ""Tissue""}]"	train
Finally, annexin II down - regulation was positively associated with lymph node metastasis, suggesting that it may be a prognostic factor in NPC.	annexin II,9,19,Gene_or_gene_product	lymph node,69,79,Multi	NPC,141,144,Cancer	"[{""token"": ""annexin II"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 69, ""end_span"": 79, ""type"": ""Multi""}, {""token"": ""NPC"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Cancer""}]"	train
In this study, the role of the proprotein convertase furin in PLAG1 proto - oncogene - induced salivary gland tumorigenesis was investigated.	furin,53,58,Gene_or_gene_product	PLAG1,62,67,Gene_or_gene_product	salivary gland,95,109,Multi	"[{""token"": ""furin"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLAG1"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""salivary gland"", ""start_span"": 95, ""end_span"": 109, ""type"": ""Multi""}]"	train
Moreover, the lymph nodes close to the salivary glands were enlarged, and histology showed that they had activated follicles.	lymph nodes,14,25,Multi	salivary glands,39,54,Organ	follicles,115,124,Multi	"[{""token"": ""lymph nodes"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Multi""}, {""token"": ""salivary glands"", ""start_span"": 39, ""end_span"": 54, ""type"": ""Organ""}, {""token"": ""follicles"", ""start_span"": 115, ""end_span"": 124, ""type"": ""Multi""}]"	train
Moreover, the M2 - PK - binding peptide aptamers also reduced the proliferation rate of human U - 2 OS osteosarcoma cells.	M2 - PK,14,21,Gene_or_gene_product	human,88,93,Organism	U - 2 OS osteosarcoma cells,94,121,Cell	"[{""token"": ""M2 - PK"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""U - 2 OS osteosarcoma cells"", ""start_span"": 94, ""end_span"": 121, ""type"": ""Cell""}]"	train
Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor - 1.	gastric cancer,27,41,Cancer	isolated tumor cells,51,71,Cell	vascular endothelial growth factor receptor - 1,90,137,Gene_or_gene_product	"[{""token"": ""gastric cancer"", ""start_span"": 27, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""isolated tumor cells"", ""start_span"": 51, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor receptor - 1"", ""start_span"": 90, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"	train
Gastric cancer metastasized when ITCs were observed in the presence of VEGFR - 1.	Gastric cancer,0,14,Cancer	ITCs,33,37,Cell	VEGFR - 1,71,80,Gene_or_gene_product	"[{""token"": ""Gastric cancer"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Cancer""}, {""token"": ""ITCs"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""VEGFR - 1"", ""start_span"": 71, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}]"	train
In the 380 patients who were ITC negative and showed low VEGFR - 1 expression, synchronous ( at the time of surgery) and heterochronous ( recurrent) metastases were not observed.	patients,11,19,Organism	ITC,29,32,Cell	VEGFR - 1,57,66,Gene_or_gene_product	"[{""token"": ""patients"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Organism""}, {""token"": ""ITC"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""VEGFR - 1"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}]"	train
This study indicates that the simultaneous presence of ITC and VEGFR - 1 expression at premetastatic sites is clinically significant for disease progression.	ITC,55,58,Cell	VEGFR - 1,63,72,Gene_or_gene_product	premetastatic sites,87,106,Multi	"[{""token"": ""ITC"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""VEGFR - 1"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""premetastatic sites"", ""start_span"": 87, ""end_span"": 106, ""type"": ""Multi""}]"	train
Together, the data establish that acute ethanol exposure significantly impairs angiogenesis and suggest that this effect is mediated by changes in endothelial cell responsiveness to both VEGF and hypoxia.	ethanol,40,47,Chemical	endothelial cell,147,163,Cell	VEGF,187,191,Gene_or_gene_product	"[{""token"": ""ethanol"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 147, ""end_span"": 163, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}]"	train
Histological examination revealed cystic or angiomatoid spaces of various sizes lined by cuboidal, low - columnar, or flattened epithelioid cells with vacuolated cytoplasm and round to oval nuclei.	epithelioid cells,128,145,Cell	vacuolated cytoplasm,151,171,Organism_substance	nuclei,190,196,Cellular_component	"[{""token"": ""epithelioid cells"", ""start_span"": 128, ""end_span"": 145, ""type"": ""Cell""}, {""token"": ""vacuolated cytoplasm"", ""start_span"": 151, ""end_span"": 171, ""type"": ""Organism_substance""}, {""token"": ""nuclei"", ""start_span"": 190, ""end_span"": 196, ""type"": ""Cellular_component""}]"	train
The role of platelet - derived endothelial cell growth factor / thymidine phosphorylase in tumor behavior.	platelet - derived endothelial cell growth factor,12,61,Gene_or_gene_product	thymidine phosphorylase,64,87,Gene_or_gene_product	tumor,91,96,Cancer	"[{""token"": ""platelet - derived endothelial cell growth factor"", ""start_span"": 12, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""thymidine phosphorylase"", ""start_span"": 64, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Cancer""}]"	train
A high TP expression at tumor sites is correlated with tumor growth, induction of angiogenesis, and metastasis.	TP,7,9,Gene_or_gene_product	tumor,24,29,Cancer	tumor,55,60,Cancer	"[{""token"": ""TP"", ""start_span"": 7, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Cancer""}]"	train
The latter in its parent form or in its sugar form, deoxyribose ( dR) may play a role in the induction of angiogenesis.	sugar,40,45,Chemical	deoxyribose,52,63,Chemical	dR,66,68,Chemical	"[{""token"": ""sugar"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""deoxyribose"", ""start_span"": 52, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""dR"", ""start_span"": 66, ""end_span"": 68, ""type"": ""Chemical""}]"	train
The mechanism of TP induction is not yet completely clear, but TNF, IL10 and other cytokines have been clearly shown to induce its expression.	TP,17,19,Gene_or_gene_product	TNF,63,66,Gene_or_gene_product	IL10,68,72,Gene_or_gene_product	"[{""token"": ""TP"", ""start_span"": 17, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL10"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}]"	train
The various complex interactions of TP give it an essential role in cellular functioning and, hence, it is an ideal target in cancer therapy.	TP,36,38,Gene_or_gene_product	cellular,68,76,Cell	cancer,126,132,Cancer	"[{""token"": ""TP"", ""start_span"": 36, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Cancer""}]"	train
Substantial studies have demonstrated that PTEN can inhibit cell proliferation, migration and invasion of many cancer cells.	PTEN,43,47,Gene_or_gene_product	cell,60,64,Cell	cancer cells,111,123,Cell	"[{""token"": ""PTEN"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 111, ""end_span"": 123, ""type"": ""Cell""}]"	train
CONCLUSION: These results demonstrated that PTEN had played an important role in the cell proliferation, cell migration and invasion dependent on its phosphatase activity.	PTEN,44,48,Gene_or_gene_product	cell,85,89,Cell	cell,105,109,Cell	"[{""token"": ""PTEN"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Cell""}]"	train
Allogeneic injection of fetal membrane - derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.	fetal membrane - derived mesenchymal stem cells,24,71,Cell	rat,110,113,Organism	hind limb,123,132,Organism_subdivision	"[{""token"": ""fetal membrane - derived mesenchymal stem cells"", ""start_span"": 24, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Organism""}, {""token"": ""hind limb"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Organism_subdivision""}]"	train
FM - MSC were obtained from Lewis rats and had surface antigen expression and multipotent potential partly similar to those of BM - MSC.	FM - MSC,0,8,Cell	rats,34,38,Organism	BM - MSC,127,135,Cell	"[{""token"": ""FM - MSC"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Cell""}, {""token"": ""rats"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""BM - MSC"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Cell""}]"	train
Malignancy in cancer is associated with aerobic glycolysis ( Warburg effect) evidenced by increased trapping of [ ( 18) F] deoxyglucose ( FdG) in patients imaged by positron emission tomography ( PET).	cancer,14,20,Cancer	FdG,138,141,Chemical	patients,146,154,Organism	"[{""token"": ""cancer"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Cancer""}, {""token"": ""FdG"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Organism""}]"	train
We have previously reported in established breast lines that HIF - 1alpha levels in the presence of oxygen leads to the Warburg effect.	breast lines,43,55,Cell	HIF - 1alpha,61,73,Gene_or_gene_product	oxygen,100,106,Chemical	"[{""token"": ""breast lines"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""HIF - 1alpha"", ""start_span"": 61, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""oxygen"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Chemical""}]"	train
Two of 12 cell lines formed xenografts in mice.	cell lines,10,20,Cell	xenografts,28,38,Cancer	mice,42,46,Organism	"[{""token"": ""cell lines"", ""start_span"": 10, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""xenografts"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Organism""}]"	train
Both were positive for HIF - 1alpha and phosphorylated c - Myc, and only one was positive for pAkt.	HIF - 1alpha,23,35,Gene_or_gene_product	c - Myc,55,62,Gene_or_gene_product	pAkt,94,98,Gene_or_gene_product	"[{""token"": ""HIF - 1alpha"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Myc"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""pAkt"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}]"	train
These findings suggest that c - Myc and / or HIF - 1alpha activities are both involved in the regulation of glycolysis in breast cancers.	c - Myc,28,35,Gene_or_gene_product	HIF - 1alpha,45,57,Gene_or_gene_product	breast cancers,122,136,Cancer	"[{""token"": ""c - Myc"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 45, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancers"", ""start_span"": 122, ""end_span"": 136, ""type"": ""Cancer""}]"	train
Following implantation within the striatum, the volume of the primary fibroblast grafts, stained immunohistochemically for fibronectin, does not differ significantly at 3 and 8 weeks.	striatum,34,42,Multi	fibroblast grafts,70,87,Tissue	fibronectin,123,134,Gene_or_gene_product	"[{""token"": ""striatum"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Multi""}, {""token"": ""fibroblast grafts"", ""start_span"": 70, ""end_span"": 87, ""type"": ""Tissue""}, {""token"": ""fibronectin"", ""start_span"": 123, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}]"	train
The graft size is dependent on the density of the cell suspension, but not dependent on either the number of passages the cells are taken through in culture prior to grafting or on the postoperative survival period.	graft,4,9,Tissue	cell,50,54,Cell	cells,122,127,Cell	"[{""token"": ""graft"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Tissue""}, {""token"": ""cell"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Cell""}]"	train
Reactive astrocytic processes and phagocytic cells are also present in the grafts.	astrocytic processes,9,29,Cellular_component	phagocytic cells,34,50,Cell	grafts,75,81,Tissue	"[{""token"": ""astrocytic processes"", ""start_span"": 9, ""end_span"": 29, ""type"": ""Cellular_component""}, {""token"": ""phagocytic cells"", ""start_span"": 34, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""grafts"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Tissue""}]"	train
Also, the grafts maintain a constant volume between 3 and 8 weeks, thereby indicating that primary skin fibroblasts do not produce tumors.	grafts,10,16,Tissue	skin fibroblasts,99,115,Cell	tumors,131,137,Cancer	"[{""token"": ""grafts"", ""start_span"": 10, ""end_span"": 16, ""type"": ""Tissue""}, {""token"": ""skin fibroblasts"", ""start_span"": 99, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Cancer""}]"	train
Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity.	visceral,29,37,Tissue	subcutaneous adipose tissue,42,69,Tissue	human,80,85,Organism	"[{""token"": ""visceral"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Tissue""}, {""token"": ""subcutaneous adipose tissue"", ""start_span"": 42, ""end_span"": 69, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism""}]"	train
This model highlighted the role of VEGF in angiogenesis in both SAT and VAT.	VEGF,35,39,Gene_or_gene_product	SAT,64,67,Tissue	VAT,72,75,Tissue	"[{""token"": ""VEGF"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""SAT"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Tissue""}, {""token"": ""VAT"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Tissue""}]"	train
BACKGROUND: M - CSF recruits mononuclear phagocytes which regulate processes such as angiogenesis and metastases in tumors.	M - CSF,12,19,Gene_or_gene_product	mononuclear phagocytes,29,51,Cell	tumors,116,122,Cancer	"[{""token"": ""M - CSF"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""mononuclear phagocytes"", ""start_span"": 29, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Cancer""}]"	train
VEGF is a potent activator of angiogenesis as it promotes endothelial cell proliferation and new blood vessel formation.	VEGF,0,4,Gene_or_gene_product	endothelial cell,58,74,Cell	blood vessel,97,109,Multi	"[{""token"": ""VEGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 58, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""blood vessel"", ""start_span"": 97, ""end_span"": 109, ""type"": ""Multi""}]"	train
Importantly, the addition of a neutralizing VEGF antibody abolished M - CSF - induced blood vessel formation.	VEGF antibody,44,57,Gene_or_gene_product	M - CSF,68,75,Gene_or_gene_product	blood vessel,86,98,Multi	"[{""token"": ""VEGF antibody"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessel"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Multi""}]"	train
BACKGROUND: Bone morphogenetic proteins ( BMPs) exert osteoinductive effects in prostate cancer ( PC) via uncharacterized mechanisms.	Bone,12,16,Organ	prostate cancer,80,95,Cancer	PC,98,100,Cancer	"[{""token"": ""Bone"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Organ""}, {""token"": ""prostate cancer"", ""start_span"": 80, ""end_span"": 95, ""type"": ""Cancer""}, {""token"": ""PC"", ""start_span"": 98, ""end_span"": 100, ""type"": ""Cancer""}]"	train
METHODS: NF - kappaB inhibition was achieved by IkappaBalpha super - repressor adenoviral vector and activation was monitored by EMSA and reporter assays.	NF - kappaB,9,20,Gene_or_gene_product	IkappaBalpha,48,60,Gene_or_gene_product	adenoviral,79,89,Organism	"[{""token"": ""NF - kappaB"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""IkappaBalpha"", ""start_span"": 48, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenoviral"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Organism""}]"	train
Smad1 / 5 / 8 phosphorylation was measured by Western blot analysis.	Smad1,0,5,Gene_or_gene_product	5,8,9,Gene_or_gene_product	8,12,13,Gene_or_gene_product	"[{""token"": ""Smad1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""5"", ""start_span"": 8, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""8"", ""start_span"": 12, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}]"	train
A novel peptide ligand, A5 - 1 ( VILVLF), with high affinity to integrin alpha5beta1 was identified from the hexapeptide libraries with this chip - based screening method on the basis of a competitive inhibition assay.	A5 - 1,24,30,Gene_or_gene_product	VILVLF,33,39,Gene_or_gene_product	integrin alpha5beta1,64,84,Gene_or_gene_product	"[{""token"": ""A5 - 1"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""VILVLF"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin alpha5beta1"", ""start_span"": 64, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}]"	train
A5 - 1 inhibits the integrin - fibronectin interaction in a dose - dependent manner ( IC ( 50); 1. 56 + / - 0. 28 microM.	A5 - 1,0,6,Gene_or_gene_product	integrin,20,28,Gene_or_gene_product	fibronectin,31,42,Gene_or_gene_product	"[{""token"": ""A5 - 1"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin"", ""start_span"": 20, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibronectin"", ""start_span"": 31, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}]"	train
Evaluation of electrical stimulation for ischemic wound therapy: a feasibility study using the lapine wound model.	wound,50,55,Pathological_formation	lapine,95,101,Organism	wound,102,107,Pathological_formation	"[{""token"": ""wound"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Pathological_formation""}, {""token"": ""lapine"", ""start_span"": 95, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""wound"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Pathological_formation""}]"	train
A feasibility study was carried out to develop the Ahn / Mustoe lapine wound model for systematic investigation of the effects of electrical stimulation on ischemic wound therapy.	lapine,64,70,Organism	wound,71,76,Pathological_formation	wound,165,170,Pathological_formation	"[{""token"": ""lapine"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Organism""}, {""token"": ""wound"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Pathological_formation""}, {""token"": ""wound"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Pathological_formation""}]"	train
Both COL - I and COL - V showed statistically significant ( P less than 0. 05) increased activity between day 7 and day 14 for pattern A, potentially indicating a continued effect on matrix remodeling.	COL - I,5,12,Gene_or_gene_product	COL - V,17,24,Gene_or_gene_product	matrix,183,189,Cellular_component	"[{""token"": ""COL - I"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""COL - V"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Cellular_component""}]"	train
Vascular endothelial growth factor ( VEGF), one of the most potent angiogenic factors, stimulates endothelial cell proliferation and induces the angiogenesis.	Vascular endothelial growth factor,0,34,Gene_or_gene_product	VEGF,37,41,Gene_or_gene_product	endothelial cell,98,114,Cell	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 98, ""end_span"": 114, ""type"": ""Cell""}]"	train
The scope of the present review is to discuss from a clinical point of view the potential interactions between VEGF and angiopoietins in the asthmatic airways, and focus on the therapeutic implications targeting for these angiogenic factors.	VEGF,111,115,Gene_or_gene_product	angiopoietins,120,133,Gene_or_gene_product	airways,151,158,Multi	"[{""token"": ""VEGF"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiopoietins"", ""start_span"": 120, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""airways"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Multi""}]"	train
The present study was designed to investigate the effect of transplanted MSCs from rats of different ages on the improvement of heart function after AMI.	MSCs,73,77,Cell	rats,83,87,Organism	heart,128,133,Organ	"[{""token"": ""MSCs"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""rats"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Organism""}, {""token"": ""heart"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Organ""}]"	train
The transplantation of old donor - derived MSCs attenuated apoptosis of cardiomyocytes in the peri - infarct region compared with the control group and the effect was elevated in young donor - derived MSCs ( P less than 0. 05).	MSCs,43,47,Cell	cardiomyocytes,72,86,Cell	MSCs,201,205,Cell	"[{""token"": ""MSCs"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""cardiomyocytes"", ""start_span"": 72, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""MSCs"", ""start_span"": 201, ""end_span"": 205, ""type"": ""Cell""}]"	train
CONCLUSIONS: Young donor - derived MSCs can improve heart function significantly through angiogenesis and decreasing cardiomyocyte apoptosis when transplanted to the infarcted area.	MSCs,35,39,Cell	heart,52,57,Organ	cardiomyocyte,117,130,Cell	"[{""token"": ""MSCs"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""heart"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Organ""}, {""token"": ""cardiomyocyte"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Cell""}]"	train
Clinical significance of chicken ovalbumin upstream promoter - transcription factor II expression in human colorectal cancer.	chicken ovalbumin upstream promoter - transcription factor II,25,86,Gene_or_gene_product	human,101,106,Organism	colorectal cancer,107,124,Cancer	"[{""token"": ""chicken ovalbumin upstream promoter - transcription factor II"", ""start_span"": 25, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Organism""}, {""token"": ""colorectal cancer"", ""start_span"": 107, ""end_span"": 124, ""type"": ""Cancer""}]"	train
A previous study showed that the expression of COUP - TFII enhanced invasiveness of human lung carcinoma cells.	COUP - TFII,47,58,Gene_or_gene_product	human,84,89,Organism	lung carcinoma cells,90,110,Cell	"[{""token"": ""COUP - TFII"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Organism""}, {""token"": ""lung carcinoma cells"", ""start_span"": 90, ""end_span"": 110, ""type"": ""Cell""}]"	train
The 3 - year disease - free survival ( DFS) and overall survival ( OS) of patients with tumors expressing different levels of COUP - TFII were evaluated by the Kaplan - Meier method.	patients,74,82,Organism	tumors,88,94,Cancer	COUP - TFII,126,137,Gene_or_gene_product	"[{""token"": ""patients"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 88, ""end_span"": 94, ""type"": ""Cancer""}, {""token"": ""COUP - TFII"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"	train
The p53 tumor suppressor plays pivotal role in the organism by supervising strict compliance of individual cells to needs of the whole organisms.	p53,4,7,Gene_or_gene_product	tumor,8,13,Cancer	cells,107,112,Cell	"[{""token"": ""p53"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Cell""}]"	train
Additional activities of p53 in non - stressed cells tune up the antioxidant defense mechanisms reducing the probability of mutations caused by DNA oxidation under conditions of daily stresses.	p53,25,28,Gene_or_gene_product	cells,47,52,Cell	DNA,144,147,Cellular_component	"[{""token"": ""p53"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Cellular_component""}]"	train
BACKGROUND AND PURPOSE: Cerebral cavernous malformations ( CCMs) are prevalent cerebral vascular lesions involving aberrant angiogenesis.	Cerebral cavernous malformations,24,56,Pathological_formation	CCMs,59,63,Pathological_formation	cerebral vascular lesions,79,104,Pathological_formation	"[{""token"": ""Cerebral cavernous malformations"", ""start_span"": 24, ""end_span"": 56, ""type"": ""Pathological_formation""}, {""token"": ""CCMs"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Pathological_formation""}, {""token"": ""cerebral vascular lesions"", ""start_span"": 79, ""end_span"": 104, ""type"": ""Pathological_formation""}]"	train
Phosphatase and tension homolog deleted on chromosome 10 ( PTEN), a tumor suppressor, is frequently deficient in various pathologies due to mutation or epigenetic alterations.	Phosphatase and tension homolog deleted on chromosome 10,0,56,Gene_or_gene_product	PTEN,59,63,Gene_or_gene_product	tumor,68,73,Cancer	"[{""token"": ""Phosphatase and tension homolog deleted on chromosome 10"", ""start_span"": 0, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Cancer""}]"	train
In addition, PTEN promoter methylation appeared more frequently in multiple CCMs, including familial cases ( 46. 7%), than that in single - lesioned CCMs ( 11. 8%; P < 0. 05).	PTEN,13,17,Gene_or_gene_product	CCMs,76,80,Pathological_formation	CCMs,149,153,Pathological_formation	"[{""token"": ""PTEN"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCMs"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Pathological_formation""}, {""token"": ""CCMs"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Pathological_formation""}]"	train
The identification of Erk1, 2 as triggered signaling in the lesions may be valuable for the development of effective therapy for this disease.	Erk1,22,26,Gene_or_gene_product	2,28,29,Gene_or_gene_product	lesions,60,67,Pathological_formation	"[{""token"": ""Erk1"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 28, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""lesions"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Pathological_formation""}]"	train
Multiple studies are ongoing to determine the clinical benefits of aflibercept in cancer patients.	aflibercept,67,78,Chemical	cancer,82,88,Cancer	patients,89,97,Organism	"[{""token"": ""aflibercept"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""cancer"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Organism""}]"	train
The effect of perfluorocarbon - based artificial oxygen carriers on tissue - engineered trachea.	perfluorocarbon,14,29,Chemical	oxygen,49,55,Chemical	tissue - engineered trachea,68,95,Multi	"[{""token"": ""perfluorocarbon"", ""start_span"": 14, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""oxygen"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""tissue - engineered trachea"", ""start_span"": 68, ""end_span"": 95, ""type"": ""Multi""}]"	train
The semaphorin 7A receptor Plexin C1 is lost during melanoma metastasis.	semaphorin 7A,4,17,Gene_or_gene_product	Plexin C1,27,36,Gene_or_gene_product	melanoma,52,60,Cancer	"[{""token"": ""semaphorin 7A"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""Plexin C1"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Cancer""}]"	train
The transformation of normal melanocytes, or melanocyte stem cells, to melanoma, is a complex process involving multiple mechanisms.	melanocytes,29,40,Cell	melanocyte stem cells,45,66,Cell	melanoma,71,79,Cancer	"[{""token"": ""melanocytes"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""melanocyte stem cells"", ""start_span"": 45, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""melanoma"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Cancer""}]"	train
In this report, we analyzed the expression of Plexin C1 using immunohistochemistry on sections of primary and matched metastatic lesions from 19 subjects and in a large melanoma tumor microarray.	Plexin C1,46,55,Gene_or_gene_product	metastatic lesions,118,136,Cancer	melanoma tumor,169,183,Cancer	"[{""token"": ""Plexin C1"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""metastatic lesions"", ""start_span"": 118, ""end_span"": 136, ""type"": ""Cancer""}, {""token"": ""melanoma tumor"", ""start_span"": 169, ""end_span"": 183, ""type"": ""Cancer""}]"	train
The coagulative parameters including the prothrombin time, activated partial thromboplastin time, and fibrinogen levels were collected and studied retrospectively.	prothrombin,41,52,Gene_or_gene_product	thromboplastin,77,91,Gene_or_gene_product	fibrinogen,102,112,Gene_or_gene_product	"[{""token"": ""prothrombin"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""thromboplastin"", ""start_span"": 77, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibrinogen"", ""start_span"": 102, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}]"	train
CONCLUSIONS: The level of fibrinogen in patients with pancreatic carcinoma was elevated.	fibrinogen,26,36,Gene_or_gene_product	patients,40,48,Organism	pancreatic carcinoma,54,74,Cancer	"[{""token"": ""fibrinogen"", ""start_span"": 26, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Organism""}, {""token"": ""pancreatic carcinoma"", ""start_span"": 54, ""end_span"": 74, ""type"": ""Cancer""}]"	train
In addition, TNFalpha treatment alone led to increased malignant transformation of mouse embryo fibroblasts, which could be partially suppressed by antioxidants.	TNFalpha,13,21,Gene_or_gene_product	mouse,83,88,Organism	embryo fibroblasts,89,107,Cell	"[{""token"": ""TNFalpha"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 89, ""end_span"": 107, ""type"": ""Cell""}]"	train
PTTG induced S100A4 and galectin - 1 mRNA and protein expression as assessed by Western blot and reverse transcription - PCR.	PTTG,0,4,Gene_or_gene_product	S100A4,13,19,Gene_or_gene_product	galectin - 1,24,36,Gene_or_gene_product	"[{""token"": ""PTTG"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""S100A4"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""galectin - 1"", ""start_span"": 24, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}]"	train
Chromatin immunoprecipitation assays further confirmed specific c - Myc binding to galectin - 1 promoter.	Chromatin,0,9,Cellular_component	c - Myc,64,71,Gene_or_gene_product	galectin - 1,83,95,Gene_or_gene_product	"[{""token"": ""Chromatin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Cellular_component""}, {""token"": ""c - Myc"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""galectin - 1"", ""start_span"": 83, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}]"	train
The cells subsequently proliferate and differentiate to form endothelial tubes and capillary - like structures.	cells,4,9,Cell	endothelial tubes,61,78,Tissue	capillary - like structures,83,110,Tissue	"[{""token"": ""cells"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Cell""}, {""token"": ""endothelial tubes"", ""start_span"": 61, ""end_span"": 78, ""type"": ""Tissue""}, {""token"": ""capillary - like structures"", ""start_span"": 83, ""end_span"": 110, ""type"": ""Tissue""}]"	train
We studied the metabolic changes of endothelial cell activation by growth factors using human umbilical vein endothelial cells ( HUVECs), [ 1, 2 - ( 13) C ( 2)] - glucose and mass isotopomer distribution analysis.	endothelial cell,36,52,Cell	human umbilical vein endothelial cells,88,126,Cell	HUVECs,129,135,Cell	"[{""token"": ""endothelial cell"", ""start_span"": 36, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""human umbilical vein endothelial cells"", ""start_span"": 88, ""end_span"": 126, ""type"": ""Cell""}, {""token"": ""HUVECs"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Cell""}]"	train
A specific VEGF receptor - 2 inhibitor demonstrated the importance of glycogen metabolism and pentose cycle pathway.	VEGF receptor - 2,11,28,Gene_or_gene_product	glycogen,70,78,Chemical	pentose,94,101,Chemical	"[{""token"": ""VEGF receptor - 2"", ""start_span"": 11, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""glycogen"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""pentose"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Chemical""}]"	train
Finally, we demonstrated that direct inhibition of key enzymes to glycogen metabolism and pentose phosphate pathways reduced HUVEC viability and migration.	glycogen,66,74,Chemical	pentose,90,97,Chemical	HUVEC,125,130,Cell	"[{""token"": ""glycogen"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Chemical""}, {""token"": ""pentose"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Chemical""}, {""token"": ""HUVEC"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Cell""}]"	train
Rab GTPase regulation of VEGFR2 trafficking and signaling in endothelial cells.	Rab,0,3,Gene_or_gene_product	VEGFR2,25,31,Gene_or_gene_product	endothelial cells,61,78,Cell	"[{""token"": ""Rab"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR2"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 61, ""end_span"": 78, ""type"": ""Cell""}]"	train
OBJECTIVE: Vascular endothelial growth factor receptor 2 ( VEGFR2) is a receptor tyrosine kinase that regulates vascular physiology.	Vascular endothelial growth factor receptor 2,11,56,Gene_or_gene_product	VEGFR2,59,65,Gene_or_gene_product	vascular,112,120,Multi	"[{""token"": ""Vascular endothelial growth factor receptor 2"", ""start_span"": 11, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR2"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Multi""}]"	train
Here, we have tested endocytic Rab GTPases for regulation of VEGFR2 trafficking and signaling linked to endothelial cell migration.	Rab,31,34,Gene_or_gene_product	VEGFR2,61,67,Gene_or_gene_product	endothelial cell,104,120,Cell	"[{""token"": ""Rab"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR2"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 104, ""end_span"": 120, ""type"": ""Cell""}]"	train
Manipulation of Rab7a GTPase activity associated with late endosomes using overexpression of wild - type or mutant proteins blocks activated VEGFR2 trafficking and degradation.	Rab7a,16,21,Gene_or_gene_product	late endosomes,54,68,Cellular_component	VEGFR2,141,147,Gene_or_gene_product	"[{""token"": ""Rab7a"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""late endosomes"", ""start_span"": 54, ""end_span"": 68, ""type"": ""Cellular_component""}, {""token"": ""VEGFR2"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"	train
Endothelial cell migration was increased by Rab5a depletion but decreased by Rab7a depletion.	Endothelial cell,0,16,Cell	Rab5a,44,49,Gene_or_gene_product	Rab7a,77,82,Gene_or_gene_product	"[{""token"": ""Endothelial cell"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""Rab5a"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rab7a"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}]"	train
We recently observed that FOXO3a gene inactivation occurs frequently in carcinogen - induced lung adenocarcinoma ( LAC).	FOXO3a,26,32,Gene_or_gene_product	lung adenocarcinoma,93,112,Cancer	LAC,115,118,Cancer	"[{""token"": ""FOXO3a"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung adenocarcinoma"", ""start_span"": 93, ""end_span"": 112, ""type"": ""Cancer""}, {""token"": ""LAC"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Cancer""}]"	train
Genes most significantly represented in this program are those with roles in cell growth and proliferation > protein synthesis > gene expression > cell death > cell cycle.	cell,77,81,Cell	cell,147,151,Cell	cell,160,164,Cell	"[{""token"": ""cell"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Cell""}]"	train
We hypothesized that Erbb2 activation contributes to UV - induced skin tumorigenesis by suppressing cell cycle arrest.	Erbb2,21,26,Gene_or_gene_product	skin,66,70,Organ	cell,100,104,Cell	"[{""token"": ""Erbb2"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""skin"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Organ""}, {""token"": ""cell"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Cell""}]"	train
A small GTPase Arf6 primarily regulates recycling of plasma membrane components.	Arf6,15,19,Gene_or_gene_product	plasma,53,59,Organism_substance	membrane components,60,79,Cellular_component	"[{""token"": ""Arf6"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasma"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Organism_substance""}, {""token"": ""membrane components"", ""start_span"": 60, ""end_span"": 79, ""type"": ""Cellular_component""}]"	train
Met amplification and tumor progression in Cdkn2a - deficient melanocytes.	Met,0,3,Gene_or_gene_product	tumor,22,27,Cancer	Cdkn2a,43,49,Gene_or_gene_product	"[{""token"": ""Met"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""Cdkn2a"", ""start_span"": 43, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}]"	train
This study validates a role for Met activation in melanoma tumor progression in the context of Cdkn2a deficiency.	Met,32,35,Gene_or_gene_product	melanoma tumor,50,64,Cancer	Cdkn2a,95,101,Gene_or_gene_product	"[{""token"": ""Met"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma tumor"", ""start_span"": 50, ""end_span"": 64, ""type"": ""Cancer""}, {""token"": ""Cdkn2a"", ""start_span"": 95, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}]"	train
Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis.	platelets,10,19,Cell	ovarian cancer cell,28,47,Cell	cellular,62,70,Cell	"[{""token"": ""platelets"", ""start_span"": 10, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""ovarian cancer cell"", ""start_span"": 28, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Cell""}]"	train
TRAP - activated platelets stimulated a dose - dependent increase in SKOV3 cell invasion.	TRAP,0,4,Gene_or_gene_product	platelets,17,26,Cell	SKOV3 cell,69,79,Cell	"[{""token"": ""TRAP"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelets"", ""start_span"": 17, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""SKOV3 cell"", ""start_span"": 69, ""end_span"": 79, ""type"": ""Cell""}]"	train
Exposure to activated platelet membranes and to soluble proteins contained in activated platelet releasate both contributed to the observed increase in invasion.	platelet,22,30,Cell	membranes,31,40,Cellular_component	platelet,88,96,Cell	"[{""token"": ""platelet"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""membranes"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Cellular_component""}, {""token"": ""platelet"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Cell""}]"	train
The inhibition of platelet activation with prostaglandin E1 ( PGE ( 1)) attenuated the invasive capacity of SKOV3 cells.	platelet,18,26,Cell	prostaglandin E1,43,59,Chemical	SKOV3 cells,108,119,Cell	"[{""token"": ""platelet"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""prostaglandin E1"", ""start_span"": 43, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""SKOV3 cells"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Cell""}]"	train
If generalizable to additional cell lines and human disease, this observation may partially explain the adverse prognosis associated with thrombocytosis in ovarian cancer.	cell lines,31,41,Cell	human,46,51,Organism	ovarian cancer,156,170,Cancer	"[{""token"": ""cell lines"", ""start_span"": 31, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Organism""}, {""token"": ""ovarian cancer"", ""start_span"": 156, ""end_span"": 170, ""type"": ""Cancer""}]"	train
Platelets, therefore, may represent a potential target for therapeutic intervention in human ovarian cancer.	Platelets,0,9,Cell	human,87,92,Organism	ovarian cancer,93,107,Cancer	"[{""token"": ""Platelets"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Organism""}, {""token"": ""ovarian cancer"", ""start_span"": 93, ""end_span"": 107, ""type"": ""Cancer""}]"	train
Mice with EC - specific deletion of Dicer, a key enzyme for generating miRNAs, display defective postnatal angiogenesis.	Mice,0,4,Organism	EC,10,12,Cell	Dicer,36,41,Gene_or_gene_product	"[{""token"": ""Mice"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""EC"", ""start_span"": 10, ""end_span"": 12, ""type"": ""Cell""}, {""token"": ""Dicer"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}]"	train
miRNA - 126, an EC - restricted miRNA, regulates vascular integrity and developmental angiogenesis.	miRNA - 126,0,11,Gene_or_gene_product	EC,16,18,Cell	vascular,49,57,Multi	"[{""token"": ""miRNA - 126"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 16, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""vascular"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Multi""}]"	train
We tested this possibility with in vitro assays using human endothelial cells, as well as in a rodent hindlimb ischemia model.	human,54,59,Organism	endothelial cells,60,77,Cell	hindlimb,102,110,Organism_subdivision	"[{""token"": ""human"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 60, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""hindlimb"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Organism_subdivision""}]"	train
OBJECTIVE: To study the activation of sterol regulatory element binding protein ( SREBP) and its critical role in endothelial cell migration.	sterol regulatory element binding protein,38,79,Gene_or_gene_product	SREBP,82,87,Gene_or_gene_product	endothelial cell,114,130,Cell	"[{""token"": ""sterol regulatory element binding protein"", ""start_span"": 38, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""SREBP"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 114, ""end_span"": 130, ""type"": ""Cell""}]"	train
METHODS: Bovine aortic endothelial cells ( ECs) were cultured.	Bovine,9,15,Organism	aortic endothelial cells,16,40,Cell	ECs,43,46,Cell	"[{""token"": ""Bovine"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""aortic endothelial cells"", ""start_span"": 16, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""ECs"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Cell""}]"	train
Fibroblast growth factor receptor 2 - positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma.	Fibroblast growth factor receptor 2,0,35,Gene_or_gene_product	tumor,99,104,Cancer	esophageal carcinoma,136,156,Cancer	"[{""token"": ""Fibroblast growth factor receptor 2"", ""start_span"": 0, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Cancer""}, {""token"": ""esophageal carcinoma"", ""start_span"": 136, ""end_span"": 156, ""type"": ""Cancer""}]"	train
RESULTS: About 43% ( 126 of 292) of known deregulated genes in TFs were associated with cell proliferation, extracellular matrix remodeling, and immune response.	TFs,63,66,Cell	cell,88,92,Cell	extracellular matrix,108,128,Cellular_component	"[{""token"": ""TFs"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 108, ""end_span"": 128, ""type"": ""Cellular_component""}]"	train
The paper reviews the data available in the literature on a role of the tumor suppressor ARF in oncogenesis and considers the structure of a gene encoding ARF protein.	tumor,72,77,Cancer	ARF,89,92,Gene_or_gene_product	ARF,155,158,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""ARF"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""ARF"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"	train
The importance of this tumor suppressor in the mechanisms of carcinogenesis is beyond question as the inactivation of ARF suppressor activity leads to the rapid growth of neoplasia.	tumor,23,28,Cancer	ARF,118,121,Gene_or_gene_product	neoplasia,171,180,Cancer	"[{""token"": ""tumor"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Cancer""}, {""token"": ""ARF"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""neoplasia"", ""start_span"": 171, ""end_span"": 180, ""type"": ""Cancer""}]"	train
Taken together, these data suggest that signal - controlled activation of SRF, MRTF - A, and CBP provides a novel connection between mechanical stimuli and angiogenic gene expression.	SRF,74,77,Gene_or_gene_product	MRTF - A,79,87,Gene_or_gene_product	CBP,93,96,Gene_or_gene_product	"[{""token"": ""SRF"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""MRTF - A"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""CBP"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"	train
Studies were therefore performed with PECAM - 1 - null mice to further define the involvement of PECAM - 1 in blood vessel formation.	PECAM - 1,38,47,Gene_or_gene_product	PECAM - 1,97,106,Gene_or_gene_product	blood vessel,110,122,Multi	"[{""token"": ""PECAM - 1"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""PECAM - 1"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessel"", ""start_span"": 110, ""end_span"": 122, ""type"": ""Multi""}]"	train
In vitro wound migration and single - cell motility by PECAM - 1 - null endothelial cells were also compromised.	wound,9,14,Pathological_formation	cell,38,42,Cell	PECAM - 1,55,64,Gene_or_gene_product	"[{""token"": ""wound"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Pathological_formation""}, {""token"": ""cell"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""PECAM - 1"", ""start_span"": 55, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}]"	train
Although, the growth of all three cell lines was suppressed by DMI, it was more effective in Ca3 / 7 cells.	cell lines,34,44,Cell	DMI,63,66,Chemical	Ca3 / 7 cells,93,106,Cell	"[{""token"": ""cell lines"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""DMI"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""Ca3 / 7 cells"", ""start_span"": 93, ""end_span"": 106, ""type"": ""Cell""}]"	train
The translocation of GR was induced by FA alone, DMI alone, and combination of both agents.	GR,21,23,Gene_or_gene_product	FA,39,41,Chemical	DMI,49,52,Chemical	"[{""token"": ""GR"", ""start_span"": 21, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""FA"", ""start_span"": 39, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""DMI"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Chemical""}]"	train
However, DMI inhibited FA - induced, GR - mediated transcription when both agents were given together.	DMI,9,12,Chemical	FA,23,25,Chemical	GR,37,39,Gene_or_gene_product	"[{""token"": ""DMI"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""FA"", ""start_span"": 23, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""GR"", ""start_span"": 37, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}]"	train
DMI is suggested to inhibit the growth of Ca3 / 7 cells and to affect GR - mediated transcription.	DMI,0,3,Chemical	Ca3 / 7 cells,42,55,Cell	GR,70,72,Gene_or_gene_product	"[{""token"": ""DMI"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""Ca3 / 7 cells"", ""start_span"": 42, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""GR"", ""start_span"": 70, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}]"	train
Using a retroviral gene transfer approach, we found that constitutive activation of MEK5 / ERK5 signaling strongly inhibits EC migration and results in massive morphological changes.	MEK5,84,88,Gene_or_gene_product	ERK5,91,95,Gene_or_gene_product	EC,124,126,Cell	"[{""token"": ""MEK5"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK5"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 124, ""end_span"": 126, ""type"": ""Cell""}]"	train
This phenotype was most likely based on decreased focal contact turnover caused by reduced expression of p130Cas, a key player in directed cell migration.	focal contact,50,63,Cellular_component	p130Cas,105,112,Gene_or_gene_product	cell,139,143,Cell	"[{""token"": ""focal contact"", ""start_span"": 50, ""end_span"": 63, ""type"": ""Cellular_component""}, {""token"": ""p130Cas"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Cell""}]"	train
We demonstrate for the first time that ERK5 signaling not only is involved in EC survival and stress response but also controls migration and morphology of EC.	ERK5,39,43,Gene_or_gene_product	EC,78,80,Cell	EC,156,158,Cell	"[{""token"": ""ERK5"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 78, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 156, ""end_span"": 158, ""type"": ""Cell""}]"	train
EPOX inhibits angiogenesis by degradation of Mcl - 1 through ERK inactivation.	EPOX,0,4,Chemical	Mcl - 1,45,52,Gene_or_gene_product	ERK,61,64,Gene_or_gene_product	"[{""token"": ""EPOX"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""Mcl - 1"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}]"	train
RESULTS: EPOX induced endothelial cell apoptosis in association with proteasome - dependent Mcl - 1 degradation.	EPOX,9,13,Chemical	endothelial cell,22,38,Cell	Mcl - 1,92,99,Gene_or_gene_product	"[{""token"": ""EPOX"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 22, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""Mcl - 1"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}]"	train
Although anti - VEGF therapies have clearly demonstrated antitumor efficacy in various malignancies, especially when combined with conventional cytotoxic chemotherapy, their mechanism of action is not fully understood.	anti - VEGF,9,20,Gene_or_gene_product	antitumor,57,66,Cancer	malignancies,87,99,Cancer	"[{""token"": ""anti - VEGF"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""antitumor"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Cancer""}, {""token"": ""malignancies"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Cancer""}]"	train
Nonetheless, anti - VEGF therapy has enhanced the arsenal of anticancer therapies and has provided new insights into the biology of malignancy.	anti - VEGF,13,24,Gene_or_gene_product	anticancer,61,71,Cancer	malignancy,132,142,Cancer	"[{""token"": ""anti - VEGF"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""anticancer"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""malignancy"", ""start_span"": 132, ""end_span"": 142, ""type"": ""Cancer""}]"	train
The review is focused on the participation of polymorphonuclear granulocytes ( neutrophils) in development and spreading of a tumor.	polymorphonuclear granulocytes,46,76,Cell	neutrophils,79,90,Cell	tumor,126,131,Cancer	"[{""token"": ""polymorphonuclear granulocytes"", ""start_span"": 46, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""neutrophils"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Cancer""}]"	train
We consider both the well known functions of neutrophils ( degranulation, production of reactive oxygen species ( ROS)) and the recently shown one ( presentation of an antigene).	neutrophils,45,56,Cell	reactive oxygen species,88,111,Chemical	ROS,114,117,Chemical	"[{""token"": ""neutrophils"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""reactive oxygen species"", ""start_span"": 88, ""end_span"": 111, ""type"": ""Chemical""}, {""token"": ""ROS"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Chemical""}]"	train
Endothelial cell migration and vascular endothelial growth factor expression are the result of loss of breast tissue polarity.	Endothelial cell,0,16,Cell	vascular endothelial growth factor,31,65,Gene_or_gene_product	breast tissue,103,116,Tissue	"[{""token"": ""Endothelial cell"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 31, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast tissue"", ""start_span"": 103, ""end_span"": 116, ""type"": ""Tissue""}]"	train
In a three - dimensional model of breast carcinogenesis, disorganized, proliferative transformed breast epithelial cells express significantly higher expression of angiogenic genes compared with their polarized, growth - arrested nonmalignant counterparts.	breast,34,40,Organism_subdivision	breast epithelial cells,97,120,Cell	nonmalignant counterparts,230,255,Cell	"[{""token"": ""breast"", ""start_span"": 34, ""end_span"": 40, ""type"": ""Organism_subdivision""}, {""token"": ""breast epithelial cells"", ""start_span"": 97, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""nonmalignant counterparts"", ""start_span"": 230, ""end_span"": 255, ""type"": ""Cell""}]"	train
In unchallenged endothelial cells, fibrillar collagen induced robust capillary morphogenesis.	endothelial cells,16,33,Cell	fibrillar collagen,35,53,Gene_or_gene_product	capillary,69,78,Tissue	"[{""token"": ""endothelial cells"", ""start_span"": 16, ""end_span"": 33, ""type"": ""Cell""}, {""token"": ""fibrillar collagen"", ""start_span"": 35, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Tissue""}]"	train
We further characterized zebrafish alpha2 integrin and discovered that this integrin is highly conserved, especially the I domain.	zebrafish,25,34,Organism	alpha2 integrin,35,50,Gene_or_gene_product	integrin,76,84,Gene_or_gene_product	"[{""token"": ""zebrafish"", ""start_span"": 25, ""end_span"": 34, ""type"": ""Organism""}, {""token"": ""alpha2 integrin"", ""start_span"": 35, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}]"	train
Islet endothelial activation and oxidative stress gene expression is reduced by IL - 1Ra treatment in the type 2 diabetic GK rat.	Islet endothelial,0,17,Cell	IL - 1Ra,80,88,Chemical	GK rat,122,128,Organism	"[{""token"": ""Islet endothelial"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""IL - 1Ra"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""GK rat"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Organism""}]"	train
We also examined islet endotheliuml / oxidative stress ( OS) / inflammation - related gene expression, islet vascularization and fibrosis after treatment with the interleukin - 1 ( IL - 1) receptor antagonist ( IL - 1Ra).	islet endotheliuml,17,35,Tissue	islet,103,108,Multi	IL - 1Ra,211,219,Chemical	"[{""token"": ""islet endotheliuml"", ""start_span"": 17, ""end_span"": 35, ""type"": ""Tissue""}, {""token"": ""islet"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Multi""}, {""token"": ""IL - 1Ra"", ""start_span"": 211, ""end_span"": 219, ""type"": ""Chemical""}]"	train
METHODOLOGY / PRINCIPAL FINDINGS: Gene expression was analyzed by quantitative RT - PCR on islets isolated from 10 - week - old diabetic GK and control Wistar rats.	islets,91,97,Multi	GK,137,139,Organism	Wistar rats,152,163,Organism	"[{""token"": ""islets"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Multi""}, {""token"": ""GK"", ""start_span"": 137, ""end_span"": 139, ""type"": ""Organism""}, {""token"": ""Wistar rats"", ""start_span"": 152, ""end_span"": 163, ""type"": ""Organism""}]"	train
CONCLUSIONS / SIGNIFICANCE: GK rat islets have increased mRNA expression of markers of early islet endothelial cell activation, possibly triggered by several metabolic factors, and also some defense mechanisms.	GK rat,28,34,Organism	islets,35,41,Multi	islet endothelial cell,93,115,Cell	"[{""token"": ""GK rat"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Organism""}, {""token"": ""islets"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Multi""}, {""token"": ""islet endothelial cell"", ""start_span"": 93, ""end_span"": 115, ""type"": ""Cell""}]"	train
AVE8062: a new combretastatin derivative vascular disrupting agent.	AVE8062,0,7,Chemical	combretastatin,15,29,Chemical	vascular,41,49,Multi	"[{""token"": ""AVE8062"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""combretastatin"", ""start_span"": 15, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""vascular"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Multi""}]"	train
The tumor vascular network is the result of pro - angiogenic and inhibitory factors as well as of the interaction between endothelial cells and extracellular matrix.	tumor vascular network,4,26,Multi	endothelial cells,122,139,Cell	extracellular matrix,144,164,Cellular_component	"[{""token"": ""tumor vascular network"", ""start_span"": 4, ""end_span"": 26, ""type"": ""Multi""}, {""token"": ""endothelial cells"", ""start_span"": 122, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 144, ""end_span"": 164, ""type"": ""Cellular_component""}]"	train
Different antiangiogenic therapeutics have been developed to improve tumor control through vascular - targeting agents ( VTA).	tumor,69,74,Cancer	vascular - targeting agents,91,118,Chemical	VTA,121,124,Chemical	"[{""token"": ""tumor"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""vascular - targeting agents"", ""start_span"": 91, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""VTA"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Chemical""}]"	train
In this review we will discuss the mechanism of action, as well as the preclinical and clinical results, of one of the most promising antitubulin agents: the combretastatin A4 - phosphate derivative, AVE8062A.	antitubulin agents,134,152,Chemical	combretastatin A4 - phosphate derivative,158,198,Chemical	AVE8062A,200,208,Chemical	"[{""token"": ""antitubulin agents"", ""start_span"": 134, ""end_span"": 152, ""type"": ""Chemical""}, {""token"": ""combretastatin A4 - phosphate derivative"", ""start_span"": 158, ""end_span"": 198, ""type"": ""Chemical""}, {""token"": ""AVE8062A"", ""start_span"": 200, ""end_span"": 208, ""type"": ""Chemical""}]"	train
Tumor necrosis factor - alpha ( TNF - alpha) was first isolated two decades ago as a macrophageproduced protein that can effectively kill tumor cells.	Tumor necrosis factor - alpha,0,29,Gene_or_gene_product	TNF - alpha,32,43,Gene_or_gene_product	tumor cells,138,149,Cell	"[{""token"": ""Tumor necrosis factor - alpha"", ""start_span"": 0, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF - alpha"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Cell""}]"	train
[ Effect of osteopontin silencing by lentivirus - mediated delivery of siRNA on glioma cell invasion and apoptosis].	osteopontin,12,23,Gene_or_gene_product	lentivirus,37,47,Organism	glioma cell,80,91,Cell	"[{""token"": ""osteopontin"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""lentivirus"", ""start_span"": 37, ""end_span"": 47, ""type"": ""Organism""}, {""token"": ""glioma cell"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Cell""}]"	train
METHODS: The invasion, apoptosis and levels of uPA, MMP - 2 and MMP - 9 were determined by invasion assay, flow cytometry, Western blot and real - time fluorescence quantitative PCR respectively.	uPA,47,50,Gene_or_gene_product	MMP - 2,52,59,Gene_or_gene_product	MMP - 9,64,71,Gene_or_gene_product	"[{""token"": ""uPA"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}]"	train
It suggests that osteopontin plays an important role in human glioma progression.	osteopontin,17,28,Gene_or_gene_product	human,56,61,Organism	glioma,62,68,Cancer	"[{""token"": ""osteopontin"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""glioma"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Cancer""}]"	train
AKT2 is a downstream target of metabotropic glutamate receptor 1 ( Grm1).	AKT2,0,4,Gene_or_gene_product	glutamate receptor 1,44,64,Gene_or_gene_product	Grm1,67,71,Gene_or_gene_product	"[{""token"": ""AKT2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""glutamate receptor 1"", ""start_span"": 44, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""Grm1"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}]"	train
We also detected strong activation of AKT in allograft tumors specifically AKT2 as the predominant isoform involved.	AKT,38,41,Gene_or_gene_product	allograft tumors,45,61,Cancer	AKT2,75,79,Gene_or_gene_product	"[{""token"": ""AKT"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""allograft tumors"", ""start_span"": 45, ""end_span"": 61, ""type"": ""Cancer""}, {""token"": ""AKT2"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}]"	train
Hormonal regulation and distinct functions of semaphorin - 3B and semaphorin - 3F in ovarian cancer.	semaphorin - 3B,46,61,Gene_or_gene_product	semaphorin - 3F,66,81,Gene_or_gene_product	ovarian cancer,85,99,Cancer	"[{""token"": ""semaphorin - 3B"", ""start_span"": 46, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""semaphorin - 3F"", ""start_span"": 66, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer"", ""start_span"": 85, ""end_span"": 99, ""type"": ""Cancer""}]"	train
We examined the status and regulation of semaphorins and their receptors in human ovarian cancer cells.	semaphorins,41,52,Gene_or_gene_product	human,76,81,Organism	ovarian cancer cells,82,102,Cell	"[{""token"": ""semaphorins"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Organism""}, {""token"": ""ovarian cancer cells"", ""start_span"": 82, ""end_span"": 102, ""type"": ""Cell""}]"	train
Forced expression of SEMA3B, but not SEMA3F, inhibited viability of ovarian cancer cells.	SEMA3B,21,27,Gene_or_gene_product	SEMA3F,37,43,Gene_or_gene_product	ovarian cancer cells,68,88,Cell	"[{""token"": ""SEMA3B"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3F"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer cells"", ""start_span"": 68, ""end_span"": 88, ""type"": ""Cell""}]"	train
The aim of the present study was to investigate the effects of doxorubicin in Hct - 116 human colon carcinoma cells in order to clarify if a time / concentration range for optimal doxorubicin - induced apoptosis exists.	doxorubicin,63,74,Chemical	Hct - 116 human colon carcinoma cells,78,115,Cell	doxorubicin,180,191,Chemical	"[{""token"": ""doxorubicin"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Chemical""}, {""token"": ""Hct - 116 human colon carcinoma cells"", ""start_span"": 78, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""doxorubicin"", ""start_span"": 180, ""end_span"": 191, ""type"": ""Chemical""}]"	train
We compared a treatment schedule were cells were bolus incubated for 3h with doxorubicin followed by 24h in drug - free medium, with a continuous doxorubicin treatment schedule for 24h.	cells,38,43,Cell	doxorubicin,77,88,Chemical	doxorubicin,146,157,Chemical	"[{""token"": ""cells"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""doxorubicin"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""doxorubicin"", ""start_span"": 146, ""end_span"": 157, ""type"": ""Chemical""}]"	train
In contrast, continuous ( 24h) treatment with doxorubicin reduced the number of living cells with no parallel raise in the amount of dead cells.	doxorubicin,46,57,Chemical	cells,87,92,Cell	cells,138,143,Cell	"[{""token"": ""doxorubicin"", ""start_span"": 46, ""end_span"": 57, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Cell""}]"	train
Lactate - dehydrogenase 5 is overexpressed in non - small cell lung cancer and correlates with the expression of the transketolase - like protein 1.	Lactate - dehydrogenase 5,0,25,Gene_or_gene_product	non - small cell lung cancer,46,74,Cancer	transketolase - like protein 1,117,147,Gene_or_gene_product	"[{""token"": ""Lactate - dehydrogenase 5"", ""start_span"": 0, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""non - small cell lung cancer"", ""start_span"": 46, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""transketolase - like protein 1"", ""start_span"": 117, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"	train
LDH5 overexpression in cancer cells induces an upregulated glycolytic metabolism and reduced dependence on the presence of oxygen.	LDH5,0,4,Gene_or_gene_product	cancer cells,23,35,Cell	oxygen,123,129,Chemical	"[{""token"": ""LDH5"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""oxygen"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Chemical""}]"	train
Here we analyzed LDH5 protein expression in a well characterized large cohort of primary lung cancers in correlation to clinico - pathological data and its possible impact on patient survival.	LDH5,17,21,Gene_or_gene_product	primary lung cancers,81,101,Cancer	patient,175,182,Organism	"[{""token"": ""LDH5"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary lung cancers"", ""start_span"": 81, ""end_span"": 101, ""type"": ""Cancer""}, {""token"": ""patient"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Organism""}]"	train
In addition, the results of the previously tested transketolase like 1 protein ( TKTL1) expression were correlated to LDH5 expression.	transketolase like 1,50,70,Gene_or_gene_product	TKTL1,81,86,Gene_or_gene_product	LDH5,118,122,Gene_or_gene_product	"[{""token"": ""transketolase like 1"", ""start_span"": 50, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""TKTL1"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""LDH5"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"	train
A significant correlation between LDH5 and TKTL1 within each histologic tumortype could not be revealed.	LDH5,34,38,Gene_or_gene_product	TKTL1,43,48,Gene_or_gene_product	tumortype,72,81,Cancer	"[{""token"": ""LDH5"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""TKTL1"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumortype"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Cancer""}]"	train
During lymphomagenesis, induction of persistent telomerase expression and activity may occur before or after telomere shortening, as a consequence of the different mechanisms through which transforming factors / agents may activate telomerase.	telomerase,48,58,Gene_or_gene_product	telomere,109,117,Cellular_component	telomerase,232,242,Gene_or_gene_product	"[{""token"": ""telomerase"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""telomere"", ""start_span"": 109, ""end_span"": 117, ""type"": ""Cellular_component""}, {""token"": ""telomerase"", ""start_span"": 232, ""end_span"": 242, ""type"": ""Gene_or_gene_product""}]"	train
We further investigated the mechanism of anticancer activity by betulin, using HeLa cells as an experimental model.	anticancer,41,51,Cancer	betulin,64,71,Chemical	HeLa cells,79,89,Cell	"[{""token"": ""anticancer"", ""start_span"": 41, ""end_span"": 51, ""type"": ""Cancer""}, {""token"": ""betulin"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""HeLa cells"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Cell""}]"	train
Taken together, the lines of evidence demonstrate that betulin triggers apoptosis of human cancer cells through the intrinsic apoptotic pathway.	betulin,55,62,Chemical	human,85,90,Organism	cancer cells,91,103,Cell	"[{""token"": ""betulin"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Organism""}, {""token"": ""cancer cells"", ""start_span"": 91, ""end_span"": 103, ""type"": ""Cell""}]"	train
Histone deacetylase inhibitors ( HDACi) are potent anti - cancer agents for variety of cancer types.	Histone deacetylase,0,19,Gene_or_gene_product	cancer,58,64,Cancer	cancer,87,93,Cancer	"[{""token"": ""Histone deacetylase"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Cancer""}]"	train
Suberoylanilide hydroxamic acid ( SAHA) has been approved as a drug to treat cutaneous T cell lymphoma, and the combination of HDACi and other agents have been actively tested in many clinical trials.	Suberoylanilide hydroxamic acid,0,31,Chemical	SAHA,34,38,Chemical	T cell lymphoma,87,102,Cancer	"[{""token"": ""Suberoylanilide hydroxamic acid"", ""start_span"": 0, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""SAHA"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""T cell lymphoma"", ""start_span"": 87, ""end_span"": 102, ""type"": ""Cancer""}]"	train
Here, we showed that proapoptotic activity of HDACi was robustly enhanced by E1A in multiple cancer cells, but not in normal cells.	E1A,77,80,Gene_or_gene_product	multiple cancer cells,84,105,Cell	cells,125,130,Cell	"[{""token"": ""E1A"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""multiple cancer cells"", ""start_span"": 84, ""end_span"": 105, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Cell""}]"	train
Together, our results provide not only a novel insight into the mechanisms underlying anti - tumor activity of E1A, but also a rationale for the combined HDACi and E1A gene therapy in future clinical trials.	tumor,93,98,Cancer	E1A,111,114,Gene_or_gene_product	E1A,164,167,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""E1A"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""E1A"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}]"	train
Conversely, knockdown of endogenous FOXO3a expression reduced PI3K / Akt activity.	FOXO3a,36,42,Gene_or_gene_product	PI3K,62,66,Gene_or_gene_product	Akt,69,72,Gene_or_gene_product	"[{""token"": ""FOXO3a"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}]"	train
Thus, our results suggest that sustained FOXO3a activation can enhance hyperactivation of the PI3K / Akt pathway.	FOXO3a,41,47,Gene_or_gene_product	PI3K,94,98,Gene_or_gene_product	Akt,101,104,Gene_or_gene_product	"[{""token"": ""FOXO3a"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}]"	train
This perspective places the report by Villani et al. that appears in this issue of the journal ( beginning on page 1222) in the context of recent work showing an intersection between two important developmental pathways implicated in oncogenesis: the hedgehog and insulin - like growth factor ( IGF) pathways.	hedgehog,251,259,Gene_or_gene_product	insulin - like growth factor,264,292,Gene_or_gene_product	IGF,295,298,Gene_or_gene_product	"[{""token"": ""hedgehog"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulin - like growth factor"", ""start_span"": 264, ""end_span"": 292, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF"", ""start_span"": 295, ""end_span"": 298, ""type"": ""Gene_or_gene_product""}]"	train
Brk1 is required for cell proliferation and cell transformation by oncogenes.	Brk1,0,4,Gene_or_gene_product	cell,21,25,Cell	cell,44,48,Cell	"[{""token"": ""Brk1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Cell""}]"	train
In addition, Brk1 downregulation results in defective directional migration and invasive growth in renal cell carcinoma cells as well as in other tumor cell types.	Brk1,13,17,Gene_or_gene_product	renal cell carcinoma cells,99,125,Cell	tumor cell,146,156,Cell	"[{""token"": ""Brk1"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal cell carcinoma cells"", ""start_span"": 99, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""tumor cell"", ""start_span"": 146, ""end_span"": 156, ""type"": ""Cell""}]"	train
Finally, genetic ablation of Brk1 results in dramatic defects in embryo compaction and development, suggesting an essential role for this protein in actin dynamics.	Brk1,29,33,Gene_or_gene_product	embryo,65,71,Developing_anatomical_structure	actin,149,154,Gene_or_gene_product	"[{""token"": ""Brk1"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""embryo"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Developing_anatomical_structure""}, {""token"": ""actin"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"	train
Thus, genetic loss or inhibition of BRK1 is likely to be protective against tumor development due to proliferation and motility defects in affected cells.	BRK1,36,40,Gene_or_gene_product	tumor,76,81,Cancer	cells,148,153,Cell	"[{""token"": ""BRK1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Cell""}]"	train
METHODS: Gene silencing and over - expression techniques were used to modulate RASSF1C expression in human breast cancer cells.	RASSF1C,79,86,Gene_or_gene_product	human,101,106,Organism	breast cancer cells,107,126,Cell	"[{""token"": ""RASSF1C"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Organism""}, {""token"": ""breast cancer cells"", ""start_span"": 107, ""end_span"": 126, ""type"": ""Cell""}]"	train
Affymetrix - microarray analysis was performed using T47D cells over - expressing RASSF1C to identify RASSF1C target genes.	T47D cells,53,63,Cell	RASSF1C,82,89,Gene_or_gene_product	RASSF1C,102,109,Gene_or_gene_product	"[{""token"": ""T47D cells"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""RASSF1C"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""RASSF1C"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"	train
RESULTS: In this article, we report the effects of altering RASSF1C expression in human breast cancer cells.	RASSF1C,60,67,Gene_or_gene_product	human,82,87,Organism	breast cancer cells,88,107,Cell	"[{""token"": ""RASSF1C"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Organism""}, {""token"": ""breast cancer cells"", ""start_span"": 88, ""end_span"": 107, ""type"": ""Cell""}]"	train
RASSF1C down - regulates several pro - apoptotic and tumor suppressor genes and up - regulates several growth promoting genes in breast cancer cells.	RASSF1C,0,7,Gene_or_gene_product	tumor,53,58,Cancer	breast cancer cells,129,148,Cell	"[{""token"": ""RASSF1C"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Cancer""}, {""token"": ""breast cancer cells"", ""start_span"": 129, ""end_span"": 148, ""type"": ""Cell""}]"	train
We quantified the expression of alpha - SMA as a marker of myofibroblasts in the invasive breast cancer.	alpha - SMA,32,43,Gene_or_gene_product	myofibroblasts,59,73,Cell	breast cancer,90,103,Cancer	"[{""token"": ""alpha - SMA"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""myofibroblasts"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""breast cancer"", ""start_span"": 90, ""end_span"": 103, ""type"": ""Cancer""}]"	train
When the patients were divided into two groups according to their alpha - SMA expression using a cutoff point at the mean value of 8. 48%, the high alpha - SMA group had a significantly poorer overall survival rate ( p < 0. 001).	patients,9,17,Organism	alpha - SMA,66,77,Gene_or_gene_product	alpha - SMA,148,159,Gene_or_gene_product	"[{""token"": ""patients"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""alpha - SMA"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - SMA"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}]"	train
CONCLUSION: Myofibroblasts represent an important prognostic factor for invasive growth that is translated into a poor clinical prognosis for patients with invasive breast cancer.	Myofibroblasts,12,26,Cell	patients,142,150,Organism	invasive breast cancer,156,178,Cancer	"[{""token"": ""Myofibroblasts"", ""start_span"": 12, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 142, ""end_span"": 150, ""type"": ""Organism""}, {""token"": ""invasive breast cancer"", ""start_span"": 156, ""end_span"": 178, ""type"": ""Cancer""}]"	train
During these processes, proteolytic activities of tumor and stromal cells modify the extracellular matrix to produce a microenvironment suitable for their growth and migration.	tumor,50,55,Cell	stromal cells,60,73,Cell	extracellular matrix,85,105,Cellular_component	"[{""token"": ""tumor"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""stromal cells"", ""start_span"": 60, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 85, ""end_span"": 105, ""type"": ""Cellular_component""}]"	train
In contrast, cancer cells depend mostly on glycolysis, the aerobic breakdown of glucose into ATP.	cancer cells,13,25,Cell	glucose,80,87,Chemical	ATP,93,96,Chemical	"[{""token"": ""cancer cells"", ""start_span"": 13, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Chemical""}]"	train
A thorough understanding of the unique metabolism of cancer cells will help to design of more effective drugs targeting metabolic pathways, which will greatly impact the capacity to effectively treat cancer patients.	cancer cells,53,65,Cell	cancer,200,206,Cancer	patients,207,215,Organism	"[{""token"": ""cancer cells"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 200, ""end_span"": 206, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 207, ""end_span"": 215, ""type"": ""Organism""}]"	train
MTSS1 ( metastasis suppressor - 1) was first identified as a metastasis suppressor missing in metastatic bladder carcinoma cell lines.	MTSS1,0,5,Gene_or_gene_product	metastasis suppressor - 1,8,33,Gene_or_gene_product	bladder carcinoma cell lines,105,133,Cell	"[{""token"": ""MTSS1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""metastasis suppressor - 1"", ""start_span"": 8, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""bladder carcinoma cell lines"", ""start_span"": 105, ""end_span"": 133, ""type"": ""Cell""}]"	train
The down - regulation of MTSS1 that may be caused by DNA methylation was also observed in many other types of cancer.	MTSS1,25,30,Gene_or_gene_product	DNA,53,56,Cellular_component	cancer,110,116,Cancer	"[{""token"": ""MTSS1"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Cellular_component""}, {""token"": ""cancer"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Cancer""}]"	train
As determined by ELISA and immunoblot assays, ras p21 in the serum increased with increased tumor growth.	ras p21,46,53,Gene_or_gene_product	serum,61,66,Organism_substance	tumor,92,97,Cancer	"[{""token"": ""ras p21"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""serum"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Organism_substance""}, {""token"": ""tumor"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Cancer""}]"	train
Serum soluble vascular adhesion protein - 1 is a valuable prognostic marker in gastric cancer.	Serum,0,5,Organism_substance	vascular adhesion protein - 1,14,43,Gene_or_gene_product	gastric cancer,79,93,Cancer	"[{""token"": ""Serum"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism_substance""}, {""token"": ""vascular adhesion protein - 1"", ""start_span"": 14, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric cancer"", ""start_span"": 79, ""end_span"": 93, ""type"": ""Cancer""}]"	train
BACKGROUND: Vascular adhesion protein - 1 ( VAP - 1) regulates leukocyte tissue infiltration.	Vascular adhesion protein - 1,12,41,Gene_or_gene_product	VAP - 1,44,51,Gene_or_gene_product	leukocyte tissue,63,79,Cell	"[{""token"": ""Vascular adhesion protein - 1"", ""start_span"": 12, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""VAP - 1"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukocyte tissue"", ""start_span"": 63, ""end_span"": 79, ""type"": ""Cell""}]"	train
Elevated serum soluble VAP - 1 ( sVAP - 1) levels occur in certain diseases having an inflammatory component.	serum,9,14,Organism_substance	VAP - 1,23,30,Gene_or_gene_product	sVAP - 1,33,41,Gene_or_gene_product	"[{""token"": ""serum"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Organism_substance""}, {""token"": ""VAP - 1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""sVAP - 1"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}]"	train
This study determines the relationship between preoperative serum sVAP - 1 levels and clinicopathological features and prognosis in gastric cancer.	serum,60,65,Organism_substance	sVAP - 1,66,74,Gene_or_gene_product	gastric cancer,132,146,Cancer	"[{""token"": ""serum"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Organism_substance""}, {""token"": ""sVAP - 1"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric cancer"", ""start_span"": 132, ""end_span"": 146, ""type"": ""Cancer""}]"	train
METHODS: Preoperative serum was collected from 107 gastric cancer patients and 33 normal controls.	serum,22,27,Organism_substance	gastric cancer,51,65,Cancer	patients,66,74,Organism	"[{""token"": ""serum"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism_substance""}, {""token"": ""gastric cancer"", ""start_span"": 51, ""end_span"": 65, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Organism""}]"	train
We are increasingly aware that cellular metabolism plays a vital role in diseases such as cancer, and that p53 is an important regulator of metabolic pathways.	cellular,31,39,Cell	cancer,90,96,Cancer	p53,107,110,Gene_or_gene_product	"[{""token"": ""cellular"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}]"	train
A better understanding of how p53 coordinates metabolic adaptation will facilitate the identification of novel therapeutic targets and will also illuminate the wider role of p53 in human biology.	p53,30,33,Gene_or_gene_product	p53,174,177,Gene_or_gene_product	human,181,186,Organism	"[{""token"": ""p53"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Organism""}]"	train
RAF265 inhibited 2 - deoxy - 2 - [ ( 18) F] fluoro - d - glucose ( FDG) accumulation in cell culture at 28 hours in a dose - dependent manner.	RAF265,0,6,Chemical	FDG,67,70,Chemical	cell,88,92,Cell	"[{""token"": ""RAF265"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""FDG"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Cell""}]"	train
RAF265 also inhibited FDG accumulation in tumor xenografts after 1 day of drug treatment.	RAF265,0,6,Chemical	FDG,22,25,Chemical	tumor xenografts,42,58,Cancer	"[{""token"": ""RAF265"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""FDG"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""tumor xenografts"", ""start_span"": 42, ""end_span"": 58, ""type"": ""Cancer""}]"	train
Our results support the use of FDG PET in clinical trials with RAF265 to assess early tumor response.	FDG,31,34,Chemical	RAF265,63,69,Chemical	tumor,86,91,Cancer	"[{""token"": ""FDG"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""RAF265"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Cancer""}]"	train
DNA microarray analysis allows for analysis of drug effects on multiple pathways linked to cancer and can suggest corresponding imaging tracers for further analysis as biomarkers of tumor response.	DNA,0,3,Cellular_component	cancer,91,97,Cancer	tumor,182,187,Cancer	"[{""token"": ""DNA"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Cellular_component""}, {""token"": ""cancer"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 182, ""end_span"": 187, ""type"": ""Cancer""}]"	train
The heat shock proteins ( HSPs) centered and NF - kappaB centered networks were also enriched in the result, which may imply the key function of inflaming on metastasis.	heat shock proteins,4,23,Gene_or_gene_product	HSPs,26,30,Gene_or_gene_product	NF - kappaB,45,56,Gene_or_gene_product	"[{""token"": ""heat shock proteins"", ""start_span"": 4, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""HSPs"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}]"	train
Similarly to other members of this family, Id - 1 is involved in the repression of cell differentiation and activation of cell growth.	Id - 1,43,49,Gene_or_gene_product	cell,83,87,Cell	cell,122,126,Cell	"[{""token"": ""Id - 1"", ""start_span"": 43, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Cell""}]"	train
"In addition, FGF - 2 has been described to induce "" neuronal - like "" differentiation and trigger apoptosis in neuroblastoma SK - N - MC cells."	FGF - 2,13,20,Gene_or_gene_product	neuronal,52,60,Cell	neuroblastoma SK - N - MC cells,111,142,Cell	"[{""token"": ""FGF - 2"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""neuroblastoma SK - N - MC cells"", ""start_span"": 111, ""end_span"": 142, ""type"": ""Cell""}]"	train
Although regulation of Id - 1 protein by several mitogenic factors is well - established, little is known about the role of FGF - 2 in the regulation of Id - 1.	Id - 1,23,29,Gene_or_gene_product	FGF - 2,124,131,Gene_or_gene_product	Id - 1,153,159,Gene_or_gene_product	"[{""token"": ""Id - 1"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF - 2"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""Id - 1"", ""start_span"": 153, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}]"	train
We also demonstrate direct interaction of Egr - 1 with Id - 1 promoter in vitro and in cell culture.	Egr - 1,42,49,Gene_or_gene_product	Id - 1,55,61,Gene_or_gene_product	cell culture,87,99,Cell	"[{""token"": ""Egr - 1"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""Id - 1"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell culture"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Cell""}]"	train
Coexpression of keratin and vimentin was found in approximately 20% of the tumors regardless of menopausal status.	keratin,16,23,Gene_or_gene_product	vimentin,28,36,Gene_or_gene_product	tumors,75,81,Cancer	"[{""token"": ""keratin"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""vimentin"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Cancer""}]"	train
Vimentin was expressed preferentially in tumor cells of high - grade ductal breast carcinomas ( 15 of 28 histologic grade 3 vs. 0 of 40 grades 1 and 2).	Vimentin,0,8,Gene_or_gene_product	tumor cells,41,52,Cell	high - grade ductal breast carcinomas,56,93,Cancer	"[{""token"": ""Vimentin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""high - grade ductal breast carcinomas"", ""start_span"": 56, ""end_span"": 93, ""type"": ""Cancer""}]"	train
More than 50% of the tumor cells coexpressed vimentin and keratin.	tumor cells,21,32,Cell	vimentin,45,53,Gene_or_gene_product	keratin,58,65,Gene_or_gene_product	"[{""token"": ""tumor cells"", ""start_span"": 21, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""vimentin"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""keratin"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}]"	train
Thus, vimentin expression may be helpful in identifying a substantial subset of ER - independent breast carcinomas with poor prognostic indicators.	vimentin,6,14,Gene_or_gene_product	ER,80,82,Gene_or_gene_product	breast carcinomas,97,114,Cancer	"[{""token"": ""vimentin"", ""start_span"": 6, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""ER"", ""start_span"": 80, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast carcinomas"", ""start_span"": 97, ""end_span"": 114, ""type"": ""Cancer""}]"	train
OBJECTIVE: To determine the expression and clinical significance of Merlin protein in non - small cell lung cancer ( NSCLC).	Merlin,68,74,Gene_or_gene_product	non - small cell lung cancer,86,114,Cancer	NSCLC,117,122,Cancer	"[{""token"": ""Merlin"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""non - small cell lung cancer"", ""start_span"": 86, ""end_span"": 114, ""type"": ""Cancer""}, {""token"": ""NSCLC"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Cancer""}]"	train
RESULTS: The expression rates of Merlin protein in NSCLC and normal lung tissue sections were 73. 33% and 15. 56%, respectively ( P < 0. 05).	Merlin,33,39,Gene_or_gene_product	NSCLC,51,56,Cancer	lung tissue sections,68,88,Multi	"[{""token"": ""Merlin"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""NSCLC"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Cancer""}, {""token"": ""lung tissue sections"", ""start_span"": 68, ""end_span"": 88, ""type"": ""Multi""}]"	train
Recombinants that lacked miR - BHRF1 - 2 or miR - BHRF1 - 3 displayed enhanced EBNA expression initiated at the Cp and Wp promoters.	miR - BHRF1 - 2,25,40,Gene_or_gene_product	miR - BHRF1 - 3,44,59,Gene_or_gene_product	EBNA,79,83,Gene_or_gene_product	"[{""token"": ""miR - BHRF1 - 2"", ""start_span"": 25, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - BHRF1 - 3"", ""start_span"": 44, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""EBNA"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}]"	train
Interestingly, we find that the deletion of miR - BHRF1 - 2 reduced the expression level of miR - BHRF1 - 3 and possibly that of miR - BHRF1 - 1, demonstrating that the expression of one miRNA can potentiate the expression of other miRNAs located in the same cluster.	miR - BHRF1 - 2,44,59,Gene_or_gene_product	miR - BHRF1 - 3,92,107,Gene_or_gene_product	miR - BHRF1 - 1,129,144,Gene_or_gene_product	"[{""token"": ""miR - BHRF1 - 2"", ""start_span"": 44, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - BHRF1 - 3"", ""start_span"": 92, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - BHRF1 - 1"", ""start_span"": 129, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"	train
Therefore, the phenotypic traits of the miR - BHRF1 - 2 null mutant could result partly from reduced miR - BHRF1 - 1 and miR - BHRF1 - 3 expression levels.	miR - BHRF1 - 2,40,55,Gene_or_gene_product	miR - BHRF1 - 1,101,116,Gene_or_gene_product	miR - BHRF1 - 3,121,136,Gene_or_gene_product	"[{""token"": ""miR - BHRF1 - 2"", ""start_span"": 40, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - BHRF1 - 1"", ""start_span"": 101, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - BHRF1 - 3"", ""start_span"": 121, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}]"	train
Development of a mouse model for lymph node metastasis with endometrial cancer.	mouse,17,22,Organism	lymph node,33,43,Multi	endometrial cancer,60,78,Cancer	"[{""token"": ""mouse"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Organism""}, {""token"": ""lymph node"", ""start_span"": 33, ""end_span"": 43, ""type"": ""Multi""}, {""token"": ""endometrial cancer"", ""start_span"": 60, ""end_span"": 78, ""type"": ""Cancer""}]"	train
Lymph node metastasis is one of the most important prognostic factors in various types of cancers, including endometrial cancer.	Lymph node,0,10,Multi	cancers,90,97,Cancer	endometrial cancer,109,127,Cancer	"[{""token"": ""Lymph node"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Multi""}, {""token"": ""cancers"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""endometrial cancer"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Cancer""}]"	train
Vascular endothelial growth factor - C ( VEGF - C) plays a crucial role in lymphangiogenesis, and is implicated to play an important role in lymph node metastasis.	Vascular endothelial growth factor - C,0,38,Gene_or_gene_product	VEGF - C,41,49,Gene_or_gene_product	lymph node,141,151,Multi	"[{""token"": ""Vascular endothelial growth factor - C"", ""start_span"": 0, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 141, ""end_span"": 151, ""type"": ""Multi""}]"	train
The number of lymph node metastases was significantly higher in HEC1A / VEGF - C cells than in HEC1A cells ( 3. 2 vs 1. 1 nodes / animal, respectively).	lymph node,14,24,Multi	VEGF,72,76,Gene_or_gene_product	HEC1A cells,95,106,Cell	"[{""token"": ""lymph node"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Multi""}, {""token"": ""VEGF"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""HEC1A cells"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Cell""}]"	train
These results indicate that VEGF - C plays a critical role in lymph node metastasis, in addition to serving as a platform to test the efficacy of various therapeutic modalities against lymph node metastasis.	VEGF - C,28,36,Gene_or_gene_product	lymph node,62,72,Multi	lymph node,185,195,Multi	"[{""token"": ""VEGF - C"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Multi""}, {""token"": ""lymph node"", ""start_span"": 185, ""end_span"": 195, ""type"": ""Multi""}]"	train
IL - 17F deficiency inhibits small intestinal tumorigenesis in ApcMin / + mice.	IL - 17F,0,8,Gene_or_gene_product	small intestinal,29,45,Organ	ApcMin,63,69,Gene_or_gene_product	"[{""token"": ""IL - 17F"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""small intestinal"", ""start_span"": 29, ""end_span"": 45, ""type"": ""Organ""}, {""token"": ""ApcMin"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}]"	train
It was recently reported for its anticancer effect on several types of cancer cells in vitro however, the molecular mechanisms of this anticancer effect are not fully understood.	anticancer,33,43,Cancer	cancer cells,71,83,Cell	anticancer,135,145,Cancer	"[{""token"": ""anticancer"", ""start_span"": 33, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""cancer cells"", ""start_span"": 71, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""anticancer"", ""start_span"": 135, ""end_span"": 145, ""type"": ""Cancer""}]"	train
In the present study, we evaluated the effects of curcumin on human mammary epithelial carcinoma MCF - 7 cells.	curcumin,50,58,Chemical	human,62,67,Organism	mammary epithelial carcinoma MCF - 7 cells,68,110,Cell	"[{""token"": ""curcumin"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""mammary epithelial carcinoma MCF - 7 cells"", ""start_span"": 68, ""end_span"": 110, ""type"": ""Cell""}]"	train
Cells were treated with curcumin and examined for cell viability by MTT assay.	Cells,0,5,Cell	curcumin,24,32,Chemical	cell,50,54,Cell	"[{""token"": ""Cells"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""curcumin"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Cell""}]"	train
Although tumor cells can exploit cytokine signaling to promote growth, invasion, and metastasis, the response of normal and premalignant epithelial cells to cytokines present in a developing tumor microenvironment remains unclear.	tumor cells,9,20,Cell	premalignant epithelial cells,124,153,Cell	tumor,191,196,Cancer	"[{""token"": ""tumor cells"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""premalignant epithelial cells"", ""start_span"": 124, ""end_span"": 153, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 191, ""end_span"": 196, ""type"": ""Cancer""}]"	train
Paradoxically, OSM can also suppress the growth of normal cells and certain tumor - derived cell lines.	OSM,15,18,Gene_or_gene_product	cells,58,63,Cell	certain tumor - derived cell lines,68,102,Cell	"[{""token"": ""OSM"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""certain tumor - derived cell lines"", ""start_span"": 68, ""end_span"": 102, ""type"": ""Cell""}]"	train
In addition, expression of c - MYC from a constitutive promoter also abrogated the STAT3 - mediated arrest, and strikingly, cooperated with OSM to promote anchorage - independent growth ( AIG), a property associated with malignant transformation.	c - MYC,27,34,Gene_or_gene_product	STAT3,83,88,Gene_or_gene_product	OSM,140,143,Gene_or_gene_product	"[{""token"": ""c - MYC"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT3"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""OSM"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}]"	train
PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target.	PTHrP,0,5,Gene_or_gene_product	breast tumor,13,25,Cancer	mice,69,73,Organism	"[{""token"": ""PTHrP"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast tumor"", ""start_span"": 13, ""end_span"": 25, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Organism""}]"	train
PTHrP is also associated with the progression of skeletal metastases, and its dysregulated expression in advanced cancers causes malignancy - associated hypercalcemia.	PTHrP,0,5,Gene_or_gene_product	skeletal,49,57,Organ	cancers,114,121,Cancer	"[{""token"": ""PTHrP"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""skeletal"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Organ""}, {""token"": ""cancers"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Cancer""}]"	train
Importantly, PTHrP - specific neutralizing antibodies slowed the progression and metastasis of human breast cancer xenografts.	PTHrP,13,18,Gene_or_gene_product	human,95,100,Organism	breast cancer xenografts,101,125,Cancer	"[{""token"": ""PTHrP"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Organism""}, {""token"": ""breast cancer xenografts"", ""start_span"": 101, ""end_span"": 125, ""type"": ""Cancer""}]"	train
Our data identify what we believe to be new functions for PTHrP in several key steps of breast cancer and suggest that PTHrP may constitute a novel target for therapeutic intervention.	PTHrP,58,63,Gene_or_gene_product	breast cancer,88,101,Cancer	PTHrP,119,124,Gene_or_gene_product	"[{""token"": ""PTHrP"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 88, ""end_span"": 101, ""type"": ""Cancer""}, {""token"": ""PTHrP"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}]"	train
However, little is known about the function of AQPs in human breast cancer.	AQPs,47,51,Gene_or_gene_product	human,55,60,Organism	breast cancer,61,74,Cancer	"[{""token"": ""AQPs"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 61, ""end_span"": 74, ""type"": ""Cancer""}]"	train
The aim of this study was to investigate the expression profile of AQPs in human breast cancer and its significance.	AQPs,67,71,Gene_or_gene_product	human,75,80,Organism	breast cancer,81,94,Cancer	"[{""token"": ""AQPs"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 81, ""end_span"": 94, ""type"": ""Cancer""}]"	train
METHODS: In this study, we screened the expression profile of AQP0 - 12 in breast cancer tissues and corresponding normal tissues by RT - PCR, Western blotting and immunohistochemistry.	AQP0 - 12,62,71,Gene_or_gene_product	breast cancer tissues,75,96,Tissue	normal tissues,115,129,Tissue	"[{""token"": ""AQP0 - 12"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer tissues"", ""start_span"": 75, ""end_span"": 96, ""type"": ""Tissue""}, {""token"": ""normal tissues"", ""start_span"": 115, ""end_span"": 129, ""type"": ""Tissue""}]"	train
Expression of AQP5 was associated with cellular differentiation, lymph node invasion, and clinicopathological staging.	AQP5,14,18,Gene_or_gene_product	cellular,39,47,Cell	lymph node,65,75,Multi	"[{""token"": ""AQP5"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""lymph node"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Multi""}]"	train
CONCLUSIONS: These observations suggested that several subtypes of the AQP family play a role in human breast carcinogenesis.	AQP,71,74,Gene_or_gene_product	human,97,102,Organism	breast,103,109,Organism_subdivision	"[{""token"": ""AQP"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Organism""}, {""token"": ""breast"", ""start_span"": 103, ""end_span"": 109, ""type"": ""Organism_subdivision""}]"	train
Research and discovery of the first human cancer virus, HTLV - 1.	human,36,41,Organism	cancer,42,48,Cancer	HTLV - 1,56,64,Organism	"[{""token"": ""human"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Cancer""}, {""token"": ""HTLV - 1"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Organism""}]"	train
Selective inhibition of nuclear factor - kappaB by nuclear factor - kappaB essential modulator - binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma.	nuclear factor - kappaB,24,47,Gene_or_gene_product	nuclear factor - kappaB essential modulator - binding domain peptide,51,119,Chemical	oral squamous cell carcinoma,167,195,Cancer	"[{""token"": ""nuclear factor - kappaB"", ""start_span"": 24, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear factor - kappaB essential modulator - binding domain peptide"", ""start_span"": 51, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""oral squamous cell carcinoma"", ""start_span"": 167, ""end_span"": 195, ""type"": ""Cancer""}]"	train
In vitro migration and invasion were assessed in these cells, and the NF - kappaB activities and expression of NF - kappaB - regulated metastasis - related molecules were also examined.	cells,55,60,Cell	NF - kappaB,70,81,Gene_or_gene_product	NF - kappaB,111,122,Gene_or_gene_product	"[{""token"": ""cells"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""NF - kappaB"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 111, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"	train
Our results suggest that the selective inhibition of NF - kappaB activation by NBD peptide may provide an effective approach for the treatment of highly metastatic OSCC.	NF - kappaB,53,64,Gene_or_gene_product	NBD peptide,79,90,Chemical	OSCC,164,168,Cancer	"[{""token"": ""NF - kappaB"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""NBD peptide"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""OSCC"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Cancer""}]"	train
BACKGROUND: Compound targeting histone deacetylase ( HDAC) represents a new era in molecular cancer therapeutics.	histone deacetylase,31,50,Gene_or_gene_product	HDAC,53,57,Gene_or_gene_product	cancer,93,99,Cancer	"[{""token"": ""histone deacetylase"", ""start_span"": 31, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""HDAC"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Cancer""}]"	train
METHODOLOGY / PRINCIPAL FINDINGS: Here, we propose a novel HDAC inhibitor, N - Hydroxy - 4 - ( 4 - phenylbutyryl - amino) benzamide ( HTPB), as a potential chemotherapeutic drug for solid tumors.	HDAC,59,63,Gene_or_gene_product	HTPB,134,138,Chemical	solid tumors,182,194,Cancer	"[{""token"": ""HDAC"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""HTPB"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""solid tumors"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Cancer""}]"	train
The HDAC inhibition of HTPB was confirmed using HDAC activity assay.	HDAC,4,8,Gene_or_gene_product	HTPB,23,27,Chemical	HDAC,48,52,Gene_or_gene_product	"[{""token"": ""HDAC"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""HTPB"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""HDAC"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}]"	train
Mice with tumor xenograft and experimental metastasis model were used to evaluate effects on tumor growth and metastasis.	Mice,0,4,Organism	tumor xenograft,10,25,Cancer	tumor,93,98,Cancer	"[{""token"": ""Mice"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""tumor xenograft"", ""start_span"": 10, ""end_span"": 25, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Cancer""}]"	train
Upon HTPB treatment, cell cycle arrest was induced and subsequently led to mitochondria - mediated apoptosis.	HTPB,5,9,Chemical	cell,21,25,Cell	mitochondria,75,87,Cellular_component	"[{""token"": ""HTPB"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""mitochondria"", ""start_span"": 75, ""end_span"": 87, ""type"": ""Cellular_component""}]"	train
HTPB disrupted F - actin dynamics via downregulating RhoA activity.	HTPB,0,4,Chemical	F - actin,15,24,Gene_or_gene_product	RhoA,53,57,Gene_or_gene_product	"[{""token"": ""HTPB"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""F - actin"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}]"	train
HTPB delayed lung metastasis of 4T1 mouse breast cancer cells.	HTPB,0,4,Chemical	lung,13,17,Organ	mouse,36,41,Organism	"[{""token"": ""HTPB"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""lung"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Organ""}, {""token"": ""mouse"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism""}]"	train
CONCLUSIONS / SIGNIFICANCE: These results suggested that intrinsic apoptotic pathway may involve in anti - tumor growth effects of HTPB in lung cancer cells.	tumor,107,112,Cancer	HTPB,131,135,Chemical	lung cancer cells,139,156,Cell	"[{""token"": ""tumor"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Cancer""}, {""token"": ""HTPB"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Chemical""}, {""token"": ""lung cancer cells"", ""start_span"": 139, ""end_span"": 156, ""type"": ""Cell""}]"	train
We have provided convincing preclinical evidence that HTPB is a potent HDAC targeted inhibitor and is thus a promising candidate for lung cancer chemotherapy.	HTPB,54,58,Chemical	HDAC,71,75,Gene_or_gene_product	lung cancer,133,144,Cancer	"[{""token"": ""HTPB"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""HDAC"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung cancer"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Cancer""}]"	train
RESULTS: HER2 receptor protein was absent in adenomas and in normal gallbladder epithelium.	HER2 receptor,9,22,Gene_or_gene_product	adenomas,45,53,Cancer	gallbladder epithelium,68,90,Tissue	"[{""token"": ""HER2 receptor"", ""start_span"": 9, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenomas"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""gallbladder epithelium"", ""start_span"": 68, ""end_span"": 90, ""type"": ""Tissue""}]"	train
Expression of basic fibroblast growth factor in normal human tissues.	basic fibroblast growth factor,14,44,Gene_or_gene_product	human,55,60,Organism	tissues,61,68,Tissue	"[{""token"": ""basic fibroblast growth factor"", ""start_span"": 14, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Organism""}, {""token"": ""tissues"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Tissue""}]"	train
Intensity and patterns of localization in blood vessels was consistent in various tissues, but varied among different regions of the vascular bed.	blood vessels,42,55,Multi	tissues,82,89,Tissue	vascular bed,133,145,Multi	"[{""token"": ""blood vessels"", ""start_span"": 42, ""end_span"": 55, ""type"": ""Multi""}, {""token"": ""tissues"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Tissue""}, {""token"": ""vascular bed"", ""start_span"": 133, ""end_span"": 145, ""type"": ""Multi""}]"	train
The presence of bFGF in the extracellular compartment of a diverse variety of organs may play a role in angiogenesis.	bFGF,16,20,Gene_or_gene_product	extracellular compartment,28,53,Immaterial_anatomical_entity	organs,78,84,Organ	"[{""token"": ""bFGF"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular compartment"", ""start_span"": 28, ""end_span"": 53, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""organs"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Organ""}]"	train
Some human cancer cells have been found to overexpress eph mRNAs without gene amplification.	human,5,10,Organism	cancer cells,11,23,Cell	eph,55,58,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Organism""}, {""token"": ""cancer cells"", ""start_span"": 11, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""eph"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}]"	train
We show here that NIH3T3 cells acquire tumorigenic ability in nude mice and make colonies in soft agar with a viral LTR ( Long Terminal Repeat) - driven artificial expression of the eph gene to a high level.	NIH3T3 cells,18,30,Cell	nude mice,62,71,Organism	eph,182,185,Gene_or_gene_product	"[{""token"": ""NIH3T3 cells"", ""start_span"": 18, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Organism""}, {""token"": ""eph"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"	train
Energy supply of the mitotic cell cycle and the Na + / H + - antiport in ascites tumors.	Na +,48,52,Chemical	H +,55,58,Chemical	ascites tumors,73,87,Cancer	"[{""token"": ""Na +"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""H +"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""ascites tumors"", ""start_span"": 73, ""end_span"": 87, ""type"": ""Cancer""}]"	train
Experimental results and theoretical calculations suggest that in glucose - containing medium the Na + transport increases from 0. 75 to 1. 78 pmol / hour per cell.	glucose,66,73,Chemical	Na +,98,102,Chemical	cell,159,163,Cell	"[{""token"": ""glucose"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Chemical""}, {""token"": ""Na +"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Cell""}]"	train
The permeability of plasma membranes for K + increases 2. 75 fold, while the passive flux of Na + diminishes.	plasma membranes,20,36,Cellular_component	K +,41,44,Chemical	Na +,93,97,Chemical	"[{""token"": ""plasma membranes"", ""start_span"": 20, ""end_span"": 36, ""type"": ""Cellular_component""}, {""token"": ""K +"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""Na +"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Chemical""}]"	train
The inhibition of fibrinolysis or proteases decreased the primary tumor growth and pulmonary metastasis, whereas the activation of fibrinolysis or proteases increased the number of metastatic foci in the lung.	tumor,66,71,Cancer	pulmonary,83,92,Organ	lung,204,208,Organ	"[{""token"": ""tumor"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""pulmonary"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Organ""}, {""token"": ""lung"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Organ""}]"	train
Differences in polyphosphoinositide metabolism have been reported for ras - transformed cells.	polyphosphoinositide,15,35,Chemical	ras,70,73,Gene_or_gene_product	cells,88,93,Cell	"[{""token"": ""polyphosphoinositide"", ""start_span"": 15, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""ras"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Cell""}]"	train
The basal phosphorylation of protein kinase C substrate of relative molecular mass ( Mr) 80, 000 ( 80K) is significantly increased in all the ras - transformed cell lines.	protein kinase C,29,45,Gene_or_gene_product	ras,142,145,Gene_or_gene_product	cell lines,160,170,Cell	"[{""token"": ""protein kinase C"", ""start_span"": 29, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell lines"", ""start_span"": 160, ""end_span"": 170, ""type"": ""Cell""}]"	train
Glutamine and glucose as energy substrates for Ehrlich ascites tumour cells.	Glutamine,0,9,Amino_acid	glucose,14,21,Chemical	Ehrlich ascites tumour cells,47,75,Cell	"[{""token"": ""Glutamine"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Amino_acid""}, {""token"": ""glucose"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""Ehrlich ascites tumour cells"", ""start_span"": 47, ""end_span"": 75, ""type"": ""Cell""}]"	train
Energy metabolism of freshly harvested Ehrlich ascites tumour cells in the presence of 5 mM glucose and / or 0. 5 mM glutamine was studied.	Ehrlich ascites tumour cells,39,67,Cell	glucose,92,99,Chemical	glutamine,117,126,Amino_acid	"[{""token"": ""Ehrlich ascites tumour cells"", ""start_span"": 39, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""glutamine"", ""start_span"": 117, ""end_span"": 126, ""type"": ""Amino_acid""}]"	train
The rate of oxygen utilization was not altered by the addition of 0. 5 mM glutamine; 5 mM glucose induced an inhibition of respiration.	oxygen,12,18,Chemical	glutamine,74,83,Amino_acid	glucose,90,97,Chemical	"[{""token"": ""oxygen"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""glutamine"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Amino_acid""}, {""token"": ""glucose"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Chemical""}]"	train
Growth state - dependent regulation of protein kinase C in normal and transformed murine cells.	protein kinase C,39,55,Gene_or_gene_product	murine,82,88,Organism	cells,89,94,Cell	"[{""token"": ""protein kinase C"", ""start_span"": 39, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Cell""}]"	train
We determined whether growth state can influence the action of protein kinase C by measuring protein kinase C activity in growing and stationary cultures of normal and transformed cells.	protein kinase C,63,79,Gene_or_gene_product	protein kinase C,93,109,Gene_or_gene_product	cells,180,185,Cell	"[{""token"": ""protein kinase C"", ""start_span"": 63, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""protein kinase C"", ""start_span"": 93, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Cell""}]"	train
In contrast, the response of cells to long - term treatment with PDBu was significantly different depending upon the initial growth state of the cells.	cells,29,34,Cell	PDBu,65,69,Chemical	cells,145,150,Cell	"[{""token"": ""cells"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""PDBu"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Cell""}]"	train
These results suggest that prolonged treatment with tumor promoters alters the sensitivity of cells to activators of protein kinase C in a growth state - dependent manner.	tumor,52,57,Cancer	cells,94,99,Cell	protein kinase C,117,133,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""protein kinase C"", ""start_span"": 117, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}]"	train
Tumorigenic hybrid derivatives contained lower numbers of chromosomes than the tetraploid parental hybrids.	hybrid derivatives,12,30,Cell	chromosomes,58,69,Cellular_component	parental hybrids,90,106,Cell	"[{""token"": ""hybrid derivatives"", ""start_span"": 12, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""chromosomes"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Cellular_component""}, {""token"": ""parental hybrids"", ""start_span"": 90, ""end_span"": 106, ""type"": ""Cell""}]"	train
Normal cells contain suppressor gene ( s) which safeguard these cells against transformation by the product of the transforming Ha - ras - 1 oncogene.	Normal cells,0,12,Cell	cells,64,69,Cell	Ha - ras - 1,128,140,Gene_or_gene_product	"[{""token"": ""Normal cells"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Cell""}, {""token"": ""Ha - ras - 1"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}]"	train
Mast cells were found to be unique among the peritoneal leukocytes by virtue of their capacity to enhance profoundly the proliferation of a variety of tumors in vitro.	Mast cells,0,10,Cell	peritoneal leukocytes,45,66,Cell	tumors,151,157,Cancer	"[{""token"": ""Mast cells"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Cell""}, {""token"": ""peritoneal leukocytes"", ""start_span"": 45, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Cancer""}]"	train
The growth factor was found to reside in mast cell granules and was identified as heparin by sequential purification and enzymatic degradation.	mast cell,41,50,Cell	granules,51,59,Organism_substance	heparin,82,89,Chemical	"[{""token"": ""mast cell"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""granules"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Organism_substance""}, {""token"": ""heparin"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Chemical""}]"	train
Cells transformed by Rous sarcoma virus release transforming growth factors.	Cells,0,5,Cell	Rous sarcoma virus,21,39,Organism	transforming growth factors,48,75,Gene_or_gene_product	"[{""token"": ""Cells"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""Rous sarcoma virus"", ""start_span"": 21, ""end_span"": 39, ""type"": ""Organism""}, {""token"": ""transforming growth factors"", ""start_span"": 48, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}]"	train
This action is not observed with uninfected CEF, and, therefore, appears to require some expression of the viral src gene in the target cells.	CEF,44,47,Cell	src,113,116,Gene_or_gene_product	cells,136,141,Cell	"[{""token"": ""CEF"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""src"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Cell""}]"	train
The enhancing factors are proteins related to the family of the transforming growth factors ( TGFs) by their molecular weight ( about 20 kd), their heat and acid resistance, and their sensitivity to dithiothreitol.	transforming growth factors,64,91,Gene_or_gene_product	TGFs,94,98,Gene_or_gene_product	dithiothreitol,199,213,Chemical	"[{""token"": ""transforming growth factors"", ""start_span"": 64, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGFs"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""dithiothreitol"", ""start_span"": 199, ""end_span"": 213, ""type"": ""Chemical""}]"	train
Molecular events leading to enhanced glucose transport in Rous sarcoma virus - transformed cells.	glucose,37,44,Chemical	Rous sarcoma virus,58,76,Organism	cells,91,96,Cell	"[{""token"": ""glucose"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""Rous sarcoma virus"", ""start_span"": 58, ""end_span"": 76, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Cell""}]"	train
The increased rate of glucose transport is dependent on the activity of pp60src, the transforming protein of Rous sarcoma virus.	glucose,22,29,Chemical	pp60src,72,79,Gene_or_gene_product	Rous sarcoma virus,109,127,Organism	"[{""token"": ""glucose"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""pp60src"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rous sarcoma virus"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Organism""}]"	train
One of these mutants ( CU2) increases the rate of glucose transport only slightly and does not render the infected cells fully anchorage independent or tumorigenic ( although other transformation parameters are fully induced).	CU2,23,26,Organism	glucose,50,57,Chemical	cells,115,120,Cell	"[{""token"": ""CU2"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Organism""}, {""token"": ""glucose"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Cell""}]"	train
Cells infected with this mutant display a 36, 000 - dalton protein that is phosphorylated to a considerably lesser extent than cells infected with wild - type virus.	Cells,0,5,Cell	cells,127,132,Cell	wild - type virus,147,164,Organism	"[{""token"": ""Cells"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""wild - type virus"", ""start_span"": 147, ""end_span"": 164, ""type"": ""Organism""}]"	train
Analyses of this sort may help to identify the cellular targets of pp60src whose phosphorylation is necessary for the increased glucose transport rate.	cellular,47,55,Cell	pp60src,67,74,Gene_or_gene_product	glucose,128,135,Chemical	"[{""token"": ""cellular"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""pp60src"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Chemical""}]"	train
In contrast, at least some of these sites were not methylated in DNA from the B - cells expressing high levels of DR alpha mRNA.	DNA,65,68,Cellular_component	B - cells,78,87,Cell	DR alpha,114,122,Gene_or_gene_product	"[{""token"": ""DNA"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Cellular_component""}, {""token"": ""B - cells"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""DR alpha"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"	train
These results suggest that the tumor - bearing animal, even prior to significant cachexia, has an excess demand for energy, the provision of which may be a significant factor in malignant cachexia.	tumor,31,36,Cancer	cachexia,81,89,Cancer	malignant cachexia,178,196,Cancer	"[{""token"": ""tumor"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Cancer""}, {""token"": ""cachexia"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Cancer""}, {""token"": ""malignant cachexia"", ""start_span"": 178, ""end_span"": 196, ""type"": ""Cancer""}]"	train
SVLT mutants, defective either in the Rb binding site, near the N - terminal end, in a region that affects binding to p53, or in the nuclear transport signal, were also employed to determine whether the interference was especially dependent on these functional domains.	SVLT,0,4,Gene_or_gene_product	Rb,38,40,Gene_or_gene_product	p53,118,121,Gene_or_gene_product	"[{""token"": ""SVLT"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 38, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}]"	train
The remaining SVLT mutants presented different degrees of ability to inhibit differentiation ( as shown by the expression of tissue - specific markers in transformants).	SVLT,14,18,Gene_or_gene_product	tissue,125,131,Tissue	transformants,154,167,Cell	"[{""token"": ""SVLT"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Tissue""}, {""token"": ""transformants"", ""start_span"": 154, ""end_span"": 167, ""type"": ""Cell""}]"	train
A transcript from the long terminal repeats of a murine retrovirus associated with trans activation of cellular genes.	long terminal repeats,22,43,Cellular_component	murine retrovirus,49,66,Organism	cellular,103,111,Cell	"[{""token"": ""long terminal repeats"", ""start_span"": 22, ""end_span"": 43, ""type"": ""Cellular_component""}, {""token"": ""murine retrovirus"", ""start_span"": 49, ""end_span"": 66, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 103, ""end_span"": 111, ""type"": ""Cell""}]"	train
Anti - transforming growth factor ( TGF) - beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity.	breast cancer cell,67,85,Cell	mouse,114,119,Organism	spleen natural killer cell,120,146,Cell	"[{""token"": ""breast cancer cell"", ""start_span"": 67, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""mouse"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Organism""}, {""token"": ""spleen natural killer cell"", ""start_span"": 120, ""end_span"": 146, ""type"": ""Cell""}]"	train
TGF - beta effects on angiogenesis, stroma formation, and immune function suggest its possible involvement in tumor progression.	TGF - beta,0,10,Gene_or_gene_product	stroma,36,42,Tissue	tumor,110,115,Cancer	"[{""token"": ""TGF - beta"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""stroma"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Tissue""}, {""token"": ""tumor"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Cancer""}]"	train
Inoculation of these cells in athymic mice decreases mouse spleen natural killer ( NK) cell activity.	cells,21,26,Cell	athymic mice,30,42,Organism	mouse,53,58,Organism	"[{""token"": ""cells"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""athymic mice"", ""start_span"": 30, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""mouse"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Organism""}]"	train
Intraperitoneal administration of 2G7 resulted in a marked increase in mouse spleen NK cell activity.	Intraperitoneal,0,15,Immaterial_anatomical_entity	mouse,71,76,Organism	spleen NK cell,77,91,Cell	"[{""token"": ""Intraperitoneal"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""mouse"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Organism""}, {""token"": ""spleen NK cell"", ""start_span"": 77, ""end_span"": 91, ""type"": ""Cell""}]"	train
These data support a possible role for tumor cell TGF - beta in the progression of mammary carcinomas by suppressing host immune surveillance.	tumor cell,39,49,Cell	TGF - beta,50,60,Gene_or_gene_product	mammary carcinomas,83,101,Cancer	"[{""token"": ""tumor cell"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""TGF - beta"", ""start_span"": 50, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary carcinomas"", ""start_span"": 83, ""end_span"": 101, ""type"": ""Cancer""}]"	train
Bicistronic retroviral vector reveals capacity of v - erbA to induce erythroleukemia and to co - operate with v - myb.	v - erbA,50,58,Gene_or_gene_product	erythroleukemia,69,84,Cancer	v - myb,110,117,Gene_or_gene_product	"[{""token"": ""v - erbA"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""erythroleukemia"", ""start_span"": 69, ""end_span"": 84, ""type"": ""Cancer""}, {""token"": ""v - myb"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}]"	train
Previous studies have shown that v - erbA and v - myb can induce the proliferation of avian erythroid cells in culture.	v - erbA,33,41,Gene_or_gene_product	v - myb,46,53,Gene_or_gene_product	erythroid cells,92,107,Cell	"[{""token"": ""v - erbA"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - myb"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""erythroid cells"", ""start_span"": 92, ""end_span"": 107, ""type"": ""Cell""}]"	train
To study the combined effects of v - erbA and v - myb, the two oncogenes were engineered into a retrovirus bicistronic vector with an internal ribosomal entry site ( IRES) or into a vector with a splice acceptor ( SPL).	v - erbA,33,41,Gene_or_gene_product	v - myb,46,53,Gene_or_gene_product	ribosomal,143,152,Cellular_component	"[{""token"": ""v - erbA"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - myb"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""ribosomal"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Cellular_component""}]"	train
Surprisingly, when injected into chicken embryos in the presence of helper virus, both viruses induced an erythroleukemia in about half of the animals.	chicken,33,40,Organism	embryos,41,48,Developing_anatomical_structure	erythroleukemia,106,121,Cancer	"[{""token"": ""chicken"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Organism""}, {""token"": ""embryos"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Developing_anatomical_structure""}, {""token"": ""erythroleukemia"", ""start_span"": 106, ""end_span"": 121, ""type"": ""Cancer""}]"	train
These results show that v - erbA is capable of inducing an erythroleukemia when expressed by a high titer bicistronic retrovirus under conditions of virus spreading and that its in vitro and in vivo transforming potential can be enhanced by v - myb.	v - erbA,24,32,Gene_or_gene_product	erythroleukemia,59,74,Cancer	v - myb,241,248,Gene_or_gene_product	"[{""token"": ""v - erbA"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""erythroleukemia"", ""start_span"": 59, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""v - myb"", ""start_span"": 241, ""end_span"": 248, ""type"": ""Gene_or_gene_product""}]"	train
Under similar conditions, both uninfected HUVECs and HUVECs infected with AdCMV. beta gal did not differentiate.	HUVECs,42,48,Cell	HUVECs,53,59,Cell	beta gal,81,89,Gene_or_gene_product	"[{""token"": ""HUVECs"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""HUVECs"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""beta gal"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}]"	train
VEGF165 or AdCMV. beta gal ( 2 x 10 ( 10) pfu) was resuspended in 0. 5 mL Matrigel and injected subcutaneously into mice.	VEGF165,0,7,Gene_or_gene_product	beta gal,18,26,Gene_or_gene_product	mice,116,120,Organism	"[{""token"": ""VEGF165"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta gal"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Organism""}]"	train
Two weeks after injection, there was histological evidence of neovascularization in the tissues surrounding the Matrigel containing AdCMV. VEGF165, whereas no significant angiogenesis was observed in response to AdCMV. beta gal.	tissues,88,95,Tissue	VEGF165,139,146,Gene_or_gene_product	beta gal,219,227,Gene_or_gene_product	"[{""token"": ""tissues"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Tissue""}, {""token"": ""VEGF165"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta gal"", ""start_span"": 219, ""end_span"": 227, ""type"": ""Gene_or_gene_product""}]"	train
Furthermore, the Matrigel plugs with AdCMV. VEGF165 demonstrated hemoglobin content fourfold higher than the plugs with AdCMV. beta gal.	VEGF165,44,51,Gene_or_gene_product	hemoglobin,65,75,Gene_or_gene_product	beta gal,127,135,Gene_or_gene_product	"[{""token"": ""VEGF165"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""hemoglobin"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta gal"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}]"	train
Modulation of apoptosis in human myeloid leukemic cells by GM - CSF.	human,27,32,Organism	myeloid leukemic cells,33,55,Cell	GM - CSF,59,67,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Organism""}, {""token"": ""myeloid leukemic cells"", ""start_span"": 33, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""GM - CSF"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}]"	train
These findings indicate that disparate mechanisms of enhancing or inhibiting apoptosis exist in myeloid leukemic cells related to environmental conditions, including HGF - regulated cellular synthesis of distinct proteins and mRNA.	myeloid leukemic cells,96,118,Cell	HGF,166,169,Gene_or_gene_product	cellular,182,190,Cell	"[{""token"": ""myeloid leukemic cells"", ""start_span"": 96, ""end_span"": 118, ""type"": ""Cell""}, {""token"": ""HGF"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 182, ""end_span"": 190, ""type"": ""Cell""}]"	train
Increased MP activity has been correlated with the metastatic potential of many cancers, including breast cancer.	MP,10,12,Gene_or_gene_product	cancers,80,87,Cancer	breast cancer,99,112,Cancer	"[{""token"": ""MP"", ""start_span"": 10, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Cancer""}, {""token"": ""breast cancer"", ""start_span"": 99, ""end_span"": 112, ""type"": ""Cancer""}]"	train
Several reports have indicated that tetracyclines can suppress tumor MPs as well.	tetracyclines,36,49,Chemical	tumor,63,68,Cancer	MPs,69,72,Gene_or_gene_product	"[{""token"": ""tetracyclines"", ""start_span"": 36, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Cancer""}, {""token"": ""MPs"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}]"	train
Transforming growth factor beta 1 promotes spontaneous transformation of cultured rat liver epithelial cells.	Transforming growth factor beta 1,0,33,Gene_or_gene_product	rat,82,85,Organism	liver epithelial cells,86,108,Cell	"[{""token"": ""Transforming growth factor beta 1"", ""start_span"": 0, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""liver epithelial cells"", ""start_span"": 86, ""end_span"": 108, ""type"": ""Cell""}]"	train
However, when the same cells were exposed to step - wise increases of TGF - beta concentration in their culture medium, the development of TGF - beta resistance was accelerated.	cells,23,28,Cell	TGF - beta,70,80,Gene_or_gene_product	TGF - beta,139,149,Gene_or_gene_product	"[{""token"": ""cells"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""TGF - beta"", ""start_span"": 70, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 139, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}]"	train
Cells which had been grown in medium containing 1 ng / ml TGF - beta developed colony - forming capacity in soft agar containing epidermal growth factor.	Cells,0,5,Cell	TGF - beta,58,68,Gene_or_gene_product	epidermal growth factor,129,152,Gene_or_gene_product	"[{""token"": ""Cells"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""TGF - beta"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""epidermal growth factor"", ""start_span"": 129, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}]"	train
When MDV was reactivated by treatment of lymphoblastoid cells with 25 micrograms of iododeoxyuridine per ml, the relative levels of the transcripts decreased.	MDV,5,8,Organism	lymphoblastoid cells,41,61,Cell	iododeoxyuridine,84,100,Chemical	"[{""token"": ""MDV"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""lymphoblastoid cells"", ""start_span"": 41, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""iododeoxyuridine"", ""start_span"": 84, ""end_span"": 100, ""type"": ""Chemical""}]"	train
By using Northern hybridization, RNase protection assays, and primer extension analysis, the MSRs were determined to map antisense to the predicted translational start site of the ICP4 homolog gene.	RNase,33,38,Gene_or_gene_product	MSRs,93,97,Gene_or_gene_product	ICP4 homolog,180,192,Gene_or_gene_product	"[{""token"": ""RNase"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""MSRs"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICP4 homolog"", ""start_span"": 180, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}]"	train
The host and tumor sensitivities to insulin are critical for such treatments, which aim to improve patient nutrition.	tumor,13,18,Cancer	insulin,36,43,Gene_or_gene_product	patient,99,106,Organism	"[{""token"": ""tumor"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Cancer""}, {""token"": ""insulin"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""patient"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Organism""}]"	train
The authors studied insulin effects on tumor and skeletal muscle metabolism with 2 - [ 18F] - fluoro - 2 - deoxy - D - glucose ( [ 18F] FDG) and positron emission tomography ( PET).	insulin,20,27,Gene_or_gene_product	tumor,39,44,Cancer	skeletal muscle,49,64,Tissue	"[{""token"": ""insulin"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""skeletal muscle"", ""start_span"": 49, ""end_span"": 64, ""type"": ""Tissue""}]"	train
The [ 18F] FDG uptake in muscle and the whole body glucose use during euglycemic hyperinsulinemic clamp were compared with those of weight - matched healthy subjects studied under similar circumstances.	muscle,25,31,Organ	body,46,50,Organism_subdivision	glucose,51,58,Chemical	"[{""token"": ""muscle"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Organ""}, {""token"": ""body"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Organism_subdivision""}, {""token"": ""glucose"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Chemical""}]"	train
CONCLUSIONS: We found that insulin does not induce major changes in glucose uptake of lymphomatous tissue.	insulin,27,34,Gene_or_gene_product	glucose,68,75,Chemical	lymphomatous tissue,86,105,Tissue	"[{""token"": ""insulin"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""lymphomatous tissue"", ""start_span"": 86, ""end_span"": 105, ""type"": ""Tissue""}]"	train
The decrease in ATP level might be explained through the interaction of the amine oxide with the cell membrane integrity.	ATP,16,19,Chemical	amine oxide,76,87,Chemical	cell membrane,97,110,Cellular_component	"[{""token"": ""ATP"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""amine oxide"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Chemical""}, {""token"": ""cell membrane"", ""start_span"": 97, ""end_span"": 110, ""type"": ""Cellular_component""}]"	train
Although several hypotheses for human carcinogenesis have been proposed, the specific genetic changes that cause normal cells to become cancer cells have not been identified.	human,32,37,Organism	cells,120,125,Cell	cancer cells,136,148,Cell	"[{""token"": ""human"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 136, ""end_span"": 148, ""type"": ""Cell""}]"	train
Increased nm23 - H1 and nm23 - H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential.	nm23 - H1,10,19,Gene_or_gene_product	nm23 - H2,24,33,Gene_or_gene_product	colon carcinomas,87,103,Cancer	"[{""token"": ""nm23 - H1"", ""start_span"": 10, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - H2"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon carcinomas"", ""start_span"": 87, ""end_span"": 103, ""type"": ""Cancer""}]"	train
PURPOSE: This study was designed to reconcile our previous findings with the recent report of nm23 - H1 allelic deletion in human colon cancers associated with poor prognosis.	nm23 - H1,94,103,Gene_or_gene_product	human,124,129,Organism	colon cancers,130,143,Cancer	"[{""token"": ""nm23 - H1"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Organism""}, {""token"": ""colon cancers"", ""start_span"": 130, ""end_span"": 143, ""type"": ""Cancer""}]"	train
Lymphoma prevalence was minimal in the T lineage but significant, although low ( 3 - 15%), in the B lineage.	Lymphoma,0,8,Cancer	T lineage,39,48,Cell	B lineage,98,107,Cell	"[{""token"": ""Lymphoma"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Cancer""}, {""token"": ""T lineage"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""B lineage"", ""start_span"": 98, ""end_span"": 107, ""type"": ""Cell""}]"	train
Among the members of this superfamily there are proteins with a regulatory function, such as ras, and proteins involved in vesicular trafficking, such as the family of rab proteins.	ras,93,96,Gene_or_gene_product	vesicular,123,132,Multi	rab,168,171,Gene_or_gene_product	"[{""token"": ""ras"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""vesicular"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Multi""}, {""token"": ""rab"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}]"	train
By contrast, ras - induced tumors were poorly differentiated fibrosarcomas.	ras,7,10,Gene_or_gene_product	tumors,27,33,Cancer	fibrosarcomas,61,74,Cancer	"[{""token"": ""ras"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""fibrosarcomas"", ""start_span"": 61, ""end_span"": 74, ""type"": ""Cancer""}]"	train
The same result was obtained when the model contained ER status and ER - tamoxifen interaction.	ER,54,56,Gene_or_gene_product	ER,68,70,Gene_or_gene_product	tamoxifen,73,82,Chemical	"[{""token"": ""ER"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""ER"", ""start_span"": 68, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""tamoxifen"", ""start_span"": 73, ""end_span"": 82, ""type"": ""Chemical""}]"	train
Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo.	DNA,23,26,Cellular_component	vascular endothelial growth factor,58,92,Gene_or_gene_product	collateral,104,114,Multi	"[{""token"": ""DNA"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Cellular_component""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 58, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""collateral"", ""start_span"": 104, ""end_span"": 114, ""type"": ""Multi""}]"	train
Vascular endothelial growth factor ( VEGF) is a naturally secreted endothelial cell - specific mitogen.	Vascular endothelial growth factor,0,34,Gene_or_gene_product	VEGF,37,41,Gene_or_gene_product	endothelial cell,67,83,Cell	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 67, ""end_span"": 83, ""type"": ""Cell""}]"	train
Similar results were obtained with phVEGF121, phVEGF165, and phVEGF189, which suggests that these isoforms are biologically equivalent with respect to in vivo angiogenesis.	phVEGF121,35,44,Gene_or_gene_product	phVEGF165,46,55,Gene_or_gene_product	phVEGF189,61,70,Gene_or_gene_product	"[{""token"": ""phVEGF121"", ""start_span"": 35, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""phVEGF165"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""phVEGF189"", ""start_span"": 61, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}]"	train
Arterial gene transfer of naked DNA encoding for a secreted angiogenic cytokine, thus, represents a potential alternative to recombinant protein administration for stimulating collateral vessel development.	Arterial,0,8,Multi	DNA,32,35,Cellular_component	collateral vessel,176,193,Multi	"[{""token"": ""Arterial"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Multi""}, {""token"": ""DNA"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Cellular_component""}, {""token"": ""collateral vessel"", ""start_span"": 176, ""end_span"": 193, ""type"": ""Multi""}]"	train
On the other hand, MnSO4 only induced transformation in Rat 6 / c - myc cells, but not the parental Rat 6 cells.	MnSO4,19,24,Chemical	c - myc,64,71,Gene_or_gene_product	Rat 6 cells,100,111,Cell	"[{""token"": ""MnSO4"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""c - myc"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rat 6 cells"", ""start_span"": 100, ""end_span"": 111, ""type"": ""Cell""}]"	train
It is believed that the role of the E1B - 55kDa protein in transformation is to protect against p53 - dependent apoptosis by binding to and inactivating p53.	E1B,36,39,Gene_or_gene_product	p53,96,99,Gene_or_gene_product	p53,153,156,Gene_or_gene_product	"[{""token"": ""E1B"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}]"	train
Non - invasive grading of primary brain tumours: results of a comparative study between SPET with 123I - alpha - methyl tyrosine and PET with 18F - deoxyglucose.	brain tumours,34,47,Cancer	123I - alpha - methyl tyrosine,98,128,Chemical	18F - deoxyglucose,142,160,Chemical	"[{""token"": ""brain tumours"", ""start_span"": 34, ""end_span"": 47, ""type"": ""Cancer""}, {""token"": ""123I - alpha - methyl tyrosine"", ""start_span"": 98, ""end_span"": 128, ""type"": ""Chemical""}, {""token"": ""18F - deoxyglucose"", ""start_span"": 142, ""end_span"": 160, ""type"": ""Chemical""}]"	train
It was the aim of this study to compare the value of measurement of glucose metabolism with that of measurement of 123I - IMT uptake for the non - invasive grading of brain tumours.	glucose,68,75,Chemical	123I - IMT,115,125,Chemical	brain tumours,167,180,Cancer	"[{""token"": ""glucose"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""123I - IMT"", ""start_span"": 115, ""end_span"": 125, ""type"": ""Chemical""}, {""token"": ""brain tumours"", ""start_span"": 167, ""end_span"": 180, ""type"": ""Cancer""}]"	train
18F - FDG and 123I - IMT uptake was quantified as ratios between the uptake by the tumour and contralateral regions of reference.	18F - FDG,0,9,Chemical	123I - IMT,14,24,Chemical	tumour,83,89,Cancer	"[{""token"": ""18F - FDG"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""123I - IMT"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""tumour"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Cancer""}]"	train
Glucose metabolism and amino acid uptake of the brain tumours correlated significantly ( r = 0. 71, P < 0. 001).	Glucose,0,7,Chemical	amino acid,23,33,Amino_acid	brain tumours,48,61,Cancer	"[{""token"": ""Glucose"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""amino acid"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Amino_acid""}, {""token"": ""brain tumours"", ""start_span"": 48, ""end_span"": 61, ""type"": ""Cancer""}]"	train
It is concluded that there is no major difference between the PET investigation of glucose metabolism and the less expensive SPET measurement of amino acid uptake in terms of their accuracy in evaluating the malignancy grade of primary brain tumours.	glucose,83,90,Chemical	amino acid,145,155,Amino_acid	brain tumours,236,249,Cancer	"[{""token"": ""glucose"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""amino acid"", ""start_span"": 145, ""end_span"": 155, ""type"": ""Amino_acid""}, {""token"": ""brain tumours"", ""start_span"": 236, ""end_span"": 249, ""type"": ""Cancer""}]"	train
This encourages the performance of further studies to analyse the potential impact of 123I - IMT SPET on the therapeutic management of patients with brain tumours.	123I - IMT,86,96,Chemical	patients,135,143,Organism	brain tumours,149,162,Cancer	"[{""token"": ""123I - IMT"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 135, ""end_span"": 143, ""type"": ""Organism""}, {""token"": ""brain tumours"", ""start_span"": 149, ""end_span"": 162, ""type"": ""Cancer""}]"	train
The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells.	Wilms tumor,4,15,Cancer	WT1,32,35,Gene_or_gene_product	myeloblastic leukemia M1 cells,71,101,Cell	"[{""token"": ""Wilms tumor"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Cancer""}, {""token"": ""WT1"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloblastic leukemia M1 cells"", ""start_span"": 71, ""end_span"": 101, ""type"": ""Cell""}]"	train
WT1 was isolated as a tumor suppressor gene of Wilms tumor.	WT1,0,3,Gene_or_gene_product	tumor,22,27,Cancer	Wilms tumor,47,58,Cancer	"[{""token"": ""WT1"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""Wilms tumor"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Cancer""}]"	train
[ Expression of metastasis suppressor gene nm23 in human hepatocellular carcinoma].	nm23,43,47,Gene_or_gene_product	human,51,56,Organism	hepatocellular carcinoma,57,81,Cancer	"[{""token"": ""nm23"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""hepatocellular carcinoma"", ""start_span"": 57, ""end_span"": 81, ""type"": ""Cancer""}]"	train
CD56 + putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis?	CD56,0,4,Gene_or_gene_product	natural killer cell lymphomas,16,45,Cancer	tumor cell,112,122,Cell	"[{""token"": ""CD56"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""natural killer cell lymphomas"", ""start_span"": 16, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""tumor cell"", ""start_span"": 112, ""end_span"": 122, ""type"": ""Cell""}]"	train
This study was aimed to investigate whether there is selective expression of these cytolytic markers in the putative NK - cell lymphomas and whether there is correlation with zonal tumor cell death in these tumors.	NK - cell lymphomas,117,136,Cancer	tumor cell,181,191,Cell	tumors,207,213,Cancer	"[{""token"": ""NK - cell lymphomas"", ""start_span"": 117, ""end_span"": 136, ""type"": ""Cancer""}, {""token"": ""tumor cell"", ""start_span"": 181, ""end_span"": 191, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 207, ""end_span"": 213, ""type"": ""Cancer""}]"	train
There was strong correlation between percentage perforin - positive cells and zonal tumor cell death.	perforin,48,56,Gene_or_gene_product	cells,68,73,Cell	zonal tumor cell,78,94,Cell	"[{""token"": ""perforin"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""zonal tumor cell"", ""start_span"": 78, ""end_span"": 94, ""type"": ""Cell""}]"	train
Prophylactic thyroidectomy in MEN IIA: does the calcitonin level correlate with tumor spread?	MEN IIA,30,37,Cancer	calcitonin,48,58,Gene_or_gene_product	tumor,80,85,Cancer	"[{""token"": ""MEN IIA"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Cancer""}, {""token"": ""calcitonin"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Cancer""}]"	train
One 9 - year - old boy with bilateral microcarcinoma already had a lymph node metastasis.	boy,19,22,Organism	microcarcinoma,38,52,Cancer	lymph node,67,77,Multi	"[{""token"": ""boy"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Organism""}, {""token"": ""microcarcinoma"", ""start_span"": 38, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Multi""}]"	train
The mean baseline calcitonin level correlated with the histologic findings ( r = 0. 71, P = 0. 003) but there was no correlation between pentagastrin - stimulated calcitonin levels and histology ( r = 0. 21, P = 0. 47).	calcitonin,18,28,Gene_or_gene_product	pentagastrin,137,149,Chemical	calcitonin,163,173,Gene_or_gene_product	"[{""token"": ""calcitonin"", ""start_span"": 18, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""pentagastrin"", ""start_span"": 137, ""end_span"": 149, ""type"": ""Chemical""}, {""token"": ""calcitonin"", ""start_span"": 163, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"	train
Ets - 1, a transcription factor, is induced in endothelial cells ( ECs) during angiogenesis.	Ets - 1,0,7,Gene_or_gene_product	endothelial cells,47,64,Cell	ECs,67,70,Cell	"[{""token"": ""Ets - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 47, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""ECs"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Cell""}]"	train
An immunohistochemical analysis revealed that Ets - 1 accumulated in migrating cells at the wound edge and returned to basal level when reendothelialization was accomplished.	Ets - 1,46,53,Gene_or_gene_product	migrating cells,69,84,Cell	wound edge,92,102,Pathological_formation	"[{""token"": ""Ets - 1"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""migrating cells"", ""start_span"": 69, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""wound edge"", ""start_span"": 92, ""end_span"": 102, ""type"": ""Pathological_formation""}]"	train
This induction of Ets - 1 could be reproduced in in vivo denudation of rat aortic endothelium by a balloon catheter.	Ets - 1,18,25,Gene_or_gene_product	rat,71,74,Organism	aortic endothelium,75,93,Tissue	"[{""token"": ""Ets - 1"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""aortic endothelium"", ""start_span"": 75, ""end_span"": 93, ""type"": ""Tissue""}]"	train
These results indicate that Ets - 1 is induced in ECs after denudation through activation of p38.	Ets - 1,28,35,Gene_or_gene_product	ECs,50,53,Cell	p38,93,96,Gene_or_gene_product	"[{""token"": ""Ets - 1"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""ECs"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""p38"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"	train
SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype.	SV40,0,4,Organism	Tag,5,8,Gene_or_gene_product	trophoblast,47,58,Cell	"[{""token"": ""SV40"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""Tag"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""trophoblast"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Cell""}]"	train
Invasion of the uterus by first trimester human placental extravillous trophoblast ( EVT) cells depends on mechanisms shared by malignant cells.	uterus,16,22,Organ	human,42,47,Organism	malignant cells,128,143,Cell	"[{""token"": ""uterus"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Organ""}, {""token"": ""human"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Organism""}, {""token"": ""malignant cells"", ""start_span"": 128, ""end_span"": 143, ""type"": ""Cell""}]"	train
However, unlike tumor invasion, trophoblast invasion of the uterus is stringently controlled in situ by local molecules such as transforming growth factor ( TGF) beta.	tumor,16,21,Cancer	trophoblast,32,43,Cell	uterus,60,66,Organ	"[{""token"": ""tumor"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Cancer""}, {""token"": ""trophoblast"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""uterus"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Organ""}]"	train
Since EVT cells possess active invasion - associated genes but are nontumorigenic, our objective was to induce premalignant and then malignant phenotype into a normal EVT cell line in order to identify the molecular basis of tumor progression.	EVT cells,6,15,Cell	EVT cell line,167,180,Cell	tumor,225,230,Cancer	"[{""token"": ""EVT cells"", ""start_span"": 6, ""end_span"": 15, ""type"": ""Cell""}, {""token"": ""EVT cell line"", ""start_span"": 167, ""end_span"": 180, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Cancer""}]"	train
A long - lived line, RSVT - 2, was produced and an immortalized subclone, RSVT2 / C, was further derived under a forced crisis regimen.	line,15,19,Cell	RSVT - 2,21,29,Cell	RSVT2 / C,74,83,Cell	"[{""token"": ""line"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""RSVT - 2"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""RSVT2 / C"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Cell""}]"	train
RSVT - 2 and RSVT2 / C cell lines were hyperproliferative and hyperinvasive when compared with the parental HTR8 cell line.	RSVT - 2,0,8,Cell	RSVT2 / C cell lines,13,33,Cell	HTR8 cell line,108,122,Cell	"[{""token"": ""RSVT - 2"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Cell""}, {""token"": ""RSVT2 / C cell lines"", ""start_span"": 13, ""end_span"": 33, ""type"": ""Cell""}, {""token"": ""HTR8 cell line"", ""start_span"": 108, ""end_span"": 122, ""type"": ""Cell""}]"	train
Both cell lines showed reduced expression of tissue inhibitor of metalloproteases ( TIMP) - 1, while TIMP - 2 and plasminogen activator inhibitor ( PAI) - I expression was was also reduced in RSVT2 / C cells, thus contributing to their hyperinvasiveness.	cell lines,5,15,Cell	TIMP - 2,101,109,Gene_or_gene_product	RSVT2 / C cells,192,207,Cell	"[{""token"": ""cell lines"", ""start_span"": 5, ""end_span"": 15, ""type"": ""Cell""}, {""token"": ""TIMP - 2"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""RSVT2 / C cells"", ""start_span"": 192, ""end_span"": 207, ""type"": ""Cell""}]"	train
A low - Km, mitochondrial type II - like tumor HK is described as the predominant form in hepatomas.	mitochondrial,12,25,Cellular_component	type II - like tumor HK,26,49,Gene_or_gene_product	hepatomas,90,99,Cancer	"[{""token"": ""mitochondrial"", ""start_span"": 12, ""end_span"": 25, ""type"": ""Cellular_component""}, {""token"": ""type II - like tumor HK"", ""start_span"": 26, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""hepatomas"", ""start_span"": 90, ""end_span"": 99, ""type"": ""Cancer""}]"	train
Highly sensitive reverse - transcription polymerase chain reaction identifies an induction and overexpression of a type II - like tumor HK RNA in a range of cancer cell lines irrespective of tissue origin.	type II - like tumor HK,115,138,Gene_or_gene_product	cancer cell lines,157,174,Cell	tissue,191,197,Tissue	"[{""token"": ""type II - like tumor HK"", ""start_span"": 115, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cell lines"", ""start_span"": 157, ""end_span"": 174, ""type"": ""Cell""}, {""token"": ""tissue"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Tissue""}]"	train
Homeobox genes have a strikingly conserved 61 - amino acid sequence, encoding DNA - binding domain.	Homeobox,0,8,Gene_or_gene_product	amino acid,48,58,Amino_acid	DNA,78,81,Cellular_component	"[{""token"": ""Homeobox"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""amino acid"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Amino_acid""}, {""token"": ""DNA"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Cellular_component""}]"	train
There are examples of the aberrant expression of a homeobox gene causing leukemias in humans.	homeobox,51,59,Gene_or_gene_product	leukemias,73,82,Cancer	humans,86,92,Organism	"[{""token"": ""homeobox"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukemias"", ""start_span"": 73, ""end_span"": 82, ""type"": ""Cancer""}, {""token"": ""humans"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Organism""}]"	train
In acute myeloid leukemia ( AML) with t ( 7; 11) translocation, the HOX A9 gene is rearranged.	acute myeloid leukemia,3,25,Cancer	AML,28,31,Cancer	HOX A9,68,74,Gene_or_gene_product	"[{""token"": ""acute myeloid leukemia"", ""start_span"": 3, ""end_span"": 25, ""type"": ""Cancer""}, {""token"": ""AML"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Cancer""}, {""token"": ""HOX A9"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}]"	train
In this review article, many functions of homeobox genes both at the early stem cell level as well as at the later stages of hematopoietic differentiation, and the leukemogenic effect of altered homeobox genes are discussed.	homeobox,42,50,Gene_or_gene_product	stem cell,75,84,Cell	homeobox,195,203,Gene_or_gene_product	"[{""token"": ""homeobox"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""stem cell"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""homeobox"", ""start_span"": 195, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}]"	train
Store - operated calcium entry promotes shape change in pulmonary endothelial cells expressing Trp1.	calcium,17,24,Chemical	pulmonary endothelial cells,56,83,Cell	Trp1,95,99,Gene_or_gene_product	"[{""token"": ""calcium"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""pulmonary endothelial cells"", ""start_span"": 56, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""Trp1"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}]"	train
They were consistent with the concept of the existence of 2 pools of both lactate and pyruvate, of which 1 pool was closely connected with exogenous lactate and oxidative metabolism, and the other pool was closely related to glycolysis and disconnected from oxidative metabolism.	lactate,74,81,Chemical	pyruvate,86,94,Chemical	lactate,149,156,Chemical	"[{""token"": ""lactate"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""pyruvate"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Chemical""}]"	train
This demonstrates that RPE tumor cells metastasize to lymph node and spleen.	RPE tumor cells,23,38,Cell	lymph node,54,64,Multi	spleen,69,75,Organ	"[{""token"": ""RPE tumor cells"", ""start_span"": 23, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""lymph node"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Multi""}, {""token"": ""spleen"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Organ""}]"	train
RESULTS: U - 995 ( 15 and 30 micrograms / ml) markedly inhibited HUVEC migration and, at 15 - 50 micrograms / ml produced a dose - dependent decline in [ 3H] - thymidine incorporation.	U - 995,9,16,Gene_or_gene_product	HUVEC,65,70,Cell	thymidine,160,169,Chemical	"[{""token"": ""U - 995"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""HUVEC"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""thymidine"", ""start_span"": 160, ""end_span"": 169, ""type"": ""Chemical""}]"	train
30 and 50 micrograms / ml of U - 995, when added to TNF alpha - induced angiogenesis caused discontinuous and disrupted blood vessels.	U - 995,29,36,Gene_or_gene_product	TNF alpha,52,61,Gene_or_gene_product	blood vessels,120,133,Multi	"[{""token"": ""U - 995"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF alpha"", ""start_span"": 52, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessels"", ""start_span"": 120, ""end_span"": 133, ""type"": ""Multi""}]"	train
Additional experiments revealed FT to be effective component of UFT; uracil remained ineffective in the inhibition of angiogenesis.	FT,32,34,Chemical	UFT,64,67,Chemical	uracil,69,75,Chemical	"[{""token"": ""FT"", ""start_span"": 32, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""UFT"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""uracil"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Chemical""}]"	valid
Moreover, we have found that gamma - hydroxybutyric acid and gamma - butyrolactone, the metabolites of FT, possess a potent angiogenesis inhibitory effect that is amplified when the compounds are administered by a continuous infusion.	gamma - hydroxybutyric acid,29,56,Chemical	gamma - butyrolactone,61,82,Chemical	FT,103,105,Chemical	"[{""token"": ""gamma - hydroxybutyric acid"", ""start_span"": 29, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""gamma - butyrolactone"", ""start_span"": 61, ""end_span"": 82, ""type"": ""Chemical""}, {""token"": ""FT"", ""start_span"": 103, ""end_span"": 105, ""type"": ""Chemical""}]"	valid
Systemic treatment with L - NAME inhibited growth of adenocarcinoma significantly but was accompanied by impaired renal function.	L - NAME,24,32,Chemical	adenocarcinoma,53,67,Cancer	renal,114,119,Organ	"[{""token"": ""L - NAME"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""adenocarcinoma"", ""start_span"": 53, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""renal"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Organ""}]"	valid
Apoptosis induced by 1 ' - acetoxychavicol acetate in Ehrlich ascites tumor cells is associated with modulation of polyamine metabolism and caspase - 3 activation.	1 ' - acetoxychavicol acetate,21,50,Chemical	Ehrlich ascites tumor cells,54,81,Cell	caspase - 3,140,151,Gene_or_gene_product	"[{""token"": ""1 ' - acetoxychavicol acetate"", ""start_span"": 21, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""Ehrlich ascites tumor cells"", ""start_span"": 54, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""caspase - 3"", ""start_span"": 140, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}]"	valid
Administration of exogenous polyamines prevented ACA - induced apoptosis represented by a reduction in the number of apoptotic bodies and also caused reduction in the induced caspase - 3 - like protease activity at 8 h.	ACA,49,52,Chemical	apoptotic bodies,117,133,Cellular_component	caspase - 3 - like protease,175,202,Gene_or_gene_product	"[{""token"": ""ACA"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""apoptotic bodies"", ""start_span"": 117, ""end_span"": 133, ""type"": ""Cellular_component""}, {""token"": ""caspase - 3 - like protease"", ""start_span"": 175, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}]"	valid
Although the importance of VEGF - A has been shown in renal carcinomas, the contribution of these new ligands in kidney tumors is not clear.	VEGF - A,27,35,Gene_or_gene_product	renal carcinomas,54,70,Cancer	kidney tumors,113,126,Cancer	"[{""token"": ""VEGF - A"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal carcinomas"", ""start_span"": 54, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""kidney tumors"", ""start_span"": 113, ""end_span"": 126, ""type"": ""Cancer""}]"	valid
In wild - type VHL cells, whereas VEGF - A was significantly up - regulated under hypoxic compared with normoxic conditions ( P less than 0. 001), expression of VEGF - C was reduced ( P less than 0. 002).	VHL,15,18,Gene_or_gene_product	VEGF - A,34,42,Gene_or_gene_product	VEGF - C,161,169,Gene_or_gene_product	"[{""token"": ""VHL"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - A"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 161, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}]"	valid
Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions.	Glucose,0,7,Chemical	cancer cells,22,34,Cell	type II hexokinase,111,129,Gene_or_gene_product	"[{""token"": ""Glucose"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""cancer cells"", ""start_span"": 22, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""type II hexokinase"", ""start_span"": 111, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}]"	valid
Moreover, we show that subjecting transfected hepatoma cells to hypoxic conditions activates the type II hexokinase promoter almost 3 - fold, a value that approaches 7 - fold in the presence of glucose.	hepatoma cells,46,60,Cell	type II hexokinase,97,115,Gene_or_gene_product	glucose,194,201,Chemical	"[{""token"": ""hepatoma cells"", ""start_span"": 46, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""type II hexokinase"", ""start_span"": 97, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Chemical""}]"	valid
Reporter gene analyses with a series of nested deletion mutants of the hepatoma type II hexokinase promoter show that a significant fraction of the total activation observed under hypoxic conditions localizes to the distal region where the overlapping HIF - 1 / E - box sequences are located.	hepatoma,71,79,Cancer	type II hexokinase,80,98,Gene_or_gene_product	HIF - 1,252,259,Gene_or_gene_product	"[{""token"": ""hepatoma"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""type II hexokinase"", ""start_span"": 80, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1"", ""start_span"": 252, ""end_span"": 259, ""type"": ""Gene_or_gene_product""}]"	valid
Herein we show that Cbl can negatively regulate another signaling molecule, namely theSrc - family kinase Hck by targeting it for degradation.	Cbl,20,23,Gene_or_gene_product	theSrc,83,89,Gene_or_gene_product	Hck,106,109,Gene_or_gene_product	"[{""token"": ""Cbl"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""theSrc"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hck"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"	valid
The expression of Cbl at the plasma membrane targets both Hck and itself for ubiquitination and degradation, requiring an intact RING finger.	Cbl,18,21,Gene_or_gene_product	plasma membrane,29,44,Cellular_component	Hck,58,61,Gene_or_gene_product	"[{""token"": ""Cbl"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasma membrane"", ""start_span"": 29, ""end_span"": 44, ""type"": ""Cellular_component""}, {""token"": ""Hck"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}]"	valid
Pharmacological inhibition of the proteasome prevents the degradation of Hck correlating with an increase in the phosphotyrosine levels within the cells.	Hck,73,76,Gene_or_gene_product	phosphotyrosine,113,128,Amino_acid	cells,147,152,Cell	"[{""token"": ""Hck"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphotyrosine"", ""start_span"": 113, ""end_span"": 128, ""type"": ""Amino_acid""}, {""token"": ""cells"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Cell""}]"	valid
This work illustrates alternate means to regulate Src - family kinases, and suggests that Cbl may be able to suppress many signaling pathways that are activated in various proliferative syndromes including cancer.	Src,50,53,Gene_or_gene_product	Cbl,90,93,Gene_or_gene_product	cancer,206,212,Cancer	"[{""token"": ""Src"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cbl"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 206, ""end_span"": 212, ""type"": ""Cancer""}]"	valid
Transfection with hTERT alone, led to the immortalization of two out of three cultures of bone marrow - derived ECs ( BMECs).	hTERT,18,23,Gene_or_gene_product	bone marrow - derived ECs,90,115,Cell	BMECs,118,123,Cell	"[{""token"": ""hTERT"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""bone marrow - derived ECs"", ""start_span"": 90, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""BMECs"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Cell""}]"	valid
BMECs transfected with SV40T ( BMSVTs) had an extended lifespan, but eventually succumbed to crisis.	BMECs,0,5,Cell	SV40T,23,28,Gene_or_gene_product	BMSVTs,31,37,Cell	"[{""token"": ""BMECs"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""SV40T"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMSVTs"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Cell""}]"	valid
Transduction of BMSVTs with hTERT resulted in immortalization of 4 out of 4 cultures.	BMSVTs,16,22,Cell	hTERT,28,33,Gene_or_gene_product	cultures,76,84,Cell	"[{""token"": ""BMSVTs"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""hTERT"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""cultures"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Cell""}]"	valid
BMSVTs immortalized with hTERT formed large colonies in vitro and small transient tumours in vivo.	BMSVTs,0,6,Cell	hTERT,25,30,Gene_or_gene_product	tumours,82,89,Cancer	"[{""token"": ""BMSVTs"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Cell""}, {""token"": ""hTERT"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumours"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Cancer""}]"	valid
This model will be useful for understanding mechanisms underlying vascular and angiogenic neoplasias, as well as for testing drugs designed to curtail aberrant EC growth.	vascular,66,74,Pathological_formation	angiogenic neoplasias,79,100,Pathological_formation	EC,160,162,Cell	"[{""token"": ""vascular"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Pathological_formation""}, {""token"": ""angiogenic neoplasias"", ""start_span"": 79, ""end_span"": 100, ""type"": ""Pathological_formation""}, {""token"": ""EC"", ""start_span"": 160, ""end_span"": 162, ""type"": ""Cell""}]"	valid
Retinal microangiopathies overlying pigment epithelial detachment in age - related macular degeneration.	Retinal,0,7,Multi	pigment epithelial,36,54,Tissue	macular,83,90,Tissue	"[{""token"": ""Retinal"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Multi""}, {""token"": ""pigment epithelial"", ""start_span"": 36, ""end_span"": 54, ""type"": ""Tissue""}, {""token"": ""macular"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Tissue""}]"	valid
RESULTS: In all, 67 vascular abnormalities were found by indocyanine green angiography and only 22 by fluorescein angiography; this finding was statistically significant ( P less than 0. 0001).	vascular,20,28,Multi	indocyanine green,57,74,Chemical	fluorescein,102,113,Chemical	"[{""token"": ""vascular"", ""start_span"": 20, ""end_span"": 28, ""type"": ""Multi""}, {""token"": ""indocyanine green"", ""start_span"": 57, ""end_span"": 74, ""type"": ""Chemical""}, {""token"": ""fluorescein"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical""}]"	valid
The number of retinal vascular findings was not significantly correlated with serous elevation of the retina.	retinal vascular,14,30,Multi	serous,78,84,Organism_substance	retina,102,108,Multi	"[{""token"": ""retinal vascular"", ""start_span"": 14, ""end_span"": 30, ""type"": ""Multi""}, {""token"": ""serous"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Organism_substance""}, {""token"": ""retina"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Multi""}]"	valid
BACKGROUND: Recent data suggest that anti - tumor activities of interleukin - 12 ( IL - 12) involve the induction of apoptosis.	tumor,44,49,Cancer	interleukin - 12,64,80,Gene_or_gene_product	IL - 12,83,90,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Cancer""}, {""token"": ""interleukin - 12"", ""start_span"": 64, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 12"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}]"	valid
The average survival time of the RM - 9 - IL12 mice was longer than 53 days, whereas the mean survival for mice transplanted with control RM - 9 cells was only 16 days.	RM - 9 - IL12 mice,33,51,Organism	mice,107,111,Organism	RM - 9 cells,138,150,Cell	"[{""token"": ""RM - 9 - IL12 mice"", ""start_span"": 33, ""end_span"": 51, ""type"": ""Organism""}, {""token"": ""mice"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Organism""}, {""token"": ""RM - 9 cells"", ""start_span"": 138, ""end_span"": 150, ""type"": ""Cell""}]"	valid
Furthermore, we found that p130 ( Cas), but not paxillin, recruited Crk to the nascent focal complex.	paxillin,48,56,Gene_or_gene_product	Crk,68,71,Gene_or_gene_product	nascent focal complex,79,100,Cellular_component	"[{""token"": ""paxillin"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""Crk"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""nascent focal complex"", ""start_span"": 79, ""end_span"": 100, ""type"": ""Cellular_component""}]"	valid
Then, we examined the role of two major downstream molecules of Crk, Rac1 and Rap1.	Crk,64,67,Gene_or_gene_product	Rac1,69,73,Gene_or_gene_product	Rap1,78,82,Gene_or_gene_product	"[{""token"": ""Crk"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rac1"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rap1"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}]"	valid
Early relapse with distant metastasis often is observed in patients with cancer after resection of the primary tumor.	patients,59,67,Organism	cancer,73,79,Cancer	tumor,111,116,Cancer	"[{""token"": ""patients"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Cancer""}]"	valid
The authors show that resection of the primary osteosarcoma tumor enhances progression of pulmonary metastasis in animal osteosarcoma models.	osteosarcoma tumor,47,65,Cancer	pulmonary,90,99,Organ	osteosarcoma,121,133,Cancer	"[{""token"": ""osteosarcoma tumor"", ""start_span"": 47, ""end_span"": 65, ""type"": ""Cancer""}, {""token"": ""pulmonary"", ""start_span"": 90, ""end_span"": 99, ""type"": ""Organ""}, {""token"": ""osteosarcoma"", ""start_span"": 121, ""end_span"": 133, ""type"": ""Cancer""}]"	valid
Matrigel plug neovascularization assay revealed that systemic angiogenic activity was elevated after primary tumor removal ( tumor intact group, 1. 61 + / - 0. 21 g / dL; tumor removed group, 4. 92 + / - 0. 35 g / dL).	tumor,109,114,Cancer	tumor,125,130,Cancer	tumor,171,176,Cancer	"[{""token"": ""tumor"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Cancer""}]"	valid
In addition, serum concentration of the angiogenesis inhibitor, endostatin, decreased significantly after primary tumor removal.	serum,13,18,Organism_substance	endostatin,64,74,Gene_or_gene_product	tumor,114,119,Cancer	"[{""token"": ""serum"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Organism_substance""}, {""token"": ""endostatin"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Cancer""}]"	valid
The antiapoptotic effect of FVIIa was confirmed by the observation that FVIIa attenuated caspase 3 activation.	FVIIa,28,33,Gene_or_gene_product	FVIIa,72,77,Gene_or_gene_product	caspase 3,89,98,Gene_or_gene_product	"[{""token"": ""FVIIa"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""FVIIa"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase 3"", ""start_span"": 89, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}]"	valid
A pair of primers bracketing the XhoI site were designed to synthesize the EBV DNA fragment from nucleotides 169, 081 - 169, 577 by using the polymerase chain reaction ( PCR) method.	XhoI,33,37,Gene_or_gene_product	EBV,75,78,Organism	DNA,79,82,Cellular_component	"[{""token"": ""XhoI"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""EBV"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""DNA"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Cellular_component""}]"	valid
Angiopoietin / tie - 2 as mediators of angiogenesis: a role in congestive heart failure?	Angiopoietin,0,12,Gene_or_gene_product	tie - 2,15,22,Gene_or_gene_product	heart,74,79,Organ	"[{""token"": ""Angiopoietin"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""tie - 2"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""heart"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organ""}]"	valid
The process of angiogenesis is also thought to occur in response to ischaemic conditions, which lie at the core of cardiovascular disease states such as coronary artery disease and congestive heart failure.	cardiovascular,115,129,Anatomical_system	coronary artery,153,168,Multi	heart,192,197,Organ	"[{""token"": ""cardiovascular"", ""start_span"": 115, ""end_span"": 129, ""type"": ""Anatomical_system""}, {""token"": ""coronary artery"", ""start_span"": 153, ""end_span"": 168, ""type"": ""Multi""}, {""token"": ""heart"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Organ""}]"	valid
High levels of these angiogenic factors in heart disease also have not translated into clinically significant new vessel formation, as in accelerated cancer growth or proliferative retinopathy.	heart,43,48,Organ	vessel,114,120,Multi	cancer,150,156,Cancer	"[{""token"": ""heart"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Organ""}, {""token"": ""vessel"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Multi""}, {""token"": ""cancer"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Cancer""}]"	valid
TAMs counts was related to VEGF - C expression in OSCC ( r = 0. 370, P < 0. 05).	TAMs,0,4,Cell	VEGF - C,27,35,Gene_or_gene_product	OSCC,50,54,Cancer	"[{""token"": ""TAMs"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Cell""}, {""token"": ""VEGF - C"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""OSCC"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Cancer""}]"	valid
Hypothesis: Induced angiogenesis after surgery in premenopausal node - positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients.	breast cancer,80,93,Cancer	patients,94,102,Organism	patients,192,200,Organism	"[{""token"": ""breast cancer"", ""start_span"": 80, ""end_span"": 93, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 192, ""end_span"": 200, ""type"": ""Organism""}]"	valid
Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age - related macular degeneration.	verteporfin,10,21,Chemical	subfoveal choroidal neovascular membranes,39,80,Multi	macular,111,118,Tissue	"[{""token"": ""verteporfin"", ""start_span"": 10, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""subfoveal choroidal neovascular membranes"", ""start_span"": 39, ""end_span"": 80, ""type"": ""Multi""}, {""token"": ""macular"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Tissue""}]"	valid
OBJECTIVE: Although DCC has been considered as a candidate tumor suppressor, the roles it plays in the uterine endometrium and in the carcinogenic process remains unclear.	DCC,20,23,Gene_or_gene_product	tumor,59,64,Cancer	uterine endometrium,103,122,Multi	"[{""token"": ""DCC"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Cancer""}, {""token"": ""uterine endometrium"", ""start_span"": 103, ""end_span"": 122, ""type"": ""Multi""}]"	valid
Restored DCC expression in the cancer cell lines in the absence of netrin - 1 induced apoptosis.	DCC,9,12,Gene_or_gene_product	cancer cell lines,31,48,Cell	netrin - 1,67,77,Gene_or_gene_product	"[{""token"": ""DCC"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cell lines"", ""start_span"": 31, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""netrin - 1"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}]"	valid
In addition, the silencing of DCC expression may contribute to the escape of endometrial cancer cells from a DCC - regulated apoptotic program, thereby promoting malignant phenotypes.	DCC,30,33,Gene_or_gene_product	endometrial cancer cells,77,101,Cell	DCC,109,112,Gene_or_gene_product	"[{""token"": ""DCC"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""endometrial cancer cells"", ""start_span"": 77, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""DCC"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}]"	valid
An evaluation of low molecular weight heparin and hyperbaric oxygen treatment in the prevention of intra - abdominal adhesions and wound healing.	low molecular weight heparin,17,45,Chemical	hyperbaric oxygen,50,67,Chemical	wound,131,136,Pathological_formation	"[{""token"": ""low molecular weight heparin"", ""start_span"": 17, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""hyperbaric oxygen"", ""start_span"": 50, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""wound"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Pathological_formation""}]"	valid
To prevent adhesions, an experimental study was planned to designate the effects of low molecular weight ( LMW) heparins and hyperbaric oxygen ( HBO) therapy both on the formation of adhesions and wound healing.	hyperbaric oxygen,125,142,Chemical	HBO,145,148,Chemical	wound,197,202,Pathological_formation	"[{""token"": ""hyperbaric oxygen"", ""start_span"": 125, ""end_span"": 142, ""type"": ""Chemical""}, {""token"": ""HBO"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Chemical""}, {""token"": ""wound"", ""start_span"": 197, ""end_span"": 202, ""type"": ""Pathological_formation""}]"	valid
METHODS: Thirty - eight Wistar albino rats underwent laparotomy to cause intra - abdominal adhesions by mechanical abrasion of the cecum and ethanol application.	Wistar albino rats,24,42,Organism	cecum,131,136,Multi	ethanol,141,148,Chemical	"[{""token"": ""Wistar albino rats"", ""start_span"": 24, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""cecum"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Multi""}, {""token"": ""ethanol"", ""start_span"": 141, ""end_span"": 148, ""type"": ""Chemical""}]"	valid
In contrast, the growth of tumors requires constant vascular growth and remodeling in order for solid tumors to grow beyond 1 - 2 mm ( 3) in size.	tumors,27,33,Cancer	vascular,52,60,Multi	solid tumors,96,108,Cancer	"[{""token"": ""tumors"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""vascular"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Multi""}, {""token"": ""solid tumors"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Cancer""}]"	valid
This review article focuses on recent developments in the use of angiogenesis inhibitors for the treatment of breast, lung, and colorectal cancers.	breast,110,116,Cancer	lung,118,122,Cancer	colorectal cancers,128,146,Cancer	"[{""token"": ""breast"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Cancer""}, {""token"": ""lung"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Cancer""}, {""token"": ""colorectal cancers"", ""start_span"": 128, ""end_span"": 146, ""type"": ""Cancer""}]"	valid
The authors evaluated the association between MDM2 expression and local failure, distant metastasis ( DM), cause - specific mortality, and overall mortality in men treated in Radiation Therapy Oncology Group 8610 with radiotherapy, with or without androgen deprivation.	MDM2,46,50,Gene_or_gene_product	men,160,163,Organism	androgen,248,256,Chemical	"[{""token"": ""MDM2"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""men"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Organism""}, {""token"": ""androgen"", ""start_span"": 248, ""end_span"": 256, ""type"": ""Chemical""}]"	valid
An image analysis system was also used to quantify the proportion of tumor nuclei with MDM2 staining ( ACIS index) and staining intensity.	tumor,69,74,Cancer	nuclei,75,81,Cellular_component	MDM2,87,91,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""nuclei"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Cellular_component""}, {""token"": ""MDM2"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}]"	valid
TSP - 1 mRNA levels were decreased in all tumours compared with normal prostate.	TSP - 1,0,7,Gene_or_gene_product	tumours,42,49,Cancer	prostate,71,79,Organ	"[{""token"": ""TSP - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumours"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Cancer""}, {""token"": ""prostate"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Organ""}]"	valid
The E7 oncoprotein of bovine papillomavirus type 1 ( BPV - 1) is required for the full transformation activity of the virus.	E7,4,6,Gene_or_gene_product	bovine papillomavirus type 1,22,50,Organism	BPV - 1,53,60,Organism	"[{""token"": ""E7"", ""start_span"": 4, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""bovine papillomavirus type 1"", ""start_span"": 22, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""BPV - 1"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Organism""}]"	valid
These studies thus identify p600 as a shared target of the E7 proteins of multiple papillomaviruses.	p600,28,32,Gene_or_gene_product	E7,59,61,Gene_or_gene_product	papillomaviruses,83,99,Organism	"[{""token"": ""p600"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 59, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""papillomaviruses"", ""start_span"": 83, ""end_span"": 99, ""type"": ""Organism""}]"	valid
Molecular requirements for epithelial - mesenchymal transition during tumor progression.	epithelial,27,37,Cell	mesenchymal,40,51,Cell	tumor,70,75,Cancer	"[{""token"": ""epithelial"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""mesenchymal"", ""start_span"": 40, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Cancer""}]"	valid
Repression of E - cadherin by transcriptional regulators such as Snail or Twist emerges as one critical step driving EMT, and this stage is currently being molecularly linked with many of the new players.	E - cadherin,14,26,Gene_or_gene_product	Snail,65,70,Gene_or_gene_product	Twist,74,79,Gene_or_gene_product	"[{""token"": ""E - cadherin"", ""start_span"": 14, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""Snail"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""Twist"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}]"	valid
Increasing evidence suggests that EMT plays a specific role in the migration of cells from a primary tumor into the circulation and may provide a rationale for developing more effective cancer therapies.	cells,80,85,Cell	tumor,101,106,Cancer	cancer,186,192,Cancer	"[{""token"": ""cells"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 186, ""end_span"": 192, ""type"": ""Cancer""}]"	valid
During embryogenesis, vascular and hemopoietic cells originate from a common precursor, the hemangioblast.	vascular,22,30,Cell	hemopoietic cells,35,52,Cell	hemangioblast,92,105,Cell	"[{""token"": ""vascular"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""hemopoietic cells"", ""start_span"": 35, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""hemangioblast"", ""start_span"": 92, ""end_span"": 105, ""type"": ""Cell""}]"	valid
Recent evidence suggests the existence of endothelial precursors in adult bone marrow cells, but it is unclear whether those precursors have a role in tumor neovascularization.	endothelial precursors,42,64,Cell	bone marrow cells,74,91,Cell	tumor,151,156,Cancer	"[{""token"": ""endothelial precursors"", ""start_span"": 42, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""bone marrow cells"", ""start_span"": 74, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Cancer""}]"	valid
A transgenic double - reporter strategy allowed us to demonstrate definitively that tumor bone marrow - derived endothelial cells arise by transdifferentiation of marrow progenitors rather than by cell fusion.	tumor bone marrow - derived endothelial cells,84,129,Cell	marrow progenitors,163,181,Cell	cell,197,201,Cell	"[{""token"": ""tumor bone marrow - derived endothelial cells"", ""start_span"": 84, ""end_span"": 129, ""type"": ""Cell""}, {""token"": ""marrow progenitors"", ""start_span"": 163, ""end_span"": 181, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Cell""}]"	valid
Histopathological development of gastric tumors induced by N - methyl - N ' - nitro - N - nitrosoguanidine in rats.	gastric tumors,33,47,Cancer	N - methyl - N ' - nitro - N - nitrosoguanidine,59,106,Chemical	rats,110,114,Organism	"[{""token"": ""gastric tumors"", ""start_span"": 33, ""end_span"": 47, ""type"": ""Cancer""}, {""token"": ""N - methyl - N ' - nitro - N - nitrosoguanidine"", ""start_span"": 59, ""end_span"": 106, ""type"": ""Chemical""}, {""token"": ""rats"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Organism""}]"	valid
Changes of bile reflux to the stomach was observed endoscopically at 24 weeks as well as the development of gastric mucosal erosions.	bile,11,15,Organism_substance	stomach,30,37,Organ	gastric mucosal erosions,108,132,Pathological_formation	"[{""token"": ""bile"", ""start_span"": 11, ""end_span"": 15, ""type"": ""Organism_substance""}, {""token"": ""stomach"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Organ""}, {""token"": ""gastric mucosal erosions"", ""start_span"": 108, ""end_span"": 132, ""type"": ""Pathological_formation""}]"	valid
Decrease in c - Myc activity enhances cancer cell sensitivity to vinblastine.	c - Myc,12,19,Gene_or_gene_product	cancer cell,38,49,Cell	vinblastine,65,76,Chemical	"[{""token"": ""c - Myc"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cell"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""vinblastine"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Chemical""}]"	valid
According to these different functions, the role of c - Myc protein in cellular sensitivity to anti - cancer drugs is controversial.	c - Myc,52,59,Gene_or_gene_product	cellular,71,79,Cell	cancer,102,108,Cancer	"[{""token"": ""c - Myc"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Cancer""}]"	valid
Analysis of VLB cytotoxicity demonstrated a 3 - fold increase in VLB sensitivity in LoVo - mycANS cells.	VLB,12,15,Chemical	VLB,65,68,Chemical	LoVo - mycANS cells,84,103,Cell	"[{""token"": ""VLB"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""VLB"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""LoVo - mycANS cells"", ""start_span"": 84, ""end_span"": 103, ""type"": ""Cell""}]"	valid
Comparison between cells revealed different apoptosis kinetics: accumulation of cells in sub - G1 phase and poly ( ADP - ribose) polymerase cleavage occurred earlier in LoVo - mycANS.	cells,19,24,Cell	cells,80,85,Cell	LoVo - mycANS,169,182,Cell	"[{""token"": ""cells"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""LoVo - mycANS"", ""start_span"": 169, ""end_span"": 182, ""type"": ""Cell""}]"	valid
Then, we demonstrated a mitochondrial membrane potential disruption followed by cytochrome c release that indicates the involvement of mitochondria in this apoptotic signaling pathway.	mitochondrial membrane,24,46,Cellular_component	cytochrome c,80,92,Gene_or_gene_product	mitochondria,135,147,Cellular_component	"[{""token"": ""mitochondrial membrane"", ""start_span"": 24, ""end_span"": 46, ""type"": ""Cellular_component""}, {""token"": ""cytochrome c"", ""start_span"": 80, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondria"", ""start_span"": 135, ""end_span"": 147, ""type"": ""Cellular_component""}]"	valid
Alteration of homeobox gene expression by N - ras transformation of PA - 1 human teratocarcinoma cells.	homeobox,14,22,Gene_or_gene_product	N - ras,42,49,Gene_or_gene_product	PA - 1 human teratocarcinoma cells,68,102,Cell	"[{""token"": ""homeobox"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""N - ras"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""PA - 1 human teratocarcinoma cells"", ""start_span"": 68, ""end_span"": 102, ""type"": ""Cell""}]"	valid
Patients had primarily relapsed diffuse large B - cell lymphoma ( 63%) were heavily pretreated ( median of three regimens) and high risk ( 79% international prognostic index, greater than or = 2) and 34% were relapsed after autologous stem cell transplant.	Patients,0,8,Organism	B - cell lymphoma,46,63,Cancer	stem cell,235,244,Cell	"[{""token"": ""Patients"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""B - cell lymphoma"", ""start_span"": 46, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""stem cell"", ""start_span"": 235, ""end_span"": 244, ""type"": ""Cell""}]"	valid
CONCLUSIONS: Low - dose cyclophosphamide and high - dose celecoxib is well tolerated and active in pretreated aggressive non - Hodgkin ' s lymphoma.	cyclophosphamide,24,40,Chemical	celecoxib,57,66,Chemical	non - Hodgkin ' s lymphoma,121,147,Cancer	"[{""token"": ""cyclophosphamide"", ""start_span"": 24, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""celecoxib"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""non - Hodgkin ' s lymphoma"", ""start_span"": 121, ""end_span"": 147, ""type"": ""Cancer""}]"	valid
METHODS: Sixty - two patients ( 62 eyes) with PM underwent PDT according to the guidelines of the Verteporfin in Photodynamic Therapy Study.	patients,21,29,Organism	eyes,35,39,Organ	Verteporfin,98,109,Chemical	"[{""token"": ""patients"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""eyes"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Organ""}, {""token"": ""Verteporfin"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Chemical""}]"	valid
Younger patients and eyes with higher refractive error appear more likely to benefit from PDT with verteporfin.	patients,8,16,Organism	eyes,21,25,Organ	verteporfin,99,110,Chemical	"[{""token"": ""patients"", ""start_span"": 8, ""end_span"": 16, ""type"": ""Organism""}, {""token"": ""eyes"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Organ""}, {""token"": ""verteporfin"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Chemical""}]"	valid
The genes regulated by Nrf2 are very important for cellular protection of the genome from xenobiotic and oxidative stresses and, consequently, for preventing carcinogenesis.	Nrf2,23,27,Gene_or_gene_product	cellular,51,59,Cell	genome,78,84,Cellular_component	"[{""token"": ""Nrf2"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""genome"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Cellular_component""}]"	valid
Angiotensin II induces soluble fms - Like tyrosine kinase - 1 release via calcineurin signaling pathway in pregnancy.	Angiotensin II,0,14,Gene_or_gene_product	fms - Like tyrosine kinase - 1,31,61,Gene_or_gene_product	calcineurin,74,85,Gene_or_gene_product	"[{""token"": ""Angiotensin II"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""fms - Like tyrosine kinase - 1"", ""start_span"": 31, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""calcineurin"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}]"	valid
Angiotensin II ( Ang II) is a potent vasoconstrictor that increases concomitant with sFlt - 1 during pregnancy.	Angiotensin II,0,14,Gene_or_gene_product	Ang II,17,23,Gene_or_gene_product	sFlt - 1,85,93,Gene_or_gene_product	"[{""token"": ""Angiotensin II"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ang II"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""sFlt - 1"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}]"	valid
p21 delays tumor onset by preservation of chromosomal stability.	p21,0,3,Gene_or_gene_product	tumor,11,16,Cancer	chromosomal,42,53,Cellular_component	"[{""token"": ""p21"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 11, ""end_span"": 16, ""type"": ""Cancer""}, {""token"": ""chromosomal"", ""start_span"": 42, ""end_span"": 53, ""type"": ""Cellular_component""}]"	valid
Remarkably, lymphomas arising in Trp53 ( 515C / 515C) mice ( encoding p53R172P) retain stable genomes.	lymphomas,12,21,Cancer	Trp53,33,38,Gene_or_gene_product	p53R172P,70,78,Gene_or_gene_product	"[{""token"": ""lymphomas"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Cancer""}, {""token"": ""Trp53"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53R172P"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}]"	valid
Mechanisms for the magnolol - induced cell death of CGTH W - 2 thyroid carcinoma cells.	magnolol,19,27,Chemical	cell,38,42,Cell	CGTH W - 2 thyroid carcinoma cells,52,86,Cell	"[{""token"": ""magnolol"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""CGTH W - 2 thyroid carcinoma cells"", ""start_span"": 52, ""end_span"": 86, ""type"": ""Cell""}]"	valid
After 24 h treatment with 80 microM magnolol in serum - containing medium, about 50% of the cells exhibited apoptotic features and 20% necrotic features.	magnolol,36,44,Chemical	serum,48,53,Organism_substance	cells,92,97,Cell	"[{""token"": ""magnolol"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Organism_substance""}, {""token"": ""cells"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Cell""}]"	valid
These data suggest that magnolol promoted apoptosis probably by alleviating the inhibitory effect of Akt on caspase 9.	magnolol,24,32,Chemical	Akt,101,104,Gene_or_gene_product	caspase 9,108,117,Gene_or_gene_product	"[{""token"": ""magnolol"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""Akt"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase 9"", ""start_span"": 108, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}]"	valid
Over a million FDG - PET studies have unequivocally identified increased glucose uptake as a hallmark of metastatic cancer in humans.	glucose,73,80,Chemical	metastatic cancer,105,122,Cancer	humans,126,132,Organism	"[{""token"": ""glucose"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Chemical""}, {""token"": ""metastatic cancer"", ""start_span"": 105, ""end_span"": 122, ""type"": ""Cancer""}, {""token"": ""humans"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Organism""}]"	valid
Alternative hypotheses, wherein the glucose is used for generation of reducing equivalents ( NADPH) or anabolic precursors ( ribose) are also discussed.	glucose,36,43,Chemical	NADPH,93,98,Chemical	ribose,125,131,Chemical	"[{""token"": ""glucose"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""NADPH"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Chemical""}, {""token"": ""ribose"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Chemical""}]"	valid
Effects of spironolactone on corneal allograft survival in the rat.	spironolactone,11,25,Chemical	corneal allograft,29,46,Multi	rat,63,66,Organism	"[{""token"": ""spironolactone"", ""start_span"": 11, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""corneal allograft"", ""start_span"": 29, ""end_span"": 46, ""type"": ""Multi""}, {""token"": ""rat"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Organism""}]"	valid
Additional grafted rats treated with spironolactone ( n = 6) or PBS ( n = 8) were sacrificed on day 12 for quantitative RT - PCR analysis for mechanistic studies.	rats,19,23,Organism	spironolactone,37,51,Chemical	PBS,64,67,Chemical	"[{""token"": ""rats"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Organism""}, {""token"": ""spironolactone"", ""start_span"": 37, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""PBS"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Chemical""}]"	valid
RESULTS: Mean ( + / - SEM) graft survival was significantly prolonged in animals receiving spironolactone ( 14. 9 + / - 2. 0 days) compared with both PBS - treated ( 12. 3 + / - 1. 2 days, p = 0. 007) and untreated controls ( 13. 0 + / - 1. 0 days, p = 0. 01).	graft,27,32,Multi	spironolactone,91,105,Chemical	PBS,150,153,Chemical	"[{""token"": ""graft"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Multi""}, {""token"": ""spironolactone"", ""start_span"": 91, ""end_span"": 105, ""type"": ""Chemical""}, {""token"": ""PBS"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Chemical""}]"	valid
FAS - 1377 G / A polymorphism and the risk of lymph node metastasis in cervical cancer.	FAS,0,3,Gene_or_gene_product	lymph node,46,56,Multi	cervical cancer,71,86,Cancer	"[{""token"": ""FAS"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 46, ""end_span"": 56, ""type"": ""Multi""}, {""token"": ""cervical cancer"", ""start_span"": 71, ""end_span"": 86, ""type"": ""Cancer""}]"	valid
Single - nucleotide polymorphisms of the FAS - 1377G / A, FAS - 670A / G, and FASL - 844T / C genes may alter transcriptional activity of these genes.	FAS,41,44,Gene_or_gene_product	FAS,58,61,Gene_or_gene_product	FASL,78,82,Gene_or_gene_product	"[{""token"": ""FAS"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""FAS"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""FASL"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}]"	valid
Genotypes of 155 patients with cervical cancer and 160 healthy control subjects were determined using polymerase chain reaction - based restriction fragment length polymorphism ( PCR - RFLP).	patients,17,25,Organism	cervical cancer,31,46,Cancer	healthy control subjects,55,79,Organism	"[{""token"": ""patients"", ""start_span"": 17, ""end_span"": 25, ""type"": ""Organism""}, {""token"": ""cervical cancer"", ""start_span"": 31, ""end_span"": 46, ""type"": ""Cancer""}, {""token"": ""healthy control subjects"", ""start_span"": 55, ""end_span"": 79, ""type"": ""Organism""}]"	valid
There was no significant association between an increased risk of cervical cancer and polymorphisms of the death pathway genes FAS and FASL.	cervical cancer,66,81,Cancer	FAS,127,130,Gene_or_gene_product	FASL,135,139,Gene_or_gene_product	"[{""token"": ""cervical cancer"", ""start_span"": 66, ""end_span"": 81, ""type"": ""Cancer""}, {""token"": ""FAS"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""FASL"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}]"	valid
PURPOSE: The aim of this study was to investigate the use of D2 - 40 for the detection of lymphovascular invasion ( LVI) in node positive and negative early breast cancer.	D2 - 40,61,68,Gene_or_gene_product	lymphovascular,90,104,Multi	breast cancer,157,170,Cancer	"[{""token"": ""D2 - 40"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphovascular"", ""start_span"": 90, ""end_span"": 104, ""type"": ""Multi""}, {""token"": ""breast cancer"", ""start_span"": 157, ""end_span"": 170, ""type"": ""Cancer""}]"	valid
Correlation with clinico - pathological factors including LVI as retrieved by routine haematoxylin and eosin ( H. E.) stained sections and the eligibility for the prediction of ALNM was assessed.	haematoxylin,86,98,Chemical	eosin,103,108,Chemical	sections,126,134,Tissue	"[{""token"": ""haematoxylin"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Chemical""}, {""token"": ""eosin"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Chemical""}, {""token"": ""sections"", ""start_span"": 126, ""end_span"": 134, ""type"": ""Tissue""}]"	valid
CONCLUSION: Immunostaining with D2 - 40 significantly increased the frequency of detection of lymphatic invasion compared to conventional H. E. - staining in early breast cancer.	D2 - 40,32,39,Gene_or_gene_product	lymphatic,94,103,Multi	breast cancer,164,177,Cancer	"[{""token"": ""D2 - 40"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphatic"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Multi""}, {""token"": ""breast cancer"", ""start_span"": 164, ""end_span"": 177, ""type"": ""Cancer""}]"	valid
N - myc augments death and attenuates protective effects of Bcl - 2 in trophically stressed neuroblastoma cells.	N - myc,0,7,Gene_or_gene_product	Bcl - 2,60,67,Gene_or_gene_product	neuroblastoma cells,92,111,Cell	"[{""token"": ""N - myc"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuroblastoma cells"", ""start_span"": 92, ""end_span"": 111, ""type"": ""Cell""}]"	valid
N - myc overrode the metabolic protection provided by Bcl - 2 - induced oxidative phosphorylation by reestablishing the glycolytic phenotype and attenuated the antiapoptotic effect of Bcl - 2 during metabolic stress.	N - myc,0,7,Gene_or_gene_product	Bcl - 2,54,61,Gene_or_gene_product	Bcl - 2,184,191,Gene_or_gene_product	"[{""token"": ""N - myc"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 184, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}]"	valid
Among these are vascular endothelial growth factor - A ( VEGF - A), the key angiogenic stimulant, and VEGF - C, a primary mediator of lymphangiogenesis.	vascular endothelial growth factor - A,16,54,Gene_or_gene_product	VEGF - A,57,65,Gene_or_gene_product	VEGF - C,102,110,Gene_or_gene_product	"[{""token"": ""vascular endothelial growth factor - A"", ""start_span"": 16, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - A"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}]"	valid
Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C.	Artemisinin,0,11,Chemical	tumor,21,26,Cancer	vascular endothelial growth factor C,63,99,Gene_or_gene_product	"[{""token"": ""Artemisinin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Cancer""}, {""token"": ""vascular endothelial growth factor C"", ""start_span"": 63, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}]"	valid
We have previously reported that dihydroartemisinin is found to have a potent ability in influencing lymphatic endothelial cell migration and tube formation.	dihydroartemisinin,33,51,Chemical	lymphatic endothelial cell,101,127,Cell	tube,142,146,Tissue	"[{""token"": ""dihydroartemisinin"", ""start_span"": 33, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""lymphatic endothelial cell"", ""start_span"": 101, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""tube"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Tissue""}]"	valid
Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases.	Bevacizumab,0,11,Chemical	irinotecan,16,26,Chemical	glioblastoma multiforme,38,61,Cancer	"[{""token"": ""Bevacizumab"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""irinotecan"", ""start_span"": 16, ""end_span"": 26, ""type"": ""Chemical""}, {""token"": ""glioblastoma multiforme"", ""start_span"": 38, ""end_span"": 61, ""type"": ""Cancer""}]"	valid
Four patients received bevacizumab at a dose of 10 mg / m2; irinotecan was given at a dose of 125 mg / m2 every week for 3 weeks.	patients,5,13,Organism	bevacizumab,23,34,Chemical	irinotecan,60,70,Chemical	"[{""token"": ""patients"", ""start_span"": 5, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""bevacizumab"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""irinotecan"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Chemical""}]"	valid
Bevacizumab was discontinued in 2 patients because of nonfatal intracranial bleeding.	Bevacizumab,0,11,Chemical	patients,34,42,Organism	intracranial,63,75,Immaterial_anatomical_entity	"[{""token"": ""Bevacizumab"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""intracranial"", ""start_span"": 63, ""end_span"": 75, ""type"": ""Immaterial_anatomical_entity""}]"	valid
The formation of functional, mature blood vessels depends on the interaction between endothelial cells and pericytes.	blood vessels,36,49,Multi	endothelial cells,85,102,Cell	pericytes,107,116,Cell	"[{""token"": ""blood vessels"", ""start_span"": 36, ""end_span"": 49, ""type"": ""Multi""}, {""token"": ""endothelial cells"", ""start_span"": 85, ""end_span"": 102, ""type"": ""Cell""}, {""token"": ""pericytes"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Cell""}]"	valid
Immunocytochemistry revealed that endosialin was present in the cytoplasmic body and in the elongated extensions essential to pericyte function.	endosialin,34,44,Gene_or_gene_product	cytoplasmic body,64,80,Organism_substance	pericyte,126,134,Cell	"[{""token"": ""endosialin"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoplasmic body"", ""start_span"": 64, ""end_span"": 80, ""type"": ""Organism_substance""}, {""token"": ""pericyte"", ""start_span"": 126, ""end_span"": 134, ""type"": ""Cell""}]"	valid
Anti - endosialin antibodies may have value in identifying vasculature in malignant tissues.	Anti - endosialin antibodies,0,28,Gene_or_gene_product	vasculature,59,70,Multi	malignant tissues,74,91,Tissue	"[{""token"": ""Anti - endosialin antibodies"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""vasculature"", ""start_span"": 59, ""end_span"": 70, ""type"": ""Multi""}, {""token"": ""malignant tissues"", ""start_span"": 74, ""end_span"": 91, ""type"": ""Tissue""}]"	valid
With the appropriate agent, targeting endosialin may interfere with blood vessel growth during tumor development.	endosialin,38,48,Gene_or_gene_product	blood vessel,68,80,Multi	tumor,95,100,Cancer	"[{""token"": ""endosialin"", ""start_span"": 38, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessel"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Cancer""}]"	valid
Efficient inhibition of ovarian cancer growth and prolonged survival by transfection with a novel pro - apoptotic gene, hPNAS - 4, in a mouse model.	ovarian cancer,24,38,Cancer	hPNAS - 4,120,129,Gene_or_gene_product	mouse,136,141,Organism	"[{""token"": ""ovarian cancer"", ""start_span"": 24, ""end_span"": 38, ""type"": ""Cancer""}, {""token"": ""hPNAS - 4"", ""start_span"": 120, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Organism""}]"	valid
CONCLUSIONS: Our promising results on the potential antitumor effects of hPNAS - 4 on ovarian cancer in vitro and in vivo may be explained, in part, by the induction of apoptosis and inhibition of angiogenesis.	antitumor,52,61,Cancer	hPNAS - 4,73,82,Gene_or_gene_product	ovarian cancer,86,100,Cancer	"[{""token"": ""antitumor"", ""start_span"": 52, ""end_span"": 61, ""type"": ""Cancer""}, {""token"": ""hPNAS - 4"", ""start_span"": 73, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer"", ""start_span"": 86, ""end_span"": 100, ""type"": ""Cancer""}]"	valid
Consequently, hPNAS - 4 has potential as a new gene therapy for human ovarian cancer.	hPNAS - 4,14,23,Gene_or_gene_product	human,64,69,Organism	ovarian cancer,70,84,Cancer	"[{""token"": ""hPNAS - 4"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Organism""}, {""token"": ""ovarian cancer"", ""start_span"": 70, ""end_span"": 84, ""type"": ""Cancer""}]"	valid
Further tumour inhibition studies showed that STX243 was also active against MCF - 7 paclitaxel - resistant tumours.	tumour,8,14,Cancer	STX243,46,52,Chemical	paclitaxel,85,95,Chemical	"[{""token"": ""tumour"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Cancer""}, {""token"": ""STX243"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""paclitaxel"", ""start_span"": 85, ""end_span"": 95, ""type"": ""Chemical""}]"	valid
Grape seed extract ( GSE), a widely used dietary supplement, is known to have antitumor activity.	Grape seed extract,0,18,Organism_substance	GSE,21,24,Organism_substance	antitumor,78,87,Cancer	"[{""token"": ""Grape seed extract"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Organism_substance""}, {""token"": ""GSE"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Organism_substance""}, {""token"": ""antitumor"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Cancer""}]"	valid
We found that GSE could directly inhibit the kinase activity of purified VEGF receptor 2, a novel activity of GSE that has not been characterized.	GSE,14,17,Organism_substance	VEGF receptor 2,73,88,Gene_or_gene_product	GSE,110,113,Organism_substance	"[{""token"": ""GSE"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Organism_substance""}, {""token"": ""VEGF receptor 2"", ""start_span"": 73, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""GSE"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Organism_substance""}]"	valid
Taken together, this study indicates that GSE is a well - tolerated and inexpensive natural VEGF inhibitor and could potentially be useful in cancer prevention or treatment.	GSE,42,45,Organism_substance	VEGF,92,96,Gene_or_gene_product	cancer,142,148,Cancer	"[{""token"": ""GSE"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 142, ""end_span"": 148, ""type"": ""Cancer""}]"	valid
We have previously shown that IFI16 is required for proinflammatory gene stimulation by IFN - gamma through the NF - kappaB complex.	IFI16,30,35,Gene_or_gene_product	IFN - gamma,88,99,Gene_or_gene_product	NF - kappaB,112,123,Gene_or_gene_product	"[{""token"": ""IFI16"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFN - gamma"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 112, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"	valid
In vivo, tumors derived from cell clones expressing high levels of VEGF displayed significantly enhanced angiogenesis and more aggressive growth.	tumors,9,15,Cancer	cell clones,29,40,Cell	VEGF,67,71,Gene_or_gene_product	"[{""token"": ""tumors"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Cancer""}, {""token"": ""cell clones"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}]"	valid
High expression of c - Ski has been found in some cancers, including gastric cancer.	c - Ski,19,26,Gene_or_gene_product	cancers,50,57,Cancer	gastric cancer,69,83,Cancer	"[{""token"": ""c - Ski"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""gastric cancer"", ""start_span"": 69, ""end_span"": 83, ""type"": ""Cancer""}]"	valid
Overexpression of c - Ski inhibited TGF - beta signaling in OCUM - 2MLN cells.	c - Ski,18,25,Gene_or_gene_product	TGF - beta,36,46,Gene_or_gene_product	OCUM - 2MLN cells,60,77,Cell	"[{""token"": ""c - Ski"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""OCUM - 2MLN cells"", ""start_span"": 60, ""end_span"": 77, ""type"": ""Cell""}]"	valid
Interestingly, c - Ski overexpression resulted in extensive acceleration of the growth of subcutaneous xenografts in BALB / c nu / nu female mice ( 6 weeks of age).	c - Ski,15,22,Gene_or_gene_product	xenografts,103,113,Cancer	BALB / c nu / nu female mice,117,145,Organism	"[{""token"": ""c - Ski"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""xenografts"", ""start_span"": 103, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""BALB / c nu / nu female mice"", ""start_span"": 117, ""end_span"": 145, ""type"": ""Organism""}]"	valid
The Down syndrome critical region gene 1 short variant promoters direct vascular bed - specific gene expression during inflammation in mice.	Down syndrome critical region gene 1,4,40,Gene_or_gene_product	vascular bed,72,84,Multi	mice,135,139,Organism	"[{""token"": ""Down syndrome critical region gene 1"", ""start_span"": 4, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular bed"", ""start_span"": 72, ""end_span"": 84, ""type"": ""Multi""}, {""token"": ""mice"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Organism""}]"	valid
We determined that lacZ was uniformly expressed in the endothelium of transgenic embryos but was markedly downregulated postnatally.	lacZ,19,23,Gene_or_gene_product	endothelium,55,66,Tissue	transgenic embryos,70,88,Developing_anatomical_structure	"[{""token"": ""lacZ"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelium"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Tissue""}, {""token"": ""transgenic embryos"", ""start_span"": 70, ""end_span"": 88, ""type"": ""Developing_anatomical_structure""}]"	valid
The DSCR1s promoter was similarly induced in the endothelium of tumor xenografts.	DSCR1s,4,10,Gene_or_gene_product	endothelium,49,60,Tissue	tumor xenografts,64,80,Cancer	"[{""token"": ""DSCR1s"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelium"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Tissue""}, {""token"": ""tumor xenografts"", ""start_span"": 64, ""end_span"": 80, ""type"": ""Cancer""}]"	valid
Angiostatin was first discovered as a plasminogen fragment with antitumor / antiangiogenic property.	Angiostatin,0,11,Gene_or_gene_product	plasminogen fragment,38,58,Gene_or_gene_product	antitumor,64,73,Cancer	"[{""token"": ""Angiostatin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasminogen fragment"", ""start_span"": 38, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""antitumor"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Cancer""}]"	valid
One of the angiostatin isoforms, that is, angiostatin 4. 5 ( AS4. 5), consisting of plasminogen kringle 1 to 4 and a most part of kringle 5, is produced by autoproteolysis and present in human plasma.	angiostatin,11,22,Gene_or_gene_product	human,187,192,Organism	plasma,193,199,Organism_substance	"[{""token"": ""angiostatin"", ""start_span"": 11, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Organism""}, {""token"": ""plasma"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Organism_substance""}]"	valid
Thus, nicked beta2GPI exerts dual effects on angiogenesis, that is, nicked beta2GPI promotes angiogenesis in the presence of AS4. 5, whereas nicked beta2GPI inhibits angiogenesis at concentrations high enough to neutralize AS4. 5.	nicked beta2GPI,6,21,Gene_or_gene_product	nicked beta2GPI,68,83,Gene_or_gene_product	nicked beta2GPI,141,156,Gene_or_gene_product	"[{""token"": ""nicked beta2GPI"", ""start_span"": 6, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""nicked beta2GPI"", ""start_span"": 68, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""nicked beta2GPI"", ""start_span"": 141, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}]"	valid
In test group, the external maxillary artery bundle was passed through the marrow cavity of the bone.	external maxillary artery bundle,19,51,Multi	marrow cavity,75,88,Immaterial_anatomical_entity	bone,96,100,Organ	"[{""token"": ""external maxillary artery bundle"", ""start_span"": 19, ""end_span"": 51, ""type"": ""Multi""}, {""token"": ""marrow cavity"", ""start_span"": 75, ""end_span"": 88, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""bone"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Organ""}]"	valid
The rabbits were sacrificed and the specimens were procured at 3 days, 1, 2, 3, 4 and 6 weeks after surgery for histological observation, Chinese ink perfusion and CD34 immunohistochemistry.	rabbits,4,11,Organism	specimens,36,45,Multi	CD34,164,168,Gene_or_gene_product	"[{""token"": ""rabbits"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Organism""}, {""token"": ""specimens"", ""start_span"": 36, ""end_span"": 45, ""type"": ""Multi""}, {""token"": ""CD34"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}]"	valid
Targeting glucose consumption and autophagy in myeloma with the novel nucleoside analogue 8 - aminoadenosine.	glucose,10,17,Chemical	myeloma,47,54,Cancer	nucleoside analogue 8 - aminoadenosine,70,108,Chemical	"[{""token"": ""glucose"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""myeloma"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""nucleoside analogue 8 - aminoadenosine"", ""start_span"": 70, ""end_span"": 108, ""type"": ""Chemical""}]"	valid
Multiple myeloma, an incurable plasma cell malignancy, is characterized by altered cellular metabolism and resistance to apoptosis.	myeloma,9,16,Cancer	plasma cell malignancy,31,53,Cancer	cellular,83,91,Cell	"[{""token"": ""myeloma"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Cancer""}, {""token"": ""plasma cell malignancy"", ""start_span"": 31, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""cellular"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Cell""}]"	valid
In this study, we have examined the ability of the purine analogue 8 - aminoadenosine to acutely reduce glucose consumption by regulating localization and expression of key glucose transporters.	purine analogue 8 - aminoadenosine,51,85,Chemical	glucose,104,111,Chemical	glucose transporters,173,193,Gene_or_gene_product	"[{""token"": ""purine analogue 8 - aminoadenosine"", ""start_span"": 51, ""end_span"": 85, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Chemical""}, {""token"": ""glucose transporters"", ""start_span"": 173, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}]"	valid
Glucose consumption by drug - resistant myeloma cells was unaffected by 8 - aminoadenosine, and accordingly, no activation of autophagy was observed.	Glucose,0,7,Chemical	myeloma cells,40,53,Cell	8 - aminoadenosine,72,90,Chemical	"[{""token"": ""Glucose"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""myeloma cells"", ""start_span"": 40, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""8 - aminoadenosine"", ""start_span"": 72, ""end_span"": 90, ""type"": ""Chemical""}]"	valid
However, these cells can be sensitized to 8 - aminoadenosine under glucose - limiting conditions.	cells,15,20,Cell	8 - aminoadenosine,42,60,Chemical	glucose,67,74,Chemical	"[{""token"": ""cells"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""8 - aminoadenosine"", ""start_span"": 42, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Chemical""}]"	valid
Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src - homology - 2 - domain - containing protein tyrosine phosphatase 2.	Dopamine,0,8,Chemical	VEGF receptor 2,38,53,Gene_or_gene_product	Src - homology - 2 - domain - containing protein tyrosine phosphatase 2,66,137,Gene_or_gene_product	"[{""token"": ""Dopamine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""VEGF receptor 2"", ""start_span"": 38, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""Src - homology - 2 - domain - containing protein tyrosine phosphatase 2"", ""start_span"": 66, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"	valid
Our data establish a novel role for SHP - 2 phosphatase in the dopamine - mediated regulation of VEGFR - 2 phosphorylation.	SHP - 2 phosphatase,36,55,Gene_or_gene_product	dopamine,63,71,Chemical	VEGFR - 2,97,106,Gene_or_gene_product	"[{""token"": ""SHP - 2 phosphatase"", ""start_span"": 36, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""dopamine"", ""start_span"": 63, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""VEGFR - 2"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}]"	valid
Cancer stem cells ( CSC) are predicted to be critical drivers of tumor progression due to their self - renewal capacity and limitless proliferative potential.	Cancer stem cells,0,17,Cell	CSC,20,23,Cell	tumor,65,70,Cancer	"[{""token"": ""Cancer stem cells"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""CSC"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Cancer""}]"	valid
An emerging area of research suggests that CSC may also support tumor progression by promoting tumor angiogenesis.	CSC,43,46,Cell	tumor,64,69,Cancer	tumor,95,100,Cancer	"[{""token"": ""CSC"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Cancer""}]"	valid
Inducible nitric oxide synthase modulates angiogenesis in ischemic hindlimb of rat.	Inducible nitric oxide synthase,0,31,Gene_or_gene_product	hindlimb,67,75,Organism_subdivision	rat,79,82,Organism	"[{""token"": ""Inducible nitric oxide synthase"", ""start_span"": 0, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""hindlimb"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Organism_subdivision""}, {""token"": ""rat"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Organism""}]"	valid
BACKGROUND: Angiogenesis plays an important role in maintaining adequate oxygen delivery, and nitric oxide ( NO) is a potential regulator of angiogenesis.	oxygen,73,79,Chemical	nitric oxide,94,106,Chemical	NO,109,111,Chemical	"[{""token"": ""oxygen"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Chemical""}, {""token"": ""nitric oxide"", ""start_span"": 94, ""end_span"": 106, ""type"": ""Chemical""}, {""token"": ""NO"", ""start_span"": 109, ""end_span"": 111, ""type"": ""Chemical""}]"	valid
NO is synthesized through three isoforms of NO synthase ( NOS).	NO,0,2,Chemical	NO synthase,44,55,Gene_or_gene_product	NOS,58,61,Gene_or_gene_product	"[{""token"": ""NO"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Chemical""}, {""token"": ""NO synthase"", ""start_span"": 44, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""NOS"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}]"	valid
To test this hypothesis, we investigated the effect of iNOS deficiency ( by L - NIL) on angiogenesis in a hindlimb ischemia model.	iNOS,55,59,Gene_or_gene_product	L - NIL,76,83,Chemical	hindlimb,106,114,Organism_subdivision	"[{""token"": ""iNOS"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""L - NIL"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Chemical""}, {""token"": ""hindlimb"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Organism_subdivision""}]"	valid
RESULTS: Serum nitrite levels were significantly lower in L - NIL groups ( p < 0. 05).	Serum,9,14,Organism_substance	nitrite,15,22,Chemical	L - NIL,58,65,Chemical	"[{""token"": ""Serum"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Organism_substance""}, {""token"": ""nitrite"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""L - NIL"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Chemical""}]"	valid
Phenolic fraction of tobacco smoke condensate potentiates benzo [ a] pyerene diol epoxide - induced cell transformation: role of protein kinase C.	tobacco smoke condensate,21,45,Chemical	cell,100,104,Cell	protein kinase C,129,145,Gene_or_gene_product	"[{""token"": ""tobacco smoke condensate"", ""start_span"": 21, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""protein kinase C"", ""start_span"": 129, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}]"	valid
Our data suggest a possible role of PKC down - regulation in potentiation of BPDE - induced tumorogenicity by TSC phenolic fraction.	PKC,36,39,Gene_or_gene_product	BPDE,77,81,Chemical	TSC phenolic fraction,110,131,Chemical	"[{""token"": ""PKC"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""BPDE"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""TSC phenolic fraction"", ""start_span"": 110, ""end_span"": 131, ""type"": ""Chemical""}]"	valid
Consequently, mitochondrial integrity is compromised, and the caspase - 9 - dependent cascade is activated in treated tumor cells.	mitochondrial,14,27,Cellular_component	caspase - 9,62,73,Gene_or_gene_product	tumor cells,118,129,Cell	"[{""token"": ""mitochondrial"", ""start_span"": 14, ""end_span"": 27, ""type"": ""Cellular_component""}, {""token"": ""caspase - 9"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 118, ""end_span"": 129, ""type"": ""Cell""}]"	valid
Loss of CDC4 / FBXW7 in gastric carcinoma.	CDC4,8,12,Gene_or_gene_product	FBXW7,15,20,Gene_or_gene_product	gastric carcinoma,24,41,Cancer	"[{""token"": ""CDC4"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinoma"", ""start_span"": 24, ""end_span"": 41, ""type"": ""Cancer""}]"	valid
RESULTS: Loss of heterozygosity of CDC4 / FBXW7 occurred in 32% of EOGCs, and correlated with loss of expression in 26%.	CDC4,35,39,Gene_or_gene_product	FBXW7,42,47,Gene_or_gene_product	EOGCs,67,72,Cancer	"[{""token"": ""CDC4"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""EOGCs"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Cancer""}]"	valid
There was a significant correlation between loss of CDC4 / FBXW7 expression and upregulation of c - myc.	CDC4,52,56,Gene_or_gene_product	FBXW7,59,64,Gene_or_gene_product	c - myc,96,103,Gene_or_gene_product	"[{""token"": ""CDC4"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - myc"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}]"	valid
Our in vitro studies showed that NIH3T3 cells overexpressing BI - 1 displayed a significantly higher growth rate and formed more and larger colonies than the control cells.	NIH3T3 cells,33,45,Cell	BI - 1,61,67,Gene_or_gene_product	control cells,158,171,Cell	"[{""token"": ""NIH3T3 cells"", ""start_span"": 33, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""BI - 1"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""control cells"", ""start_span"": 158, ""end_span"": 171, ""type"": ""Cell""}]"	valid
The results showed 0. 01 mM GA induced the same level of cell toxicity as 4. 0mM PCA.	GA,28,30,Chemical	cell,57,61,Cell	PCA,81,84,Chemical	"[{""token"": ""GA"", ""start_span"": 28, ""end_span"": 30, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""PCA"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Chemical""}]"	valid
Using wound - healing assay and Boyden chamber assay, GA had potent inhibitory effects on AGS cell migration.	wound,6,11,Pathological_formation	GA,54,56,Chemical	AGS cell,90,98,Cell	"[{""token"": ""wound"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Pathological_formation""}, {""token"": ""GA"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""AGS cell"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Cell""}]"	valid
Furthermore, immunoreactivity assay of cytoskeletal F - actin demonstrated a significant inhibitory effect of GA treatment.	cytoskeletal,39,51,Cellular_component	F - actin,52,61,Gene_or_gene_product	GA,110,112,Chemical	"[{""token"": ""cytoskeletal"", ""start_span"": 39, ""end_span"": 51, ""type"": ""Cellular_component""}, {""token"": ""F - actin"", ""start_span"": 52, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""GA"", ""start_span"": 110, ""end_span"": 112, ""type"": ""Chemical""}]"	valid
The lack of treatment for worried - well patients with high - grade prostatic intraepithelial neoplasia combined with issues of recurrence and hormone resistance in prostate cancer survivors remains a major public health obstacle.	patients,41,49,Organism	prostatic intraepithelial neoplasia,68,103,Pathological_formation	prostate cancer,165,180,Cancer	"[{""token"": ""patients"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Organism""}, {""token"": ""prostatic intraepithelial neoplasia"", ""start_span"": 68, ""end_span"": 103, ""type"": ""Pathological_formation""}, {""token"": ""prostate cancer"", ""start_span"": 165, ""end_span"": 180, ""type"": ""Cancer""}]"	valid
p - XSC effectively inhibits AR expression and transcriptional activity in both cell lines.	p - XSC,0,7,Chemical	AR,29,31,Gene_or_gene_product	cell lines,80,90,Cell	"[{""token"": ""p - XSC"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""AR"", ""start_span"": 29, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell lines"", ""start_span"": 80, ""end_span"": 90, ""type"": ""Cell""}]"	valid
Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways.	Sanguinarine,0,12,Chemical	human,34,39,Organism	osteosarcoma cells,40,58,Cell	"[{""token"": ""Sanguinarine"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Organism""}, {""token"": ""osteosarcoma cells"", ""start_span"": 40, ""end_span"": 58, ""type"": ""Cell""}]"	valid
We have found that sanguinarine alters the morphology and reduces the viability of MG - 63 and SaOS - 2 human osteosarcoma cell lines in concentration - and time - dependent manner.	sanguinarine,19,31,Chemical	MG - 63,83,90,Cell	SaOS - 2 human osteosarcoma cell lines,95,133,Cell	"[{""token"": ""sanguinarine"", ""start_span"": 19, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""MG - 63"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""SaOS - 2 human osteosarcoma cell lines"", ""start_span"": 95, ""end_span"": 133, ""type"": ""Cell""}]"	valid
Angiogenesis is induced by soluble factors such as vascular endothelial growth factor ( VEGF) released from tumor cells in hypoxia.	vascular endothelial growth factor,51,85,Gene_or_gene_product	VEGF,88,92,Gene_or_gene_product	tumor cells,108,119,Cell	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 51, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Cell""}]"	valid
It enhances solid tumor growth and provides an ability to establish metastasis at peripheral sites by tumor cell migration.	solid tumor,12,23,Cancer	peripheral sites,82,98,Multi	tumor cell,102,112,Cell	"[{""token"": ""solid tumor"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Cancer""}, {""token"": ""peripheral sites"", ""start_span"": 82, ""end_span"": 98, ""type"": ""Multi""}, {""token"": ""tumor cell"", ""start_span"": 102, ""end_span"": 112, ""type"": ""Cell""}]"	valid
Here, we investigated whether angiogenesis and tumor metastasis are dependent on hypoxia conditioning - induced TB4 expression in B16F10 melanoma cells.	tumor,47,52,Cancer	TB4,112,115,Gene_or_gene_product	B16F10 melanoma cells,130,151,Cell	"[{""token"": ""tumor"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""TB4"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""B16F10 melanoma cells"", ""start_span"": 130, ""end_span"": 151, ""type"": ""Cell""}]"	valid
In addition, we found an increase of angiogenesis and HIF - 1alpha expression in TB4 - transgenic ( Tg) mice as compared to wildtype mice.	HIF - 1alpha,54,66,Gene_or_gene_product	TB4,81,84,Gene_or_gene_product	mice,104,108,Organism	"[{""token"": ""HIF - 1alpha"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""TB4"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Organism""}]"	valid
When wound healing assay was used to assess in vitro tumor cell migration, hypoxia conditioning for 1 h enhanced B16F10 cell migration.	wound,5,10,Pathological_formation	tumor cell,53,63,Cell	B16F10 cell,113,124,Cell	"[{""token"": ""wound"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Pathological_formation""}, {""token"": ""tumor cell"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""B16F10 cell"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Cell""}]"	valid
In addition, hypoxia conditioning - induced tumor cell migration was reduced by the infection of lentiviral shRNA of TB4.	tumor cell,44,54,Cell	lentiviral,97,107,Organism	TB4,117,120,Gene_or_gene_product	"[{""token"": ""tumor cell"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""lentiviral"", ""start_span"": 97, ""end_span"": 107, ""type"": ""Organism""}, {""token"": ""TB4"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}]"	valid
Collectively, hypoxia conditioning induced tumor cell migration by TB4 expression - dependent HIF - 1alpha stabilization.	tumor cell,43,53,Cell	TB4,67,70,Gene_or_gene_product	HIF - 1alpha,94,106,Gene_or_gene_product	"[{""token"": ""tumor cell"", ""start_span"": 43, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""TB4"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 94, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}]"	valid
It suggests that TB4 could be a hypoxia responsive regulator to control tumor cell migration in angiogenesis and tumor metastasis.	TB4,17,20,Gene_or_gene_product	tumor cell,72,82,Cell	tumor,113,118,Cancer	"[{""token"": ""TB4"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cell"", ""start_span"": 72, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Cancer""}]"	valid
Up - regulation of PFKFB2 expression was mediated by the direct binding of ligand - activated androgen receptor to the PFKFB2 promoter.	PFKFB2,19,25,Gene_or_gene_product	androgen,94,102,Chemical	PFKFB2,119,125,Gene_or_gene_product	"[{""token"": ""PFKFB2"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""androgen"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Chemical""}, {""token"": ""PFKFB2"", ""start_span"": 119, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}]"	valid
However, there is no report to show that DATS induced apoptosis in vitro and inhibited CT26 cancer cells in vivo on a murine allograft animal model.	DATS,41,45,Chemical	CT26 cancer cells,87,104,Cell	murine,118,124,Organism	"[{""token"": ""DATS"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""CT26 cancer cells"", ""start_span"": 87, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""murine"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Organism""}]"	valid
DATS were injected once per four days intraperitoneally ( i. p.), with treatment starting 4 weeks prior to cells inoculation.	DATS,0,4,Chemical	intraperitoneally,38,55,Immaterial_anatomical_entity	cells,107,112,Cell	"[{""token"": ""DATS"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""intraperitoneally"", ""start_span"": 38, ""end_span"": 55, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""cells"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Cell""}]"	valid
In addition to its role in embryonic development, the Hedgehog pathway has been shown to be an active participant in cancer development, progression, and metastasis.	embryonic,27,36,Developing_anatomical_structure	Hedgehog,54,62,Gene_or_gene_product	cancer,117,123,Cancer	"[{""token"": ""embryonic"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Developing_anatomical_structure""}, {""token"": ""Hedgehog"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Cancer""}]"	valid
As a result of paracrine signal transmission, the effects of Hedgehog signaling most profoundly influence the stromal cells that constitute the tumor microenvironment.	Hedgehog,61,69,Gene_or_gene_product	stromal cells,110,123,Cell	tumor,144,149,Cancer	"[{""token"": ""Hedgehog"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromal cells"", ""start_span"": 110, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Cancer""}]"	valid
Here, we review the role of the Hedgehog pathway in the signature characteristics of cancer cells that determine tumor development, progression, and metastasis.	Hedgehog,32,40,Gene_or_gene_product	cancer cells,85,97,Cell	tumor,113,118,Cancer	"[{""token"": ""Hedgehog"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Cancer""}]"	valid
In this study, we aimed to investigate the role of aberrations in the APC and beta - catenin genes in the pathogenesis of CRC in the Kashmir valley, and to correlate it with various clinicopathological variables.	APC,70,73,Gene_or_gene_product	beta - catenin,78,92,Gene_or_gene_product	CRC,122,125,Cancer	"[{""token"": ""APC"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 78, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""CRC"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Cancer""}]"	valid
Rhizochalin is a two - headed sphingolipid - like compound isolated from the sponge Rhizochalina incrustata.	Rhizochalin,0,11,Chemical	sphingolipid,30,42,Chemical	Rhizochalina incrustata,84,107,Organism	"[{""token"": ""Rhizochalin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""sphingolipid"", ""start_span"": 30, ""end_span"": 42, ""type"": ""Chemical""}, {""token"": ""Rhizochalina incrustata"", ""start_span"": 84, ""end_span"": 107, ""type"": ""Organism""}]"	valid
TS expression of the primary oral cancer cells in the group with lymph node metastasis was higher than that of those without.	TS,0,2,Gene_or_gene_product	oral cancer cells,29,46,Cell	lymph node,65,75,Multi	"[{""token"": ""TS"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Gene_or_gene_product""}, {""token"": ""oral cancer cells"", ""start_span"": 29, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""lymph node"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Multi""}]"	valid
When stably over - expressed in maximal transformed SV - 52 cells, CK1delta mutants induced reversion to a minimal transformed phenotype by dominant - negative interference with endogenous wtCK1delta.	SV - 52 cells,52,65,Cell	CK1delta,67,75,Gene_or_gene_product	wtCK1delta,189,199,Gene_or_gene_product	"[{""token"": ""SV - 52 cells"", ""start_span"": 52, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""CK1delta"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""wtCK1delta"", ""start_span"": 189, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}]"	valid
Osteonectin transcript and metastatic behavior in v - Ki - ras transformed fibroblasts.	Osteonectin,0,11,Gene_or_gene_product	v - Ki - ras,50,62,Gene_or_gene_product	fibroblasts,75,86,Cell	"[{""token"": ""Osteonectin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - Ki - ras"", ""start_span"": 50, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Cell""}]"	valid
We have investigated the expression of osteonectin gene in fresh BALB / c fibroblasts transformed by v - Ki - ras.	osteonectin,39,50,Gene_or_gene_product	BALB / c fibroblasts,65,85,Cell	v - Ki - ras,101,113,Gene_or_gene_product	"[{""token"": ""osteonectin"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""BALB / c fibroblasts"", ""start_span"": 65, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""v - Ki - ras"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}]"	valid
The transformed cells were cloned after in vivo tumorigenic assay, and 4 clones were analyzed for osteonectin expression by Northern blots.	cells,16,21,Cell	clones,73,79,Cell	osteonectin,98,109,Gene_or_gene_product	"[{""token"": ""cells"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Cell""}, {""token"": ""clones"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""osteonectin"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"	valid
Our data align osteonectin with other matrix - components and adhesion molecules in affecting potential metastatic spreading of transformed cells.	osteonectin,15,26,Gene_or_gene_product	matrix,38,44,Cellular_component	transformed cells,128,145,Cell	"[{""token"": ""osteonectin"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Cellular_component""}, {""token"": ""transformed cells"", ""start_span"": 128, ""end_span"": 145, ""type"": ""Cell""}]"	valid
A perifusion system was designed in order to study glucose and glutamine metabolism by freshly harvested Ehrlich ascites tumour cells in steady state conditions.	glucose,51,58,Chemical	glutamine,63,72,Amino_acid	Ehrlich ascites tumour cells,105,133,Cell	"[{""token"": ""glucose"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""glutamine"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Amino_acid""}, {""token"": ""Ehrlich ascites tumour cells"", ""start_span"": 105, ""end_span"": 133, ""type"": ""Cell""}]"	valid
Glutamine consumption in the presence of glucose was higher than with glutamine alone.	Glutamine,0,9,Amino_acid	glucose,41,48,Chemical	glutamine,70,79,Amino_acid	"[{""token"": ""Glutamine"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Amino_acid""}, {""token"": ""glucose"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""glutamine"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Amino_acid""}]"	valid
New functions of epidermal growth factor: stimulation of capillary endothelial cell migration and matrix dependent proliferation.	epidermal growth factor,17,40,Gene_or_gene_product	capillary endothelial cell,57,83,Cell	matrix,98,104,Cellular_component	"[{""token"": ""epidermal growth factor"", ""start_span"": 17, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary endothelial cell"", ""start_span"": 57, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Cellular_component""}]"	valid
Bovine capillary endothelial cells are also stimulated to actively migrate when exposed to EGF in vitro.	Bovine,0,6,Organism	capillary endothelial cells,7,34,Cell	EGF,91,94,Gene_or_gene_product	"[{""token"": ""Bovine"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Organism""}, {""token"": ""capillary endothelial cells"", ""start_span"": 7, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""EGF"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}]"	valid
These include activated macrophages, sensitized lymphocytes, and adipocytes.	macrophages,24,35,Cell	lymphocytes,48,59,Cell	adipocytes,65,75,Cell	"[{""token"": ""macrophages"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""lymphocytes"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""adipocytes"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Cell""}]"	valid
In vitro studies have shown that the mast cell seems to behave as a helper cell for capillary endothelial cells, in some way speeding up their rate of directional migration.	mast cell,37,46,Cell	helper cell,68,79,Cell	capillary endothelial cells,84,111,Cell	"[{""token"": ""mast cell"", ""start_span"": 37, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""helper cell"", ""start_span"": 68, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""capillary endothelial cells"", ""start_span"": 84, ""end_span"": 111, ""type"": ""Cell""}]"	valid
At this writing, heparin appears to be the principal mast cell factor responsible for this effect on capillary endothelial cells.	heparin,17,24,Chemical	mast cell,53,62,Cell	capillary endothelial cells,101,128,Cell	"[{""token"": ""heparin"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""mast cell"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""capillary endothelial cells"", ""start_span"": 101, ""end_span"": 128, ""type"": ""Cell""}]"	valid
Epithelial keratitis, disciform edema, and necrotizing keratitis with neovascularization of the cornea developed in control animals.	Epithelial,0,10,Tissue	disciform edema,22,37,Pathological_formation	cornea,96,102,Multi	"[{""token"": ""Epithelial"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Tissue""}, {""token"": ""disciform edema"", ""start_span"": 22, ""end_span"": 37, ""type"": ""Pathological_formation""}, {""token"": ""cornea"", ""start_span"": 96, ""end_span"": 102, ""type"": ""Multi""}]"	valid
Both phosphoserine and phosphothreonine, but in no case phosphotyrosine, were detected after an immune complex kinase reaction.	phosphoserine,5,18,Amino_acid	phosphothreonine,23,39,Amino_acid	phosphotyrosine,56,71,Amino_acid	"[{""token"": ""phosphoserine"", ""start_span"": 5, ""end_span"": 18, ""type"": ""Amino_acid""}, {""token"": ""phosphothreonine"", ""start_span"": 23, ""end_span"": 39, ""type"": ""Amino_acid""}, {""token"": ""phosphotyrosine"", ""start_span"": 56, ""end_span"": 71, ""type"": ""Amino_acid""}]"	valid
We previously reported that the murine fibroblast cell line LTA is tumorigenic but non - metastatic, and is non - responsive to a transfected H - ras oncogene.	murine,32,38,Organism	fibroblast cell line LTA,39,63,Cell	H - ras,142,149,Gene_or_gene_product	"[{""token"": ""murine"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""fibroblast cell line LTA"", ""start_span"": 39, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""H - ras"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}]"	valid
In contrast, NIH 3T3 cells are non - tumorigenic but are ras - responsive and become metastatic when transfected with ras.	NIH 3T3 cells,13,26,Cell	ras,57,60,Gene_or_gene_product	ras,118,121,Gene_or_gene_product	"[{""token"": ""NIH 3T3 cells"", ""start_span"": 13, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}]"	valid
Our results suggest that a key change in the metastatic hybrids, relative to non - metastatic parental LTA cells, is induction of expression of 72 kDa type IV collagenase.	hybrids,56,63,Cell	LTA cells,103,112,Cell	72 kDa type IV collagenase,144,170,Gene_or_gene_product	"[{""token"": ""hybrids"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""LTA cells"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""72 kDa type IV collagenase"", ""start_span"": 144, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}]"	valid
The interaction of neoplastic cells with the extracellular matrix is a critical event for the initiation of cancer invasion and metastasis.	neoplastic cells,19,35,Cell	extracellular matrix,45,65,Cellular_component	cancer,108,114,Cancer	"[{""token"": ""neoplastic cells"", ""start_span"": 19, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 45, ""end_span"": 65, ""type"": ""Cellular_component""}, {""token"": ""cancer"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Cancer""}]"	valid
Induction of these genes also occurred in diverticulitis and digestive neoplasms such as gastric and esophageal carcinomas.	neoplasms,71,80,Cancer	gastric,89,96,Cancer	esophageal carcinomas,101,122,Cancer	"[{""token"": ""neoplasms"", ""start_span"": 71, ""end_span"": 80, ""type"": ""Cancer""}, {""token"": ""gastric"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Cancer""}, {""token"": ""esophageal carcinomas"", ""start_span"": 101, ""end_span"": 122, ""type"": ""Cancer""}]"	valid
A reduction in the expression of collagen XII might have profound effects on the stability of the extracellular matrix of transformed cells.	collagen XII,33,45,Gene_or_gene_product	extracellular matrix,98,118,Cellular_component	cells,134,139,Cell	"[{""token"": ""collagen XII"", ""start_span"": 33, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular matrix"", ""start_span"": 98, ""end_span"": 118, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Cell""}]"	valid
Following i. v. infusion with [ 13C] alanine, [ 13C] lactate and glutamate, evidence of oxidation via the TCA cycle, were observed in H4 tumors.	glutamate,65,74,Amino_acid	TCA,106,109,Chemical	H4 tumors,134,143,Cancer	"[{""token"": ""glutamate"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Amino_acid""}, {""token"": ""TCA"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Chemical""}, {""token"": ""H4 tumors"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Cancer""}]"	valid
The transformation is a consequence of the ability of viruses to integrate into the host cell ' s DNA and to produce transforming proteins.	viruses,54,61,Organism	host cell,84,93,Cell	DNA,98,101,Cellular_component	"[{""token"": ""viruses"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""host cell"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Cellular_component""}]"	valid
This is the first report of increased p53 levels caused by HCMV in infected fibroblasts.	p53,38,41,Gene_or_gene_product	HCMV,59,63,Organism	fibroblasts,76,87,Cell	"[{""token"": ""p53"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""HCMV"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Cell""}]"	valid
H - ras mutations in human pituitary carcinoma metastases.	H - ras,0,7,Gene_or_gene_product	human,21,26,Organism	pituitary carcinoma,27,46,Cancer	"[{""token"": ""H - ras"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Organism""}, {""token"": ""pituitary carcinoma"", ""start_span"": 27, ""end_span"": 46, ""type"": ""Cancer""}]"	valid
Rat tissues known to express these glucose transporters were used as controls.	Rat,0,3,Organism	tissues,4,11,Tissue	glucose,35,42,Chemical	"[{""token"": ""Rat"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Organism""}, {""token"": ""tissues"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Tissue""}, {""token"": ""glucose"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Chemical""}]"	valid
RESULTS: All the primary breast cancers and the lymph node metastases were positive for Glut - 1.	breast cancers,25,39,Cancer	lymph node metastases,48,69,Cancer	Glut - 1,88,96,Gene_or_gene_product	"[{""token"": ""breast cancers"", ""start_span"": 25, ""end_span"": 39, ""type"": ""Cancer""}, {""token"": ""lymph node metastases"", ""start_span"": 48, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""Glut - 1"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"	valid
Staining of the normal mammary epithelium, if present, was much lower than observed in tumor cells from the same patient.	mammary epithelium,23,41,Tissue	tumor cells,87,98,Cell	patient,113,120,Organism	"[{""token"": ""mammary epithelium"", ""start_span"": 23, ""end_span"": 41, ""type"": ""Tissue""}, {""token"": ""tumor cells"", ""start_span"": 87, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""patient"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Organism""}]"	valid
Glut - 2 was expressed in all of the tumors, but the intensity of staining was not consistently stronger than that seen in healthy breast.	Glut - 2,0,8,Gene_or_gene_product	tumors,37,43,Cancer	healthy breast,123,137,Tissue	"[{""token"": ""Glut - 2"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""healthy breast"", ""start_span"": 123, ""end_span"": 137, ""type"": ""Tissue""}]"	valid
Clusters of Glut - 4 - positive granule were observed in cells in six of the tumors.	Glut - 4,12,20,Gene_or_gene_product	cells,57,62,Cell	tumors,77,83,Cancer	"[{""token"": ""Glut - 4"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Cancer""}]"	valid
Increased glucose transporter protein expression may contribute to the increased uptake of 2 - [ 18F] - fluoro - 2 - deoxy - D - glucose ( FDG) by these tumors observed by positron emission tomography ( PET) imaging.	glucose,10,17,Chemical	FDG,139,142,Chemical	tumors,153,159,Cancer	"[{""token"": ""glucose"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""FDG"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Chemical""}, {""token"": ""tumors"", ""start_span"": 153, ""end_span"": 159, ""type"": ""Cancer""}]"	valid
In all cases, the somatostatin receptors were localized in veins, particularly in the smooth - muscle cell layer.	somatostatin receptors,18,40,Gene_or_gene_product	veins,59,64,Multi	smooth - muscle cell layer,86,112,Tissue	"[{""token"": ""somatostatin receptors"", ""start_span"": 18, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""veins"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Multi""}, {""token"": ""smooth - muscle cell layer"", ""start_span"": 86, ""end_span"": 112, ""type"": ""Tissue""}]"	valid
Syndecan - 1 expression in mammary epithelial tumor cells is E - cadherin - dependent.	Syndecan - 1,0,12,Gene_or_gene_product	mammary epithelial tumor cells,27,57,Cell	E - cadherin,61,73,Gene_or_gene_product	"[{""token"": ""Syndecan - 1"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary epithelial tumor cells"", ""start_span"": 27, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""E - cadherin"", ""start_span"": 61, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}]"	valid
In invasive NM - e - ras - MAC1 cells, where E - cadherin was partially downregulated by specific antisense RNA, syndecan - 1 expression was suppressed.	NM - e - ras - MAC1 cells,12,37,Cell	E - cadherin,45,57,Gene_or_gene_product	syndecan - 1,113,125,Gene_or_gene_product	"[{""token"": ""NM - e - ras - MAC1 cells"", ""start_span"": 12, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""E - cadherin"", ""start_span"": 45, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""syndecan - 1"", ""start_span"": 113, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}]"	valid
Furthermore, transfection of E - cadherin cDNA into invasive NM - f - ras - TD cells resulted in the upregulation of syndecan - 1 expression in association with decreased invasiveness.	E - cadherin cDNA,29,46,Gene_or_gene_product	NM - f - ras - TD cells,61,84,Cell	syndecan - 1,117,129,Gene_or_gene_product	"[{""token"": ""E - cadherin cDNA"", ""start_span"": 29, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""NM - f - ras - TD cells"", ""start_span"": 61, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""syndecan - 1"", ""start_span"": 117, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}]"	valid
Another cell adhesion protein, beta 1 - integrin was not affected by E - cadherin expression.	cell,8,12,Cell	beta 1 - integrin,31,48,Gene_or_gene_product	E - cadherin,69,81,Gene_or_gene_product	"[{""token"": ""cell"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Cell""}, {""token"": ""beta 1 - integrin"", ""start_span"": 31, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 69, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}]"	valid
The 5T4 antigen is defined by a monoclonal antibody ( MAb) specific for human trophoblast.	5T4,4,7,Gene_or_gene_product	human,72,77,Organism	trophoblast,78,89,Cell	"[{""token"": ""5T4"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Organism""}, {""token"": ""trophoblast"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Cell""}]"	valid
From the above, we concluded that carcinostatic agents may increase the metastatic ability of cancer cells in patients with cancer.	cancer cells,94,106,Cell	patients,110,118,Organism	cancer,124,130,Cancer	"[{""token"": ""cancer cells"", ""start_span"": 94, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Cancer""}]"	valid
Increased urokinase plasminogen activator ( uPA) levels are increased in a number of malignancies and have been correlated with decreased disease - free interval and decreased overall survival.	urokinase plasminogen activator,10,41,Gene_or_gene_product	uPA,44,47,Gene_or_gene_product	malignancies,85,97,Cancer	"[{""token"": ""urokinase plasminogen activator"", ""start_span"": 10, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPA"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignancies"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Cancer""}]"	valid
Increased levels of PAI - 1 were associated with a decreased survival in squamous cell carcinoma ( SCC) X2 = 5. 72, p = 0. 017 ( n = 74).	PAI - 1,20,27,Gene_or_gene_product	squamous cell carcinoma,73,96,Cancer	SCC,99,102,Cancer	"[{""token"": ""PAI - 1"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 73, ""end_span"": 96, ""type"": ""Cancer""}, {""token"": ""SCC"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Cancer""}]"	valid
uPA and uPAR levels were not significantly associated with tumour staging or survival.	uPA,0,3,Gene_or_gene_product	uPAR,8,12,Gene_or_gene_product	tumour,59,65,Cancer	"[{""token"": ""uPA"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPAR"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Cancer""}]"	valid
We conclude that increased PAI - 1 antigen levels may be associated with a decreased survival in patients with SCC.	PAI - 1,27,34,Gene_or_gene_product	patients,97,105,Organism	SCC,111,114,Cancer	"[{""token"": ""PAI - 1"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Organism""}, {""token"": ""SCC"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Cancer""}]"	valid
In cultured cells, this molecule is physically associated with focal adhesions, which are well - defined regions of intimate cell - to - substratum adhesion.	cells,12,17,Cell	focal adhesions,63,78,Cellular_component	cell,125,129,Cell	"[{""token"": ""cells"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""focal adhesions"", ""start_span"": 63, ""end_span"": 78, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Cell""}]"	valid
In this location, it interacts with other proteins of the focal adhesion to activate intracellular signalling events associated with cell adhesion.	focal adhesion,58,72,Cellular_component	intracellular,85,98,Immaterial_anatomical_entity	cell,133,137,Cell	"[{""token"": ""focal adhesion"", ""start_span"": 58, ""end_span"": 72, ""type"": ""Cellular_component""}, {""token"": ""intracellular"", ""start_span"": 85, ""end_span"": 98, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""cell"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Cell""}]"	valid
Because these phenomena are all of critical importance during morphogenesis, and because FAK is expressed in embryonic cells, evidence has been accumulating to indicate that FAK may be an important modulator of developmental processes.	FAK,89,92,Gene_or_gene_product	embryonic cells,109,124,Cell	FAK,174,177,Gene_or_gene_product	"[{""token"": ""FAK"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""embryonic cells"", ""start_span"": 109, ""end_span"": 124, ""type"": ""Cell""}, {""token"": ""FAK"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}]"	valid
Due to the low prevalence of hemangiopericytomas ( HPCs), data on the biophysiological characteristics of this tumor are rare.	hemangiopericytomas,29,48,Cancer	HPCs,51,55,Cancer	tumor,111,116,Cancer	"[{""token"": ""hemangiopericytomas"", ""start_span"": 29, ""end_span"": 48, ""type"": ""Cancer""}, {""token"": ""HPCs"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Cancer""}]"	test
The characteristics of HPCs in PET described herein for the first time offer additional diagnostic criteria and may help especially to differentiate these tumors from meningiomas.	HPCs,23,27,Cancer	tumors,155,161,Cancer	meningiomas,167,178,Cancer	"[{""token"": ""HPCs"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""tumors"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Cancer""}, {""token"": ""meningiomas"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Cancer""}]"	test
However, the role of the TSH - R - related cAMP pathway alterations in thyroid transformation remains to be elucidated.	TSH - R -,25,34,Gene_or_gene_product	cAMP,43,47,Chemical	thyroid,71,78,Organ	"[{""token"": ""TSH - R -"", ""start_span"": 25, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""cAMP"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Chemical""}, {""token"": ""thyroid"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Organ""}]"	test
In this review, the role of TSH - R gene alterations in benign and malignant thyroid neoplasia is examined.	TSH - R,28,35,Gene_or_gene_product	benign,56,62,Pathological_formation	malignant thyroid neoplasia,67,94,Cancer	"[{""token"": ""TSH - R"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""benign"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Pathological_formation""}, {""token"": ""malignant thyroid neoplasia"", ""start_span"": 67, ""end_span"": 94, ""type"": ""Cancer""}]"	test
A reduction in alpha - catenin expression and p53 overexpression correlated to lymph node metastases, respectively.	alpha - catenin,15,30,Gene_or_gene_product	p53,46,49,Gene_or_gene_product	lymph node,79,89,Multi	"[{""token"": ""alpha - catenin"", ""start_span"": 15, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Multi""}]"	test
Multivariate analysis showed that cooccurrence of reduced expression of alpha - catenin and overexpression of p53 was an independent factor indicating lymph node metastases.	alpha - catenin,72,87,Gene_or_gene_product	p53,110,113,Gene_or_gene_product	lymph node,151,161,Multi	"[{""token"": ""alpha - catenin"", ""start_span"": 72, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 151, ""end_span"": 161, ""type"": ""Multi""}]"	test
Proto - oncogene N - myc promoter is down regulated by the Wilms ' tumor suppressor gene WT1.	N - myc,17,24,Gene_or_gene_product	Wilms ' tumor,59,72,Cancer	WT1,89,92,Gene_or_gene_product	"[{""token"": ""N - myc"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""Wilms ' tumor"", ""start_span"": 59, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""WT1"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}]"	test
This finding may help to elucidate the relationship of WT1 and N - myc in tumorigenesis and renal development.	WT1,55,58,Gene_or_gene_product	N - myc,63,70,Gene_or_gene_product	renal,92,97,Organ	"[{""token"": ""WT1"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""N - myc"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Organ""}]"	test
The role of BRCA1 in sporadic breast and ovarian cancers remains elusive.	BRCA1,12,17,Gene_or_gene_product	breast,30,36,Cancer	ovarian cancers,41,56,Cancer	"[{""token"": ""BRCA1"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Cancer""}, {""token"": ""ovarian cancers"", ""start_span"": 41, ""end_span"": 56, ""type"": ""Cancer""}]"	test
Despite intensive investigations, the target genes of c - myb that are specifically involved in development of these myeloid lineage neoplasms are still unknown.	c - myb,54,61,Gene_or_gene_product	myeloid,117,124,Cell	neoplasms,133,142,Cancer	"[{""token"": ""c - myb"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Cell""}, {""token"": ""neoplasms"", ""start_span"": 133, ""end_span"": 142, ""type"": ""Cancer""}]"	test
In vitro assays have indicated that c - myc may be a target gene of c - Myb; however, regulation of the resident chromosomal gene has not yet been demonstrated.	c - myc,36,43,Gene_or_gene_product	c - Myb,68,75,Gene_or_gene_product	chromosomal,113,124,Cellular_component	"[{""token"": ""c - myc"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Myb"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""chromosomal"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Cellular_component""}]"	test
c - myc is a major target that transduces Myb ' s proliferative signal, as shown by the ability of a c - Myc - estrogen receptor fusion protein alone to also reverse growth arrest in this system.	c - myc,0,7,Gene_or_gene_product	Myb,42,45,Gene_or_gene_product	c - Myc - estrogen receptor,101,128,Gene_or_gene_product	"[{""token"": ""c - myc"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""Myb"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Myc - estrogen receptor"", ""start_span"": 101, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}]"	test
To investigate the possibility that this regulatory connection contributes to Myb ' s oncogenicity, we expressed a dominant negative Myb in the myeloid leukemic cell line RI - 4 - 11.	Myb,78,81,Gene_or_gene_product	Myb,133,136,Gene_or_gene_product	myeloid leukemic cell line RI - 4 - 11,144,182,Cell	"[{""token"": ""Myb"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""Myb"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid leukemic cell line RI - 4 - 11"", ""start_span"": 144, ""end_span"": 182, ""type"": ""Cell""}]"	test
Adenovirus - mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.	Adenovirus,0,10,Organism	endostatin,39,49,Gene_or_gene_product	tumor,122,127,Cancer	"[{""token"": ""Adenovirus"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Organism""}, {""token"": ""endostatin"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Cancer""}]"	test
In addition, the endostatin vector treatment completely prevented the formation of pulmonary micrometastases in Lewis lung carcinoma ( P = 0. 0001).	endostatin,17,27,Gene_or_gene_product	pulmonary micrometastases,83,108,Cancer	Lewis lung carcinoma,112,132,Cancer	"[{""token"": ""endostatin"", ""start_span"": 17, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""pulmonary micrometastases"", ""start_span"": 83, ""end_span"": 108, ""type"": ""Cancer""}, {""token"": ""Lewis lung carcinoma"", ""start_span"": 112, ""end_span"": 132, ""type"": ""Cancer""}]"	test
By SAGE ( serial analysis of gene expression) analysis, we identified final sigma as a gene whose expression is 7 - fold lower in breast carcinoma cells than in normal breast epithelium.	final sigma,70,81,Gene_or_gene_product	breast carcinoma cells,130,152,Cell	breast epithelium,168,185,Tissue	"[{""token"": ""final sigma"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast carcinoma cells"", ""start_span"": 130, ""end_span"": 152, ""type"": ""Cell""}, {""token"": ""breast epithelium"", ""start_span"": 168, ""end_span"": 185, ""type"": ""Tissue""}]"	test
Breast cancer cells lacking final sigma expression showed increased number of chromosomal breaks and gaps when exposed to gamma - irradiation.	Breast cancer cells,0,19,Cell	final sigma,28,39,Gene_or_gene_product	chromosomal,78,89,Cellular_component	"[{""token"": ""Breast cancer cells"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""final sigma"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""chromosomal"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Cellular_component""}]"	test
These results show that the actin - binding domain of Abl enhances leukemia development but does not appear to be an absolute requirement for leukemogenesis.	actin,28,33,Gene_or_gene_product	Abl,54,57,Gene_or_gene_product	leukemia,67,75,Cancer	"[{""token"": ""actin"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""Abl"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukemia"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Cancer""}]"	test
A cohort of unspecified mesodermal cells differentiates into primitive endothelial cells, which migrate to and occupy positions within the stereotypical blueprint of the primitive vasculature.	mesodermal cells,24,40,Cell	endothelial cells,71,88,Cell	vasculature,180,191,Anatomical_system	"[{""token"": ""mesodermal cells"", ""start_span"": 24, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 71, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""vasculature"", ""start_span"": 180, ""end_span"": 191, ""type"": ""Anatomical_system""}]"	test
METHODS: Tissues samples were taken from 60 patients with esophageal SCC after surgery.	Tissues samples,9,24,Tissue	patients,44,52,Organism	esophageal SCC,58,72,Cancer	"[{""token"": ""Tissues samples"", ""start_span"": 9, ""end_span"": 24, ""type"": ""Tissue""}, {""token"": ""patients"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""esophageal SCC"", ""start_span"": 58, ""end_span"": 72, ""type"": ""Cancer""}]"	test
The expression of VEGF and p53 protein in these SCC was examined immunohistochemically.	VEGF,18,22,Gene_or_gene_product	p53,27,30,Gene_or_gene_product	SCC,48,51,Cancer	"[{""token"": ""VEGF"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""SCC"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Cancer""}]"	test
RESULTS: VEGF expression was observed in 58. 3%, and p53 protein expression was observed in 61. 7% of the 60 patients.	VEGF,9,13,Gene_or_gene_product	p53,53,56,Gene_or_gene_product	patients,109,117,Organism	"[{""token"": ""VEGF"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 109, ""end_span"": 117, ""type"": ""Organism""}]"	test
The two parameters were more frequently observed in the SCC with VEGF / p53 coexpression than in those without the coexpression.	SCC,56,59,Cancer	VEGF,65,69,Gene_or_gene_product	p53,72,75,Gene_or_gene_product	"[{""token"": ""SCC"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""VEGF"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}]"	test
[ mRNA expression of metastasis - suppressor gene nm23 in carcinoma of buccal mucosa. II. Quantitative reverse transcription PCR amplification].	nm23,50,54,Gene_or_gene_product	carcinoma,58,67,Cancer	buccal mucosa,71,84,Multi	"[{""token"": ""nm23"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinoma"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""buccal mucosa"", ""start_span"": 71, ""end_span"": 84, ""type"": ""Multi""}]"	test
Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts.	phospholipase D,78,93,Gene_or_gene_product	murine,115,121,Organism	fibroblasts,122,133,Cell	"[{""token"": ""phospholipase D"", ""start_span"": 78, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 122, ""end_span"": 133, ""type"": ""Cell""}]"	test
Phospholipase D ( PLD) has been suggested to play an important role in a variety of cellular functions.	Phospholipase D,0,15,Gene_or_gene_product	PLD,18,21,Gene_or_gene_product	cellular,84,92,Cell	"[{""token"": ""Phospholipase D"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLD"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Cell""}]"	test
Both PLD1 and PLD2 also induced an up - regulation of the activity of matrix metalloprotease - 9 as detected by zymograms.	PLD1,5,9,Gene_or_gene_product	PLD2,14,18,Gene_or_gene_product	matrix metalloprotease - 9,70,96,Gene_or_gene_product	"[{""token"": ""PLD1"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLD2"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloprotease - 9"", ""start_span"": 70, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"	test
RhoA activation promotes transformation and loss of thyroid cell differentiation interfering with thyroid transcription factor - 1 activity.	RhoA,0,4,Gene_or_gene_product	thyroid cell,52,64,Cell	thyroid transcription factor - 1,98,130,Gene_or_gene_product	"[{""token"": ""RhoA"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""thyroid cell"", ""start_span"": 52, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""thyroid transcription factor - 1"", ""start_span"": 98, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}]"	test
The implication of the small GTPase RhoA in TSH - mediated proliferation of FRTL - 5 rat thyroid cells has been previously demonstrated.	RhoA,36,40,Gene_or_gene_product	TSH,44,47,Gene_or_gene_product	FRTL - 5 rat thyroid cells,76,102,Cell	"[{""token"": ""RhoA"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSH"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""FRTL - 5 rat thyroid cells"", ""start_span"": 76, ""end_span"": 102, ""type"": ""Cell""}]"	test
Clinical significance of plasma endostatin in acute myeloid leukemia / myelodysplastic syndrome.	plasma,25,31,Organism_substance	endostatin,32,42,Gene_or_gene_product	acute myeloid leukemia,46,68,Cancer	"[{""token"": ""plasma"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Organism_substance""}, {""token"": ""endostatin"", ""start_span"": 32, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""acute myeloid leukemia"", ""start_span"": 46, ""end_span"": 68, ""type"": ""Cancer""}]"	test
While endostatin is being investigated for its usefulness in treating solid tumors, its significance in hematologic malignancies is unknown.	endostatin,6,16,Gene_or_gene_product	solid tumors,70,82,Cancer	hematologic malignancies,104,128,Cancer	"[{""token"": ""endostatin"", ""start_span"": 6, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""solid tumors"", ""start_span"": 70, ""end_span"": 82, ""type"": ""Cancer""}, {""token"": ""hematologic malignancies"", ""start_span"": 104, ""end_span"": 128, ""type"": ""Cancer""}]"	test
RESULTS: There was no significant difference in the median PE level between AML / MDS patients and the normal controls.	PE,59,61,Gene_or_gene_product	AML,76,79,Cancer	patients,86,94,Organism	"[{""token"": ""PE"", ""start_span"": 59, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""AML"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Organism""}]"	test
CONCLUSIONS: PE is a useful prognostic predictor of CR and OS for AML / MDS patients.	PE,13,15,Gene_or_gene_product	AML,66,69,Cancer	patients,76,84,Organism	"[{""token"": ""PE"", ""start_span"": 13, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""AML"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Organism""}]"	test
The mechanism underlying the association between high PE and poor clinical outcome is unclear, although it may be related to the possible PE reflection of tumor burden.	PE,54,56,Gene_or_gene_product	PE,138,140,Gene_or_gene_product	tumor,155,160,Cancer	"[{""token"": ""PE"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""PE"", ""start_span"": 138, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Cancer""}]"	test
The pentapeptide SFLLR, like thrombin, caused a marked stimulation of angiogenesis in the CAM.	pentapeptide SFLLR,4,22,Gene_or_gene_product	thrombin,29,37,Gene_or_gene_product	CAM,90,93,Multi	"[{""token"": ""pentapeptide SFLLR"", ""start_span"": 4, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""CAM"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Multi""}]"	test
FPR and the piperazine derivatives caused suppression of angiogenesis and in combination with thrombin antagonized its angiogenic effect.	FPR,0,3,Gene_or_gene_product	piperazine derivatives,12,34,Chemical	thrombin,94,102,Gene_or_gene_product	"[{""token"": ""FPR"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""piperazine derivatives"", ""start_span"": 12, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""thrombin"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}]"	test
They also antagonised the effects of both thrombin and SFLLR on MMP - 2 activation.	thrombin,42,50,Gene_or_gene_product	SFLLR,55,60,Gene_or_gene_product	MMP - 2,64,71,Gene_or_gene_product	"[{""token"": ""thrombin"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""SFLLR"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}]"	test
Multivariate analysis revealed abnormal E - cadherin expression as an independent factor that correlated with submucosal invasion in early gastric cancer.	E - cadherin,40,52,Gene_or_gene_product	submucosal,110,120,Multi	gastric cancer,139,153,Cancer	"[{""token"": ""E - cadherin"", ""start_span"": 40, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""submucosal"", ""start_span"": 110, ""end_span"": 120, ""type"": ""Multi""}, {""token"": ""gastric cancer"", ""start_span"": 139, ""end_span"": 153, ""type"": ""Cancer""}]"	test
Dominant negative interference of transcription factor AP - 2 causes inhibition of ErbB - 3 expression and suppresses malignant cell growth.	AP - 2,55,61,Gene_or_gene_product	ErbB - 3,83,91,Gene_or_gene_product	malignant cell,118,132,Cell	"[{""token"": ""AP - 2"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant cell"", ""start_span"": 118, ""end_span"": 132, ""type"": ""Cell""}]"	test
ErbB - 3 ( HER3) is a member of the epidermal growth factor receptor family.	ErbB - 3,0,8,Gene_or_gene_product	HER3,11,15,Gene_or_gene_product	epidermal growth factor receptor,36,68,Gene_or_gene_product	"[{""token"": ""ErbB - 3"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""HER3"", ""start_span"": 11, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""epidermal growth factor receptor"", ""start_span"": 36, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}]"	test
Taken together, these data strongly support a role for the AP - 2 gene family, in particular, AP - 2gamma, in the control of ErbB - 3 expression.	AP - 2,59,65,Gene_or_gene_product	AP - 2gamma,94,105,Gene_or_gene_product	ErbB - 3,125,133,Gene_or_gene_product	"[{""token"": ""AP - 2"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2gamma"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}]"	test
Overexpression of NRP1 by prostate tumor cells in vivo results in increased tumor angiogenesis and growth.	NRP1,18,22,Gene_or_gene_product	prostate tumor cells,26,46,Cell	tumor,76,81,Cancer	"[{""token"": ""NRP1"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate tumor cells"", ""start_span"": 26, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Cancer""}]"	test
We investigated the molecular mechanisms underlying NRP1 - mediated angiogenesis by analyzing the association of NRP1 and KDR.	NRP1,52,56,Gene_or_gene_product	NRP1,113,117,Gene_or_gene_product	KDR,122,125,Gene_or_gene_product	"[{""token"": ""NRP1"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""NRP1"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}]"	test
Invasive carcinomas without spiculated margins are poorly differentiated tumors.	carcinomas,9,19,Cancer	spiculated margins,28,46,Multi	tumors,73,79,Cancer	"[{""token"": ""carcinomas"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Cancer""}, {""token"": ""spiculated margins"", ""start_span"": 28, ""end_span"": 46, ""type"": ""Multi""}, {""token"": ""tumors"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Cancer""}]"	test
A diagnosis of advanced gastric cancer with extensive lymph node metastases and multiple pulmonary metastases was made.	gastric cancer,24,38,Cancer	lymph node,54,64,Multi	pulmonary,89,98,Organ	"[{""token"": ""gastric cancer"", ""start_span"": 24, ""end_span"": 38, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Multi""}, {""token"": ""pulmonary"", ""start_span"": 89, ""end_span"": 98, ""type"": ""Organ""}]"	test
After two courses, the primary tumor was reduced to an ulcer scar with pathological confirmation of a complete disappearance of the cancer tissue.	tumor,31,36,Cancer	ulcer scar,55,65,Pathological_formation	cancer tissue,132,145,Tissue	"[{""token"": ""tumor"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Cancer""}, {""token"": ""ulcer scar"", ""start_span"": 55, ""end_span"": 65, ""type"": ""Pathological_formation""}, {""token"": ""cancer tissue"", ""start_span"": 132, ""end_span"": 145, ""type"": ""Tissue""}]"	test
The serum level of CEA was reduced from 172. 7 ng / ml to 8. 1 ng / ml after TS - 1 treatment.	serum,4,9,Organism_substance	CEA,19,22,Gene_or_gene_product	TS - 1,77,83,Chemical	"[{""token"": ""serum"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Organism_substance""}, {""token"": ""CEA"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""TS - 1"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Chemical""}]"	test
As for adverse events, only pigmentation of the skin and Grade 2 oral aphta were observed.	pigmentation,28,40,Pathological_formation	skin,48,52,Organ	oral aphta,65,75,Pathological_formation	"[{""token"": ""pigmentation"", ""start_span"": 28, ""end_span"": 40, ""type"": ""Pathological_formation""}, {""token"": ""skin"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Organ""}, {""token"": ""oral aphta"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Pathological_formation""}]"	test
hADA3 functions as a coactivator for p53 - mediated transactivation by stabilizing p53 protein.	hADA3,0,5,Gene_or_gene_product	p53,37,40,Gene_or_gene_product	p53,83,86,Gene_or_gene_product	"[{""token"": ""hADA3"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}]"	test
Seventy - five patients underwent biopsies of carcinomas metastatic to the brain.	patients,15,23,Organism	carcinomas,46,56,Cancer	brain,75,80,Organ	"[{""token"": ""patients"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Organism""}, {""token"": ""carcinomas"", ""start_span"": 46, ""end_span"": 56, ""type"": ""Cancer""}, {""token"": ""brain"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Organ""}]"	test
At the time of brain biopsy, the primary site of tumor origin was known in 45 cases and unknown in 30 cases.	brain,15,20,Organ	site,41,45,Multi	tumor,49,54,Cancer	"[{""token"": ""brain"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Organ""}, {""token"": ""site"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Cancer""}]"	test
Administration of 317615 x 2HCl also increased the tumor growth delay produced by fractionated radiation therapy in the MX - 1 tumor.	317615 x 2HCl,18,31,Chemical	tumor,51,56,Cancer	MX - 1 tumor,120,132,Cancer	"[{""token"": ""317615 x 2HCl"", ""start_span"": 18, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Cancer""}, {""token"": ""MX - 1 tumor"", ""start_span"": 120, ""end_span"": 132, ""type"": ""Cancer""}]"	test
The combination of paclitaxel and 317615 x 2HCl resulted in 100% 120 - day survival of SKOV - 3 bearing animals.	paclitaxel,19,29,Chemical	317615 x 2HCl,34,47,Chemical	SKOV - 3,87,95,Cancer	"[{""token"": ""paclitaxel"", ""start_span"": 19, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""317615 x 2HCl"", ""start_span"": 34, ""end_span"": 47, ""type"": ""Chemical""}, {""token"": ""SKOV - 3"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Cancer""}]"	test
We found coexpression of CD40 and CD154 in most of the renal carcinoma cell lines.	CD40,25,29,Gene_or_gene_product	CD154,34,39,Gene_or_gene_product	renal carcinoma cell lines,55,81,Cell	"[{""token"": ""CD40"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD154"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal carcinoma cell lines"", ""start_span"": 55, ""end_span"": 81, ""type"": ""Cell""}]"	test
CD154, but not CD40 expression, significantly correlated with tumor stage.	CD154,0,5,Gene_or_gene_product	CD40,15,19,Gene_or_gene_product	tumor,62,67,Cancer	"[{""token"": ""CD154"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD40"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Cancer""}]"	test
On the contrary, CD154 stimulated cell proliferation, motility and production of PAF, a phospholipid mediator of inflammation with angiogenic properties.	CD154,17,22,Gene_or_gene_product	cell,34,38,Cell	PAF,81,84,Chemical	"[{""token"": ""CD154"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""PAF"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Chemical""}]"	test
Survivin is a novel member of the inhibitor of apoptosis protein ( IAP) family.	Survivin,0,8,Gene_or_gene_product	inhibitor of apoptosis,34,56,Gene_or_gene_product	IAP,67,70,Gene_or_gene_product	"[{""token"": ""Survivin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""inhibitor of apoptosis"", ""start_span"": 34, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""IAP"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}]"	test
A possible explanation for the decrease in the ATP level might be interaction of the amine oxide with the cell membrane.	ATP,47,50,Chemical	amine oxide,85,96,Chemical	cell membrane,106,119,Cellular_component	"[{""token"": ""ATP"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""amine oxide"", ""start_span"": 85, ""end_span"": 96, ""type"": ""Chemical""}, {""token"": ""cell membrane"", ""start_span"": 106, ""end_span"": 119, ""type"": ""Cellular_component""}]"	test
During 8 days of culture under 5% O ( 2), but not room air, the addition of FGF2 to explants stimulated the formation of Gs - IB ( 4 -) positive, CD31 - positive, and Flk - 1 - positive microvessels in a concentration - dependent manner.	FGF2,76,80,Gene_or_gene_product	CD31,146,150,Gene_or_gene_product	Flk - 1,167,174,Gene_or_gene_product	"[{""token"": ""FGF2"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD31"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""Flk - 1"", ""start_span"": 167, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}]"	test
Levels of FGFR1, but not FGFR2, were increased in embryonic aorta cultured under 5% O ( 2) relative to room air.	FGFR1,10,15,Gene_or_gene_product	FGFR2,25,30,Gene_or_gene_product	embryonic aorta,50,65,Multi	"[{""token"": ""FGFR1"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGFR2"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""embryonic aorta"", ""start_span"": 50, ""end_span"": 65, ""type"": ""Multi""}]"	test
Insulin - like growth factor - I receptor - mediated vasculogenesis / angiogenesis in human lung development.	Insulin - like growth factor - I receptor,0,41,Gene_or_gene_product	human,86,91,Organism	lung,92,96,Organ	"[{""token"": ""Insulin - like growth factor - I receptor"", ""start_span"": 0, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Organ""}]"	test
Inactivation of IGF - IR resulted in a loss of endothelial cells, accompanied by dramatic changes in fetal lung explant morphology.	IGF - IR,16,24,Gene_or_gene_product	endothelial cells,47,64,Cell	fetal lung,101,111,Organ	"[{""token"": ""IGF - IR"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 47, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""fetal lung"", ""start_span"": 101, ""end_span"": 111, ""type"": ""Organ""}]"	test
Terminal transferase dUTP end - labeling assay and TEM studies of anti - IGF - IR - treated lungs demonstrated numerous apoptotic mesenchymal cells.	IGF - IR,73,81,Gene_or_gene_product	lungs,92,97,Organ	mesenchymal cells,130,147,Cell	"[{""token"": ""IGF - IR"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""lungs"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Organ""}, {""token"": ""mesenchymal cells"", ""start_span"": 130, ""end_span"": 147, ""type"": ""Cell""}]"	test
Enhanced expression of vascular endothelial growth factor by periodontal pathogens in gingival fibroblasts.	vascular endothelial growth factor,23,57,Gene_or_gene_product	periodontal,61,72,Organism_subdivision	gingival fibroblasts,86,106,Cell	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 23, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""periodontal"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Organism_subdivision""}, {""token"": ""gingival fibroblasts"", ""start_span"": 86, ""end_span"": 106, ""type"": ""Cell""}]"	test
Vascular endothelial growth factor ( VEGF) has recently attracted attention as a potent inducer of vascular permeability and angiogenesis.	Vascular endothelial growth factor,0,34,Gene_or_gene_product	VEGF,37,41,Gene_or_gene_product	vascular,99,107,Multi	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Multi""}]"	test
Supernatant from cultures of Ve - and OMP - stimulated HGF strongly induced VPE.	Ve,29,31,Gene_or_gene_product	OMP,38,41,Gene_or_gene_product	HGF,55,58,Cell	"[{""token"": ""Ve"", ""start_span"": 29, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""OMP"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""HGF"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Cell""}]"	test
Heating and protease treatment of the stimulants reduced the VEGF enhancing levels in Ve and OMP in vitro.	VEGF,61,65,Gene_or_gene_product	Ve,86,88,Gene_or_gene_product	OMP,93,96,Gene_or_gene_product	"[{""token"": ""VEGF"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ve"", ""start_span"": 86, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""OMP"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"	test
In addition, VEGF might be associated with the etiology of periodontitis in its early stages according to neovascularization stimulated by periodontal pathogens causing swelling and edema.	VEGF,13,17,Gene_or_gene_product	periodontal,139,150,Organism_subdivision	edema,182,187,Pathological_formation	"[{""token"": ""VEGF"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""periodontal"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Organism_subdivision""}, {""token"": ""edema"", ""start_span"": 182, ""end_span"": 187, ""type"": ""Pathological_formation""}]"	test
NF - kappaB / Rel transcriptional pathway: implications in pancreatic cancer.	NF - kappaB,0,11,Gene_or_gene_product	Rel,14,17,Gene_or_gene_product	pancreatic cancer,59,76,Cancer	"[{""token"": ""NF - kappaB"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rel"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""pancreatic cancer"", ""start_span"": 59, ""end_span"": 76, ""type"": ""Cancer""}]"	test
Based on its role in malignant transformation, apoptosis, and cell proliferation, the transcription factor NF - kappaB / Rel has gained the attention of many laboratories.	cell,62,66,Cell	NF - kappaB,107,118,Gene_or_gene_product	Rel,121,124,Gene_or_gene_product	"[{""token"": ""cell"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""NF - kappaB"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rel"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}]"	test
Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.	fluconazole,17,28,Chemical	corticosteroid,33,47,Chemical	Candida albicans,75,91,Organism	"[{""token"": ""fluconazole"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Chemical""}, {""token"": ""corticosteroid"", ""start_span"": 33, ""end_span"": 47, ""type"": ""Chemical""}, {""token"": ""Candida albicans"", ""start_span"": 75, ""end_span"": 91, ""type"": ""Organism""}]"	test
PURPOSE: To determine the most efficient time point and concentration of topical corticosteroids in Candida albicans keratitis treated with fluconazole.	corticosteroids,81,96,Chemical	Candida albicans,100,116,Organism	fluconazole,140,151,Chemical	"[{""token"": ""corticosteroids"", ""start_span"": 81, ""end_span"": 96, ""type"": ""Chemical""}, {""token"": ""Candida albicans"", ""start_span"": 100, ""end_span"": 116, ""type"": ""Organism""}, {""token"": ""fluconazole"", ""start_span"": 140, ""end_span"": 151, ""type"": ""Chemical""}]"	test
After a 48 - hour incubation period, seven groups of animals were treated for 21 days with fluconazole, with group I acting as a control, and groups II to VII receiving adjunct therapy with the corticosteroid prednisolone ( 5 or 10 times daily; 3, 9, or 15 days after infection).	fluconazole,91,102,Chemical	corticosteroid,194,208,Chemical	prednisolone,209,221,Chemical	"[{""token"": ""fluconazole"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Chemical""}, {""token"": ""corticosteroid"", ""start_span"": 194, ""end_span"": 208, ""type"": ""Chemical""}, {""token"": ""prednisolone"", ""start_span"": 209, ""end_span"": 221, ""type"": ""Chemical""}]"	test
The delayed application of corticosteroids after treatment with antimycotic drugs in cases of fungal keratitis is therefore not contraindicated and may be beneficial in patients.	corticosteroids,27,42,Chemical	antimycotic drugs,64,81,Chemical	patients,169,177,Organism	"[{""token"": ""corticosteroids"", ""start_span"": 27, ""end_span"": 42, ""type"": ""Chemical""}, {""token"": ""antimycotic drugs"", ""start_span"": 64, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 169, ""end_span"": 177, ""type"": ""Organism""}]"	test
Solid tumor therapy: manipulation of the vasculature with TNF.	Solid tumor,0,11,Cancer	vasculature,41,52,Multi	TNF,58,61,Gene_or_gene_product	"[{""token"": ""Solid tumor"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Cancer""}, {""token"": ""vasculature"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Multi""}, {""token"": ""TNF"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}]"	test
A major step forwards in the treatment of solid tumors is the recognition of the tumor - associated vasculature as an important target for therapy.	solid tumors,42,54,Cancer	tumor,81,86,Cancer	vasculature,100,111,Multi	"[{""token"": ""solid tumors"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Cancer""}, {""token"": ""vasculature"", ""start_span"": 100, ""end_span"": 111, ""type"": ""Multi""}]"	test
In these settings TNF demonstrates potent and selective activity on the tumor vascular bed, which strongly improves tumor response.	TNF,18,21,Gene_or_gene_product	tumor vascular bed,72,90,Multi	tumor,116,121,Cancer	"[{""token"": ""TNF"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor vascular bed"", ""start_span"": 72, ""end_span"": 90, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Cancer""}]"	test
The polyester prostheses utilized were polyester flat ( PF) and polyester soft three - dimensional ( PS); the PP mesh utilized was Marlex.	polyester,4,13,Chemical	polyester,39,48,Chemical	polyester,64,73,Chemical	"[{""token"": ""polyester"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""polyester"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""polyester"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Chemical""}]"	test
T140 analogs as CXCR4 antagonists identified as anti - metastatic agents in the treatment of breast cancer.	T140 analogs,0,12,Chemical	CXCR4,16,21,Gene_or_gene_product	breast cancer,93,106,Cancer	"[{""token"": ""T140 analogs"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""CXCR4"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 93, ""end_span"": 106, ""type"": ""Cancer""}]"	test
Here we report that CCL16 activates an angiogenic program in vascular endothelial cells by activating CCR1.	CCL16,20,25,Gene_or_gene_product	vascular endothelial cells,61,87,Cell	CCR1,102,106,Gene_or_gene_product	"[{""token"": ""CCL16"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial cells"", ""start_span"": 61, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""CCR1"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}]"	test
CCL16 may be specifically cross - linked to CCR1 expressed on endothelial cells.	CCL16,0,5,Gene_or_gene_product	CCR1,44,48,Gene_or_gene_product	endothelial cells,62,79,Cell	"[{""token"": ""CCL16"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCR1"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 62, ""end_span"": 79, ""type"": ""Cell""}]"	test
BACKGROUND AND OBJECTIVES: Chronic lymphocytic leukemia ( CLL) is the most common leukemia in the western world.	Chronic lymphocytic leukemia,27,55,Cancer	CLL,58,61,Cancer	leukemia,82,90,Cancer	"[{""token"": ""Chronic lymphocytic leukemia"", ""start_span"": 27, ""end_span"": 55, ""type"": ""Cancer""}, {""token"": ""CLL"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Cancer""}, {""token"": ""leukemia"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Cancer""}]"	test
METHODS AND RESULTS: Purified B - CLL cells from 15 patients were cultured either alone or with Sim at concentrations of 10, 50, and 100 microM.	B - CLL cells,30,43,Cell	patients,52,60,Organism	Sim,96,99,Chemical	"[{""token"": ""B - CLL cells"", ""start_span"": 30, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Organism""}, {""token"": ""Sim"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Chemical""}]"	test
Viability, measured by the activity of mitochondrial dehydrogenases, was reduced significantly in the cells treated with Sim at 50 and 100 microM for 24 hours ( p < 0. 005).	mitochondrial,39,52,Cellular_component	cells,102,107,Cell	Sim,121,124,Chemical	"[{""token"": ""mitochondrial"", ""start_span"": 39, ""end_span"": 52, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Cell""}, {""token"": ""Sim"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Chemical""}]"	test
The level of apoptosis, as measured by annexin binding to exposed phosphatidylserine moieties, increased significantly in the treated cells at concentrations higher than 50 microM for 24 hours ( p < 0. 003).	annexin,39,46,Gene_or_gene_product	phosphatidylserine,66,84,Amino_acid	cells,134,139,Cell	"[{""token"": ""annexin"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphatidylserine"", ""start_span"": 66, ""end_span"": 84, ""type"": ""Amino_acid""}, {""token"": ""cells"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Cell""}]"	test
These showed cleavage of caspases 9, 8, and 3.	caspases 9,25,35,Gene_or_gene_product	8,37,38,Gene_or_gene_product	3,44,45,Gene_or_gene_product	"[{""token"": ""caspases 9"", ""start_span"": 25, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""8"", ""start_span"": 37, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""3"", ""start_span"": 44, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}]"	test
Endothelial cell expression of c - src was constitutively elevated after stable infection with a retroviral vector containing the c - src coding sequence.	Endothelial cell,0,16,Cell	c - src,31,38,Gene_or_gene_product	c - src,130,137,Gene_or_gene_product	"[{""token"": ""Endothelial cell"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""c - src"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - src"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"	test
Constitutively increased c - src kinase activity reconstituted the increases in migration and u - PA observed with angiotensin system interruption.	c - src,25,32,Gene_or_gene_product	u - PA,94,100,Gene_or_gene_product	angiotensin,115,126,Gene_or_gene_product	"[{""token"": ""c - src"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""u - PA"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiotensin"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}]"	test
Antisera to bovine u - PA blocked the increase in migration associated with increased c - src expression.	bovine,12,18,Organism	u - PA,19,25,Gene_or_gene_product	c - src,86,93,Gene_or_gene_product	"[{""token"": ""bovine"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Organism""}, {""token"": ""u - PA"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - src"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}]"	test
Cell type - specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia - inducible factor 1.	Cell,0,4,Cell	nonischemic tissue,109,127,Tissue	hypoxia - inducible factor 1,163,191,Gene_or_gene_product	"[{""token"": ""Cell"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Cell""}, {""token"": ""nonischemic tissue"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Tissue""}, {""token"": ""hypoxia - inducible factor 1"", ""start_span"": 163, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}]"	test
These results indicate that HIF - 1 functions as a master regulator of angiogenesis by controlling the expression of multiple angiogenic growth factors and that adenovirus - mediated expression of a constitutively active form of HIF - 1alpha is sufficient to induce angiogenesis in nonischemic tissue of an adult animal.	HIF - 1,28,35,Gene_or_gene_product	HIF - 1alpha,229,241,Gene_or_gene_product	nonischemic tissue,282,300,Tissue	"[{""token"": ""HIF - 1"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 229, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}, {""token"": ""nonischemic tissue"", ""start_span"": 282, ""end_span"": 300, ""type"": ""Tissue""}]"	test
We showed that the ANG II - induced stimulation of angiogenesis is linked to the AT2 receptor as an impaired induction of angiogenesis was obtained in AT2 receptor knockout mice.	ANG II,19,25,Gene_or_gene_product	AT2 receptor,81,93,Gene_or_gene_product	AT2 receptor,151,163,Gene_or_gene_product	"[{""token"": ""ANG II"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""AT2 receptor"", ""start_span"": 81, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""AT2 receptor"", ""start_span"": 151, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}]"	test
Insulin - like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt / Bcl - x ( L) pathway.	Insulin - like growth factor 1 receptor,0,39,Gene_or_gene_product	colon cancer cells,97,115,Cell	Akt,128,131,Gene_or_gene_product	"[{""token"": ""Insulin - like growth factor 1 receptor"", ""start_span"": 0, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon cancer cells"", ""start_span"": 97, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""Akt"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"	test
Our data demonstrate, for the first time, that IGF1 - R / Akt / Bcl - x ( L) pathway may contribute to a more aggressive malignant phenotype, in a subset of colorectal cancers.	IGF1 - R,47,55,Gene_or_gene_product	Akt,58,61,Gene_or_gene_product	colorectal cancers,157,175,Cancer	"[{""token"": ""IGF1 - R"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal cancers"", ""start_span"": 157, ""end_span"": 175, ""type"": ""Cancer""}]"	test
Recently, overexpression of EphA2, a member of the Eph family of receptor tyrosine kinases, has been reported in several cancers.	EphA2,28,33,Gene_or_gene_product	Eph,51,54,Gene_or_gene_product	cancers,121,128,Cancer	"[{""token"": ""EphA2"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""Eph"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Cancer""}]"	test
The expression level of EphA2 had a statistically significant relationship with liver metastasis, lymphatic vessel invasion and clinical stage ( p = 0. 0477, 0. 0316 and 0. 0467, respectively).	EphA2,24,29,Gene_or_gene_product	liver,80,85,Organ	lymphatic vessel,98,114,Multi	"[{""token"": ""EphA2"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""liver"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organ""}, {""token"": ""lymphatic vessel"", ""start_span"": 98, ""end_span"": 114, ""type"": ""Multi""}]"	test
In addition, the positivity rate of EphA2 was significantly higher in primary lesions with lymph node metastasis than in those without metastasis ( p = 0. 0014).	EphA2,36,41,Gene_or_gene_product	primary lesions,70,85,Cancer	lymph node,91,101,Multi	"[{""token"": ""EphA2"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary lesions"", ""start_span"": 70, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Multi""}]"	test
However, the expression level of E - cadherin had an inverse relationship with both differentiation level of the tumor and lymphatic vessel invasion ( p = 0. 0430 and 0. 0320, respectively).	E - cadherin,33,45,Gene_or_gene_product	tumor,113,118,Cancer	lymphatic vessel,123,139,Multi	"[{""token"": ""E - cadherin"", ""start_span"": 33, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Cancer""}, {""token"": ""lymphatic vessel"", ""start_span"": 123, ""end_span"": 139, ""type"": ""Multi""}]"	test
Clusterin gene expression is potently induced in experimental models in which apoptosis is activated, such as rat prostate involution following castration.	Clusterin,0,9,Gene_or_gene_product	rat,110,113,Organism	prostate,114,122,Organ	"[{""token"": ""Clusterin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Organism""}, {""token"": ""prostate"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Organ""}]"	test
Furthermore, Cox regression analysis showed that CYR61 and CTGF expression had a significant correlation with patient survival.	CYR61,49,54,Gene_or_gene_product	CTGF,59,63,Gene_or_gene_product	patient,110,117,Organism	"[{""token"": ""CYR61"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""CTGF"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""patient"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Organism""}]"	test
These results suggest that CYR61 and CTGF may play a role in the progression of gliomas; their levels at diagnosis may have prognostic significance; and these proteins might serve as valuable targets for therapeutic intervention.	CYR61,27,32,Gene_or_gene_product	CTGF,37,41,Gene_or_gene_product	gliomas,80,87,Cancer	"[{""token"": ""CYR61"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""CTGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""gliomas"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Cancer""}]"	test
Targeting wide - range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90.	PU24FCl,52,59,Chemical	tumor,85,90,Cancer	Hsp90,91,96,Gene_or_gene_product	"[{""token"": ""PU24FCl"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Cancer""}, {""token"": ""Hsp90"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"	test
Applying cell immunohistochemistry and RT - PCR, we further validated two interesting and different proteins, annexin1 and S100A4.	cell,9,13,Cell	annexin1,110,118,Gene_or_gene_product	S100A4,123,129,Gene_or_gene_product	"[{""token"": ""cell"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""annexin1"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""S100A4"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}]"	test
Clinical implication of expression of cyclooxygenase - 2 and peroxisome proliferator activated - receptor gamma in epithelial ovarian tumours.	cyclooxygenase - 2,38,56,Gene_or_gene_product	peroxisome proliferator activated - receptor gamma,61,111,Gene_or_gene_product	epithelial ovarian tumours,115,141,Cancer	"[{""token"": ""cyclooxygenase - 2"", ""start_span"": 38, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""peroxisome proliferator activated - receptor gamma"", ""start_span"": 61, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""epithelial ovarian tumours"", ""start_span"": 115, ""end_span"": 141, ""type"": ""Cancer""}]"	test
The COX - 2 protein was not detected in the three borderline tumours, whereas PPARgamma protein was detected in all of them.	COX - 2,4,11,Gene_or_gene_product	tumours,61,68,Cancer	PPARgamma,78,87,Gene_or_gene_product	"[{""token"": ""COX - 2"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumours"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Cancer""}, {""token"": ""PPARgamma"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}]"	test
COX - 2 protein was detected in eight of the 12 carcinomas, whereas PPARgamma protein was detected in only two cases.	COX - 2,0,7,Gene_or_gene_product	carcinomas,48,58,Cancer	PPARgamma,68,77,Gene_or_gene_product	"[{""token"": ""COX - 2"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinomas"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Cancer""}, {""token"": ""PPARgamma"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}]"	test
Role of osteopontin in adhesion, migration, cell survival and bone remodeling.	osteopontin,8,19,Gene_or_gene_product	cell,44,48,Cell	bone,62,66,Organ	"[{""token"": ""osteopontin"", ""start_span"": 8, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""bone"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Organ""}]"	test
Osteopontin ( OPN) is a secreted adhesive glycophosphoprotein expressed by several cell types.	Osteopontin,0,11,Gene_or_gene_product	OPN,14,17,Gene_or_gene_product	cell,83,87,Cell	"[{""token"": ""Osteopontin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPN"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Cell""}]"	test
In this review focus will be on OPN in bone and its role in adhesion, migration and cell survival.	OPN,32,35,Gene_or_gene_product	bone,39,43,Tissue	cell,84,88,Cell	"[{""token"": ""OPN"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""bone"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Tissue""}, {""token"": ""cell"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Cell""}]"	test
Glucocorticoid receptor ( GR) activation has recently been shown to inhibit apoptosis in breast epithelial cells.	Glucocorticoid receptor,0,23,Gene_or_gene_product	GR,26,28,Gene_or_gene_product	breast epithelial cells,89,112,Cell	"[{""token"": ""Glucocorticoid receptor"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""GR"", ""start_span"": 26, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast epithelial cells"", ""start_span"": 89, ""end_span"": 112, ""type"": ""Cell""}]"	test
We have previously described a group of genes that is rapidly up - regulated in these cells following dexamethasone ( Dex) treatment.	cells,86,91,Cell	dexamethasone,102,115,Chemical	Dex,118,121,Chemical	"[{""token"": ""cells"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""dexamethasone"", ""start_span"": 102, ""end_span"": 115, ""type"": ""Chemical""}, {""token"": ""Dex"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Chemical""}]"	test
In an effort to dissect the mechanisms of GR - mediated breast epithelial cell survival, we now examine the molecular events downstream of GR activation.	GR,42,44,Gene_or_gene_product	breast epithelial cell,56,78,Cell	GR,139,141,Gene_or_gene_product	"[{""token"": ""GR"", ""start_span"": 42, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast epithelial cell"", ""start_span"": 56, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""GR"", ""start_span"": 139, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}]"	test
Here we show that GR activation leads to both the rapid induction of MAPK phosphatase - 1 ( MKP - 1) mRNA and its sustained expression.	GR,18,20,Gene_or_gene_product	MAPK phosphatase - 1,69,89,Gene_or_gene_product	MKP - 1,92,99,Gene_or_gene_product	"[{""token"": ""GR"", ""start_span"": 18, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK phosphatase - 1"", ""start_span"": 69, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""MKP - 1"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}]"	test
Induction of the MKP - 1 protein in the MCF10A - Myc and MDA - MB - 231 breast epithelial cell lines was also seen.	MKP - 1,17,24,Gene_or_gene_product	MCF10A - Myc,40,52,Cell	MDA - MB - 231 breast epithelial cell lines,57,100,Cell	"[{""token"": ""MKP - 1"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""MCF10A - Myc"", ""start_span"": 40, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""MDA - MB - 231 breast epithelial cell lines"", ""start_span"": 57, ""end_span"": 100, ""type"": ""Cell""}]"	test
We verified the predicted ELK - 1 - - > tPA transcriptional regulatory relationship using a luciferase reporter assay.	ELK - 1,26,33,Gene_or_gene_product	tPA,40,43,Gene_or_gene_product	luciferase,92,102,Gene_or_gene_product	"[{""token"": ""ELK - 1"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""tPA"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 92, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}]"	test
We conclude that GR - mediated MAPK inactivation contributes to cell survival and that the potential transcriptional targets of this inhibition can be identified from large scale gene array analysis.	GR,17,19,Gene_or_gene_product	MAPK,31,35,Gene_or_gene_product	cell,64,68,Cell	"[{""token"": ""GR"", ""start_span"": 17, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Cell""}]"	test
Both models yield significantly reduced placental weights and an asymmetrically growth - restricted fetus, and display altered maternal hormone concentrations, indicative of an impaired trophoblast capacity.	placental,40,49,Organ	fetus,100,105,Developing_anatomical_structure	trophoblast,186,197,Cell	"[{""token"": ""placental"", ""start_span"": 40, ""end_span"": 49, ""type"": ""Organ""}, {""token"": ""fetus"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Developing_anatomical_structure""}, {""token"": ""trophoblast"", ""start_span"": 186, ""end_span"": 197, ""type"": ""Cell""}]"	test
However, fetal utilization of oxygen and glucose, on a weight basis, remain constant compared with control pregnancies.	fetal,9,14,Developing_anatomical_structure	oxygen,30,36,Chemical	glucose,41,48,Chemical	"[{""token"": ""fetal"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Developing_anatomical_structure""}, {""token"": ""oxygen"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Chemical""}]"	test
The fact that the apoptotic and antiproliferative functions of p53 can be dissociated in certain mutants also suggests another level of complexity in the relationships between p53 inactivation and neoplasia.	p53,63,66,Gene_or_gene_product	p53,176,179,Gene_or_gene_product	neoplasia,197,206,Cancer	"[{""token"": ""p53"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""neoplasia"", ""start_span"": 197, ""end_span"": 206, ""type"": ""Cancer""}]"	test
OBJECTIVES: Bisphosphonates have been used successfully in the treatment of hypercalcemia and to reduce skeletal - related complications of bone metastases.	Bisphosphonates,12,27,Chemical	skeletal,104,112,Anatomical_system	bone metastases,140,155,Cancer	"[{""token"": ""Bisphosphonates"", ""start_span"": 12, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""skeletal"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Anatomical_system""}, {""token"": ""bone metastases"", ""start_span"": 140, ""end_span"": 155, ""type"": ""Cancer""}]"	test
RESULTS: The percentage of patients being bone metastases free at 12 mo was 60% in the zoledronic acid and 10% in the control group ( p less than 0. 0005), while the percentages at 18 mo were 20% and 5% respectively ( p = 0. 0002).	patients,27,35,Organism	bone metastases,42,57,Cancer	zoledronic acid,87,102,Chemical	"[{""token"": ""patients"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Organism""}, {""token"": ""bone metastases"", ""start_span"": 42, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""zoledronic acid"", ""start_span"": 87, ""end_span"": 102, ""type"": ""Chemical""}]"	test
In the meantime preventive use of bisphosphonates in patients without any bone metastases should not be used outside the scope of a clinical trial.	bisphosphonates,34,49,Chemical	patients,53,61,Organism	bone metastases,74,89,Cancer	"[{""token"": ""bisphosphonates"", ""start_span"": 34, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 53, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""bone metastases"", ""start_span"": 74, ""end_span"": 89, ""type"": ""Cancer""}]"	test
BACKGROUND: Diabetic patients have been reported to have impaired coronary collateral vessel growth, although they have excessive neovascularization in the retina.	patients,21,29,Organism	coronary collateral vessel,66,92,Multi	retina,156,162,Multi	"[{""token"": ""patients"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""coronary collateral vessel"", ""start_span"": 66, ""end_span"": 92, ""type"": ""Multi""}, {""token"": ""retina"", ""start_span"": 156, ""end_span"": 162, ""type"": ""Multi""}]"	test
HYPOTHESIS: This study was designed to compare coronary collateral circulation ( CCC) in patients with proliferative diabetic retinopathy ( PDR) with that in patients without DR.	coronary collateral,47,66,Multi	patients,89,97,Organism	patients,158,166,Organism	"[{""token"": ""coronary collateral"", ""start_span"": 47, ""end_span"": 66, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 158, ""end_span"": 166, ""type"": ""Organism""}]"	test
Serum vascular endothelial growth factor ( VEGF) levels were measured using the enzyme - linked immunosorbent assay ( ELISA) kit.	Serum,0,5,Organism_substance	vascular endothelial growth factor,6,40,Gene_or_gene_product	VEGF,43,47,Gene_or_gene_product	"[{""token"": ""Serum"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism_substance""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 6, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}]"	test
CONCLUSIONS: We have shown that patients with PDR have a lower coronary collateral score than patients without DR.	patients,32,40,Organism	coronary collateral,63,82,Multi	patients,94,102,Organism	"[{""token"": ""patients"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Organism""}, {""token"": ""coronary collateral"", ""start_span"": 63, ""end_span"": 82, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Organism""}]"	test
Also, serum VEGF was significantly higher in patients with PDR than in those without DR.	serum,6,11,Organism_substance	VEGF,12,16,Gene_or_gene_product	patients,45,53,Organism	"[{""token"": ""serum"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Organism""}]"	test
Conditioned media obtained from distinct tumour types with unique patterns of metastatic spread redirected fibronectin expression and cluster formation, thereby transforming the metastatic profile.	tumour,41,47,Cancer	fibronectin,107,118,Gene_or_gene_product	cluster,134,141,Cell	"[{""token"": ""tumour"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Cancer""}, {""token"": ""fibronectin"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""cluster"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Cell""}]"	test
The Kaposi ' s sarcoma - associated herpesvirus G protein - coupled receptor as a therapeutic target for the treatment of Kaposi ' s sarcoma.	Kaposi ' s sarcoma - associated herpesvirus,4,47,Organism	G protein - coupled receptor,48,76,Gene_or_gene_product	Kaposi ' s sarcoma,122,140,Cancer	"[{""token"": ""Kaposi ' s sarcoma - associated herpesvirus"", ""start_span"": 4, ""end_span"": 47, ""type"": ""Organism""}, {""token"": ""G protein - coupled receptor"", ""start_span"": 48, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""Kaposi ' s sarcoma"", ""start_span"": 122, ""end_span"": 140, ""type"": ""Cancer""}]"	test
Moreover, we observed an increase in apoptosis of latent gene - expressing cells after the pharmacologic deletion of the vGPCR - expressing cells.	cells,75,80,Cell	vGPCR,121,126,Gene_or_gene_product	cells,140,145,Cell	"[{""token"": ""cells"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""vGPCR"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Cell""}]"	test
Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases.	pericyte,14,22,Cell	tumour,38,44,Cancer	metalloproteinases,74,92,Gene_or_gene_product	"[{""token"": ""pericyte"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""tumour"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""metalloproteinases"", ""start_span"": 74, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}]"	test
Pericytes occur in tumour blood vessels and are critical for the development of a functional vascular network.	Pericytes,0,9,Cell	tumour blood vessels,19,39,Multi	vascular network,93,109,Anatomical_system	"[{""token"": ""Pericytes"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Cell""}, {""token"": ""tumour blood vessels"", ""start_span"": 19, ""end_span"": 39, ""type"": ""Multi""}, {""token"": ""vascular network"", ""start_span"": 93, ""end_span"": 109, ""type"": ""Anatomical_system""}]"	test
Transforming growth factor - beta1 enhances tumour vascularization and microvessel maturation.	Transforming growth factor - beta1,0,34,Gene_or_gene_product	tumour,44,50,Cancer	microvessel,71,82,Tissue	"[{""token"": ""Transforming growth factor - beta1"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Cancer""}, {""token"": ""microvessel"", ""start_span"": 71, ""end_span"": 82, ""type"": ""Tissue""}]"	test
Sensitization to gimatecan - induced apoptosis by tumor necrosis factor - related apoptosis inducing ligand in prostate carcinoma cells.	gimatecan,17,26,Chemical	tumor necrosis factor - related apoptosis inducing ligand,50,107,Gene_or_gene_product	prostate carcinoma cells,111,135,Cell	"[{""token"": ""gimatecan"", ""start_span"": 17, ""end_span"": 26, ""type"": ""Chemical""}, {""token"": ""tumor necrosis factor - related apoptosis inducing ligand"", ""start_span"": 50, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate carcinoma cells"", ""start_span"": 111, ""end_span"": 135, ""type"": ""Cell""}]"	test
Potentiation of camptothecin - induced apoptosis by TRAIL appears dependent on cooperation between extrinsic and intrinsic pathways, as documented by loss of the sensitization to apoptosis following reduction of caspase 8 after small interfering RNA transfection.	camptothecin,16,28,Chemical	TRAIL,52,57,Gene_or_gene_product	caspase 8,212,221,Gene_or_gene_product	"[{""token"": ""camptothecin"", ""start_span"": 16, ""end_span"": 28, ""type"": ""Chemical""}, {""token"": ""TRAIL"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase 8"", ""start_span"": 212, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}]"	test
c - Met expression is regulated by Mitf in the melanocyte lineage.	c - Met,0,7,Gene_or_gene_product	Mitf,35,39,Gene_or_gene_product	melanocyte lineage,47,65,Cell	"[{""token"": ""c - Met"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mitf"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanocyte lineage"", ""start_span"": 47, ""end_span"": 65, ""type"": ""Cell""}]"	test
Here, HGF stimulation of melanocytes was seen to up - regulate c - Met expression.	HGF,6,9,Gene_or_gene_product	melanocytes,25,36,Cell	c - Met,63,70,Gene_or_gene_product	"[{""token"": ""HGF"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanocytes"", ""start_span"": 25, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""c - Met"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}]"	test
In an effort to decipher the mechanism by which HGF up - regulates its receptor, we found that c - Met is a direct transcriptional target of Mitf.	HGF,48,51,Gene_or_gene_product	c - Met,95,102,Gene_or_gene_product	Mitf,141,145,Gene_or_gene_product	"[{""token"": ""HGF"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Met"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mitf"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}]"	test
Previous studies have shown that activation of the signal transducer and activator of transcription 5 ( STAT5) plays an essential role in leukemogenesis mediated through constitutive activated protein tyrosine kinases ( PTK).	signal transducer and activator of transcription 5,51,101,Gene_or_gene_product	STAT5,104,109,Gene_or_gene_product	tyrosine,201,209,Amino_acid	"[{""token"": ""signal transducer and activator of transcription 5"", ""start_span"": 51, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT5"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 201, ""end_span"": 209, ""type"": ""Amino_acid""}]"	test
Our observations indicate that combined inactivation of PIM - 1 and PIM - 2 interferes with oncogenic PTKs and suggest that PIMs are alternative therapeutic targets in PTK - mediated leukemia.	PIM - 1,56,63,Gene_or_gene_product	PIM - 2,68,75,Gene_or_gene_product	leukemia,183,191,Cancer	"[{""token"": ""PIM - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 2"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukemia"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Cancer""}]"	test
This ectopic ATP synthase catalyzes ATP synthesis and is inhibited by angiostatin over a wide pH range.	ATP synthase,13,25,Gene_or_gene_product	ATP,36,39,Chemical	angiostatin,70,81,Gene_or_gene_product	"[{""token"": ""ATP synthase"", ""start_span"": 13, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATP"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Chemical""}, {""token"": ""angiostatin"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}]"	test
Although angiostatin administered intravenously is cleared from the circulation in a matter of minutes, angiostatin - mimetics that are more stable have potential for clinical application.	angiostatin,9,20,Gene_or_gene_product	intravenously,34,47,Immaterial_anatomical_entity	angiostatin - mimetics,104,126,Chemical	"[{""token"": ""angiostatin"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""intravenously"", ""start_span"": 34, ""end_span"": 47, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""angiostatin - mimetics"", ""start_span"": 104, ""end_span"": 126, ""type"": ""Chemical""}]"	test
We previously reported the cloning and characterization of a HBV insert from a Chinese HCC.	HBV,61,64,Organism	Chinese,79,86,Organism	HCC,87,90,Cancer	"[{""token"": ""HBV"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Organism""}, {""token"": ""Chinese"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Organism""}, {""token"": ""HCC"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Cancer""}]"	test
The viral insert mapped to chromosome 17p11. 2 - 12, and cellular sequences were duplicated at the site of viral integration.	viral,4,9,Organism	cellular,57,65,Cell	viral,107,112,Organism	"[{""token"": ""viral"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""viral"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Organism""}]"	test
As the p53 gene is known to possess tumor suppressor activity, the functional loss of this gene may be a significant step in the development of a subset of HCCs.	p53,7,10,Gene_or_gene_product	tumor,36,41,Cancer	HCCs,156,160,Cancer	"[{""token"": ""p53"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""HCCs"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Cancer""}]"	test
Here we show that angiogenesis is severely impaired in PSMA - null animals and that this angiogenic defect occurs at the level of endothelial cell invasion through the extracellular matrix barrier.	PSMA,55,59,Gene_or_gene_product	endothelial cell,130,146,Cell	extracellular matrix barrier,168,196,Cellular_component	"[{""token"": ""PSMA"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 130, ""end_span"": 146, ""type"": ""Cell""}, {""token"": ""extracellular matrix barrier"", ""start_span"": 168, ""end_span"": 196, ""type"": ""Cellular_component""}]"	test
Interestingly, the neutralization of beta ( 1) or the inactivation of PAK increases PSMA activity, suggesting that they negatively regulate PSMA.	PAK,70,73,Gene_or_gene_product	PSMA,84,88,Gene_or_gene_product	PSMA,140,144,Gene_or_gene_product	"[{""token"": ""PAK"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"	test
Therefore, we have identified a novel role for PSMA as a true molecular interface, integrating both extracellular and intracellular signals during angiogenesis.	PSMA,47,51,Gene_or_gene_product	extracellular,100,113,Immaterial_anatomical_entity	intracellular,118,131,Immaterial_anatomical_entity	"[{""token"": ""PSMA"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular"", ""start_span"": 100, ""end_span"": 113, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""intracellular"", ""start_span"": 118, ""end_span"": 131, ""type"": ""Immaterial_anatomical_entity""}]"	test
The bFGF loaded PLGA - heparin microspheres were tested for in vitro release and in vivo angiogenic activity.	bFGF,4,8,Gene_or_gene_product	PLGA,16,20,Chemical	heparin,23,30,Chemical	"[{""token"": ""bFGF"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLGA"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Chemical""}, {""token"": ""heparin"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Chemical""}]"	test
CONCLUSIONS: PLGA microspheres with an open porous structure allowed significant amount of heparin immobilization and bFGF loading.	PLGA,13,17,Chemical	heparin,91,98,Chemical	bFGF,118,122,Gene_or_gene_product	"[{""token"": ""PLGA"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""heparin"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Chemical""}, {""token"": ""bFGF"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"	test
C / EBPbeta is over - expressed in gastric carcinogenesis and is associated with COX - 2 expression.	C / EBPbeta,0,11,Gene_or_gene_product	gastric,35,42,Organ	COX - 2,81,88,Gene_or_gene_product	"[{""token"": ""C / EBPbeta"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Organ""}, {""token"": ""COX - 2"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}]"	test
The CCAAT / enhancer - binding protein beta ( C / EBPbeta) transcription factor has been associated with several cancer models.	CCAAT / enhancer - binding protein beta,4,43,Gene_or_gene_product	C / EBPbeta,46,57,Gene_or_gene_product	cancer,113,119,Cancer	"[{""token"": ""CCAAT / enhancer - binding protein beta"", ""start_span"": 4, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""C / EBPbeta"", ""start_span"": 46, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Cancer""}]"	test
In this study, the expression of C / EBPbeta was analysed in a series of 90 gastric carcinomas ( GCs).	C / EBPbeta,33,44,Gene_or_gene_product	gastric carcinomas,76,94,Cancer	GCs,97,100,Cancer	"[{""token"": ""C / EBPbeta"", ""start_span"": 33, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric carcinomas"", ""start_span"": 76, ""end_span"": 94, ""type"": ""Cancer""}, {""token"": ""GCs"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Cancer""}]"	test
We also observed an overlap between C / EBPbeta and COX - 2 expression in GC.	C / EBPbeta,36,47,Gene_or_gene_product	COX - 2,52,59,Gene_or_gene_product	GC,74,76,Cancer	"[{""token"": ""C / EBPbeta"", ""start_span"": 36, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""GC"", ""start_span"": 74, ""end_span"": 76, ""type"": ""Cancer""}]"	test
These results suggest that C / EBPbeta may be a marker of neoplastic transformation and also play an active role in gastric tumourigenesis by regulating COX - 2 expression.	C / EBPbeta,27,38,Gene_or_gene_product	gastric,116,123,Organ	COX - 2,153,160,Gene_or_gene_product	"[{""token"": ""C / EBPbeta"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Organ""}, {""token"": ""COX - 2"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}]"	test
We have found that LPA downregulates tissue inhibitor of metalloproteinases ( TIMPs).	LPA,19,22,Chemical	tissue inhibitor of metalloproteinases,37,75,Gene_or_gene_product	TIMPs,78,83,Gene_or_gene_product	"[{""token"": ""LPA"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""tissue inhibitor of metalloproteinases"", ""start_span"": 37, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMPs"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}]"	test
TIMP2 and TIMP3 play functional role in LPA - induced invasion as negative regulators.	TIMP2,0,5,Gene_or_gene_product	TIMP3,10,15,Gene_or_gene_product	LPA,40,43,Chemical	"[{""token"": ""TIMP2"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMP3"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""LPA"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Chemical""}]"	test
TIMP3 may affect two independent downstream targets, vascular endothelial growth factor receptor and p38 MAPK.	TIMP3,0,5,Gene_or_gene_product	vascular endothelial growth factor receptor,53,96,Gene_or_gene_product	p38 MAPK,101,109,Gene_or_gene_product	"[{""token"": ""TIMP3"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor receptor"", ""start_span"": 53, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38 MAPK"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"	test
The extracellular matrix ( ECM) directs all phases of healing following trauma or disease and is therefore a natural source of prosthetic mesh material that can be used strategically to induce the repair and restoration of soft tissues following surgery.	extracellular matrix,4,24,Cellular_component	ECM,27,30,Cellular_component	soft tissues,223,235,Tissue	"[{""token"": ""extracellular matrix"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Cellular_component""}, {""token"": ""ECM"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Cellular_component""}, {""token"": ""soft tissues"", ""start_span"": 223, ""end_span"": 235, ""type"": ""Tissue""}]"	test
The 3 - D organization of these extracellular components distinguishes the Surgisis mesh from synthetic materials and is associated with constructive tissue remodelling instead of scar tissue.	extracellular components,32,56,Cellular_component	tissue,150,156,Tissue	scar tissue,180,191,Tissue	"[{""token"": ""extracellular components"", ""start_span"": 32, ""end_span"": 56, ""type"": ""Cellular_component""}, {""token"": ""tissue"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Tissue""}, {""token"": ""scar tissue"", ""start_span"": 180, ""end_span"": 191, ""type"": ""Tissue""}]"	test
The average IMVD in positive and negative cervical lymphatic metastasis was ( 26. 33 + / - 9. 70) and ( 17. 68 + / - 6. 06) respectively, and the IMVD with positive lymphatic metastasis tumors was statistical significantly higher than those with negative cervical lymphatic metastasis tumors ( P less than 0. 01).	cervical lymphatic,42,60,Multi	lymphatic metastasis tumors,165,192,Cancer	cervical lymphatic metastasis tumors,255,291,Cancer	"[{""token"": ""cervical lymphatic"", ""start_span"": 42, ""end_span"": 60, ""type"": ""Multi""}, {""token"": ""lymphatic metastasis tumors"", ""start_span"": 165, ""end_span"": 192, ""type"": ""Cancer""}, {""token"": ""cervical lymphatic metastasis tumors"", ""start_span"": 255, ""end_span"": 291, ""type"": ""Cancer""}]"	test
VEGF might be an important angiogenic factor, and could promote tumor angiogenesis in LSCC.	VEGF,0,4,Gene_or_gene_product	tumor,64,69,Cancer	LSCC,86,90,Cancer	"[{""token"": ""VEGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""LSCC"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Cancer""}]"	test
Tumor angiogenesis might contribute to tumor malignant progression by inhibiting spontaneous apoptosis in LSCC.	Tumor,0,5,Cancer	tumor,39,44,Cancer	LSCC,106,110,Cancer	"[{""token"": ""Tumor"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""LSCC"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Cancer""}]"	test
"In such cancers, glycolysis may contribute nearly half the ATP even in the presence of oxygen ( "" Warburg effect "")."	cancers,8,15,Cancer	ATP,59,62,Chemical	oxygen,87,93,Chemical	"[{""token"": ""cancers"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Cancer""}, {""token"": ""ATP"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""oxygen"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Chemical""}]"	test
Microvascular corrosion casts of caruncles from non - pregnant and pregnant doe goats at 4, 7, 10, 13, 16, and 18 weeks were examined with scanning electron microscopy.	Microvascular,0,13,Tissue	caruncles,33,42,Organism_subdivision	goats,80,85,Organism	"[{""token"": ""Microvascular"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Tissue""}, {""token"": ""caruncles"", ""start_span"": 33, ""end_span"": 42, ""type"": ""Organism_subdivision""}, {""token"": ""goats"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism""}]"	test
The internal convex surface of the caruncles of non - pregnant does was covered with capillary meshes of regular diameter and form, without crypts.	caruncles,35,44,Organism_subdivision	does,63,67,Organism	capillary meshes,85,101,Multi	"[{""token"": ""caruncles"", ""start_span"": 35, ""end_span"": 44, ""type"": ""Organism_subdivision""}, {""token"": ""does"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""capillary meshes"", ""start_span"": 85, ""end_span"": 101, ""type"": ""Multi""}]"	test
At later stages, branches of radial arteries penetrated the periphery forming an extensive mesh of capillaries on the concave surface.	branches,17,25,Multi	radial arteries,29,44,Multi	capillaries,99,110,Tissue	"[{""token"": ""branches"", ""start_span"": 17, ""end_span"": 25, ""type"": ""Multi""}, {""token"": ""radial arteries"", ""start_span"": 29, ""end_span"": 44, ""type"": ""Multi""}, {""token"": ""capillaries"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Tissue""}]"	test
Clear cell renal cell carcinoma ( CC - RCC) is a highly vascularised tumour and is therefore an attractive disease to study angiogenesis and to test novel angiogenesis inhibitors in early clinical development.	Clear cell renal cell carcinoma,0,31,Cancer	CC - RCC,34,42,Cancer	tumour,69,75,Cancer	"[{""token"": ""Clear cell renal cell carcinoma"", ""start_span"": 0, ""end_span"": 31, ""type"": ""Cancer""}, {""token"": ""CC - RCC"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Cancer""}, {""token"": ""tumour"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Cancer""}]"	test
The aim of this study was to compare angiogenesis parameters in low nuclear grade ( n = 87) vs high nuclear grade CC - RCC ( n = 63).	nuclear,68,75,Cellular_component	nuclear,100,107,Cellular_component	CC - RCC,114,122,Cancer	"[{""token"": ""nuclear"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Cellular_component""}, {""token"": ""nuclear"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Cellular_component""}, {""token"": ""CC - RCC"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Cancer""}]"	test
Our results suggest heterogeneity in angiogenic activity and vessel maturation of CC - RCC, to a large extent linked to nuclear grade, and, with probable therapeutic implications.	vessel,61,67,Multi	CC - RCC,82,90,Cancer	nuclear,120,127,Cellular_component	"[{""token"": ""vessel"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Multi""}, {""token"": ""CC - RCC"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Cancer""}, {""token"": ""nuclear"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Cellular_component""}]"	test
Transformation of mammary epithelial cells ( MECs) from the normal to the neoplastic stage requires the dysregulation of tumor suppressor genes and proto - oncogenes.	mammary epithelial cells,18,42,Cell	MECs,45,49,Cell	tumor,121,126,Cancer	"[{""token"": ""mammary epithelial cells"", ""start_span"": 18, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""MECs"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Cancer""}]"	test
Knockdown of either Wisp2 or Igf - 1 using short interfering RNA dramatically inhibited proliferation of Tip30 ( - / -) cells.	Wisp2,20,25,Gene_or_gene_product	Igf - 1,29,36,Gene_or_gene_product	Tip30,105,110,Gene_or_gene_product	"[{""token"": ""Wisp2"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Igf - 1"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tip30"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}]"	test
Here we review the recent evidence of a simple genetic mechanism by which tumor suppressor p53 regulates mitochondrial respiration with secondary changes in glycolysis that are reminiscent of the Warburg effect.	tumor,74,79,Cancer	p53,91,94,Gene_or_gene_product	mitochondrial,105,118,Cellular_component	"[{""token"": ""tumor"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Cellular_component""}]"	test
These fundamental discoveries led to additional research conducted by Napoleone Ferrara and his laboratory, confirming the cloning of VPF and renaming the protein vascular endothelial growth factor ( VEGF).	VPF,134,137,Gene_or_gene_product	vascular endothelial growth factor,163,197,Gene_or_gene_product	VEGF,200,204,Gene_or_gene_product	"[{""token"": ""VPF"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 163, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}]"	test
In 1986, Dvorak proposed that by secreting VPF, tumors induce angiogenesis by turning on the wound healing response.	VPF,43,46,Gene_or_gene_product	tumors,48,54,Cancer	wound,93,98,Pathological_formation	"[{""token"": ""VPF"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 48, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""wound"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Pathological_formation""}]"	test
This work is again extremely significant for patients worldwide, as Dvorak ' s scientific research is leading his colleagues all over the world to examine how to treat a tumor through its blood supply.	patients,45,53,Organism	tumor,170,175,Cancer	blood,188,193,Organism_substance	"[{""token"": ""patients"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Cancer""}, {""token"": ""blood"", ""start_span"": 188, ""end_span"": 193, ""type"": ""Organism_substance""}]"	test
Together, we proposed that MOG alone or administered with other anticancer agents may provide a novel therapeutic strategy for leukemia.	MOG,27,30,Chemical	anticancer,64,74,Cancer	leukemia,127,135,Cancer	"[{""token"": ""MOG"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Chemical""}, {""token"": ""anticancer"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""leukemia"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Cancer""}]"	test
Hedgehog signaling in the murine melanoma microenvironment.	Hedgehog,0,8,Gene_or_gene_product	murine,26,32,Organism	melanoma,33,41,Cancer	"[{""token"": ""Hedgehog"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Organism""}, {""token"": ""melanoma"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Cancer""}]"	test
The Hedgehog pathway antagonist cyclopamine effectively reduced Shh - induced proliferation to control levels.	Hedgehog,4,12,Gene_or_gene_product	cyclopamine,32,43,Chemical	Shh,64,67,Gene_or_gene_product	"[{""token"": ""Hedgehog"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclopamine"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""Shh"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}]"	test
To study Hedgehog signaling in vivo a hind limb tumor model with the B16F0 cell line was used.	Hedgehog,9,17,Gene_or_gene_product	hind limb tumor,38,53,Cancer	B16F0 cell line,69,84,Cell	"[{""token"": ""Hedgehog"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""hind limb tumor"", ""start_span"": 38, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""B16F0 cell line"", ""start_span"": 69, ""end_span"": 84, ""type"": ""Cell""}]"	test
To study tumor related angiogenesis a vascular window model was used to monitor tumor vascularity.	tumor,9,14,Cancer	vascular,38,46,Multi	tumor,80,85,Cancer	"[{""token"": ""tumor"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Cancer""}, {""token"": ""vascular"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Cancer""}]"	test
Treatment with cyclopamine significantly attenuated vascular formation by a factor of 2. 5 ( P less than 0. 001) and altered vascular morphology.	cyclopamine,15,26,Chemical	vascular,52,60,Multi	vascular,125,133,Multi	"[{""token"": ""cyclopamine"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Chemical""}, {""token"": ""vascular"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Multi""}, {""token"": ""vascular"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Multi""}]"	test
These studies suggest that Hedgehog signaling regulates melanoma related vascular formation and function.	Hedgehog,27,35,Gene_or_gene_product	melanoma,56,64,Cancer	vascular,73,81,Multi	"[{""token"": ""Hedgehog"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Cancer""}, {""token"": ""vascular"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Multi""}]"	test
We also compared the presence of EGFR and TGF - alpha and Ki - 67 index with clinical data.	EGFR,33,37,Gene_or_gene_product	TGF - alpha,42,53,Gene_or_gene_product	Ki - 67,58,65,Gene_or_gene_product	"[{""token"": ""EGFR"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - alpha"", ""start_span"": 42, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ki - 67"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}]"	test
CX3CR1 - dependent subretinal microglia cell accumulation is associated with cardinal features of age - related macular degeneration.	CX3CR1,0,6,Gene_or_gene_product	subretinal microglia cell,19,44,Cell	macular,112,119,Tissue	"[{""token"": ""CX3CR1"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""subretinal microglia cell"", ""start_span"": 19, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""macular"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Tissue""}]"	test
The role of retinal microglial cells ( MCs) in age - related macular degeneration ( AMD) is unclear.	retinal microglial cells,12,36,Cell	MCs,39,42,Cell	macular,61,68,Tissue	"[{""token"": ""retinal microglial cells"", ""start_span"": 12, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""MCs"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""macular"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Tissue""}]"	test
Male double Smad1 Smad5 conditional knockout mice are fertile but demonstrate metastatic testicular tumor development.	Smad1,12,17,Gene_or_gene_product	Smad5,18,23,Gene_or_gene_product	testicular tumor,89,105,Cancer	"[{""token"": ""Smad1"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad5"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""testicular tumor"", ""start_span"": 89, ""end_span"": 105, ""type"": ""Cancer""}]"	test
These data strongly implicate the BR - SMADs as part of a critical developmental pathway in ovaries and testis that, when disrupted, leads to malignant transformation.	BR - SMADs,34,44,Gene_or_gene_product	ovaries,92,99,Organ	testis,104,110,Organ	"[{""token"": ""BR - SMADs"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovaries"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Organ""}, {""token"": ""testis"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Organ""}]"	test
[ Clinical significance of interleukin - 6 ( IL - 6) as a prognostic factor of cancer disease]	interleukin - 6,27,42,Gene_or_gene_product	IL - 6,45,51,Gene_or_gene_product	cancer,79,85,Cancer	"[{""token"": ""interleukin - 6"", ""start_span"": 27, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Cancer""}]"	test
Interleukin - 6 has been shown to be associated with tumor progression including inhibition of cancer cells apoptosis and stimulation of angiogenesis.	Interleukin - 6,0,15,Gene_or_gene_product	tumor,53,58,Cancer	cancer cells,95,107,Cell	"[{""token"": ""Interleukin - 6"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Cancer""}, {""token"": ""cancer cells"", ""start_span"": 95, ""end_span"": 107, ""type"": ""Cell""}]"	test
Thus, we show that deregulation of CDK expression in the primitive oral epithelium plays a unique function, providing a selective advantage that gives rise to transgene - positive TA - like pituitary cells.	CDK,35,38,Gene_or_gene_product	primitive oral epithelium,57,82,Tissue	transgene - positive TA - like pituitary cells,159,205,Cell	"[{""token"": ""CDK"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""primitive oral epithelium"", ""start_span"": 57, ""end_span"": 82, ""type"": ""Tissue""}, {""token"": ""transgene - positive TA - like pituitary cells"", ""start_span"": 159, ""end_span"": 205, ""type"": ""Cell""}]"	test
This model suggests that forced expression of CDK4 sensitizes cells and synergizes with a second change resulting in tumor development.	CDK4,46,50,Gene_or_gene_product	cells,62,67,Cell	tumor,117,122,Cancer	"[{""token"": ""CDK4"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Cancer""}]"	test
It has been suggested that the expression of this protein may be of prognostic significance in gastric, colorectal, and bladder carcinomas.	gastric,95,102,Cancer	colorectal,104,114,Cancer	bladder carcinomas,120,138,Cancer	"[{""token"": ""gastric"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Cancer""}, {""token"": ""colorectal"", ""start_span"": 104, ""end_span"": 114, ""type"": ""Cancer""}, {""token"": ""bladder carcinomas"", ""start_span"": 120, ""end_span"": 138, ""type"": ""Cancer""}]"	test
CONCLUSION: The majority ( 81%) of breast carcinomas show survivin expression which correlates with bcl - x, another antiapoptotic marker, and both markers tend to correlate with prognosis.	breast carcinomas,35,52,Cancer	survivin,58,66,Gene_or_gene_product	bcl - x,100,107,Gene_or_gene_product	"[{""token"": ""breast carcinomas"", ""start_span"": 35, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""survivin"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - x"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}]"	test
Functional significance of VEGF - a in human ovarian carcinoma: role in vasculogenic mimicry.	VEGF - a,27,35,Gene_or_gene_product	human,39,44,Organism	ovarian carcinoma,45,62,Cancer	"[{""token"": ""VEGF - a"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Organism""}, {""token"": ""ovarian carcinoma"", ""start_span"": 45, ""end_span"": 62, ""type"": ""Cancer""}]"	test
Ovarian cancer is a silent killer, and shows early extensive tumor invasion and peritoneal metastasis.	Ovarian cancer,0,14,Cancer	tumor,61,66,Cancer	peritoneal,80,90,Multi	"[{""token"": ""Ovarian cancer"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Cancer""}, {""token"": ""peritoneal"", ""start_span"": 80, ""end_span"": 90, ""type"": ""Multi""}]"	test
Our studies highlight the plasticity of aggressive human ovarian carcinoma cells and call into question the underlying significance of their ability to form VM in vitro induced by VEGF - a.	human,51,56,Organism	ovarian carcinoma cells,57,80,Cell	VEGF - a,180,188,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""ovarian carcinoma cells"", ""start_span"": 57, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""VEGF - a"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}]"	test
In contrast, ectopic TSP - 1 expression in SiHa cells has little effect on the invasive ability of the NIH3T3 cells.	TSP - 1,21,28,Gene_or_gene_product	SiHa cells,43,53,Cell	NIH3T3 cells,103,115,Cell	"[{""token"": ""TSP - 1"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""SiHa cells"", ""start_span"": 43, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""NIH3T3 cells"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Cell""}]"	test
Targeting a tumor - specific laminin domain critical for human carcinogenesis.	tumor,12,17,Cancer	laminin,29,36,Gene_or_gene_product	human,57,62,Organism	"[{""token"": ""tumor"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Cancer""}, {""token"": ""laminin"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Organism""}]"	test
Primary human keratinocytes lacking G45 ( DeltaG45) showed alterations of basal receptor organization, impaired matrix deposition, and increased migration.	human,8,13,Organism	G45,36,39,Gene_or_gene_product	DeltaG45,42,50,Cell	"[{""token"": ""human"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""G45"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""DeltaG45"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Cell""}]"	test
Expression of G45 or activated PI3K subunit in DeltaG45 cells reversed these abnormalities.	G45,14,17,Gene_or_gene_product	PI3K,31,35,Gene_or_gene_product	DeltaG45,47,55,Gene_or_gene_product	"[{""token"": ""G45"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""DeltaG45"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}]"	test
However, the role of IL - 8 in non - Hodgkin ' s lymphoma ( NHL) has not been fully determined.	IL - 8,21,27,Gene_or_gene_product	non - Hodgkin ' s lymphoma,31,57,Cancer	NHL,60,63,Cancer	"[{""token"": ""IL - 8"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""non - Hodgkin ' s lymphoma"", ""start_span"": 31, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""NHL"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Cancer""}]"	test
We developed reference intervals for serum and urine IL - 8 level in 131 control individuals.	serum,37,42,Organism_substance	urine,47,52,Organism_substance	IL - 8,53,59,Gene_or_gene_product	"[{""token"": ""serum"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Organism_substance""}, {""token"": ""urine"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}]"	test
Nitric oxide ( NO) plays an important role in maintaining vascular homeostasis.	Nitric oxide,0,12,Chemical	NO,15,17,Chemical	vascular,58,66,Multi	"[{""token"": ""Nitric oxide"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""NO"", ""start_span"": 15, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""vascular"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Multi""}]"	test
In EC109 cells, growth arrest was by induction of apoptosis, associated with downregulation of Bcl - 2, but not Bax.	EC109 cells,3,14,Cell	Bcl - 2,95,102,Gene_or_gene_product	Bax,112,115,Gene_or_gene_product	"[{""token"": ""EC109 cells"", ""start_span"": 3, ""end_span"": 14, ""type"": ""Cell""}, {""token"": ""Bcl - 2"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}]"	test
Cyclooxygenase - 2 inhibitor may be a promising therapeutic agent for human esophageal squamous cell carcinoma.	Cyclooxygenase - 2,0,18,Gene_or_gene_product	human,70,75,Organism	esophageal squamous cell carcinoma,76,110,Cancer	"[{""token"": ""Cyclooxygenase - 2"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Organism""}, {""token"": ""esophageal squamous cell carcinoma"", ""start_span"": 76, ""end_span"": 110, ""type"": ""Cancer""}]"	test
Here, we show that gene transfer - induced p75 ( NTR) expression impairs the survival, proliferation, migration, and adhesion capacities of cultured ECs and endothelial progenitor cells ( EPCs) and inhibits angiogenesis in vitro.	ECs,149,152,Cell	endothelial progenitor cells,157,185,Cell	EPCs,188,192,Cell	"[{""token"": ""ECs"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Cell""}, {""token"": ""endothelial progenitor cells"", ""start_span"": 157, ""end_span"": 185, ""type"": ""Cell""}, {""token"": ""EPCs"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Cell""}]"	test
Tumor endothelial cell targeted cyclic RGD - modified heparin derivative: inhibition of angiogenesis and tumor growth.	Tumor endothelial cell,0,22,Cell	cyclic RGD - modified heparin derivative,32,72,Chemical	tumor,105,110,Cancer	"[{""token"": ""Tumor endothelial cell"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""cyclic RGD - modified heparin derivative"", ""start_span"": 32, ""end_span"": 72, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Cancer""}]"	test
Compared to cRGDyK and HL, cRGD - HL has high binding affinity to purified alpha ( v) beta ( 3) integrin.	cRGDyK,12,18,Chemical	HL,23,25,Chemical	cRGD - HL,27,36,Chemical	"[{""token"": ""cRGDyK"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""HL"", ""start_span"": 23, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""cRGD - HL"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Chemical""}]"	test
The enhanced antiangiogenic effect of cRGD - HL was confirmed in Matrigel assay by showing the significant inhibition of bFGF - driven angiogenesis and blood vessel formation.	cRGD - HL,38,47,Chemical	bFGF,121,125,Gene_or_gene_product	blood vessel,152,164,Multi	"[{""token"": ""cRGD - HL"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Chemical""}, {""token"": ""bFGF"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessel"", ""start_span"": 152, ""end_span"": 164, ""type"": ""Multi""}]"	test
It was thought that potent antiangiogenic effect of cRGD - HL was probably due to the interference of alpha ( v) beta ( 3) - mediated interaction, resulting in the enhanced antitumoral activity against SCC7 tumor.	cRGD - HL,52,61,Chemical	antitumoral,173,184,Cancer	SCC7 tumor,202,212,Cancer	"[{""token"": ""cRGD - HL"", ""start_span"": 52, ""end_span"": 61, ""type"": ""Chemical""}, {""token"": ""antitumoral"", ""start_span"": 173, ""end_span"": 184, ""type"": ""Cancer""}, {""token"": ""SCC7 tumor"", ""start_span"": 202, ""end_span"": 212, ""type"": ""Cancer""}]"	test
CONCLUSION: These results demonstrated that cRGD - modified heparin derivative enhanced anti - angiotherapeutic effects against solid tumor, and therefore, it could be applied to treat various cancers and angiogenic diseases as a potent angiogenesis inhibitor.	cRGD - modified heparin derivative,44,78,Chemical	solid tumor,128,139,Cancer	cancers,193,200,Cancer	"[{""token"": ""cRGD - modified heparin derivative"", ""start_span"": 44, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""solid tumor"", ""start_span"": 128, ""end_span"": 139, ""type"": ""Cancer""}, {""token"": ""cancers"", ""start_span"": 193, ""end_span"": 200, ""type"": ""Cancer""}]"	test
METHODS: Transplant tumor model was induced by subcutaneous inoculation of 2 x 10 ( 6) Lewis lung cancer ( LLC) cells into the back of C57BL / 6 mice.	Transplant tumor,9,25,Cancer	back,127,131,Organism_subdivision	C57BL / 6 mice,135,149,Organism	"[{""token"": ""Transplant tumor"", ""start_span"": 9, ""end_span"": 25, ""type"": ""Cancer""}, {""token"": ""back"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Organism_subdivision""}, {""token"": ""C57BL / 6 mice"", ""start_span"": 135, ""end_span"": 149, ""type"": ""Organism""}]"	test
The mice were treated by intratumoral injection of 2 x 10 ( 9) pfu Ad - mEndostatin.	mice,4,8,Organism	intratumoral,25,37,Cancer	Ad - mEndostatin,67,83,Gene_or_gene_product	"[{""token"": ""mice"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""intratumoral"", ""start_span"": 25, ""end_span"": 37, ""type"": ""Cancer""}, {""token"": ""Ad - mEndostatin"", ""start_span"": 67, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}]"	test
Serum endostatin concentration was 1540 + / - 560 ng / ml at the second week of administration, the expression of endostatin diminished a month later.	Serum,0,5,Organism_substance	endostatin,6,16,Gene_or_gene_product	endostatin,114,124,Gene_or_gene_product	"[{""token"": ""Serum"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism_substance""}, {""token"": ""endostatin"", ""start_span"": 6, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""endostatin"", ""start_span"": 114, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}]"	test
The microvessel density ( MVD)) decreased from 42. 4 + / - 4. 8 to 10. 5 + / - 3. 2 per x 200 magnificetion microscopic field by CD10 staining and from 68. 5 + / - 4. 5 to 37. 5 + / - 4. 6 by CD31 staining, respectively ( P less than 0. 05).	microvessel,4,15,Tissue	CD10,129,133,Gene_or_gene_product	CD31,192,196,Gene_or_gene_product	"[{""token"": ""microvessel"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Tissue""}, {""token"": ""CD10"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD31"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}]"	test
CONCLUSION: Endostatin gene therapy mediated by adenoviral vector efficiently induces expression of endostatin in vivo, and inhibits the growth and metastasis of tumor.	Endostatin,12,22,Gene_or_gene_product	endostatin,100,110,Gene_or_gene_product	tumor,162,167,Cancer	"[{""token"": ""Endostatin"", ""start_span"": 12, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""endostatin"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Cancer""}]"	test
For verifying apoptosis, both DNA Fragmentation by ELISA assay and caspase 3 / 7 activity measurement were used.	DNA,30,33,Cellular_component	caspase 3,67,76,Gene_or_gene_product	7,79,80,Gene_or_gene_product	"[{""token"": ""DNA"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Cellular_component""}, {""token"": ""caspase 3"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""7"", ""start_span"": 79, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}]"	test
RESULTS: Our results revealed that docetaxel and ATRA were synergistically cytotoxic and apoptotic in DU - 145 cells, in a dose - and time dependent manner.	docetaxel,35,44,Chemical	ATRA,49,53,Chemical	DU - 145 cells,102,116,Cell	"[{""token"": ""docetaxel"", ""start_span"": 35, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""ATRA"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Chemical""}, {""token"": ""DU - 145 cells"", ""start_span"": 102, ""end_span"": 116, ""type"": ""Cell""}]"	test
Perlecan is a ubiquitous pericellular proteoglycan ideally placed to mediate cell signaling events controlling migration, proliferation, and differentiation.	Perlecan,0,8,Gene_or_gene_product	pericellular,25,37,Immaterial_anatomical_entity	cell,77,81,Cell	"[{""token"": ""Perlecan"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""pericellular"", ""start_span"": 25, ""end_span"": 37, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""cell"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Cell""}]"	test
Y705 phosphorylation is conventionally thought to be required for Stat3 signal - dependent activation and seems to play an essential role in some malignancies.	Y705,0,4,Amino_acid	Stat3,66,71,Gene_or_gene_product	malignancies,146,158,Cancer	"[{""token"": ""Y705"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Amino_acid""}, {""token"": ""Stat3"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignancies"", ""start_span"": 146, ""end_span"": 158, ""type"": ""Cancer""}]"	test
Moreover, there is a positive correlation between phosphoS727 - Stat3 expression and Gleason score in these prostate cancer tissues ( P = 0. 05).	phosphoS727,50,61,Amino_acid	Stat3,64,69,Gene_or_gene_product	prostate cancer tissues,108,131,Tissue	"[{""token"": ""phosphoS727"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Amino_acid""}, {""token"": ""Stat3"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate cancer tissues"", ""start_span"": 108, ""end_span"": 131, ""type"": ""Tissue""}]"	test
Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung.	pulmonary,9,18,Organ	tumor cells,72,83,Cell	lung,91,95,Organ	"[{""token"": ""pulmonary"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Organ""}, {""token"": ""tumor cells"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""lung"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Organ""}]"	test
Allergen - induced respiratory inflammation facilitates and / or elicits the extravasation of proinflammatory leukocytes by well - understood mechanisms that mediate the movement of multiple cell types.	respiratory,19,30,Anatomical_system	proinflammatory leukocytes,94,120,Cell	cell,191,195,Cell	"[{""token"": ""respiratory"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Anatomical_system""}, {""token"": ""proinflammatory leukocytes"", ""start_span"": 94, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Cell""}]"	test
Interventional strategies showed that existing therapeutic modalities for asthma, such as inhaled corticosteroids, were sufficient to block the enhanced pulmonary recruitment of cancer cells from circulation.	corticosteroids,98,113,Chemical	pulmonary,153,162,Organ	cancer cells,178,190,Cell	"[{""token"": ""corticosteroids"", ""start_span"": 98, ""end_span"": 113, ""type"": ""Chemical""}, {""token"": ""pulmonary"", ""start_span"": 153, ""end_span"": 162, ""type"": ""Organ""}, {""token"": ""cancer cells"", ""start_span"": 178, ""end_span"": 190, ""type"": ""Cell""}]"	test
Additional mechanistic studies further suggested that the ability of circulating cancer cells to extravasate to surrounding lung tissues was linked to the activation of the vascular endothelium via one or more Galpha ( i) - coupled receptors.	cancer cells,81,93,Cell	lung tissues,124,136,Tissue	vascular endothelium,173,193,Tissue	"[{""token"": ""cancer cells"", ""start_span"": 81, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""lung tissues"", ""start_span"": 124, ""end_span"": 136, ""type"": ""Tissue""}, {""token"": ""vascular endothelium"", ""start_span"": 173, ""end_span"": 193, ""type"": ""Tissue""}]"	test
Interestingly, a survey of a clinical breast cancer surgical database showed that the incidence of asthma was higher among patients with lung metastases.	breast cancer,38,51,Cancer	patients,123,131,Organism	lung metastases,137,152,Cancer	"[{""token"": ""breast cancer"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Organism""}, {""token"": ""lung metastases"", ""start_span"": 137, ""end_span"": 152, ""type"": ""Cancer""}]"	test
In the present study it was found that incubation of HepG2 cells with a low concentration of 3 - BrPA for a short period ( 150 microM for 30 min) significantly affected both glycolysis and mitochondrial respiratory functions.	HepG2 cells,53,64,Cell	3 - BrPA,93,101,Chemical	mitochondrial,189,202,Cellular_component	"[{""token"": ""HepG2 cells"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""3 - BrPA"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 189, ""end_span"": 202, ""type"": ""Cellular_component""}]"	test
RESULTS: Robo1 and Robo4 knockdown cells display distinct activity in endothelial cell migration assay.	Robo1,9,14,Gene_or_gene_product	Robo4,19,24,Gene_or_gene_product	endothelial cell,70,86,Cell	"[{""token"": ""Robo1"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""Robo4"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 70, ""end_span"": 86, ""type"": ""Cell""}]"	test
Transcriptional activity of HIF - 1 ( hypoxia - inducible factor - 1) has been reported to be up - regulated in solid tumors after ionizing radiation; however, the molecular mechanism underlying the response remains to be elucidated.	HIF - 1,28,35,Gene_or_gene_product	hypoxia - inducible factor - 1,38,68,Gene_or_gene_product	solid tumors,112,124,Cancer	"[{""token"": ""HIF - 1"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxia - inducible factor - 1"", ""start_span"": 38, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""solid tumors"", ""start_span"": 112, ""end_span"": 124, ""type"": ""Cancer""}]"	test
The accumulation was inhibited with a nonmetabolizable glucose analog, 2 - deoxy - d - glucose, through the suppression of radiation - induced phosphorylation of Akt in the reoxygenated regions.	glucose,55,62,Chemical	2 - deoxy - d - glucose,71,94,Chemical	Akt,162,165,Gene_or_gene_product	"[{""token"": ""glucose"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""2 - deoxy - d - glucose"", ""start_span"": 71, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""Akt"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}]"	test
In vitro experiments confirmed that an increase in glucose availability induced Akt phosphorylation under reoxygenated conditions and consequently up - regulated HIF - 1alpha translation.	glucose,51,58,Chemical	Akt,80,83,Gene_or_gene_product	HIF - 1alpha,162,174,Gene_or_gene_product	"[{""token"": ""glucose"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""Akt"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 162, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}]"	test
Moreover, both the accelerated translation and the previously reported reactive oxygen species - mediated stabilization of HIF - 1alpha protein were essential to the activation of HIF - 1.	reactive oxygen species,71,94,Chemical	HIF - 1alpha,123,135,Gene_or_gene_product	HIF - 1,180,187,Gene_or_gene_product	"[{""token"": ""reactive oxygen species"", ""start_span"": 71, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""HIF - 1alpha"", ""start_span"": 123, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}]"	test
Estrogen is crucial in breast carcinogenesis and tumor progression.	Estrogen,0,8,Chemical	breast,23,29,Organism_subdivision	tumor,49,54,Cancer	"[{""token"": ""Estrogen"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""breast"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Organism_subdivision""}, {""token"": ""tumor"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Cancer""}]"	test
Whether sex steroids affect IL - 8 secretion of normal breast tissue or breast cancer is not known.	IL - 8,28,34,Gene_or_gene_product	breast tissue,55,68,Tissue	breast cancer,72,85,Cancer	"[{""token"": ""IL - 8"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast tissue"", ""start_span"": 55, ""end_span"": 68, ""type"": ""Tissue""}, {""token"": ""breast cancer"", ""start_span"": 72, ""end_span"": 85, ""type"": ""Cancer""}]"	test
Several cell types in a tissue secrete IL - 8.	cell,8,12,Cell	tissue,24,30,Tissue	IL - 8,39,45,Gene_or_gene_product	"[{""token"": ""cell"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Cell""}, {""token"": ""tissue"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Tissue""}, {""token"": ""IL - 8"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}]"	test
Ex vivo, estradiol exposure increased the IL - 8 secretion of normal whole breast tissue in culture.	estradiol,9,18,Chemical	IL - 8,42,48,Gene_or_gene_product	breast tissue,75,88,Tissue	"[{""token"": ""estradiol"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""IL - 8"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast tissue"", ""start_span"": 75, ""end_span"": 88, ""type"": ""Tissue""}]"	test
We also examined cell proliferation, migration, and anti - apoptotic activity in response to stromal cell - derived factor ( SDF) - 1alpha and evaluated SDF - 1alpha / CXCR4 signaling pathways.	cell,17,21,Cell	SDF - 1alpha,153,165,Gene_or_gene_product	CXCR4,168,173,Gene_or_gene_product	"[{""token"": ""cell"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Cell""}, {""token"": ""SDF - 1alpha"", ""start_span"": 153, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""CXCR4"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"	test
In contrast, KATO III cells expressed membrane CXCR4.	KATO III cells,13,27,Cell	membrane,38,46,Cellular_component	CXCR4,47,52,Gene_or_gene_product	"[{""token"": ""KATO III cells"", ""start_span"": 13, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""membrane"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Cellular_component""}, {""token"": ""CXCR4"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}]"	test
Effect of platelet - rich plasma and fibrin glue on healing of critical - size calvarial bone defects.	platelet - rich plasma,10,32,Organism_substance	fibrin,37,43,Gene_or_gene_product	calvarial bone,79,93,Organ	"[{""token"": ""platelet - rich plasma"", ""start_span"": 10, ""end_span"": 32, ""type"": ""Organism_substance""}, {""token"": ""fibrin"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""calvarial bone"", ""start_span"": 79, ""end_span"": 93, ""type"": ""Organ""}]"	test
Histologic parameters ( primary and secondary bone trabecula, neovascularization, and bone marrow and connective tissue formation) were compared between 4 - and 16 - week groups. More rapid decrease in defect size was observed in groups 3 and 4 than in groups 1 and 2, both in the 4th and 16th weeks.	bone trabecula,46,60,Tissue	bone marrow,86,97,Multi	connective tissue,102,119,Tissue	"[{""token"": ""bone trabecula"", ""start_span"": 46, ""end_span"": 60, ""type"": ""Tissue""}, {""token"": ""bone marrow"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Multi""}, {""token"": ""connective tissue"", ""start_span"": 102, ""end_span"": 119, ""type"": ""Tissue""}]"	test
Collectively, the experiments define the role of Ang - 2 during tumor angiogenesis and establish a better rationale for combination therapies involving Ang - 2 manipulatory therapies.	Ang - 2,49,56,Gene_or_gene_product	tumor,64,69,Cancer	Ang - 2,152,159,Gene_or_gene_product	"[{""token"": ""Ang - 2"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""Ang - 2"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}]"	test
Thus, we identified for the first time that honokiol provided therapeutic benefit not only by direct effects on tumor cells and antiangiogenesis but also by inhibiting lymphangiogenesis and metastasis via the VEGFR - 3 pathway.	honokiol,44,52,Chemical	tumor cells,112,123,Cell	VEGFR - 3,209,218,Gene_or_gene_product	"[{""token"": ""honokiol"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""tumor cells"", ""start_span"": 112, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""VEGFR - 3"", ""start_span"": 209, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}]"	test
The present findings may be of importance to investigate the molecular mechanisms underlying the spread of cancer via the lymphatics and explore the therapeutical strategy of honokiol on antilymphangiogenesis and antimetastasis.	cancer,107,113,Cancer	lymphatics,122,132,Multi	honokiol,175,183,Chemical	"[{""token"": ""cancer"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""lymphatics"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Multi""}, {""token"": ""honokiol"", ""start_span"": 175, ""end_span"": 183, ""type"": ""Chemical""}]"	test
PURPOSE: Pigment epithelial - derived factor ( PEDF) is a potent angiogenesis inhibitor with multiple other functions, some of which enhance tumor growth.	Pigment epithelial - derived factor,9,44,Gene_or_gene_product	PEDF,47,51,Gene_or_gene_product	tumor,141,146,Cancer	"[{""token"": ""Pigment epithelial - derived factor"", ""start_span"": 9, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""PEDF"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Cancer""}]"	test
EXPERIMENTAL DESIGN: We analyzed antigenicity, hydrophilicity, and charge distribution of the angioinhibitory epitope ( the 34 - mer) and designed three peptides covering its COOH terminus, P14, P18, and P23.	P14,190,193,Gene_or_gene_product	P18,195,198,Gene_or_gene_product	P23,204,207,Gene_or_gene_product	"[{""token"": ""P14"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}, {""token"": ""P18"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}, {""token"": ""P23"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Gene_or_gene_product""}]"	test
The selected peptide was tested for the antitumor activity against mildly aggressive xenografted prostate carcinoma and highly aggressive renal cell carcinoma.	antitumor,40,49,Cancer	prostate carcinoma,97,115,Cancer	renal cell carcinoma,138,158,Cancer	"[{""token"": ""antitumor"", ""start_span"": 40, ""end_span"": 49, ""type"": ""Cancer""}, {""token"": ""prostate carcinoma"", ""start_span"": 97, ""end_span"": 115, ""type"": ""Cancer""}, {""token"": ""renal cell carcinoma"", ""start_span"": 138, ""end_span"": 158, ""type"": ""Cancer""}]"	test
P18 showed the highest IC50 and blocked angiogenesis in vivo: P23 was inactive and P14 was proangiogenic.	P18,0,3,Gene_or_gene_product	P23,62,65,Gene_or_gene_product	P14,83,86,Gene_or_gene_product	"[{""token"": ""P18"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""P23"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""P14"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}]"	test
CONCLUSIONS: P18 is a novel and potent antiangiogenic biotherapeutic agent that has potential to be developed for the treatment of prostate and renal cancer.	P18,13,16,Gene_or_gene_product	prostate,131,139,Cancer	renal cancer,144,156,Cancer	"[{""token"": ""P18"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Cancer""}, {""token"": ""renal cancer"", ""start_span"": 144, ""end_span"": 156, ""type"": ""Cancer""}]"	test
Distinct role of PLCbeta3 in VEGF - mediated directional migration and vascular sprouting.	PLCbeta3,17,25,Gene_or_gene_product	VEGF,29,33,Gene_or_gene_product	vascular,71,79,Multi	"[{""token"": ""PLCbeta3"", ""start_span"": 17, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Multi""}]"	test
In addition, the microtubule - destabilizing agents cause prominent changes in endothelial cell morphology, an action associated with rapid vascular collapse in vivo.	microtubule - destabilizing agents,17,51,Chemical	endothelial cell,79,95,Cell	vascular,140,148,Multi	"[{""token"": ""microtubule - destabilizing agents"", ""start_span"": 17, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 79, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""vascular"", ""start_span"": 140, ""end_span"": 148, ""type"": ""Multi""}]"	test
This review will focus on recent studies to define the molecular mechanisms for the antivascular actions of the MBDs, information that could be useful in the identification or design of agents whose actions more selectively target the tumor vasculature.	antivascular,84,96,Multi	MBDs,112,116,Chemical	tumor vasculature,235,252,Multi	"[{""token"": ""antivascular"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Multi""}, {""token"": ""MBDs"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Chemical""}, {""token"": ""tumor vasculature"", ""start_span"": 235, ""end_span"": 252, ""type"": ""Multi""}]"	test
Recent data suggest that activation of the integrin - associated protein CD47 promotes neuronal cell death.	integrin,43,51,Gene_or_gene_product	CD47,73,77,Gene_or_gene_product	neuronal cell,87,100,Cell	"[{""token"": ""integrin"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD47"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal cell"", ""start_span"": 87, ""end_span"": 100, ""type"": ""Cell""}]"	test
Promotion of inflammation was also involved because lower TSP - 1 was able to up - regulate the adhesion molecules intercellular adhesion molecule - 1 and vascular cell adhesion molecule - 1.	TSP - 1,58,65,Gene_or_gene_product	intercellular adhesion molecule - 1,115,150,Gene_or_gene_product	vascular cell adhesion molecule - 1,155,190,Gene_or_gene_product	"[{""token"": ""TSP - 1"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 115, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 155, ""end_span"": 190, ""type"": ""Gene_or_gene_product""}]"	test
Cisplatin reduces endothelial cell migration via regulation of type 2 - matrix metalloproteinase activity.	Cisplatin,0,9,Chemical	endothelial cell,18,34,Cell	type 2 - matrix metalloproteinase,63,96,Gene_or_gene_product	"[{""token"": ""Cisplatin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 18, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""type 2 - matrix metalloproteinase"", ""start_span"": 63, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"	test
AIMS: In this study we investigated the effect of cisplatin on endothelial cell migration, an essential process for vascular remodeling and regeneration in several physiological and pathological situations.	cisplatin,50,59,Chemical	endothelial cell,63,79,Cell	vascular,116,124,Multi	"[{""token"": ""cisplatin"", ""start_span"": 50, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 63, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""vascular"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Multi""}]"	test
MMP2 and MMP9 activity were determined by zymographic assay, and MAPK activation by Western blotting analysis.	MMP2,0,4,Gene_or_gene_product	MMP9,9,13,Gene_or_gene_product	MAPK,65,69,Gene_or_gene_product	"[{""token"": ""MMP2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP9"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}]"	test
Studies, both in human and animal models support the notion that, various angiogenic growth factors and progenitor cells can enhance new blood vessels.	human,17,22,Organism	progenitor cells,104,120,Cell	blood vessels,137,150,Multi	"[{""token"": ""human"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Organism""}, {""token"": ""progenitor cells"", ""start_span"": 104, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""blood vessels"", ""start_span"": 137, ""end_span"": 150, ""type"": ""Multi""}]"	test
Netrin - 1 up - regulation in inflammatory bowel diseases is required for colorectal cancer progression.	Netrin - 1,0,10,Gene_or_gene_product	bowel,43,48,Organ	colorectal cancer,74,91,Cancer	"[{""token"": ""Netrin - 1"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""bowel"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Organ""}, {""token"": ""colorectal cancer"", ""start_span"": 74, ""end_span"": 91, ""type"": ""Cancer""}]"	test
This is particularly true for inflammatory bowel diseases ( IBD), such as ulcerative colitis and Crohn ' s disease, which show a major increased risk for colorectal cancer.	bowel,43,48,Organ	ulcerative colitis,74,92,Pathological_formation	colorectal cancer,154,171,Cancer	"[{""token"": ""bowel"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Organ""}, {""token"": ""ulcerative colitis"", ""start_span"": 74, ""end_span"": 92, ""type"": ""Pathological_formation""}, {""token"": ""colorectal cancer"", ""start_span"": 154, ""end_span"": 171, ""type"": ""Cancer""}]"	test
One of these mechanisms is NF - kappaB pathway activation which in turn may contribute to tumor formation by providing anti - apoptotic survival signals to the epithelial cells.	NF - kappaB,27,38,Gene_or_gene_product	tumor,90,95,Cancer	epithelial cells,160,176,Cell	"[{""token"": ""NF - kappaB"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Cancer""}, {""token"": ""epithelial cells"", ""start_span"": 160, ""end_span"": 176, ""type"": ""Cell""}]"	test
Vascular endothelial growth factor ( VEGF) is one of the most potent and a specific regulator of angiogenesis which principally targets endothelial cells and regulates several of their functions, including mitogenesis, permeability and migration.	Vascular endothelial growth factor,0,34,Gene_or_gene_product	VEGF,37,41,Gene_or_gene_product	endothelial cells,136,153,Cell	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 136, ""end_span"": 153, ""type"": ""Cell""}]"	test
METHODS: We studied VEGF expression of 85 CML patients ( median age 50 years, range 16 - 75 years).	VEGF,20,24,Gene_or_gene_product	CML,42,45,Cancer	patients,46,54,Organism	"[{""token"": ""VEGF"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""CML"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Organism""}]"	test
The temporal expression ( percentage positivity per 1000 analysed cells) VEGF proteins over the course of CML were studied using the immunohistochemical technique utilizing relevant monoclonal antibodies.	cells,66,71,Cell	VEGF,73,77,Gene_or_gene_product	CML,106,109,Cancer	"[{""token"": ""cells"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""CML"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Cancer""}]"	test
It was correlated with the laboratory ( Hb, WBC and platelet counts, and the percentage of blasts) and clinical parameters ( organomegaly, duration of CP, AP, and BC) of disease progression.	Hb,40,42,Gene_or_gene_product	WBC,44,47,Cell	platelet,52,60,Cell	"[{""token"": ""Hb"", ""start_span"": 40, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""WBC"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""platelet"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Cell""}]"	test
Aberrant expression of Evi - 1 has been frequently found in myeloid leukemia, and is associated with a poor patient survival.	Evi - 1,23,30,Gene_or_gene_product	myeloid leukemia,60,76,Cancer	patient,108,115,Organism	"[{""token"": ""Evi - 1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid leukemia"", ""start_span"": 60, ""end_span"": 76, ""type"": ""Cancer""}, {""token"": ""patient"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Organism""}]"	test
Recently, we reported candidate target genes of Evi - 1 shared in HSCs and leukemic cells using gene expression profiling analysis.	Evi - 1,48,55,Gene_or_gene_product	HSCs,66,70,Cell	leukemic cells,75,89,Cell	"[{""token"": ""Evi - 1"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""HSCs"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""leukemic cells"", ""start_span"": 75, ""end_span"": 89, ""type"": ""Cell""}]"	test
In this study, we identified Pbx1, a proto - oncogene in hematopoietic malignancy, as a target gene of Evi - 1.	Pbx1,29,33,Gene_or_gene_product	hematopoietic malignancy,57,81,Pathological_formation	Evi - 1,103,110,Gene_or_gene_product	"[{""token"": ""Pbx1"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""hematopoietic malignancy"", ""start_span"": 57, ""end_span"": 81, ""type"": ""Pathological_formation""}, {""token"": ""Evi - 1"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}]"	test
An analysis of the Pbx1 promoter region revealed that Evi - 1 upregulates Pbx1 transcription.	Pbx1,19,23,Gene_or_gene_product	Evi - 1,54,61,Gene_or_gene_product	Pbx1,74,78,Gene_or_gene_product	"[{""token"": ""Pbx1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi - 1"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pbx1"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}]"	test
These results indicate that Pbx1 is a target gene of Evi - 1 involved in Evi - 1 - mediated leukemogenesis.	Pbx1,28,32,Gene_or_gene_product	Evi - 1,53,60,Gene_or_gene_product	Evi - 1,73,80,Gene_or_gene_product	"[{""token"": ""Pbx1"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi - 1"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi - 1"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}]"	test
Tumor Angiogenesis: Initiation and Targeting - Therapeutic Targeting of an FGF - Binding Protein, an Angiogenic Switch Molecule, and Indicator of Early Stages of Gastrointestinal Adenocarcinomas -.	Tumor,0,5,Cancer	FGF - Binding Protein,75,96,Gene_or_gene_product	Gastrointestinal Adenocarcinomas,162,194,Cancer	"[{""token"": ""Tumor"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cancer""}, {""token"": ""FGF - Binding Protein"", ""start_span"": 75, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""Gastrointestinal Adenocarcinomas"", ""start_span"": 162, ""end_span"": 194, ""type"": ""Cancer""}]"	test
Tumor angiogenesis has been related to the initiation as well as progression toward more aggressive behavior of human tumors.	Tumor,0,5,Cancer	human,112,117,Organism	tumors,118,124,Cancer	"[{""token"": ""Tumor"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Cancer""}]"	test
We found that FGF - BP is dramatically upregulated during the initiation of colorectal and pancreatic adenocarcinoma.	FGF - BP,14,22,Gene_or_gene_product	colorectal,76,86,Cancer	pancreatic adenocarcinoma,91,116,Cancer	"[{""token"": ""FGF - BP"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal"", ""start_span"": 76, ""end_span"": 86, ""type"": ""Cancer""}, {""token"": ""pancreatic adenocarcinoma"", ""start_span"": 91, ""end_span"": 116, ""type"": ""Cancer""}]"	test
2 - BE is a hemolytic agent that induces hemangiosarcomas in mice.	2 - BE,0,6,Chemical	hemangiosarcomas,41,57,Cancer	mice,61,65,Organism	"[{""token"": ""2 - BE"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""hemangiosarcomas"", ""start_span"": 41, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Organism""}]"	test
The resulting mechanistic model confirms previous work proposing that 2 - BE induces macrophage activation and inflammation in the liver.	2 - BE,70,76,Chemical	macrophage,85,95,Cell	liver,131,136,Organ	"[{""token"": ""2 - BE"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Chemical""}, {""token"": ""macrophage"", ""start_span"": 85, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""liver"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Organ""}]"	test
Finally, an immunohistochemistry method ( Hypoxyprobe) demonstrated that tissue hypoxia was present in the spleen and BM.	tissue,73,79,Tissue	spleen,107,113,Organ	BM,118,120,Multi	"[{""token"": ""tissue"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Tissue""}, {""token"": ""spleen"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Organ""}, {""token"": ""BM"", ""start_span"": 118, ""end_span"": 120, ""type"": ""Multi""}]"	test
Pancreatic endocrine tumors: expression profiling evidences a role for AKT - mTOR pathway.	Pancreatic endocrine tumors,0,27,Cancer	AKT,71,74,Gene_or_gene_product	mTOR,77,81,Gene_or_gene_product	"[{""token"": ""Pancreatic endocrine tumors"", ""start_span"": 0, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""AKT"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}]"	test
PURPOSE: We investigated the global gene expression in a large panel of pancreatic endocrine tumors ( PETs) aimed at identifying new potential targets for therapy and biomarkers to predict patient outcome.	pancreatic endocrine tumors,72,99,Cancer	PETs,102,106,Cancer	patient,189,196,Organism	"[{""token"": ""pancreatic endocrine tumors"", ""start_span"": 72, ""end_span"": 99, ""type"": ""Cancer""}, {""token"": ""PETs"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Cancer""}, {""token"": ""patient"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Organism""}]"	test
The finding of differential SSTR expression raises the potential for SSTR expression to be evaluated as a marker of response to somatostatin analogs.	SSTR,28,32,Gene_or_gene_product	SSTR,69,73,Gene_or_gene_product	somatostatin,128,140,Gene_or_gene_product	"[{""token"": ""SSTR"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""SSTR"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""somatostatin"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}]"	test
Activity of several transcriptional factors located downstream in the Akt pathway was also tested, and constitutive activation of adenosine 3 ', 5 ' - monophosphate response element - binding protein ( CREB) by ICAM - 3 was detected.	Akt,70,73,Gene_or_gene_product	CREB,202,206,Gene_or_gene_product	ICAM - 3,211,219,Gene_or_gene_product	"[{""token"": ""Akt"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""CREB"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 3"", ""start_span"": 211, ""end_span"": 219, ""type"": ""Gene_or_gene_product""}]"	test
This result indicates that CREB functions in the signaling pathway between Akt and MMP.	CREB,27,31,Gene_or_gene_product	Akt,75,78,Gene_or_gene_product	MMP,83,86,Gene_or_gene_product	"[{""token"": ""CREB"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}]"	test
The p53 protein functions to prevent tumour development by inhibiting the outgrowth of stressed or damaged cells.	p53,4,7,Gene_or_gene_product	tumour,37,43,Cancer	cells,107,112,Cell	"[{""token"": ""p53"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Cell""}]"	test
In addition to well established functions to block cell proliferation, recent studies have revealed a role for p53 in the regulation of pathways involved in glucose metabolism.	cell,51,55,Cell	p53,111,114,Gene_or_gene_product	glucose,157,164,Chemical	"[{""token"": ""cell"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Chemical""}]"	test
The metabolic functions of p53 resist the shift to glycolysis that is characteristically seen in cancers, and also help cells adapt to and survive limited periods of metabolic stress.	p53,27,30,Gene_or_gene_product	cancers,97,104,Cancer	cells,120,125,Cell	"[{""token"": ""p53"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Cell""}]"	test
14 - 3 - 3zeta Overexpression and abnormal beta - catenin expression are associated with poor differentiation and progression in stage I non - small cell lung cancer.	14 - 3 - 3zeta,0,14,Gene_or_gene_product	beta - catenin,43,57,Gene_or_gene_product	stage I non - small cell lung cancer,129,165,Cancer	"[{""token"": ""14 - 3 - 3zeta"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 43, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""stage I non - small cell lung cancer"", ""start_span"": 129, ""end_span"": 165, ""type"": ""Cancer""}]"	test
Recent studies have shown that 14 - 3 - 3zeta interacted with other key cellular proteins involved in the tumor development and progression.	14 - 3 - 3zeta,31,45,Gene_or_gene_product	cellular,72,80,Cell	tumor,106,111,Cancer	"[{""token"": ""14 - 3 - 3zeta"", ""start_span"": 31, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 72, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Cancer""}]"	test
Knowledge of 14 - 3 - 3zeta and beta - catenin expression and clinical significance in the same tumor tissues is limited.	14 - 3 - 3zeta,13,27,Gene_or_gene_product	beta - catenin,32,46,Gene_or_gene_product	same tumor tissues,91,109,Tissue	"[{""token"": ""14 - 3 - 3zeta"", ""start_span"": 13, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 32, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""same tumor tissues"", ""start_span"": 91, ""end_span"": 109, ""type"": ""Tissue""}]"	test
Specimens of NSCLC and adjacent normal lung tissues were collected from 110 patients.	NSCLC,13,18,Cancer	normal lung tissues,32,51,Tissue	patients,76,84,Organism	"[{""token"": ""NSCLC"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Cancer""}, {""token"": ""normal lung tissues"", ""start_span"": 32, ""end_span"": 51, ""type"": ""Tissue""}, {""token"": ""patients"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Organism""}]"	test
In conclusion, 14 - 3 - 3zeta and beta - catenin might have an important role in development, progression and metastatic process of NSCLC.	14 - 3 - 3zeta,15,29,Gene_or_gene_product	beta - catenin,34,48,Gene_or_gene_product	NSCLC,132,137,Cancer	"[{""token"": ""14 - 3 - 3zeta"", ""start_span"": 15, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 34, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""NSCLC"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Cancer""}]"	test
p24 family type 1 transmembrane proteins are required for insulin biosynthesis and secretion in pancreatic beta - cells.	p24 family type 1 transmembrane proteins,0,40,Gene_or_gene_product	insulin,58,65,Gene_or_gene_product	pancreatic beta - cells,96,119,Cell	"[{""token"": ""p24 family type 1 transmembrane proteins"", ""start_span"": 0, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulin"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""pancreatic beta - cells"", ""start_span"": 96, ""end_span"": 119, ""type"": ""Cell""}]"	test
Expression of KISS1 and MMP - 9 in non - small cell lung cancer and their relations to metastasis and survival.	KISS1,14,19,Gene_or_gene_product	MMP - 9,24,31,Gene_or_gene_product	non - small cell lung cancer,35,63,Cancer	"[{""token"": ""KISS1"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""non - small cell lung cancer"", ""start_span"": 35, ""end_span"": 63, ""type"": ""Cancer""}]"	test
The goals of this study were to determine the mRNA and protein expressions of KISS1 and MMP - 9 in NSCLC and their relations to metastasis and prognosis.	KISS1,78,83,Gene_or_gene_product	MMP - 9,88,95,Gene_or_gene_product	NSCLC,99,104,Cancer	"[{""token"": ""KISS1"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""NSCLC"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Cancer""}]"	test
Our data suggest that KISS1 and MMP - 9 may serve as potential prognostic and therapeutic markers in lung cancer.	KISS1,22,27,Gene_or_gene_product	MMP - 9,32,39,Gene_or_gene_product	lung cancer,101,112,Cancer	"[{""token"": ""KISS1"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung cancer"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Cancer""}]"	test
Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer.	SPARC,44,49,Gene_or_gene_product	VEGF,54,58,Gene_or_gene_product	colon cancer,81,93,Cancer	"[{""token"": ""SPARC"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon cancer"", ""start_span"": 81, ""end_span"": 93, ""type"": ""Cancer""}]"	test
CONCLUSION: The low expression or absence of stromal SPARC was an independent prognostic factor for poor prognosis of colon cancer.	stromal,45,52,Cell	SPARC,53,58,Gene_or_gene_product	colon cancer,118,130,Cancer	"[{""token"": ""stromal"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""SPARC"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon cancer"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Cancer""}]"	test
A growing body of evidence indicates that deregulation of stem cell fate determinants is a hallmark of many types of malignancies.	body,10,14,Organism_subdivision	stem cell,58,67,Cell	malignancies,117,129,Cancer	"[{""token"": ""body"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Organism_subdivision""}, {""token"": ""stem cell"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""malignancies"", ""start_span"": 117, ""end_span"": 129, ""type"": ""Cancer""}]"	test
Our results indicate that TLX is involved in glioma stem cell genesis and represents a potential therapeutic target for this type of malignancy.	TLX,26,29,Gene_or_gene_product	glioma stem cell,45,61,Cell	malignancy,133,143,Cancer	"[{""token"": ""TLX"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""glioma stem cell"", ""start_span"": 45, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""malignancy"", ""start_span"": 133, ""end_span"": 143, ""type"": ""Cancer""}]"	test
In addition, detailed metabolic assessment of these MEFs confirmed their dependence on glycolysis, and an elevated rate of lactate efflux, associated with the upregulation of glycolytic enzymes known to be associated with tumorigenesis.	MEFs,52,56,Cell	lactate,123,130,Chemical	glycolytic enzymes,175,193,Gene_or_gene_product	"[{""token"": ""MEFs"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""lactate"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Chemical""}, {""token"": ""glycolytic enzymes"", ""start_span"": 175, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}]"	test
Based on the models assessed herein, we infer that that FH deficiency compels cells to adopt an early, reversible, and progressive protumorigenic metabolic milieu that is reminiscent of that driving the Warburg effect.	herein,29,35,Chemical	FH,56,58,Gene_or_gene_product	cells,78,83,Cell	"[{""token"": ""herein"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""FH"", ""start_span"": 56, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Cell""}]"	test
A STAT3 - mediated metabolic switch is involved in tumour transformation and STAT3 addiction.	STAT3,2,7,Gene_or_gene_product	tumour,51,57,Cancer	STAT3,77,82,Gene_or_gene_product	"[{""token"": ""STAT3"", ""start_span"": 2, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""STAT3"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}]"	test
The pro - oncogenic transcription factor STAT3 is constitutively activated in a wide variety of tumours that often become addicted to its activity, but no unifying view of a core function determining this widespread STAT3 - dependence has yet emerged.	STAT3,41,46,Gene_or_gene_product	tumours,96,103,Cancer	STAT3,216,221,Gene_or_gene_product	"[{""token"": ""STAT3"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumours"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Cancer""}, {""token"": ""STAT3"", ""start_span"": 216, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}]"	test
Here we report a zebrafish brca2 insertional mutant that shares phenotypes with human patients and identifies a novel brca2 function in oogenesis.	brca2,27,32,Gene_or_gene_product	human patients,80,94,Organism	brca2,118,123,Gene_or_gene_product	"[{""token"": ""brca2"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""human patients"", ""start_span"": 80, ""end_span"": 94, ""type"": ""Organism""}, {""token"": ""brca2"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"	test
KISS1 is a metastasis suppressor gene that is lost in several malignancies, including bladder cancer.	KISS1,0,5,Gene_or_gene_product	malignancies,62,74,Cancer	bladder cancer,86,100,Cancer	"[{""token"": ""KISS1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignancies"", ""start_span"": 62, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""bladder cancer"", ""start_span"": 86, ""end_span"": 100, ""type"": ""Cancer""}]"	test
METHODS: A clinicopathologic data review was performed in 60 patients with PTMC treated with total thyroidectomies involving neck dissections.	patients,61,69,Organism	PTMC,75,79,Cancer	neck,125,129,Organism_subdivision	"[{""token"": ""patients"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Organism""}, {""token"": ""PTMC"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""neck"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Organism_subdivision""}]"	test
The patterns of lymphatic vessels, the expression of VEGFs, and their correlation with neck metastases were assessed.	lymphatic vessels,16,33,Multi	VEGFs,53,58,Gene_or_gene_product	neck,87,91,Organism_subdivision	"[{""token"": ""lymphatic vessels"", ""start_span"": 16, ""end_span"": 33, ""type"": ""Multi""}, {""token"": ""VEGFs"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""neck"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Organism_subdivision""}]"	test
The expression of VEGFs did not correlate with either lymphatic density or neck metastasis.	VEGFs,18,23,Gene_or_gene_product	lymphatic,54,63,Organ	neck,75,79,Organism_subdivision	"[{""token"": ""VEGFs"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphatic"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Organ""}, {""token"": ""neck"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Organism_subdivision""}]"	test
Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.	antitumor,40,49,Cancer	sorafenib,86,95,Chemical	hepatocellular carcinoma,99,123,Cancer	"[{""token"": ""antitumor"", ""start_span"": 40, ""end_span"": 49, ""type"": ""Cancer""}, {""token"": ""sorafenib"", ""start_span"": 86, ""end_span"": 95, ""type"": ""Chemical""}, {""token"": ""hepatocellular carcinoma"", ""start_span"": 99, ""end_span"": 123, ""type"": ""Cancer""}]"	test
Sorafenib inhibited the mammalian target of rapamycin complex 1 and its inhibition led to accumulation of LC3 - II.	Sorafenib,0,9,Chemical	mammalian target of rapamycin complex 1,24,63,Gene_or_gene_product	LC3 - II,106,114,Gene_or_gene_product	"[{""token"": ""Sorafenib"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""mammalian target of rapamycin complex 1"", ""start_span"": 24, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""LC3 - II"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}]"	test
Pharmacological inhibition of autophagic flux by chloroquine increased apoptosis and decreased cell viability in hepatoma cells.	chloroquine,49,60,Chemical	cell,95,99,Cell	hepatoma cells,113,127,Cell	"[{""token"": ""chloroquine"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""hepatoma cells"", ""start_span"": 113, ""end_span"": 127, ""type"": ""Cell""}]"	test
siRNA - mediated knockdown of the ATG7 gene also sensitized hepatoma cells to sorafenib.	ATG7,34,38,Gene_or_gene_product	hepatoma cells,60,74,Cell	sorafenib,78,87,Chemical	"[{""token"": ""ATG7"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""hepatoma cells"", ""start_span"": 60, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""sorafenib"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Chemical""}]"	test
In conclusion, sorafenib administration induced autophagosome formation and enhanced autophagic activity, which conferred a survival advantage to hepatoma cells.	sorafenib,15,24,Chemical	autophagosome,48,61,Cellular_component	hepatoma cells,146,160,Cell	"[{""token"": ""sorafenib"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""autophagosome"", ""start_span"": 48, ""end_span"": 61, ""type"": ""Cellular_component""}, {""token"": ""hepatoma cells"", ""start_span"": 146, ""end_span"": 160, ""type"": ""Cell""}]"	test
Concomitant inhibition of autophagy may be an attractive strategy for unlocking the antitumor potential of sorafenib in HCC.	antitumor,84,93,Cancer	sorafenib,107,116,Chemical	HCC,120,123,Cancer	"[{""token"": ""antitumor"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Cancer""}, {""token"": ""sorafenib"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Chemical""}, {""token"": ""HCC"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Cancer""}]"	test
A reduction and not an increase in tumor glucose availability could be a more appropriate strategy for the induction of energy failure in tumors.	tumor,35,40,Cancer	glucose,41,48,Chemical	tumors,138,144,Cancer	"[{""token"": ""tumor"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""tumors"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Cancer""}]"	test
Notably, ARD1 was critical for transcriptionally regulating a number of AR target genes that are involved in prostate tumorigenesis.	ARD1,9,13,Gene_or_gene_product	AR,72,74,Gene_or_gene_product	prostate,109,117,Organ	"[{""token"": ""ARD1"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 72, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate"", ""start_span"": 109, ""end_span"": 117, ""type"": ""Organ""}]"	test
The role of Hes genes in intestinal development, homeostasis and tumor formation.	Hes,12,15,Gene_or_gene_product	intestinal,25,35,Multi	tumor,65,70,Cancer	"[{""token"": ""Hes"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""intestinal"", ""start_span"": 25, ""end_span"": 35, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Cancer""}]"	test
An exception is the adaptive immune system where lymphocytes utilize programmed DNA damage to effect antigen receptor diversification.	immune system,29,42,Anatomical_system	lymphocytes,49,60,Cell	DNA,80,83,Cellular_component	"[{""token"": ""immune system"", ""start_span"": 29, ""end_span"": 42, ""type"": ""Anatomical_system""}, {""token"": ""lymphocytes"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Cellular_component""}]"	test
AID deaminates cytidines in DNA resulting in U: G mismatches that are processed into point mutations in SHM or double - strand breaks in CSR.	AID,0,3,Gene_or_gene_product	cytidines,15,24,Chemical	DNA,28,31,Cellular_component	"[{""token"": ""AID"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytidines"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Cellular_component""}]"	test
Here, we review the molecular basis of AID regulation, targeting, and initiation of CSR and SHM, as well as AID ' s role in generating chromosome translocations that contribute to lymphomagenesis.	AID,39,42,Gene_or_gene_product	AID,108,111,Gene_or_gene_product	chromosome,135,145,Cellular_component	"[{""token"": ""AID"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""AID"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""chromosome"", ""start_span"": 135, ""end_span"": 145, ""type"": ""Cellular_component""}]"	test
The aim of the present study was to investigate the frequency of the less common p. Val600Lys ( V600K) mutation in metastatic melanoma from a high incidence region.	Val600Lys,84,93,Amino_acid	V600K,96,101,Amino_acid	melanoma,126,134,Cancer	"[{""token"": ""Val600Lys"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Amino_acid""}, {""token"": ""V600K"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Amino_acid""}, {""token"": ""melanoma"", ""start_span"": 126, ""end_span"": 134, ""type"": ""Cancer""}]"	test
Dogs with lymphoma had similar glucose tolerance curves when compared with controls.	Dogs,0,4,Organism	lymphoma,10,18,Cancer	glucose,31,38,Chemical	"[{""token"": ""Dogs"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""lymphoma"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Chemical""}]"	test
These results indicate carbohydrate metabolism is altered in dogs with lymphoma.	carbohydrate,23,35,Chemical	dogs,61,65,Organism	lymphoma,71,79,Cancer	"[{""token"": ""carbohydrate"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""dogs"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Organism""}, {""token"": ""lymphoma"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Cancer""}]"	test
Additionally, this sequence shares some homology with the DNA binding domain of GCN4 and c - jun protein.	DNA,58,61,Cellular_component	GCN4,80,84,Gene_or_gene_product	c - jun,89,96,Gene_or_gene_product	"[{""token"": ""DNA"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Cellular_component""}, {""token"": ""GCN4"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - jun"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"	test
The amount of radioactivity released into the medium during the subsequent 24 to 72 h was measured, and it was found that all - trans - RA treatment inhibited degradation of extracellular matrix and type IV collagen by 50 to 60%.	all - trans - RA,122,138,Chemical	extracellular matrix,174,194,Cellular_component	type IV collagen,199,215,Gene_or_gene_product	"[{""token"": ""all - trans - RA"", ""start_span"": 122, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""extracellular matrix"", ""start_span"": 174, ""end_span"": 194, ""type"": ""Cellular_component""}, {""token"": ""type IV collagen"", ""start_span"": 199, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}]"	test
The growth of the cells was not inhibited under these conditions, except after treatment with 10 microM all - trans - RA in serum - free medium.	cells,18,23,Cell	all - trans - RA,104,120,Chemical	serum,124,129,Organism_substance	"[{""token"": ""cells"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""all - trans - RA"", ""start_span"": 104, ""end_span"": 120, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Organism_substance""}]"	test
The apparent molecular weights of the collagenolytic enzymes were determined by electrophoresis of cell extracts and concentrated conditioned medium in type IV collagen - embedded polyacrylamide gels followed by renaturation and activation of the enzymes within the gels.	cell extracts,99,112,Organism_substance	type IV collagen,152,168,Gene_or_gene_product	polyacrylamide,180,194,Chemical	"[{""token"": ""cell extracts"", ""start_span"": 99, ""end_span"": 112, ""type"": ""Organism_substance""}, {""token"": ""type IV collagen"", ""start_span"": 152, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""polyacrylamide"", ""start_span"": 180, ""end_span"": 194, ""type"": ""Chemical""}]"	test
The Mr 64, 000 enzyme could be extracted from viable cells ( presumably from the cell membrane) by 2% 1 - butanol.	cells,53,58,Cell	cell membrane,81,94,Cellular_component	1 - butanol,102,113,Chemical	"[{""token"": ""cells"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""cell membrane"", ""start_span"": 81, ""end_span"": 94, ""type"": ""Cellular_component""}, {""token"": ""1 - butanol"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical""}]"	test
Treatment with all - trans - RA decreased the level of these enzymes in the cellular, cell membrane, and conditioned medium compartments. ( ABSTRACT TRUNCATED AT 400 WORDS)	all - trans - RA,15,31,Chemical	cellular,76,84,Cell	cell membrane,86,99,Cellular_component	"[{""token"": ""all - trans - RA"", ""start_span"": 15, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""cellular"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""cell membrane"", ""start_span"": 86, ""end_span"": 99, ""type"": ""Cellular_component""}]"	test
Malate - citrate cycle during glycolysis and glutaminolysis in Ehrlich ascites tumor cells.	Malate,0,6,Chemical	citrate,9,16,Chemical	Ehrlich ascites tumor cells,63,90,Cell	"[{""token"": ""Malate"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""citrate"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Chemical""}, {""token"": ""Ehrlich ascites tumor cells"", ""start_span"": 63, ""end_span"": 90, ""type"": ""Cell""}]"	test
The experimental approach includes: estimation of mitochondrial NAD [ P] + - dependent malic enzyme activity; respiratory activity of freshly harvested or fasted cells, and of isolated mitochondria; and determination of the metabolites involved in the glycolytic and glutaminolytic pathways.	mitochondrial,50,63,Cellular_component	cells,162,167,Cell	mitochondria,185,197,Cellular_component	"[{""token"": ""mitochondrial"", ""start_span"": 50, ""end_span"": 63, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Cell""}, {""token"": ""mitochondria"", ""start_span"": 185, ""end_span"": 197, ""type"": ""Cellular_component""}]"	test
Less than 15% of the glucose uptake was affected by the 1, 2, 3 - benzenetricarboxylate inhibition of the malate - citrate shuttle.	glucose,21,28,Chemical	malate,106,112,Chemical	citrate,115,122,Chemical	"[{""token"": ""glucose"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Chemical""}, {""token"": ""malate"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Chemical""}, {""token"": ""citrate"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Chemical""}]"	test
Moreover, in the presence of glucose, the malate - citrate cycle did not appear to play an important role in the glutaminolytic process.	glucose,29,36,Chemical	malate,42,48,Chemical	citrate,51,58,Chemical	"[{""token"": ""glucose"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""malate"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""citrate"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Chemical""}]"	test
None of the epithelial cell lines induced foci in a focus formation assay.	epithelial cell lines,12,33,Cell	foci,42,46,Cell	focus,52,57,Cell	"[{""token"": ""epithelial cell lines"", ""start_span"": 12, ""end_span"": 33, ""type"": ""Cell""}, {""token"": ""foci"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""focus"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Cell""}]"	test
To assay for the possible presence of transforming genes which were not active in a focus formation assay, two of the epithelial lines were analysed further by co - transfection with a dominant selectable marker, followed by selection and inoculation into nude mice.	focus,84,89,Cell	epithelial lines,118,134,Cell	nude mice,256,265,Organism	"[{""token"": ""focus"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""epithelial lines"", ""start_span"": 118, ""end_span"": 134, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 256, ""end_span"": 265, ""type"": ""Organism""}]"	test
Low - level X - radiation effects on functional vascular changes in Syrian hamster cheek pouch epithelium during hydrocarbon carcinogenesis.	vascular,48,56,Multi	Syrian hamster,68,82,Organism	cheek pouch epithelium,83,105,Tissue	"[{""token"": ""vascular"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Multi""}, {""token"": ""Syrian hamster"", ""start_span"": 68, ""end_span"": 82, ""type"": ""Organism""}, {""token"": ""cheek pouch epithelium"", ""start_span"": 83, ""end_span"": 105, ""type"": ""Tissue""}]"	test
Hamsters were treated with either radiation, DMBA, radiation + DMBA, or no treatment.	Hamsters,0,8,Organism	DMBA,45,49,Chemical	DMBA,63,67,Chemical	"[{""token"": ""Hamsters"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""DMBA"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""DMBA"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Chemical""}]"	test
All treatments resulted in significant changes in vascular volume with time, while only DMBA treatments alone resulted in significant changes in vascular permeability with time.	vascular,50,58,Multi	DMBA,88,92,Chemical	vascular,145,153,Multi	"[{""token"": ""vascular"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Multi""}, {""token"": ""DMBA"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Chemical""}, {""token"": ""vascular"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Multi""}]"	test
Prior to the appearances of frank neoplasms, volumetric changes in DMBA only and radiation only groups were similar, while volume changes in DMBA + radiation groups increased slowly to a peak later than in other groups and then declined steadily to levels similar to the radiation only group.	neoplasms,34,43,Cancer	DMBA,67,71,Chemical	DMBA,141,145,Chemical	"[{""token"": ""neoplasms"", ""start_span"": 34, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""DMBA"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""DMBA"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Chemical""}]"	test
In each experimental situation, the casts provided a valuable three dimensional representation of the newly formed blood vessels and permitted subclassification of the vessels within normal and proliferating vascular networks.	blood vessels,115,128,Multi	vessels,168,175,Multi	vascular networks,208,225,Multi	"[{""token"": ""blood vessels"", ""start_span"": 115, ""end_span"": 128, ""type"": ""Multi""}, {""token"": ""vessels"", ""start_span"": 168, ""end_span"": 175, ""type"": ""Multi""}, {""token"": ""vascular networks"", ""start_span"": 208, ""end_span"": 225, ""type"": ""Multi""}]"	test
The resultant foci contain cells of a markedly altered morphology which produce high levels of p53.	foci,14,18,Cell	cells,27,32,Cell	p53,95,98,Gene_or_gene_product	"[{""token"": ""foci"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}]"	test
Cell lines established from such foci elicit tumours in syngeneic animals.	Cell lines,0,10,Cell	foci,33,37,Cell	tumours,45,52,Cancer	"[{""token"": ""Cell lines"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Cell""}, {""token"": ""foci"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""tumours"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Cancer""}]"	test
It is concluded that VCSA is a complex of several antigenic determinants, and that some of these differ in different cells transformed by RSV.	VCSA,21,25,Gene_or_gene_product	cells,117,122,Cell	RSV,138,141,Organism	"[{""token"": ""VCSA"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Cell""}, {""token"": ""RSV"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Organism""}]"	test
The effect of translocations on the cellular myc gene in Burkitt lymphomas.	cellular,36,44,Cell	myc,45,48,Gene_or_gene_product	Burkitt lymphomas,57,74,Cancer	"[{""token"": ""cellular"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""myc"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""Burkitt lymphomas"", ""start_span"": 57, ""end_span"": 74, ""type"": ""Cancer""}]"	test
Activation of the myc gene may play a role in transformation by promoting growth of the cells bearing the rearranged chromosomes.	myc,18,21,Gene_or_gene_product	cells,88,93,Cell	chromosomes,117,128,Cellular_component	"[{""token"": ""myc"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""chromosomes"", ""start_span"": 117, ""end_span"": 128, ""type"": ""Cellular_component""}]"	test
Preliminary in vitro studies showed that the agents significantly inhibited RNA and DNA synthesis in Ehrlich ascites cells.	RNA,76,79,Chemical	DNA,84,87,Cellular_component	Ehrlich ascites cells,101,122,Cell	"[{""token"": ""RNA"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Cellular_component""}, {""token"": ""Ehrlich ascites cells"", ""start_span"": 101, ""end_span"": 122, ""type"": ""Cell""}]"	test
Mast cell heparin stimulates migration of capillary endothelial cells in vitro.	Mast cell,0,9,Cell	heparin,10,17,Chemical	capillary endothelial cells,42,69,Cell	"[{""token"": ""Mast cell"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Cell""}, {""token"": ""heparin"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""capillary endothelial cells"", ""start_span"": 42, ""end_span"": 69, ""type"": ""Cell""}]"	test
We have used a quantitative assay in vitro to demonstrate that mast cells release a factor that significantly increases bovine capillary endothelial cell migration.	mast cells,63,73,Cell	bovine,120,126,Organism	capillary endothelial cell,127,153,Cell	"[{""token"": ""mast cells"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""bovine"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Organism""}, {""token"": ""capillary endothelial cell"", ""start_span"": 127, ""end_span"": 153, ""type"": ""Cell""}]"	test
Of all the secretory products of mast cells tested, only heparin stimulated capillary endothelial cell migration in vitro.	mast cells,33,43,Cell	heparin,57,64,Chemical	capillary endothelial cell,76,102,Cell	"[{""token"": ""mast cells"", ""start_span"": 33, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""heparin"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Chemical""}, {""token"": ""capillary endothelial cell"", ""start_span"": 76, ""end_span"": 102, ""type"": ""Cell""}]"	test
Heparin preparations from a variety of sources stimulated capillary endothelial cell migration to the same degree but did not stimulate migration of several other cell types.	Heparin,0,7,Chemical	capillary endothelial cell,58,84,Cell	cell,163,167,Cell	"[{""token"": ""Heparin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""capillary endothelial cell"", ""start_span"": 58, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Cell""}]"	test
These results suggest that the role of mast cells in angiogenesis may be to enhance migration of the endothelial cells of growing capillaries.	mast cells,39,49,Cell	endothelial cells,101,118,Cell	capillaries,130,141,Tissue	"[{""token"": ""mast cells"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 101, ""end_span"": 118, ""type"": ""Cell""}, {""token"": ""capillaries"", ""start_span"": 130, ""end_span"": 141, ""type"": ""Tissue""}]"	test
"The p53 gene is a "" guardian of the genome "" - - it regulates multiple components of the DNA damage control response and promotes cellular senescence."	p53,4,7,Gene_or_gene_product	DNA,89,92,Cellular_component	cellular,130,138,Cell	"[{""token"": ""p53"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Cellular_component""}, {""token"": ""cellular"", ""start_span"": 130, ""end_span"": 138, ""type"": ""Cell""}]"	test
Disabling mutations and deletions of p53 occur in 50% of human tumours.	p53,37,40,Gene_or_gene_product	human,57,62,Organism	tumours,63,70,Cancer	"[{""token"": ""p53"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""tumours"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Cancer""}]"	test
The Met proto - oncogene mesenchymal to epithelial cell conversion.	Met,4,7,Gene_or_gene_product	mesenchymal,25,36,Cell	epithelial cell,40,55,Cell	"[{""token"": ""Met"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""mesenchymal"", ""start_span"": 25, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""epithelial cell"", ""start_span"": 40, ""end_span"": 55, ""type"": ""Cell""}]"	test
The tumor cells also display enhanced expression of desmosomal and tight - junction proteins.	tumor cells,4,15,Cell	desmosomal,52,62,Cellular_component	tight - junction,67,83,Cellular_component	"[{""token"": ""tumor cells"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Cell""}, {""token"": ""desmosomal"", ""start_span"": 52, ""end_span"": 62, ""type"": ""Cellular_component""}, {""token"": ""tight - junction"", ""start_span"": 67, ""end_span"": 83, ""type"": ""Cellular_component""}]"	test
UV radiation has been shown to play a role in the initiation of human cutaneous melanoma, but its role in the development of malignant melanoma to the metastatic state is not very well defined.	human,64,69,Organism	cutaneous melanoma,70,88,Cancer	malignant melanoma,125,143,Cancer	"[{""token"": ""human"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Organism""}, {""token"": ""cutaneous melanoma"", ""start_span"": 70, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""malignant melanoma"", ""start_span"": 125, ""end_span"": 143, ""type"": ""Cancer""}]"	test
UV - B - induced IL - 8 was constitutively expressed 60 days after irradiation in tumors implanted in mice.	IL - 8,17,23,Gene_or_gene_product	tumors,82,88,Cancer	mice,102,106,Organism	"[{""token"": ""IL - 8"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Organism""}]"	test
The acquisition of the metastatic phenotype induced by UV - B could not be attributed to abnormalities in the p53 or MTS - 1 ( p16INK4) genes.	p53,110,113,Gene_or_gene_product	MTS - 1,117,124,Gene_or_gene_product	p16INK4,127,134,Gene_or_gene_product	"[{""token"": ""p53"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""MTS - 1"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""p16INK4"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}]"	test
Endocytosis of the conjugate and decomposition of the acid - labile linkage inside lysosomes and other acidic intracellular compartments should then lead to release of the cortisol and expression of its antiproliferative activity.	lysosomes,83,92,Cellular_component	intracellular compartments,110,136,Cellular_component	cortisol,172,180,Chemical	"[{""token"": ""lysosomes"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Cellular_component""}, {""token"": ""intracellular compartments"", ""start_span"": 110, ""end_span"": 136, ""type"": ""Cellular_component""}, {""token"": ""cortisol"", ""start_span"": 172, ""end_span"": 180, ""type"": ""Chemical""}]"	test
Differential expression and mutation of NME genes in autologous cultured human melanoma cells with different metastatic potentials.	NME,40,43,Gene_or_gene_product	human,73,78,Organism	melanoma cells,79,93,Cell	"[{""token"": ""NME"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""melanoma cells"", ""start_span"": 79, ""end_span"": 93, ""type"": ""Cell""}]"	test
Highly metastatic IV Cl 1 cells expressed approximately 5 fold lower levels of protein encoded by NME genes than non - metastatic IV Cl 3 cells.	IV Cl 1 cells,18,31,Cell	NME,98,101,Gene_or_gene_product	IV Cl 3 cells,130,143,Cell	"[{""token"": ""IV Cl 1 cells"", ""start_span"": 18, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""NME"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""IV Cl 3 cells"", ""start_span"": 130, ""end_span"": 143, ""type"": ""Cell""}]"	test
As a consequence the cyclin D1 ( bcl - 1) gene is juxtaposed to the immunoglobulin heavy chain enhancer E mu.	cyclin D1,21,30,Gene_or_gene_product	bcl - 1,33,40,Gene_or_gene_product	immunoglobulin heavy chain enhancer E mu,68,108,Gene_or_gene_product	"[{""token"": ""cyclin D1"", ""start_span"": 21, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - 1"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""immunoglobulin heavy chain enhancer E mu"", ""start_span"": 68, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}]"	test
The data presented here demonstrate that transcriptional activation of cyclin D1 can oncogenically transform B - cells in concert with a myc gene.	cyclin D1,71,80,Gene_or_gene_product	B - cells,109,118,Cell	myc,137,140,Gene_or_gene_product	"[{""token"": ""cyclin D1"", ""start_span"": 71, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""B - cells"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Cell""}, {""token"": ""myc"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}]"	test
Elevated expression of the junB proto - oncogene is essential for v - fos induced transformation of Rat - 1 cells.	junB,27,31,Gene_or_gene_product	v - fos,66,73,Gene_or_gene_product	Rat - 1 cells,100,113,Cell	"[{""token"": ""junB"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - fos"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rat - 1 cells"", ""start_span"": 100, ""end_span"": 113, ""type"": ""Cell""}]"	test
In the present study we examined the possibility that the revertant phenotype resulted from mutations that altered the expression or activities of the c - jun or junB proto - oncogenes.	revertant,58,67,Cell	c - jun,151,158,Gene_or_gene_product	junB,162,166,Gene_or_gene_product	"[{""token"": ""revertant"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""c - jun"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""junB"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}]"	test
Although one mutant allele was detected in revertant EMS - 1 - 19, overexpression of this mutant allele failed to inhibit v - fos induced cell transformation.	revertant EMS - 1 - 19,43,65,Cell	v - fos,122,129,Gene_or_gene_product	cell,138,142,Cell	"[{""token"": ""revertant EMS - 1 - 19"", ""start_span"": 43, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""v - fos"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Cell""}]"	test
In contrast to the results obtained with c - jun, the levels of junB mRNA and protein were found to be reduced two - or threefold in revertant EMS - 1 - 19.	c - jun,41,48,Gene_or_gene_product	junB,64,68,Gene_or_gene_product	revertant EMS - 1 - 19,133,155,Cell	"[{""token"": ""c - jun"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""junB"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""revertant EMS - 1 - 19"", ""start_span"": 133, ""end_span"": 155, ""type"": ""Cell""}]"	test
Ectopic overexpression of junB induced transformation of revertant EMS - 1 - 19, but failed to transform Rat - 1 cells.	junB,26,30,Gene_or_gene_product	EMS - 1 - 19,67,79,Cell	Rat - 1 cells,105,118,Cell	"[{""token"": ""junB"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""EMS - 1 - 19"", ""start_span"": 67, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""Rat - 1 cells"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Cell""}]"	test
Moreover, about 10% of v - fos transformed cells transfected with vectors that express antisense junB mRNA acquired a non - transformed phenotype.	v - fos,23,30,Gene_or_gene_product	cells,43,48,Cell	junB,97,101,Gene_or_gene_product	"[{""token"": ""v - fos"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""junB"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}]"	test
Together these results indicate that expression of junB above a threshold level is essential for v - fos - induced transformation of Rat - 1 fibroblasts.	junB,51,55,Gene_or_gene_product	v - fos,97,104,Gene_or_gene_product	Rat - 1 fibroblasts,133,152,Cell	"[{""token"": ""junB"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - fos"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rat - 1 fibroblasts"", ""start_span"": 133, ""end_span"": 152, ""type"": ""Cell""}]"	test
HBO is useful in chronic nonhealing wounds of the diabetic foot and of the diabetic foot with impending amputation.	chronic nonhealing wounds,17,42,Pathological_formation	foot,59,63,Organism_subdivision	foot,84,88,Organism_subdivision	"[{""token"": ""chronic nonhealing wounds"", ""start_span"": 17, ""end_span"": 42, ""type"": ""Pathological_formation""}, {""token"": ""foot"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Organism_subdivision""}, {""token"": ""foot"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Organism_subdivision""}]"	test
After successive growth in vitro for longer than one month which was scarcely observed with the erythrophores, the vast majority of such transformants began to differentiate into erythrophores and ceased proliferation spontaneously.	erythrophores,96,109,Cell	transformants,137,150,Cell	erythrophores,179,192,Cell	"[{""token"": ""erythrophores"", ""start_span"": 96, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""transformants"", ""start_span"": 137, ""end_span"": 150, ""type"": ""Cell""}, {""token"": ""erythrophores"", ""start_span"": 179, ""end_span"": 192, ""type"": ""Cell""}]"	test
A vascular prosthesis needs angiogenesis for endothelialization of the luminal surface, as endothelial cells have natural and permanent antithrombogenic properties.	vascular,2,10,Multi	luminal surface,71,86,Multi	endothelial cells,91,108,Cell	"[{""token"": ""vascular"", ""start_span"": 2, ""end_span"": 10, ""type"": ""Multi""}, {""token"": ""luminal surface"", ""start_span"": 71, ""end_span"": 86, ""type"": ""Multi""}, {""token"": ""endothelial cells"", ""start_span"": 91, ""end_span"": 108, ""type"": ""Cell""}]"	test
The grafts were implanted in the abdominal aortic position of 24 dogs autologously.	grafts,4,10,Multi	abdominal aortic,33,49,Multi	dogs,65,69,Organism	"[{""token"": ""grafts"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Multi""}, {""token"": ""abdominal aortic"", ""start_span"": 33, ""end_span"": 49, ""type"": ""Multi""}, {""token"": ""dogs"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Organism""}]"	test
Marrow cells survived and continued exogenous hemopoiesis for up to six months and were immunohistochemically reactive to basic fibroblast growth factor ( bFGF).	Marrow cells,0,12,Cell	basic fibroblast growth factor,122,152,Gene_or_gene_product	bFGF,155,159,Gene_or_gene_product	"[{""token"": ""Marrow cells"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Cell""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 122, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}]"	test
Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer.	ovarian,47,54,Cancer	endometrial cancers,59,78,Cancer	cancer,94,100,Cancer	"[{""token"": ""ovarian"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""endometrial cancers"", ""start_span"": 59, ""end_span"": 78, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Cancer""}]"	test
Simultaneous involvement of the endometrium and the ovary by carcinoma is a familiar problem in the routine practice of surgical pathology.	endometrium,32,43,Multi	ovary,52,57,Organ	carcinoma,61,70,Cancer	"[{""token"": ""endometrium"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Multi""}, {""token"": ""ovary"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Organ""}, {""token"": ""carcinoma"", ""start_span"": 61, ""end_span"": 70, ""type"": ""Cancer""}]"	test
The interaction of virally derived and endogenous cellular proteins converges in deregulation of cell cycle progression and appears to be critical for the development of cervical cancers.	cellular,50,58,Cell	cell,97,101,Cell	cervical cancers,170,186,Cancer	"[{""token"": ""cellular"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""cervical cancers"", ""start_span"": 170, ""end_span"": 186, ""type"": ""Cancer""}]"	test
One additional event that appears to play a role in tumor progression is integration of HPV DNA into the host genome.	tumor,52,57,Cancer	HPV,88,91,Organism	DNA,92,95,Cellular_component	"[{""token"": ""tumor"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""HPV"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""DNA"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Cellular_component""}]"	test
In the present study, the vascular grade was assessed in 107 ( T1, 2 - N0, 1) operable non - small cell lung carcinomas, using the JC70 monoclonal antibody to CD31.	vascular,26,34,Multi	non - small cell lung carcinomas,87,119,Cancer	JC70 monoclonal antibody to CD31,131,163,Gene_or_gene_product	"[{""token"": ""vascular"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Multi""}, {""token"": ""non - small cell lung carcinomas"", ""start_span"": 87, ""end_span"": 119, ""type"": ""Cancer""}, {""token"": ""JC70 monoclonal antibody to CD31"", ""start_span"": 131, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}]"	test
Kaplan - Meier survival curves showed a statistically significant worse prognosis for patients with high vascular grade, but no difference was observed between low and medium vascular grade.	patients,86,94,Organism	vascular,105,113,Multi	vascular,175,183,Multi	"[{""token"": ""patients"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Organism""}, {""token"": ""vascular"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Multi""}, {""token"": ""vascular"", ""start_span"": 175, ""end_span"": 183, ""type"": ""Multi""}]"	test
These data suggest that angiogenesis in operable non - small cell lung cancer is a major prognostic factor for survival and, among the parameters tested, is the only factor related to cancer cell migration to lymph nodes.	non - small cell lung cancer,49,77,Cancer	cancer cell,184,195,Cell	lymph nodes,209,220,Multi	"[{""token"": ""non - small cell lung cancer"", ""start_span"": 49, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""cancer cell"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Cell""}, {""token"": ""lymph nodes"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Multi""}]"	test
Group 1 animals had the left buccal pouches painted three times weekly with 7, 12 - dimethylbenz ( a) anthracene ( DMBA) for 14 weeks.	Group 1 animals,0,15,Organism	left buccal pouches,24,43,Organism_subdivision	DMBA,115,119,Chemical	"[{""token"": ""Group 1 animals"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""left buccal pouches"", ""start_span"": 24, ""end_span"": 43, ""type"": ""Organism_subdivision""}, {""token"": ""DMBA"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Chemical""}]"	test
Group 2 animals had the same procedure of DMBA applications but also received alpha tocopherol.	Group 2 animals,0,15,Organism	DMBA,42,46,Chemical	alpha tocopherol,78,94,Chemical	"[{""token"": ""Group 2 animals"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""DMBA"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Chemical""}, {""token"": ""alpha tocopherol"", ""start_span"": 78, ""end_span"": 94, ""type"": ""Chemical""}]"	test
Groups 3 and 4 were vitamin E and untreated controls.	Groups 3,0,8,Organism	4,13,14,Organism	vitamin E,20,29,Chemical	"[{""token"": ""Groups 3"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""4"", ""start_span"": 13, ""end_span"": 14, ""type"": ""Organism""}, {""token"": ""vitamin E"", ""start_span"": 20, ""end_span"": 29, ""type"": ""Chemical""}]"	test
Angiogenesis was studied with factor 8 - related antigen ( F8 - RA) which identifies endothelial cells.	factor 8 - related antigen,30,56,Gene_or_gene_product	F8 - RA,59,66,Gene_or_gene_product	endothelial cells,85,102,Cell	"[{""token"": ""factor 8 - related antigen"", ""start_span"": 30, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""F8 - RA"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 85, ""end_span"": 102, ""type"": ""Cell""}]"	test
Angiogenesis was significantly inhibited in the DMBA - vitamin E group and TGF alpha expression was also inhibited.	DMBA,48,52,Chemical	vitamin E,55,64,Chemical	TGF alpha,75,84,Gene_or_gene_product	"[{""token"": ""DMBA"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""vitamin E"", ""start_span"": 55, ""end_span"": 64, ""type"": ""Chemical""}, {""token"": ""TGF alpha"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}]"	test
Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines.	Curcumin,0,8,Chemical	NIH 3T3,43,50,Cell	malignant cancer cell lines,55,82,Cell	"[{""token"": ""Curcumin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""NIH 3T3"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""malignant cancer cell lines"", ""start_span"": 55, ""end_span"": 82, ""type"": ""Cell""}]"	test
Fas - mediated cell death was examined in MCF - 10AT preneoplastic human breast epithelial cells.	Fas,0,3,Gene_or_gene_product	cell,15,19,Cell	MCF - 10AT preneoplastic human breast epithelial cells,42,96,Cell	"[{""token"": ""Fas"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""MCF - 10AT preneoplastic human breast epithelial cells"", ""start_span"": 42, ""end_span"": 96, ""type"": ""Cell""}]"	test
On day 21, all rats received 5 x 10 ( 5) hepatoma cells intrasplenically.	rats,15,19,Organism	hepatoma cells,41,55,Cell	intrasplenically,56,72,Immaterial_anatomical_entity	"[{""token"": ""rats"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Organism""}, {""token"": ""hepatoma cells"", ""start_span"": 41, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""intrasplenically"", ""start_span"": 56, ""end_span"": 72, ""type"": ""Immaterial_anatomical_entity""}]"	test
Combination therapy was more effective, and completely eliminated tumor in 4 of 12 IFN - GM - CSF and 8 of 11 IFN - IL - 2 animals.	tumor,66,71,Cancer	IFN - GM - CSF,83,97,Gene_or_gene_product	IFN - IL - 2,110,122,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""IFN - GM - CSF"", ""start_span"": 83, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFN - IL - 2"", ""start_span"": 110, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"	test
Additional rats underwent partial hepatectomy, an immunosuppressive procedure known to accelerate the growth of hepatic tumor, following tumor challenge.	rats,11,15,Organism	hepatic tumor,112,125,Cancer	tumor,137,142,Cancer	"[{""token"": ""rats"", ""start_span"": 11, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""hepatic tumor"", ""start_span"": 112, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Cancer""}]"	test
Vaccination is associated with enhancement of splenocyte - mediated tumoricidal activity, whereas the effect of gammaIFN is mediated by KC.	splenocyte,46,56,Cell	gammaIFN,112,120,Gene_or_gene_product	KC,136,138,Cell	"[{""token"": ""splenocyte"", ""start_span"": 46, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""gammaIFN"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""KC"", ""start_span"": 136, ""end_span"": 138, ""type"": ""Cell""}]"	test
Combination therapy targets both lymphocytes and macrophages, and is more effective in reducing tumor than either therapy alone.	lymphocytes,33,44,Cell	macrophages,49,60,Cell	tumor,96,101,Cancer	"[{""token"": ""lymphocytes"", ""start_span"": 33, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""macrophages"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Cancer""}]"	test
Since hexokinase is the first rate limiting enzyme in the glycolytic pathway, elevated levels of Type II like hexokinase in tumors are of great significance in this context.	hexokinase,6,16,Gene_or_gene_product	Type II like hexokinase,97,120,Gene_or_gene_product	tumors,124,130,Cancer	"[{""token"": ""hexokinase"", ""start_span"": 6, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""Type II like hexokinase"", ""start_span"": 97, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Cancer""}]"	test
Under normal conditions insulin regulates expression of hexokinase Type II isoenzyme, which is predominantly expressed in muscle.	insulin,24,31,Gene_or_gene_product	hexokinase Type II,56,74,Gene_or_gene_product	muscle,122,128,Organ	"[{""token"": ""insulin"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""hexokinase Type II"", ""start_span"": 56, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""muscle"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Organ""}]"	test
On the other hand cancer cells overexpress insulin - like growth factors and their receptors which mimic many activities of insulin.	cancer cells,18,30,Cell	insulin - like growth factors,43,72,Gene_or_gene_product	insulin,124,131,Gene_or_gene_product	"[{""token"": ""cancer cells"", ""start_span"": 18, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""insulin - like growth factors"", ""start_span"": 43, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulin"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"	test
This prompted us to examine a hypothesis that insulin - like growth factors may be responsible for overexpression of tumor hexokinase.	insulin - like growth factors,46,75,Gene_or_gene_product	tumor,117,122,Cancer	hexokinase,123,133,Gene_or_gene_product	"[{""token"": ""insulin - like growth factors"", ""start_span"": 46, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Cancer""}, {""token"": ""hexokinase"", ""start_span"": 123, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}]"	test
Our experiments demonstrate that insulin - like growth factor I indeed induces hexokinase gene expression in a concentration and time dependent manner in two cancer cell lines we studied.	insulin - like growth factor I,33,63,Gene_or_gene_product	hexokinase,79,89,Gene_or_gene_product	cancer cell lines,158,175,Cell	"[{""token"": ""insulin - like growth factor I"", ""start_span"": 33, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""hexokinase"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cell lines"", ""start_span"": 158, ""end_span"": 175, ""type"": ""Cell""}]"	test
For investigation of cell suspensions, four pleural fluids were incubated with anticalretinin antiserum.	cell suspensions,21,37,Cell	pleural fluids,44,58,Organism_substance	antiserum,94,103,Organism_substance	"[{""token"": ""cell suspensions"", ""start_span"": 21, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""pleural fluids"", ""start_span"": 44, ""end_span"": 58, ""type"": ""Organism_substance""}, {""token"": ""antiserum"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Organism_substance""}]"	test
After cytocentrifugation the specimens were stained in accordance with the alkaline phosphatase anti - alkaline phosphatase ( APAAP) method.	specimens,29,38,Multi	alkaline phosphatase,75,95,Gene_or_gene_product	alkaline phosphatase,103,123,Gene_or_gene_product	"[{""token"": ""specimens"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Multi""}, {""token"": ""alkaline phosphatase"", ""start_span"": 75, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""alkaline phosphatase"", ""start_span"": 103, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"	test
CONCLUSION: Calretinin is a very useful marker for positive identification of normal and tumor mesothelial cells in serous effusions.	Calretinin,12,22,Gene_or_gene_product	tumor mesothelial cells,89,112,Cell	serous effusions,116,132,Organism_substance	"[{""token"": ""Calretinin"", ""start_span"": 12, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor mesothelial cells"", ""start_span"": 89, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""serous effusions"", ""start_span"": 116, ""end_span"": 132, ""type"": ""Organism_substance""}]"	test
Prognostic value of HLA - DR expression and dendritic cell infiltration in gastric cancer.	HLA - DR,20,28,Gene_or_gene_product	dendritic cell,44,58,Cell	gastric cancer,75,89,Cancer	"[{""token"": ""HLA - DR"", ""start_span"": 20, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""dendritic cell"", ""start_span"": 44, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""gastric cancer"", ""start_span"": 75, ""end_span"": 89, ""type"": ""Cancer""}]"	test
Infiltration of dendritic cells correlated negatively with distant lymph node metastases, clinical stage, and peritoneal invasion.	dendritic cells,16,31,Cell	lymph node,67,77,Multi	peritoneal,110,120,Multi	"[{""token"": ""dendritic cells"", ""start_span"": 16, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""lymph node"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Multi""}, {""token"": ""peritoneal"", ""start_span"": 110, ""end_span"": 120, ""type"": ""Multi""}]"	test
In patients with resectable gastric cancer, the grade of infiltrating dendritic cells may be a suitable predictor of prognosis.	patients,3,11,Organism	gastric cancer,28,42,Cancer	dendritic cells,70,85,Cell	"[{""token"": ""patients"", ""start_span"": 3, ""end_span"": 11, ""type"": ""Organism""}, {""token"": ""gastric cancer"", ""start_span"": 28, ""end_span"": 42, ""type"": ""Cancer""}, {""token"": ""dendritic cells"", ""start_span"": 70, ""end_span"": 85, ""type"": ""Cell""}]"	test
Patients with other genetic blistering disorders do not have elevated collagenase or an increased risk of squamous cell carcinoma, despite chronic wounding.	Patients,0,8,Organism	collagenase,70,81,Gene_or_gene_product	squamous cell carcinoma,106,129,Cancer	"[{""token"": ""Patients"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""collagenase"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 106, ""end_span"": 129, ""type"": ""Cancer""}]"	test
The connection between collagen type VII deficiency, increased collagenase, and squamous cell carcinoma is not understood.	collagen type VII,23,40,Gene_or_gene_product	collagenase,63,74,Gene_or_gene_product	squamous cell carcinoma,80,103,Cancer	"[{""token"": ""collagen type VII"", ""start_span"": 23, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""collagenase"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 80, ""end_span"": 103, ""type"": ""Cancer""}]"	test
RESULTS: Fifty - one percent of patients with RDEB had elevated levels ( greater than 5000 pg / g) of urinary bFGF.	patients,32,40,Organism	urinary,102,109,Organism_substance	bFGF,110,114,Gene_or_gene_product	"[{""token"": ""patients"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Organism""}, {""token"": ""urinary"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Organism_substance""}, {""token"": ""bFGF"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}]"	test
Twenty - one percent of clinically unaffected family members had elevated levels of bFGF, and 13% of patients with EBS had elevated levels of bFGF.	bFGF,84,88,Gene_or_gene_product	patients,101,109,Organism	bFGF,142,146,Gene_or_gene_product	"[{""token"": ""bFGF"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Organism""}, {""token"": ""bFGF"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}]"	test
The frequency of elevated bFGF values among all groups was statistically significant ( p = 0. 002), and the levels of bFGF in RDEB patients were significantly elevated compared with those of other groups ( p less than 0. 05).	bFGF,26,30,Gene_or_gene_product	bFGF,118,122,Gene_or_gene_product	patients,131,139,Organism	"[{""token"": ""bFGF"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Organism""}]"	test
At 6 weeks, animals were killed, and flaps were analyzed for length, width, and weight; perfused with fluorescein or lead oxide; and examined histologically.	flaps,37,42,Multi	fluorescein,102,113,Chemical	lead oxide,117,127,Chemical	"[{""token"": ""flaps"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Multi""}, {""token"": ""fluorescein"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical""}, {""token"": ""lead oxide"", ""start_span"": 117, ""end_span"": 127, ""type"": ""Chemical""}]"	test
A preponderance of viable fat, with evidence of neovascularization, was found in experimental flaps, compared with the necrotic fat that characterized the controls.	fat,26,29,Tissue	flaps,94,99,Multi	fat,128,131,Tissue	"[{""token"": ""fat"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Tissue""}, {""token"": ""flaps"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Multi""}, {""token"": ""fat"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Tissue""}]"	test
Coexpression of the progesterone receptor with mutant K - Ras led to suppression of tumorigenicity and inhibition of the activation of ER.	progesterone receptor,20,41,Gene_or_gene_product	K - Ras,54,61,Gene_or_gene_product	ER,135,137,Gene_or_gene_product	"[{""token"": ""progesterone receptor"", ""start_span"": 20, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""K - Ras"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""ER"", ""start_span"": 135, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"	test
These observations support the importance of ER in Ras - mediated cell transformation.	ER,45,47,Gene_or_gene_product	Ras,51,54,Gene_or_gene_product	cell,66,70,Cell	"[{""token"": ""ER"", ""start_span"": 45, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ras"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Cell""}]"	test
Gene therapy for gliomas: p53 and E2F - 1 proteins and the target of apoptosis.	gliomas,17,24,Cancer	p53,26,29,Gene_or_gene_product	E2F - 1,34,41,Gene_or_gene_product	"[{""token"": ""gliomas"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""E2F - 1"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}]"	test
We have previously shown that massive apoptosis occurs when wild - type p53 or E2F - 1 expression is induced in glioma.	p53,72,75,Gene_or_gene_product	E2F - 1,79,86,Gene_or_gene_product	glioma,112,118,Cancer	"[{""token"": ""p53"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""E2F - 1"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""glioma"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Cancer""}]"	test
However, the transfer of either the p16 or Rb gene to glioma cells results in cytostatic effect.	p16,36,39,Gene_or_gene_product	Rb,43,45,Gene_or_gene_product	glioma cells,54,66,Cell	"[{""token"": ""p16"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 43, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""glioma cells"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Cell""}]"	test
